| Information Collection Domains | Indicates the category of information collection by time period that corresponds to the burden table.  For each of the following domains, there is a corresponding tab. 1- Pre-Transplant Information Collection 2- Transplant Procedure and Product Information 3- Post-Transplant Periodic Information Collection Below are the defintions for each column heading. | 
| Column Header Title | Column Header Title Definitions | 
| Item ID | Unique identifier | 
| Time Point | Indicates the information collection domain | 
| Information Collection Domain Sub-Type | Identifies a grouping of information collection within a domain and roughly corresponds to domain titles currently found on CIBMTR data collection instruments. | 
| Information Collection Domain Additional Sub Domain | Identifies a grouping of information collection within domain sub-types and roughly correspons to section headers currently found on CIBMTR data collection instruments. | 
| Information Collection may be requested multiple times | Response options are "yes" or "no". Some information may be collected at "multiple" time points or in multiple iterations. For example: prior infusion information, drugs as part of the preparative regimen, chimerism studies performed on different dates, etc. | 
| Current Information Collection Data Element (if applicable) | Depicts the information collection data element currently being requested. A single data element is depicted in grey or white color. | 
| Current Information Collection Data Element Response Option (if applicable) | Depicts the information collection data element response option currently being requested. | 
| Information Collection update | Notes the type of update. The options are: | 
| No Change | |
| Deletion of Information Requested (Deletion of data element and/or data element response option) | |
| Addition of Information Requested (Addition of data element and/or data element response option) | |
| Change/Clarification of Information Requested (Update of data element) | |
| Change/Clarification of Information Requested and Deletion of Response Option (Update of data element and deletion of data element response option) | |
| Change/Clarification of Information Requested and Addition of Response Option (Update of data element and addition of data element response option) | |
| Merged to Check all that Apply (Deletion of Information Requested) (Allows selection from a list of data element response options and deletion of data element and/or data element response option) | |
| Merged to Check all that Apply (Addition of Information Requested) (Allows selection from a list of data element response options and addition of data element and/or data element response option) | |
| Merged from Multiple to Grid (Deletion of Information Requested) (Data element captured in grid format, deletion of data element and/or data element response option (Example: Chimerism Studies data capture)) | |
| Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) (Data element captured in grid format, deletion of data element and/or data element response option and auto-filled (Example: Chimerism Studies data capture)) | |
| Merged from Multiple to Grid (Addition of Information Requested) (Data element captured in Grid format - addition of data element and/or data element response option (Example: Chimerism Studies data capture)) | |
| New Structure and Addition of Information Requested (New technical validation intended to reduce burden and addition of data element response option (Example: "Registry or UCB Bank ID" data capture)) | |
| New Structure and Change/Clarification of Information Requested (New technical validation intended to reduce burden and update of data element response option (Example: "Registry or UCB Bank ID" data capture)) | |
| New Structure for Allogeneic Boost Data Capture (New information collection domain sub-type without data element or data element response option changes (Example: Donor Cellular Infusion data capture)) | |
| New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) (New information collection domain sub-type and addition of data element and/or data element response option (Example: Donor Cellular Infusion data capture)) | |
| New Functionality (New technical feature intended to reduce burden) | |
| Addition of Instructional text (Addition of instructional text that indicates an action) | |
| Proposed Information Collection Data Element Update (if applicable) | Depicts the proposed information collection data element requested. | 
| Proposed Information Collection Data Element Response Option Update (if applicable) | Depicts the proposed information collection data element response option. | 
| Instructional Text Indicating an Action | Response options are "yes" or "no". Instructive text that indicates an action (Example: Request to submit documentation to CIBMTR). This is the only instructional text included within the information collection domains. | 
| Rationale for Information Collection Update | The following options identify the rationale for the change: | 
| Capture data accurately | |
| Be consistent with current clinical landscape, improve transplant outcome data | |
| Typographical/grammatical errors corrected for clarification | |
| Reduce burden | |
| Reduce burden - information no longer needed | |
| Reduce burden - prevent / reduce data redundancy | |
| Reduce burden - allogeneic boost data capture | |
| Reduce burden - reduce data entry | |
| Reduce burden - reduce requirement for multiple sets of data | 
| Item ID | Time Point | Information Collection Domain Sub-Type | Information Collection Domain Additional Sub Domain | Information Collection may be requested multiple times | Current Information Collection Data Element (if applicable) | Current Information Collection Data Element Response Option (if applicable) | Information Collection update | Proposed Information Collection Data Element Update (if applicable) | Proposed Information Collection Data Element Response Option Update (if applicable) | Instructional Text Indicating an Action | Rationale for Information Collection Update | 
| PRE0001 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Key Fields | No | EBMT Code (CIC): | Auto-filled field | No Change | No Change | No Change | No | |
| PRE0002 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Date of birth: | Open text | No Change | No Change | No Change | No | |
| PRE0003 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Sex | Male | No Change | No Change | No Change | No | |
| PRE0004 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Sex | Female | No Change | No Change | No Change | No | |
| PRE0005 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Ethnicity | Hispanic or Latino | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0006 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Ethnicity | Not Hispanic or Latino | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0007 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Ethnicity | Not applicable (not a resident of the USA) | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0008 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Ethnicity | Unknown | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0009 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | White | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0010 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Black or African American | Change/Clarification of Information Requested | Geographic ancestry | Black or African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0011 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Asian | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0012 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | American Indian or Alaska Native | Change/Clarification of Information Requested | Geographic ancestry | Indigenous American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0013 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Native Hawaiian or Other Pacific Islander | Change/Clarification of Information Requested | Geographic ancestry | Pacific Islander | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0014 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Not reported | Change/Clarification of Information Requested | Geographic ancestry | Prefer not to answer | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0015 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Unknown | Change/Clarification of Information Requested | Geographic ancestry | Not otherwise specified | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0016 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry | Jewish | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0017 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry | Middle Eastern or North African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0018 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Eastern European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0019 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Mediterranean | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0020 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Middle Eastern | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0021 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | North Coast of Africa | Change/Clarification of Information Requested | Geographic ancestry detail | North African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0022 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | North American | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0023 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Northern European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0024 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Western European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0025 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | White Caribbean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0026 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | White South or Central American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0027 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Other White | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified White | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0028 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | African | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0029 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | African American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0030 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Black Caribbean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0031 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Black South or Central American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0032 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Other Black | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified Black/African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0033 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Alaskan Native or Aleut | Change/Clarification of Information Requested | Geographic ancestry detail | Alaska Native | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0034 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | North American Indian | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous North American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0035 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | American Indian, South or Central America | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous South/Central American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0036 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Caribbean Indian | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous Caribbean | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0037 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | South Asian | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0038 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Filipino (Pilipino) | Change/Clarification of Information Requested | Geographic ancestry detail | Filipino | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0039 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Japanese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0040 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Korean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0041 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Chinese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0042 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Vietnamese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0043 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Other Southeast Asian | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0044 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Guamanian | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0045 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Hawaiian | Change/Clarification of Information Requested | Geographic ancestry detail | Native Hawaiian | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0046 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Samoan | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0047 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Other Pacific Islander | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified Pacific Islander | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0048 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Unknown | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0049 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Caribbean Indian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0050 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Indian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0051 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Malaysian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0052 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mongolian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0053 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Pakistani | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0054 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Taiwanese | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0055 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Thai | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0056 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Other Indian Subcontinent | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0057 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Asian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0058 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | East African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0059 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | South African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0060 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | West African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0061 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Brazilian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0062 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Caribbean Hispanic | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0063 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Cuban | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0064 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mexican | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0065 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Puerto Rican | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0066 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | South / Central American Hispanic | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0067 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Hispanic / Latino | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0068 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Indigenous Caribbean | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0069 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Indigenous American | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0070 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Ashkenazi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0071 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mizrahi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0072 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Sephardi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0073 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Jewish | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0074 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Arab Peninsula | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0075 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Central Asian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0076 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | East Mediterranean | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0077 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Middle Eastern / North African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0078 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Melanesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0079 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Micronesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0080 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Polynesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0081 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Russian or Former Soviet Union | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0082 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Southern European | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0083 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Afghanistan | No Change | No Change | No Change | No | |
| PRE0084 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Aland Islands | No Change | No Change | No Change | No | |
| PRE0085 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Albania | No Change | No Change | No Change | No | |
| PRE0086 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Algeria | No Change | No Change | No Change | No | |
| PRE0087 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | American Samoa | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0088 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Andorra | No Change | No Change | No Change | No | |
| PRE0089 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Angola | No Change | No Change | No Change | No | |
| PRE0090 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Anguilla | No Change | No Change | No Change | No | |
| PRE0091 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Antarctica | No Change | No Change | No Change | No | |
| PRE0092 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Antigua and Barbuda | No Change | No Change | No Change | No | |
| PRE0093 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Argentina | No Change | No Change | No Change | No | |
| PRE0094 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Armenia | No Change | No Change | No Change | No | |
| PRE0095 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Aruba | No Change | No Change | No Change | No | |
| PRE0096 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Australia | No Change | No Change | No Change | No | |
| PRE0097 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Austria | No Change | No Change | No Change | No | |
| PRE0098 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Azerbaijan | No Change | No Change | No Change | No | |
| PRE0099 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bahamas | No Change | No Change | No Change | No | |
| PRE0100 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bahrain | No Change | No Change | No Change | No | |
| PRE0101 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bangladesh | No Change | No Change | No Change | No | |
| PRE0102 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Barbados | No Change | No Change | No Change | No | |
| PRE0103 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Belarus | No Change | No Change | No Change | No | |
| PRE0104 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Belgium | No Change | No Change | No Change | No | |
| PRE0105 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Belize | No Change | No Change | No Change | No | |
| PRE0106 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Benin | No Change | No Change | No Change | No | |
| PRE0107 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bermuda | No Change | No Change | No Change | No | |
| PRE0108 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bhutan | No Change | No Change | No Change | No | |
| PRE0109 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bolivia | No Change | No Change | No Change | No | |
| PRE0110 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bonaire, Sint Eustatius and Saba | No Change | No Change | No Change | No | |
| PRE0111 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bosnia and Herzegovina | No Change | No Change | No Change | No | |
| PRE0112 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Botswana | No Change | No Change | No Change | No | |
| PRE0113 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bouvet Island | No Change | No Change | No Change | No | |
| PRE0114 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Brazil | No Change | No Change | No Change | No | |
| PRE0115 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | British Indian Ocean Territory | No Change | No Change | No Change | No | |
| PRE0116 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | British Virgin Islands | No Change | No Change | No Change | No | |
| PRE0117 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Brunei Darussalam | No Change | No Change | No Change | No | |
| PRE0118 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Bulgaria | No Change | No Change | No Change | No | |
| PRE0119 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Burkina Faso | No Change | No Change | No Change | No | |
| PRE0120 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Burundi | No Change | No Change | No Change | No | |
| PRE0121 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cambodia | No Change | No Change | No Change | No | |
| PRE0122 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cameroon | No Change | No Change | No Change | No | |
| PRE0123 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Canada | No Change | No Change | No Change | No | |
| PRE0124 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cape Verde | No Change | No Change | No Change | No | |
| PRE0125 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cayman Islands | No Change | No Change | No Change | No | |
| PRE0126 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Central African Republic | No Change | No Change | No Change | No | |
| PRE0127 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Chad | No Change | No Change | No Change | No | |
| PRE0128 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Chile | No Change | No Change | No Change | No | |
| PRE0129 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | China | No Change | No Change | No Change | No | |
| PRE0130 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Christmas Island | No Change | No Change | No Change | No | |
| PRE0131 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cocos (Keeling) Islands | No Change | No Change | No Change | No | |
| PRE0132 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Colombia | No Change | No Change | No Change | No | |
| PRE0133 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Comoros | No Change | No Change | No Change | No | |
| PRE0134 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Congo, Democratic Republic of the | No Change | No Change | No Change | No | |
| PRE0135 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Congo, Republic of the | No Change | No Change | No Change | No | |
| PRE0136 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cook Islands | No Change | No Change | No Change | No | |
| PRE0137 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Costa Rica | No Change | No Change | No Change | No | |
| PRE0138 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cote d'Ivoire | No Change | No Change | No Change | No | |
| PRE0139 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Croatia | No Change | No Change | No Change | No | |
| PRE0140 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cuba | No Change | No Change | No Change | No | |
| PRE0141 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Curacao | No Change | No Change | No Change | No | |
| PRE0142 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Cyprus | No Change | No Change | No Change | No | |
| PRE0143 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Czech Republic | No Change | No Change | No Change | No | |
| PRE0144 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Denmark | No Change | No Change | No Change | No | |
| PRE0145 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Djibouti | No Change | No Change | No Change | No | |
| PRE0146 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Dominica | No Change | No Change | No Change | No | |
| PRE0147 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Dominican Republic | No Change | No Change | No Change | No | |
| PRE0148 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Ecuador | No Change | No Change | No Change | No | |
| PRE0149 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Egypt | No Change | No Change | No Change | No | |
| PRE0150 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | El Salvador | No Change | No Change | No Change | No | |
| PRE0151 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Equatorial Guinea | No Change | No Change | No Change | No | |
| PRE0152 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Eritrea | No Change | No Change | No Change | No | |
| PRE0153 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Estonia | No Change | No Change | No Change | No | |
| PRE0154 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Ethiopia | No Change | No Change | No Change | No | |
| PRE0155 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Falkland Islands | No Change | No Change | No Change | No | |
| PRE0156 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Faroe Islands | No Change | No Change | No Change | No | |
| PRE0157 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Fiji | No Change | No Change | No Change | No | |
| PRE0158 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Finland | No Change | No Change | No Change | No | |
| PRE0159 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | France | No Change | No Change | No Change | No | |
| PRE0160 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | French Guiana | No Change | No Change | No Change | No | |
| PRE0161 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | French Polynesia | No Change | No Change | No Change | No | |
| PRE0162 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | French Southern Territories | No Change | No Change | No Change | No | |
| PRE0163 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Gabon | No Change | No Change | No Change | No | |
| PRE0164 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Gambia | No Change | No Change | No Change | No | |
| PRE0165 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Georgia | No Change | No Change | No Change | No | |
| PRE0166 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Germany | No Change | No Change | No Change | No | |
| PRE0167 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Ghana | No Change | No Change | No Change | No | |
| PRE0168 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Gibraltar | No Change | No Change | No Change | No | |
| PRE0169 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Greece | No Change | No Change | No Change | No | |
| PRE0170 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Greenland | No Change | No Change | No Change | No | |
| PRE0171 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Grenada | No Change | No Change | No Change | No | |
| PRE0172 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guadeloupe | No Change | No Change | No Change | No | |
| PRE0173 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guam | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0174 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guatemala | No Change | No Change | No Change | No | |
| PRE0175 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guernsey | No Change | No Change | No Change | No | |
| PRE0176 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guinea | No Change | No Change | No Change | No | |
| PRE0177 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guinea-Bissau | No Change | No Change | No Change | No | |
| PRE0178 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Guyana | No Change | No Change | No Change | No | |
| PRE0179 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Haiti | No Change | No Change | No Change | No | |
| PRE0180 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Heard Island and McDonald Islands | No Change | No Change | No Change | No | |
| PRE0181 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Holy See | No Change | No Change | No Change | No | |
| PRE0182 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Honduras | No Change | No Change | No Change | No | |
| PRE0183 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Hong Kong | No Change | No Change | No Change | No | |
| PRE0184 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Hungary | No Change | No Change | No Change | No | |
| PRE0185 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Iceland | No Change | No Change | No Change | No | |
| PRE0186 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | India | No Change | No Change | No Change | No | |
| PRE0187 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Indonesia | No Change | No Change | No Change | No | |
| PRE0188 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Iran | No Change | No Change | No Change | No | |
| PRE0189 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Iraq | No Change | No Change | No Change | No | |
| PRE0190 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Ireland | No Change | No Change | No Change | No | |
| PRE0191 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Isle of Man | No Change | No Change | No Change | No | |
| PRE0192 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Israel | No Change | No Change | No Change | No | |
| PRE0193 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Italy | No Change | No Change | No Change | No | |
| PRE0194 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Jamaica | No Change | No Change | No Change | No | |
| PRE0195 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Japan | No Change | No Change | No Change | No | |
| PRE0196 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Jersey | No Change | No Change | No Change | No | |
| PRE0197 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Jordan | No Change | No Change | No Change | No | |
| PRE0198 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Kazakhstan | No Change | No Change | No Change | No | |
| PRE0199 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Kenya | No Change | No Change | No Change | No | |
| PRE0200 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Kiribati | No Change | No Change | No Change | No | |
| PRE0201 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Kuwait | No Change | No Change | No Change | No | |
| PRE0202 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Kyrgyzstan | No Change | No Change | No Change | No | |
| PRE0203 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Laos | No Change | No Change | No Change | No | |
| PRE0204 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Latvia | No Change | No Change | No Change | No | |
| PRE0205 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Lebanon | No Change | No Change | No Change | No | |
| PRE0206 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Lesotho | No Change | No Change | No Change | No | |
| PRE0207 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Liberia | No Change | No Change | No Change | No | |
| PRE0208 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Libya | No Change | No Change | No Change | No | |
| PRE0209 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Liechtenstein | No Change | No Change | No Change | No | |
| PRE0210 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Lithuania | No Change | No Change | No Change | No | |
| PRE0211 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Luxembourg | No Change | No Change | No Change | No | |
| PRE0212 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Macau | No Change | No Change | No Change | No | |
| PRE0213 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Macedonia | No Change | No Change | No Change | No | |
| PRE0214 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Madagascar | No Change | No Change | No Change | No | |
| PRE0215 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Malawi | No Change | No Change | No Change | No | |
| PRE0216 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Malaysia | No Change | No Change | No Change | No | |
| PRE0217 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Maldives | No Change | No Change | No Change | No | |
| PRE0218 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mali | No Change | No Change | No Change | No | |
| PRE0219 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Malta | No Change | No Change | No Change | No | |
| PRE0220 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Marshall Islands | No Change | No Change | No Change | No | |
| PRE0221 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Martinique | No Change | No Change | No Change | No | |
| PRE0222 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mauritania | No Change | No Change | No Change | No | |
| PRE0223 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mauritius | No Change | No Change | No Change | No | |
| PRE0224 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mayotte | No Change | No Change | No Change | No | |
| PRE0225 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mexico | No Change | No Change | No Change | No | |
| PRE0226 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Micronesia | No Change | No Change | No Change | No | |
| PRE0227 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Moldova | No Change | No Change | No Change | No | |
| PRE0228 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Monaco | No Change | No Change | No Change | No | |
| PRE0229 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mongolia | No Change | No Change | No Change | No | |
| PRE0230 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Montenegro | No Change | No Change | No Change | No | |
| PRE0231 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Montserrat | No Change | No Change | No Change | No | |
| PRE0232 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Morocco | No Change | No Change | No Change | No | |
| PRE0233 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Mozambique | No Change | No Change | No Change | No | |
| PRE0234 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Myanmar | No Change | No Change | No Change | No | |
| PRE0235 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Namibia | No Change | No Change | No Change | No | |
| PRE0236 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Nauru | No Change | No Change | No Change | No | |
| PRE0237 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Nepal | No Change | No Change | No Change | No | |
| PRE0238 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Netherlands | No Change | No Change | No Change | No | |
| PRE0239 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Netherlands Antilles | No Change | No Change | No Change | No | |
| PRE0240 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | New Caledonia | No Change | No Change | No Change | No | |
| PRE0241 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | New Zealand | No Change | No Change | No Change | No | |
| PRE0242 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Nicaragua | No Change | No Change | No Change | No | |
| PRE0243 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Niger | No Change | No Change | No Change | No | |
| PRE0244 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Nigeria | No Change | No Change | No Change | No | |
| PRE0245 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Niue | No Change | No Change | No Change | No | |
| PRE0246 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Norfolk Island | No Change | No Change | No Change | No | |
| PRE0247 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | North Korea | No Change | No Change | No Change | No | |
| PRE0248 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Northern Mariana Islands | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0249 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Norway | No Change | No Change | No Change | No | |
| PRE0250 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Oman | No Change | No Change | No Change | No | |
| PRE0251 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Pakistan | No Change | No Change | No Change | No | |
| PRE0252 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Palau | No Change | No Change | No Change | No | |
| PRE0253 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Palestine, State of | No Change | No Change | No Change | No | |
| PRE0254 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Panama | No Change | No Change | No Change | No | |
| PRE0255 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Papua New Guinea | No Change | No Change | No Change | No | |
| PRE0256 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Paraguay | No Change | No Change | No Change | No | |
| PRE0257 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Peru | No Change | No Change | No Change | No | |
| PRE0258 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Philippines | No Change | No Change | No Change | No | |
| PRE0259 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Pitcairn Islands | No Change | No Change | No Change | No | |
| PRE0260 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Poland | No Change | No Change | No Change | No | |
| PRE0261 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Portugal | No Change | No Change | No Change | No | |
| PRE0262 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Puerto Rico | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0263 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Qatar | No Change | No Change | No Change | No | |
| PRE0264 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Reunion | No Change | No Change | No Change | No | |
| PRE0265 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Romania | No Change | No Change | No Change | No | |
| PRE0266 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Russia | No Change | No Change | No Change | No | |
| PRE0267 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Rwanda | No Change | No Change | No Change | No | |
| PRE0268 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Barthelemy | No Change | No Change | No Change | No | |
| PRE0269 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Helena | No Change | No Change | No Change | No | |
| PRE0270 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Kitts and Nevis | No Change | No Change | No Change | No | |
| PRE0271 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Lucia | No Change | No Change | No Change | No | |
| PRE0272 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Martin, French | No Change | No Change | No Change | No | |
| PRE0273 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Pierre and Miquelon | No Change | No Change | No Change | No | |
| PRE0274 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saint Vincent and the Grenadines | No Change | No Change | No Change | No | |
| PRE0275 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Samoa | No Change | No Change | No Change | No | |
| PRE0276 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | San Marino | No Change | No Change | No Change | No | |
| PRE0277 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sao Tome and Principe | No Change | No Change | No Change | No | |
| PRE0278 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Saudi Arabia | No Change | No Change | No Change | No | |
| PRE0279 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Senegal | No Change | No Change | No Change | No | |
| PRE0280 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Serbia | No Change | No Change | No Change | No | |
| PRE0281 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Seychelles | No Change | No Change | No Change | No | |
| PRE0282 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sierra Leone | No Change | No Change | No Change | No | |
| PRE0283 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Singapore | No Change | No Change | No Change | No | |
| PRE0284 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sint Maarten, Dutch | No Change | No Change | No Change | No | |
| PRE0285 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Slovak Republic | No Change | No Change | No Change | No | |
| PRE0286 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Slovenia | No Change | No Change | No Change | No | |
| PRE0287 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Solomon Islands | No Change | No Change | No Change | No | |
| PRE0288 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Somalia | No Change | No Change | No Change | No | |
| PRE0289 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | South Africa | No Change | No Change | No Change | No | |
| PRE0290 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | South Georgia and the South Sandwich Islands | No Change | No Change | No Change | No | |
| PRE0291 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | South Korea | No Change | No Change | No Change | No | |
| PRE0292 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | South Sudan | No Change | No Change | No Change | No | |
| PRE0293 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Spain | No Change | No Change | No Change | No | |
| PRE0294 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sri Lanka | No Change | No Change | No Change | No | |
| PRE0295 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sudan | No Change | No Change | No Change | No | |
| PRE0296 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Suriname | No Change | No Change | No Change | No | |
| PRE0297 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Svalbard and Jan Mayen | No Change | No Change | No Change | No | |
| PRE0298 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Swaziland | No Change | No Change | No Change | No | |
| PRE0299 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Sweden | No Change | No Change | No Change | No | |
| PRE0300 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Switzerland | No Change | No Change | No Change | No | |
| PRE0301 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Syria | No Change | No Change | No Change | No | |
| PRE0302 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Taiwan | No Change | No Change | No Change | No | |
| PRE0303 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tajikistan | No Change | No Change | No Change | No | |
| PRE0304 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tanzania | No Change | No Change | No Change | No | |
| PRE0305 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Thailand | No Change | No Change | No Change | No | |
| PRE0306 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Timor-Leste | No Change | No Change | No Change | No | |
| PRE0307 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Togo | No Change | No Change | No Change | No | |
| PRE0308 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tokelau | No Change | No Change | No Change | No | |
| PRE0309 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tonga | No Change | No Change | No Change | No | |
| PRE0310 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Trinidad and Tobago | No Change | No Change | No Change | No | |
| PRE0311 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tunisia | No Change | No Change | No Change | No | |
| PRE0312 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Turkey | No Change | No Change | No Change | No | |
| PRE0313 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Turkmenistan | No Change | No Change | No Change | No | |
| PRE0314 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Turks and Caicos Islands | No Change | No Change | No Change | No | |
| PRE0315 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Tuvalu | No Change | No Change | No Change | No | |
| PRE0316 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Uganda | No Change | No Change | No Change | No | |
| PRE0317 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Ukraine | No Change | No Change | No Change | No | |
| PRE0318 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | United Arab Emirates | No Change | No Change | No Change | No | |
| PRE0319 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | United Kingdom (England, Wales, Scotland, Northern Ireland) | No Change | No Change | No Change | No | |
| PRE0320 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | United States | No Change | No Change | No Change | No | |
| PRE0321 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | United States Minor Outlying Islands | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0322 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | United States Virgin Islands | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0323 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Uruguay | No Change | No Change | No Change | No | |
| PRE0324 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Uzbekistan | No Change | No Change | No Change | No | |
| PRE0325 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Vanuatu | No Change | No Change | No Change | No | |
| PRE0326 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Venezuela | No Change | No Change | No Change | No | |
| PRE0327 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Vietnam | No Change | No Change | No Change | No | |
| PRE0328 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Wallis and Futuna Islands | No Change | No Change | No Change | No | |
| PRE0329 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Western Sahara | No Change | No Change | No Change | No | |
| PRE0330 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Yemen | No Change | No Change | No Change | No | |
| PRE0331 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Zambia | No Change | No Change | No Change | No | |
| PRE0332 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Country of primary residence | Zimbabwe | No Change | No Change | No Change | No | |
| PRE0333 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Acre | No Change | No Change | No Change | No | |
| PRE0334 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Alagoas | No Change | No Change | No Change | No | |
| PRE0335 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Amapá | No Change | No Change | No Change | No | |
| PRE0336 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Amazonas | No Change | No Change | No Change | No | |
| PRE0337 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Bahia | No Change | No Change | No Change | No | |
| PRE0338 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Ceará | No Change | No Change | No Change | No | |
| PRE0339 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Distrito Federal | No Change | No Change | No Change | No | |
| PRE0340 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Espírito Santo | No Change | No Change | No Change | No | |
| PRE0341 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Goiás | No Change | No Change | No Change | No | |
| PRE0342 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Maranhão | No Change | No Change | No Change | No | |
| PRE0343 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Mato Grosso | No Change | No Change | No Change | No | |
| PRE0344 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Mato Grosso do Sul | No Change | No Change | No Change | No | |
| PRE0345 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Minas Gerais | No Change | No Change | No Change | No | |
| PRE0346 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Pará | No Change | No Change | No Change | No | |
| PRE0347 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Paraiba | No Change | No Change | No Change | No | |
| PRE0348 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Paraná | No Change | No Change | No Change | No | |
| PRE0349 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Pernambuco | No Change | No Change | No Change | No | |
| PRE0350 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Piaui | No Change | No Change | No Change | No | |
| PRE0351 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Rio de Janeiro | No Change | No Change | No Change | No | |
| PRE0352 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Rio Grande do Norte | No Change | No Change | No Change | No | |
| PRE0353 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Rio Grande do Sul | No Change | No Change | No Change | No | |
| PRE0354 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Rondônia | No Change | No Change | No Change | No | |
| PRE0355 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Roraima | No Change | No Change | No Change | No | |
| PRE0356 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Santa Catarina | No Change | No Change | No Change | No | |
| PRE0357 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | São Paulo | No Change | No Change | No Change | No | |
| PRE0358 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Sergipe | No Change | No Change | No Change | No | |
| PRE0359 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Tocantins | No Change | No Change | No Change | No | |
| PRE0360 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Alberta | No Change | No Change | No Change | No | |
| PRE0361 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | British Columbia | No Change | No Change | No Change | No | |
| PRE0362 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Manitoba | No Change | No Change | No Change | No | |
| PRE0363 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | New Brunswick | No Change | No Change | No Change | No | |
| PRE0364 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Newfoundland and Labrador | No Change | No Change | No Change | No | |
| PRE0365 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Nova Scotia | No Change | No Change | No Change | No | |
| PRE0366 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Ontario | No Change | No Change | No Change | No | |
| PRE0367 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Prince Edward Island | No Change | No Change | No Change | No | |
| PRE0368 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Quebec | No Change | No Change | No Change | No | |
| PRE0369 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Saskatchewan | No Change | No Change | No Change | No | |
| PRE0370 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Northwest Territories | No Change | No Change | No Change | No | |
| PRE0371 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Nunavut | No Change | No Change | No Change | No | |
| PRE0372 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Province or territory of residence of recipient | Yukon | No Change | No Change | No Change | No | |
| PRE0373 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Alabama | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0374 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Alaska | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0375 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Arizona | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0376 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Arkansas | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0377 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | California | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0378 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Colorado | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0379 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Connecticut | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0380 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Delaware | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0381 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | District of Columbia | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0382 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Florida | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0383 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Georgia | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0384 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Hawaii | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0385 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Idaho | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0386 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Illinois | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0387 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Indiana | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0388 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Iowa | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0389 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Kansas | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0390 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Kentucky | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0391 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Louisiana | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0392 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Maine | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0393 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Maryland | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0394 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Massachusetts | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0395 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Michigan | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0396 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Minnesota | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0397 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Mississippi | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0398 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Missouri | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0399 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Montana | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0400 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Nebraska | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0401 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Nevada | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0402 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | New Hampshire | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0403 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | New Jersey | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0404 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | New Mexico | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0405 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | New York | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0406 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | North Carolina | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0407 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | North Dakota | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0408 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Ohio | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0409 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Oklahoma | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0410 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Oregon | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0411 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Pennsylvania | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0412 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Rhode Island | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0413 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | South Carolina | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0414 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | South Dakota | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0415 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Tennessee | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0416 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Texas | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0417 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Utah | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0418 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Vermont | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0419 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Virginia | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0420 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Washington | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0421 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | West Virginia | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0422 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Wisconsin | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0423 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | State of residence of recipient | Wyoming | Change/Clarification of Information Requested | State / territory of residence of recipient | No Change | No | Capture data accurately | 
| PRE0424 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient stationed on an overseas US military base? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0425 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient stationed on an overseas US military base? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0426 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | NMDP recipient ID (RID): | Open text | No Change | No Change | No Change | No | |
| PRE0427 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Zip or postal code for place of reicpient's residence | Open text | No Change | No Change | No Change | No | |
| PRE0428 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Does the recipient require interpreter services? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0429 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Does the recipient require interpreter services? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0430 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Does the recipient require interpreter services? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0431 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient an emancipated minor? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0432 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient an emancipated minor? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0433 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify the recipient's current relationship status | Single, never married | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0434 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify the recipient's current relationship status | Married or living with a partner | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0435 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify the recipient's current relationship status | Separated / Divorced | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0436 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify the recipient's current relationship status | Widowed | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0437 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Under school age or no schooling | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0438 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Up to 8th grade | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0439 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | 9th to 12th grade, no diploma | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0440 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | High school diploma or equivalent (GED) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0441 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Some college, no degree | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0442 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Vocational or associate degree | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0443 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | College degree (B.A. / B.S.) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0444 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Advanced degree (e.g. Master's or Doctorate program) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0445 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | What is the highest degree or level of school that the recipient has completed? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0446 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient covered by health insurance? | yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0447 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Is the recipient covered by health insurance? | no | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0448 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Private health insurance | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0449 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | National Health Insurance | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0450 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Medicare | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0451 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Medigap | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0452 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Medicaid | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0453 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Children's Health Insurance Program | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0454 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Military-related health care | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0455 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Indian Health Service | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0456 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | State-sponsored health plan | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0457 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Disability insurance | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0458 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Other government program | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0459 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify type of health insurance | Other health insurance coverage | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0460 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify private insurance type | Private insurance through a current or former employer or union (of this person or another family member) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0461 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify private insurance type | Private insurance purchased directly from an insurance company (by this person or another family member) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0462 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify private insurance type | Private insurance, type unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0463 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify Medicare type | Original or Traditional Medicare | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0464 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify Medicare type | Medicare Advantage | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0465 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify Medicare type | Medicare, not otherwise specified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0466 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify other government program: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0467 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Addition of Information Requested | Specify other health insurance: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0468 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Is the recipient participating in a clinical trial? | Yes | No Change | No Change | No Change | No | |
| PRE0469 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | No | Is the recipient participating in a clinical trial? | No | No Change | No Change | No Change | No | |
| PRE0470 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | ANZCTR | No | Capture data accurately | |
| PRE0471 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | BMT CTN | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0472 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | CIBMTR CRO Services | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0473 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | COG | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0474 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | ECOG | No | Capture data accurately | |
| PRE0475 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | PIDTC | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0476 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | PTCTC | No | Capture data accurately | |
| PRE0477 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | SWOG | No | Capture data accurately | |
| PRE0478 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | USIDNET | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0479 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | Corporate / Industry | No | Capture data accurately | |
| PRE0480 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Change/Clarification of Information Requested and Addition of Response Option | Sponsor | Investigator initiated | No | Capture data accurately | |
| PRE0481 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | PedAL | Change/Clarification of Information Requested and Deletion of Response Option | Sponsor | No | Capture data accurately | |
| PRE0482 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study Sponsor | Other sponsor | Change/Clarification of Information Requested | Sponsor | No Change | No | Capture data accurately | 
| PRE0483 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Addition of Information Requested | Specify ACTRN number: | Open text | No | Capture data accurately | ||
| PRE0484 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Addition of Information Requested | Specify corporate / industry sponsor name: | Open text | No | Capture data accurately | ||
| PRE0485 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Specify other sponsor: | Open text | No Change | No Change | No Change | No | |
| PRE0486 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Study ID Number | Dropdown with a frequently updated list of active studies – changes in response options do not affect burden | Change/Clarification of Information Requested | Protocol ID | No Change | No | Capture data accurately | 
| PRE0487 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Subject ID: | Open text | No Change | No Change | No Change | No | |
| PRE0488 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Recipient Information | Yes | Specify the ClinicalTrials.gov identification number: | Open text | No Change | No Change | No Change | No | |
| PRE0489 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | No | Multiple donors? | yes | No Change | No Change | No Change | No | |
| PRE0490 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | No | Multiple donors? | no | No Change | No Change | No Change | No | |
| PRE0491 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | No | Specify number of donors: | Open text | No Change | No Change | No Change | No | |
| PRE0492 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify donor | Autologous | No Change | No Change | No Change | No | |
| PRE0493 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify donor | Allogeneic, related donor | No Change | No Change | No Change | No | |
| PRE0494 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify donor | Allogeneic, unrelated donor | No Change | No Change | No Change | No | |
| PRE0495 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify product type | Bone marrow | No Change | No Change | No Change | No | |
| PRE0496 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify product type | PBSC | No Change | No Change | No Change | No | |
| PRE0497 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify product type | Single cord blood unit | No Change | No Change | No Change | No | |
| PRE0498 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify product type | Other product | No Change | No Change | No Change | No | |
| PRE0499 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify other product: | Open text | No Change | No Change | No Change | No | |
| PRE0500 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Is the product genetically modified? | Yes | No Change | No Change | No Change | No | |
| PRE0501 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Is the product genetically modified? | No | No Change | No Change | No Change | No | |
| PRE0502 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the related donor type | Syngeneic (monozygotic twin) | No Change | No Change | No Change | No | |
| PRE0503 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the related donor type | HLA-identical sibling (may include non-monozygotic twin) | No Change | No Change | No Change | No | |
| PRE0504 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the related donor type | HLA-matched other relative (does NOT include a haplo-identical donor) | No Change | No Change | No Change | No | |
| PRE0505 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the related donor type | HLA-mismatched relative | Change/Clarification of Information Requested | No Change | HLA-mismatched relative (includes haplo-identical donor) | No | Capture data accurately | 
| PRE0506 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Mother | No Change | No Change | No Change | No | |
| PRE0507 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Father | No Change | No Change | No Change | No | |
| PRE0508 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Child | No Change | No Change | No Change | No | |
| PRE0509 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Sibling | No Change | No Change | No Change | No | |
| PRE0510 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Fraternal twin | No Change | No Change | No Change | No | |
| PRE0511 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Maternal aunt | Change/Clarification of Information Requested | No Change | Aunt | No | Capture data accurately | 
| PRE0512 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Maternal uncle | Change/Clarification of Information Requested | No Change | Uncle | No | Capture data accurately | 
| PRE0513 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Maternal cousin | Change/Clarification of Information Requested | No Change | Cousin | No | Capture data accurately | 
| PRE0514 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Paternal aunt | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0515 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Paternal uncle | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0516 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Paternal cousin | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0517 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Grandparent | No Change | No Change | No Change | No | |
| PRE0518 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Grandchild | No Change | No Change | No Change | No | |
| PRE0519 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the biological relationship of the donor to the recipient | Other biological relative | No Change | No Change | No Change | No | |
| PRE0520 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify other biological relative: | Open text | No Change | No Change | No Change | No | |
| PRE0521 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Degree of mismatch | HLA-mismatched 1 allele | No Change | No Change | No Change | No | |
| PRE0522 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Degree of mismatch | HLA-mismatched ≥2 HLA alleles | No Change | No Change | No Change | No | |
| PRE0523 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify unrelated donor type | HLA matched unrelated | No Change | No Change | No Change | No | |
| PRE0524 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify unrelated donor type | HLA mismatched unrelated | No Change | No Change | No Change | No | |
| PRE0525 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Did NMDP / Be the Match facilitate the procurement, collection, or transportation of the product? | Yes | Change/Clarification of Information Requested | Did NMDP facilitate the procurement, collection, or transportation of the product? | No Change | No | Capture data accurately | 
| PRE0526 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Did NMDP / Be the Match facilitate the procurement, collection, or transportation of the product? | No | Change/Clarification of Information Requested | Did NMDP facilitate the procurement, collection, or transportation of the product? | No Change | No | Capture data accurately | 
| PRE0527 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Was this donor used for any prior HCTs? | yes | No Change | No Change | No Change | No | |
| PRE0528 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Was this donor used for any prior HCTs? | no | No Change | No Change | No Change | No | |
| PRE0529 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Global Registration Identifier for Donors (GRID) | Open text | No Change | No Change | No Change | No | |
| PRE0530 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | NMDP cord blood unit ID: | Open text | No Change | No Change | No Change | No | |
| PRE0531 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry donor ID: | Open text | No Change | No Change | No Change | No | |
| PRE0532 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Non-NMDP cord blood unit ID: | Open text | No Change | No Change | No Change | No | |
| PRE0533 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Is the CBU ID also the ISBT DIN number? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0534 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Is the CBU ID also the ISBT DIN number? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0535 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Is the CBU ID also the ISBT DIN number? | Unknown | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0536 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the ISBT DIN number: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0537 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (A) Austrian Bone Marrow Donors | New Structure and Change/Clarification of Information Requested | No Change | [AT](2614)Austrian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0538 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ACB) Austrian Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [AT](2614)Austrian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0539 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ACCB) StemCyte, Inc | New Structure and Change/Clarification of Information Requested | No Change | [US](8379)StemCyte Inc. United States | No | Reduce burden - reduce data entry | 
| PRE0540 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AE) Emirates Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0541 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AM) Armenian Bone Marrow Donor Registry Charitable Trust | New Structure and Change/Clarification of Information Requested | No Change | [AM](5019)Armenian Bone Marrow Donor Registry Charitable Trust | No | Reduce burden - reduce data entry | 
| PRE0542 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AOCB) University of Colorado Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0543 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AR) Argentine CPH Donors Registry | New Structure and Change/Clarification of Information Requested | No Change | [AR](5117)Argentine HSC Donors Registry - INCUCAI | No | Reduce burden - reduce data entry | 
| PRE0544 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ARCB) BANCEL - Argentina Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0545 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AUCB) Australian Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [AU](7748)Australian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0546 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (AUS) Australian / New Zealand Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0547 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (B) Marrow Donor Program Belgium | New Structure and Change/Clarification of Information Requested | No Change | [BE](4201)Marrow Donor Program Registry Belgium | No | Reduce burden - reduce data entry | 
| PRE0548 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (BCB) Belgium Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [BE](4201)Marrow Donor Program Registry Belgium | No | Reduce burden - reduce data entry | 
| PRE0549 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (BG) Bulgarian Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [BG](7197)Bulgarian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0550 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (BR) INCA/REDOMO | New Structure and Change/Clarification of Information Requested | No Change | [BR](8766)REDOME - Registro Nacional de Doadores Voluntarios de Medula Ossea | No | Reduce burden - reduce data entry | 
| PRE0551 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (BSCB) British Bone Marrow Registry - Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [GB](2731)NHS Blood and Transplant - BBMR | No | Reduce burden - reduce data entry | 
| PRE0552 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CB) Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [US]Cord Blood Registry | No | Reduce burden - reduce data entry | 
| PRE0553 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CH) Swiss BloodStem Cells - Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [CH](9341)Blutspende SRK Schweiz AG | No | Reduce burden - reduce data entry | 
| PRE0554 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CHCB) Swiss Blood Stem Cells - Cord Blood | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0555 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CKCB) Celgene Cord Blood Bank | New Structure and Change/Clarification of Information Requested | No Change | [US](7470)Celularity, Inc. | No | Reduce burden - reduce data entry | 
| PRE0556 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CN) China Marrow Donor Program (CMDP) | New Structure and Change/Clarification of Information Requested | No Change | [CN](2197)China Marrow Donor Program | No | Reduce burden - reduce data entry | 
| PRE0557 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CNCB) Shan Dong Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0558 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CND) Canadian Blood Services Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [CA](5103)Canadian Blood Services Stem Cell Registry | No | Reduce burden - reduce data entry | 
| PRE0559 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CS2) Czech National Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [CZ](5440)Czech National Marrow Donor Registry Plzeň | No | Reduce burden - reduce data entry | 
| PRE0560 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CSCR) Czech Stem Cells Registry | New Structure and Change/Clarification of Information Requested | No Change | [CZ](4753)Czech Stem Cells Registry Prague (CSCR) | No | Reduce burden - reduce data entry | 
| PRE0561 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CY) Cyprus Paraskevaidio Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [CY](4278)Cyprus Paraskevaidio Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0562 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (CY2) The Cyprus Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [CY](9751)Cyprus Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0563 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (D) ZKRD - Zentrales Knochenmarkspender - Register Deutschland Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [DE](6939)ZKRD - Zentrales Knochenmarkspender-Register Deutschland | No | Reduce burden - reduce data entry | 
| PRE0564 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (DCB) ZKRD - Zentrales Knochenmarkspender - Register Deutschland Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [DE](6939)ZKRD - Zentrales Knochenmarkspender-Register Deutschland | No | Reduce burden - reduce data entry | 
| PRE0565 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (DK) The Danish Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [DK](2015)Danish Stem Cell Donors - West | No | Reduce burden - reduce data entry | 
| PRE0566 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (DK2) Bone Marrow Donors Copenhagen (BMDC) | New Structure and Change/Clarification of Information Requested | No Change | [DK](7484)Danish Stem Cell Donors - East (DSDE) | No | Reduce burden - reduce data entry | 
| PRE0567 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (DUCB) German Branch of the European Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0568 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (E) REDMO | New Structure and Change/Clarification of Information Requested | No Change | [ES](7813)Registro de Donantes de Médula Ósea (REDMO) | No | Reduce burden - reduce data entry | 
| PRE0569 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ECB) Spanish Cord Blood Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0570 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (F) France Greffe de Moelle - Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [FR](1804)France Greffe de Moelle Registry - FGM | No | Reduce burden - reduce data entry | 
| PRE0571 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (FCB) France Greffe de Moelle - Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [FR](1804)France Greffe de Moelle Registry - FGM | No | Reduce burden - reduce data entry | 
| PRE0572 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (FI) Finnish Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [FI](9738)Finnish Stem Cell Registry | No | Reduce burden - reduce data entry | 
| PRE0573 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (FICB) Finnish Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [FI](9738)Finnish Stem Cell Registry | No | Reduce burden - reduce data entry | 
| PRE0574 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (GB) The Anthony Nolan Trust | New Structure and Change/Clarification of Information Requested | No Change | [GB](6354)Anthony Nolan | No | Reduce burden - reduce data entry | 
| PRE0575 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (GB3) Welsh Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [GB](1726)Welsh Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0576 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (GB4) British Bone Marrow Registry | New Structure and Change/Clarification of Information Requested | No Change | [GB](2731)NHS Blood and Transplant - BBMR | No | Reduce burden - reduce data entry | 
| PRE0577 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (GR) Unrelated Hematopoietic Stem Cell Donor Registry Greece | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0578 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (GRCB) Michigan Community Blood Centers Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0579 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (H) Hungarian Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [HU](1695)Hungarian Stem Cell Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0580 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (HEM) Hema-Quebec | New Structure and Change/Clarification of Information Requested | No Change | [CA](6912)Hema-Quebec Stem Cell Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0581 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (HK) Hong Kong Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [CN](4070)Hong Kong Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0582 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (HR) Croatian Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [HR](5712)Croatian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0583 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (I) Italian Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [IT](7450)Italian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0584 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (I3CB) Sheba Medical Centre Cord Blood Registry | New Structure and Change/Clarification of Information Requested | No Change | [IL](4068)Chaim Sheba Medical Center | No | Reduce burden - reduce data entry | 
| PRE0585 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ICB) Italian Cord Blood Bank Network | New Structure and Change/Clarification of Information Requested | No Change | [IT](7450)Italian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0586 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IL) Hadassah BMDR | New Structure and Change/Clarification of Information Requested | No Change | [IL](5239)Bone Marrow and Cord Blood Bank Registry Hadassah University Hospital | No | Reduce burden - reduce data entry | 
| PRE0587 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IL2) Ezer Mizion Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [IL](4987)Ezer Mizion Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0588 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IL3) Sheba Medical Center Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [IL](4068)Chaim Sheba Medical Center | No | Reduce burden - reduce data entry | 
| PRE0589 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ILCB) Isreal Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0590 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IN) Asian Indian Donor Marrow Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0591 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IN2) Dept. of Transfusion Medicine | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0592 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (IRL) The Irish Unrelated Bone Marrow Panel | New Structure and Change/Clarification of Information Requested | No Change | [IE](5590)Irish Unrelated Bone Marrow Registry | No | Reduce burden - reduce data entry | 
| PRE0593 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (JP) Japan Marrow Donor Program | New Structure and Change/Clarification of Information Requested | No Change | [JP](4364)JMDP - Japan Marrow Donor Program | No | Reduce burden - reduce data entry | 
| PRE0594 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (KR) Korea Marrow Donor Program | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0595 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (LT) Lithuanian National Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [LT](2073)Lithuanian National Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0596 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (LVCB) Leuven Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0597 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (MACB) Victoria Angel Registry of Hope | New Structure and Change/Clarification of Information Requested | No Change | [CA](3066)Victoria Angel Registry of Hope | No | Reduce burden - reduce data entry | 
| PRE0598 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (MX) Mexican Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [MX](1671)Mexican BMDR - DONORMO | No | Reduce burden - reduce data entry | 
| PRE0599 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (N) The Norwegian Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [NO](7214)Norwegian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0600 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (NL) Europdonor Foundation- Adult Donors | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0601 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (NLCB) Europdonor Foundation - Cord Blood | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0602 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (NYCB) National Cord Blood Program, New York Blood Center | New Structure and Change/Clarification of Information Requested | No Change | [US](8691)National Cord Blood Program New York Blood Center | No | Reduce burden - reduce data entry | 
| PRE0603 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (P) Portuguese Bone Marrow Donors Registry | New Structure and Change/Clarification of Information Requested | No Change | [PT](7358)CEDACE/Portuguese BMD Registry | No | Reduce burden - reduce data entry | 
| PRE0604 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PL) National Polish Bone Marrow Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0605 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PL2) Unrelated Bone Marrow Donor Registry -Adult Donors | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0606 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PL3) Against Leukemia Foundation Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [PL](3918)Against Leukemia Foundation (ALF) Warsaw | No | Reduce burden - reduce data entry | 
| PRE0607 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PL4) Ursula Jaworska Foundation - Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0608 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PL5) Polish Central Bone Marrow Donor Registry - Adult Donors | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0609 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (PMCB) Elie Katz Umbilical Cord Blood Program | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0610 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (R) Russian Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0611 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (R2) Karelian Registry of Unrelated Donors of Hematopoietic Stem Cells | New Structure and Change/Clarification of Information Requested | No Change | [RU](8256)Karelian Registry of Hematopoietic Stem Cells | No | Reduce burden - reduce data entry | 
| PRE0612 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (S) Tobias Registry of Swedish Bone Marrow Donors | New Structure and Change/Clarification of Information Requested | No Change | [SE](5285)Tobias Registry | No | Reduce burden - reduce data entry | 
| PRE0613 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SG) Singapore Bone Marrow Donor Programme (BMDP) | New Structure and Change/Clarification of Information Requested | No Change | [SG](3785)Singapore BMDP | No | Reduce burden - reduce data entry | 
| PRE0614 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SK) Slovak National Bone Marrow Donor Registry | New Structure and Change/Clarification of Information Requested | No Change | [SK](1005)Slovak National BMD Registry | No | Reduce burden - reduce data entry | 
| PRE0615 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SKCB) Eurocord Slovakia / Slovak Pacental Stem Cell Registry | New Structure and Change/Clarification of Information Requested | No Change | [SK](4398)Slovenský register placentárnych krvotvorných buniek- Eurocord-Slovakia (SRPKB) | No | Reduce burden - reduce data entry | 
| PRE0616 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SLCBB) St Louis Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0617 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SLO) Slovenia Donor | New Structure and Change/Clarification of Information Requested | No Change | [SI](4565)Slovenia Donor | No | Reduce burden - reduce data entry | 
| PRE0618 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (SM) San Marino Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0619 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (T1CB) TRAN - Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [TR](3893)Ankara University Faculty of Medicine/TRAN Ankara | No | Reduce burden - reduce data entry | 
| PRE0620 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TACB) StemCyte, Inc. Taiwan | New Structure and Change/Clarification of Information Requested | No Change | [CN](5812)StemCyte Taiwan | No | Reduce burden - reduce data entry | 
| PRE0621 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TECB) Healthbanks Biotech, Co., Ltd | New Structure and Change/Clarification of Information Requested | No Change | [CN](6692)Healthbanks biomedical Co. Ltd. | No | Reduce burden - reduce data entry | 
| PRE0622 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TH) Thai Stem Cell Donor Registry (TSCDR) | New Structure and Change/Clarification of Information Requested | No Change | [TH](8362)Thai National Stem Cell Donor Registry | No | Reduce burden - reduce data entry | 
| PRE0623 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TOCB) Tokyo Cord Blood Bank | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0624 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TPCB) BIONET / BabyBanks | New Structure and Change/Clarification of Information Requested | No Change | [CN](6459)Bionet Corporation | No | Reduce burden - reduce data entry | 
| PRE0625 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TRAN) TRAN - Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [TR](3893)Ankara University Faculty of Medicine/TRAN Ankara | No | Reduce burden - reduce data entry | 
| PRE0626 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TRIS) Bone Marrow Bank of Istanbul Medical Faculty | New Structure and Change/Clarification of Information Requested | No Change | [TR](5509)Blood and Bone Marrow Donor Registry of Istanbul Medical Faculty | No | Reduce burden - reduce data entry | 
| PRE0627 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TW) Buddhist Tzu Chi Stem Cells Center - Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [CN](3458)Buddhist Tzu Chi Stem Cells Center - BTCSCC | No | Reduce burden - reduce data entry | 
| PRE0628 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (TWCB) Buddhist Tzu Chi Stem Cells Center - Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [CN](3458)Buddhist Tzu Chi Stem Cells Center - BTCSCC | No | Reduce burden - reduce data entry | 
| PRE0629 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (U1CB) National Marrow Donor Program - Cord Blood | New Structure and Change/Clarification of Information Requested | No Change | [US](3553)NMDP | No | Reduce burden - reduce data entry | 
| PRE0630 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (USA1) National Marrow Donor Program - Adult Donors | New Structure and Change/Clarification of Information Requested | No Change | [US](3553)NMDP | No | Reduce burden - reduce data entry | 
| PRE0631 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (USA2) America Bone Marrow Donor Registry | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0632 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (UY) SINDOME | New Structure and Change/Clarification of Information Requested | No Change | [UY](6517)Sindome | No | Reduce burden - reduce data entry | 
| PRE0633 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (VIAC) Viacord | New Structure and Change/Clarification of Information Requested | No Change | [US]Viacord | No | Reduce burden - reduce data entry | 
| PRE0634 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (W3CB) Polish Central Bone Marrow Donor Registry - Cord Blood | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0635 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (WACB) Unrelated Bone Marrow Donor Registry - Cord Blood | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0636 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (ZA) South African Bone Marrow Registry | New Structure and Change/Clarification of Information Requested | No Change | [ZA](8118)South African Bone Marrow Registry | No | Reduce burden - reduce data entry | 
| PRE0637 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | (OTH) Other Registry | No Change | No Change | No Change | No | |
| PRE0638 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [AE](5003)EMBDR Emirates Marrow Blood Donor Registry Sharjah Blood Transfusion & Research Center | No | Reduce burden - reduce data entry | |
| PRE0639 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [AT](4961)Verein Geben für Leben | No | Reduce burden - reduce data entry | |
| PRE0640 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [AT](8162)Vita 34 Gesellschaft für Zelltransplantate mbH | No | Reduce burden - reduce data entry | |
| PRE0641 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CL](1574)Fundación de Beneficencia Pública DKMS | No | Reduce burden - reduce data entry | |
| PRE0642 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CL](4946)Fundacion de Beneficencia Publica DKMS | No | Reduce burden - reduce data entry | |
| PRE0643 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CN](1212)Supercell Biotechnology Corporation | No | Reduce burden - reduce data entry | |
| PRE0644 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CN](1714)Meribank Biotech Co. Ltd | No | Reduce burden - reduce data entry | |
| PRE0645 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CN](3105)Hong Kong Red Cross Blood Transfusion Service Cord Blood Bank | No | Reduce burden - reduce data entry | |
| PRE0646 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CN](6681)Beijing New Sunshine Charity Foundation | No | Reduce burden - reduce data entry | |
| PRE0647 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [CN](9281) Mononuclear Therapeutics Limited | No | Reduce burden - reduce data entry | |
| PRE0648 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [DE](2547)VKS Paraguay | No | Reduce burden - reduce data entry | |
| PRE0649 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [DE](4596)DKMS Registry gGmbH | No | Reduce burden - reduce data entry | |
| PRE0650 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [DE](4744)DKMS Stem Cell Bank gGmbH | No | Reduce burden - reduce data entry | |
| PRE0651 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [DE](4908)José Carreras Cord Blood Bank Düsseldorf-Universitätsklinikum Düsseldorf | No | Reduce burden - reduce data entry | |
| PRE0652 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [DE](5525)DKMS Donor Center | No | Reduce burden - reduce data entry | |
| PRE0653 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [ES](2329)DKMS Espana | No | Reduce burden - reduce data entry | |
| PRE0654 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [GB](3509)Precious Cells International | No | Reduce burden - reduce data entry | |
| PRE0655 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [GB](9968)DKMS United Kingdom | No | Reduce burden - reduce data entry | |
| PRE0656 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [GR](1461)Centre of Bone Marrow Donor Volunteers - Save a life, University of Patras | No | Reduce burden - reduce data entry | |
| PRE0657 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [GR](4979)EOM Hellenic Transplant Organization | No | Reduce burden - reduce data entry | |
| PRE0658 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](2824) GeneBandhu New Delhi | No | Reduce burden - reduce data entry | |
| PRE0659 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](4131)MDR Marrow Donor Registry India Mumbai | No | Reduce burden - reduce data entry | |
| PRE0660 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](4460)Be The Cure Registry by Jeevan Stem Cell Foundation | No | Reduce burden - reduce data entry | |
| PRE0661 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](5451)Bangalore Medical Services Trust, Rotary Bangalore - TTK Blood Bank | No | Reduce burden - reduce data entry | |
| PRE0662 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](8196)The Arjan Vir Foundation | No | Reduce burden - reduce data entry | |
| PRE0663 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](8486)DATRI Blood Stem Cell Donors Registry | No | Reduce burden - reduce data entry | |
| PRE0664 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IN](9935)DKMS BMST Foundation India | No | Reduce burden - reduce data entry | |
| PRE0665 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IR](1102)Royan Institute Cord Blood Bank | No | Reduce burden - reduce data entry | |
| PRE0666 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IR](3146)Taleghani Stem Cell Transplantation and Cell Therapy Center | No | Reduce burden - reduce data entry | |
| PRE0667 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IR](4993)Iranian National Stem Cell Donor Network (INSCDN) | No | Reduce burden - reduce data entry | |
| PRE0668 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [IR](6887)Iranian Stem Cell Donor Program (ISCDP) | No | Reduce burden - reduce data entry | |
| PRE0669 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [KR](8405)National Institute of Organ_Tissue_Blood Management Korea | No | Reduce burden - reduce data entry | |
| PRE0670 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [KZ](5070) National Register of Bone Marrow Donors in the Republic of Kazakhstan (NRDKMRK) | No | Reduce burden - reduce data entry | |
| PRE0671 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [LU](3099) Luxembourg Marrow Donor Program (LMDP) | No | Reduce burden - reduce data entry | |
| PRE0672 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [MK](2285)Scientific Foundation SPIROSKI - Marrow Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0673 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [MK](4307)MBMDR - Macedonian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0674 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [MX](9275)Be The Match Mexico | No | Reduce burden - reduce data entry | |
| PRE0675 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [NG](3034)Bone Marrow Registry Nigeria | No | Reduce burden - reduce data entry | |
| PRE0676 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [NL](1131)Sanquin | No | Reduce burden - reduce data entry | |
| PRE0677 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [NL](8139)Matchis Foundation | No | Reduce burden - reduce data entry | |
| PRE0678 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [NZ](8261)New Zealand Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0679 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [PE](6132)Dirección General de Donaciones, Trasplantes y Banco de Sangre - Ministerio de Salud | No | Reduce burden - reduce data entry | |
| PRE0680 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [PL](5391) Poltransplant | No | Reduce burden - reduce data entry | |
| PRE0681 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [PL](7414)Fundacja DKMS | No | Reduce burden - reduce data entry | |
| PRE0682 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [QA](7593)National Center for Cancer Care & Research - Qatar Stem Cell Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0683 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [RO](1372)National Registry of Hematopoietic Stem Cells Voluntary Donors | No | Reduce burden - reduce data entry | |
| PRE0684 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [RU](4381)National Bone Marrow Donors Registry named after Vasya Perevoshchikov | No | Reduce burden - reduce data entry | |
| PRE0685 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [RU](5971)BMD Registry Blood Banks of Russia | No | Reduce burden - reduce data entry | |
| PRE0686 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [RU](8714)Kirov Research Institute of Hematology and Blood Transfusion (KRIHBT) | No | Reduce burden - reduce data entry | |
| PRE0687 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [RU](9778)HPC Registry (Samara) | No | Reduce burden - reduce data entry | |
| PRE0688 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [SA](1810) King Faisal Specialist Hospital & Research Centre Stem Cell Donor Registry (KFSH&RC;-UDR) | No | Reduce burden - reduce data entry | |
| PRE0689 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [SA](2107)Saudi Stem Cells Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0690 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [SG](4291)Singapore Cord Blood Bank | No | Reduce burden - reduce data entry | |
| PRE0691 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [TR](3503)TURKOK - Turkish Stem Cell Coordination Centre | No | Reduce burden - reduce data entry | |
| PRE0692 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [UA](6933)Ukrainian Bone Marrow Donor Registry | No | Reduce burden - reduce data entry | |
| PRE0693 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](1033)Gift of Life Marrow Registry | No | Reduce burden - reduce data entry | |
| PRE0694 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](4857)Celebration Stem Cell Centre | No | Reduce burden - reduce data entry | |
| PRE0695 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](5081)DKMS United States of America | No | Reduce burden - reduce data entry | |
| PRE0696 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](5315)C.W. Bill Young Department of Defense Marrow Donor Program/Georgetown University | No | Reduce burden - reduce data entry | |
| PRE0697 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](5928)Mayo Clinic | No | Reduce burden - reduce data entry | |
| PRE0698 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [US](6579)Cleveland Cord Blood Center | No | Reduce burden - reduce data entry | |
| PRE0699 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Registry or UCB Bank ID | New Structure and Addition of Information Requested | No Change | [ZA](6738)DKMS Africa | No | Reduce burden - reduce data entry | |
| PRE0700 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify other Registry or UCB Bank: | Open text | No Change | No Change | No Change | No | |
| PRE0701 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor date of birth | Known | No Change | No Change | No Change | No | |
| PRE0702 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor date of birth | Unknown | No Change | No Change | No Change | No | |
| PRE0703 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor date of birth [value]: | Open text | No Change | No Change | No Change | No | |
| PRE0704 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor age | Known | No Change | No Change | No Change | No | |
| PRE0705 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor age | Unknown | No Change | No Change | No Change | No | |
| PRE0706 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor age: | Open text | No Change | No Change | No Change | No | |
| PRE0707 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Months | checked | No Change | No Change | No Change | No | |
| PRE0708 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | years | checked | No Change | No Change | No Change | No | |
| PRE0709 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor sex | male | No Change | No Change | No Change | No | |
| PRE0710 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor sex | female | No Change | No Change | No Change | No | |
| PRE0711 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify blood type | A | No Change | No Change | No Change | No | |
| PRE0712 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify blood type | B | No Change | No Change | No Change | No | |
| PRE0713 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify blood type | AB | No Change | No Change | No Change | No | |
| PRE0714 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify blood type | O | No Change | No Change | No Change | No | |
| PRE0715 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify Rh factor | Positive | No Change | No Change | No Change | No | |
| PRE0716 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify Rh factor | Negative | No Change | No Change | No Change | No | |
| PRE0717 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor CMV-antibodies (IgG or Total) | Reactive | No Change | No Change | No Change | No | |
| PRE0718 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor CMV-antibodies (IgG or Total) | Non-reactive | No Change | No Change | No Change | No | |
| PRE0719 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor CMV-antibodies (IgG or Total) | Indeterminate | No Change | No Change | No Change | No | |
| PRE0720 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor CMV-antibodies (IgG or Total) | Not done | No Change | No Change | No Change | No | |
| PRE0721 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Donor CMV-antibodies (IgG or Total) | Not applicable | No Change | No Change | No Change | No | |
| PRE0722 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Yes | Change/Clarification of Information Requested | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0723 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | No | Change/Clarification of Information Requested | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0724 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Not approached | Change/Clarification of Information Requested | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0725 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Not applicable | Change/Clarification of Information Requested | Has the donor signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0726 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Date form was signed: | Open text | No Change | No Change | No Change | No | |
| PRE0727 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Did the donor submit a research sample to the NMDP/CIBMTR repository? | yes | No Change | No Change | No Change | No | |
| PRE0728 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Did the donor submit a research sample to the NMDP/CIBMTR repository? | no | No Change | No Change | No Change | No | |
| PRE0729 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Research sample donor ID: | Open text | No Change | No Change | No Change | No | |
| PRE0730 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify number of products infused from this donor: | Open text | No Change | No Change | No Change | No | |
| PRE0731 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify the number of these products intended to achieve hematopoietic engraftment: | Open text | No Change | No Change | No Change | No | |
| PRE0732 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | G-CSF (TBO-filgrastim, filgrastim, Granix, Neupogen) | Change/Clarification of Information Requested | No Change | G-CSF (TBO-filgrastim, filgrastim, Granix, Neupogen and biosimilars) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0733 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | GM-CSF (sargramostim, Leukine) | No Change | No Change | No Change | No | |
| PRE0734 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Pegylated G-CSF (pegfilgrastim, Neulasta) | No Change | No Change | No Change | No | |
| PRE0735 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Motixafortide (Aphexda) | No Change | No Change | No Change | No | |
| PRE0736 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Plerixafor (Mozobil) | Change/Clarification of Information Requested | No Change | Plerixafor (Mozobil and biosimilars) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0737 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Combined with chemotherapy | No Change | No Change | No Change | No | |
| PRE0738 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Anti-CD20 (rituximab, Rituxan) | No Change | No Change | No Change | No | |
| PRE0739 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | What agents were used to mobilize the autologous recipient for this HCT? | Other agent | No Change | No Change | No Change | No | |
| PRE0740 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify other agent: | Open text | No Change | No Change | No Change | No | |
| PRE0741 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Name of product | Betibeglogene autotemcel (Zynteglo®) | No Change | No Change | No Change | No | |
| PRE0742 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Name of product | Elivaldogene autotemcel (Skysona®) | No Change | No Change | No Change | No | |
| PRE0743 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Name of product | Exagamglogene autotemcel | Change/Clarification of Information Requested | No Change | Exagamglogene autotemcel (Casgevy ®) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0744 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Name of product | Addition of Information Requested | No Change | Lovotibeglogene autotemcel (Lyfgenia ™) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE0745 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Name of product | Other name | No Change | No Change | No Change | No | |
| PRE0746 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Donor Information | Yes | Specify other name: | Open text | No Change | No Change | No Change | No | |
| PRE0747 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Is a subsequent HCT planned as part of the overall treatment protocol? | yes | No Change | No Change | No Change | No | |
| PRE0748 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Is a subsequent HCT planned as part of the overall treatment protocol? | no | No Change | No Change | No Change | No | |
| PRE0749 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Specify subsequent HCT planned | Autologous | No Change | No Change | No Change | No | |
| PRE0750 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Specify subsequent HCT planned | Allogeneic | No Change | No Change | No Change | No | |
| PRE0751 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient ever had a prior HCT? | Yes | No Change | No Change | No Change | No | |
| PRE0752 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient ever had a prior HCT? | No | No Change | No Change | No Change | No | |
| PRE0753 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Specify the number of prior HCTs: | Open text | No Change | No Change | No Change | No | |
| PRE0754 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior HCTs reported to the CIBMTR? | Yes | No Change | No Change | No Change | No | |
| PRE0755 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior HCTs reported to the CIBMTR? | No | No Change | No Change | No Change | No | |
| PRE0756 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior HCTs reported to the CIBMTR? | Unknown | No Change | No Change | No Change | No | |
| PRE0757 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Date of the prior HCT: | Open text | No Change | No Change | No Change | No | |
| PRE0758 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Date estimated | checked | No Change | No Change | No Change | No | |
| PRE0759 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Was the prior HCT performed at a different institution? | Yes | No Change | No Change | No Change | No | |
| PRE0760 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Was the prior HCT performed at a different institution? | No | No Change | No Change | No Change | No | |
| PRE0761 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Was the prior HCT performed at a CIBMTR Affiliated Network Center? | Yes | No | Capture data accurately | ||
| PRE0762 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Was the prior HCT performed at a CIBMTR Affiliated Network Center? | No | No | Capture data accurately | ||
| PRE0763 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | New Functionality | CIBMTR Center Number (CCN): | Dropdown with a frequently updated list of active transplant centers - changes in response options do not affect burden | No | Reduce burden - reduce data entry | ||
| PRE0764 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Name: | Open text | No Change | No Change | No Change | No | |
| PRE0765 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | City: | Open text | No Change | No Change | No Change | No | |
| PRE0766 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | State: | Open text | No Change | No Change | No Change | No | |
| PRE0767 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Country: | Open text | No Change | No Change | No Change | No | |
| PRE0768 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | What was the HPC source for the prior HCT? | Autologous | Change/Clarification of Information Requested | What was the donor source(s) for the prior HCT? | No Change | No | Capture data accurately | 
| PRE0769 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | What was the HPC source for the prior HCT? | Allogeneic, unrelated | Change/Clarification of Information Requested | What was the donor source(s) for the prior HCT? | No Change | No | Capture data accurately | 
| PRE0770 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | What was the HPC source for the prior HCT? | Allogeneic, related | Change/Clarification of Information Requested | What was the donor source(s) for the prior HCT? | No Change | No | Capture data accurately | 
| PRE0771 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Specify product type | Bone marrow | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0772 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Specify product type | PBSC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0773 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Specify product type | Single cord blood unit | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0774 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Specify product type | Other product | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0775 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Specify other product: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0776 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Graft failure / insufficient hematopoietic recovery | Change/Clarification of Information Requested | No Change | Graft failure | No | Capture data accurately | 
| PRE0777 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Addition of Information Requested | No Change | Poor graft function / insufficient donor chimerism | No | Capture data accurately | |
| PRE0778 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Persistent primary disease | No Change | No Change | No Change | No | |
| PRE0779 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Recurrent primary disease | No Change | No Change | No Change | No | |
| PRE0780 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Planned subsequent HCT, per protocol | No Change | No Change | No Change | No | |
| PRE0781 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | New malignancy | No Change | No Change | No Change | No | |
| PRE0782 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Insufficient chimerism | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE0783 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Reason for current HCT | Other | No Change | No Change | No Change | No | |
| PRE0784 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Date of graft failure / rejection: | Open text | No Change | No Change | No Change | No | |
| PRE0785 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Date of relapse: | Open text | No Change | No Change | No Change | No | |
| PRE0786 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Date of secondary malignancy: | Open text | No Change | No Change | No Change | No | |
| PRE0787 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Specify other reason: | Open text | No Change | No Change | No Change | No | |
| PRE0788 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient ever had a prior cellular therapy? | Yes | No Change | No Change | No Change | No | |
| PRE0789 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient ever had a prior cellular therapy? | No | No Change | No Change | No Change | No | |
| PRE0790 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient ever had a prior cellular therapy? | Unknown | No Change | No Change | No Change | No | |
| PRE0791 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior cellular therapies reported to the CIBMTR? | Yes | No Change | No Change | No Change | No | |
| PRE0792 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior cellular therapies reported to the CIBMTR? | No | No Change | No Change | No Change | No | |
| PRE0793 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Were all prior cellular therapies reported to the CIBMTR? | Unknown | No Change | No Change | No Change | No | |
| PRE0794 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Date of the prior cellular therapy: | Open text | No Change | No Change | No Change | No | |
| PRE0795 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Was the cellular therapy performed at a different institution? | Yes | No Change | No Change | No Change | No | |
| PRE0796 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Was the cellular therapy performed at a different institution? | No | No Change | No Change | No Change | No | |
| PRE0797 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Was the prior cellular therapies performed at a CIBMTR Affiliated Network Center? | Yes | No | Capture data accurately | ||
| PRE0798 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Addition of Information Requested | Was the prior cellular therapies performed at a CIBMTR Affiliated Network Center? | No | No | Capture data accurately | ||
| PRE0799 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | New Functionality | CIBMTR Center Number (CCN): [CIBMTR Affiliated Network Center] | Dropdown with a frequently updated list of active transplant centers - changes in response options do not affect burden | No | Reduce burden - reduce data entry | ||
| PRE0800 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Name: [institution that performed last HCT] | Open text | Change/Clarification of Information Requested | Name: [Non-CIBMTR Affiliated Network Centers ONLY] | No Change | No | Reduce burden | 
| PRE0801 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | City: [institution that performed last HCT] | Open text | Change/Clarification of Information Requested | City: [Non-CIBMTR Affiliated Network Centers ONLY] | No Change | No | Reduce burden | 
| PRE0802 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | State: [institution that performed last HCT] | Open text | Change/Clarification of Information Requested | State [Non-CIBMTR Affiliated Network Centers ONLY] | No Change | No | Reduce burden | 
| PRE0803 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Country: [institution that performed last HCT] | Open text | Change/Clarification of Information Requested | Country: [Non-CIBMTR Affiliated Network Centers ONLY] | No Change | No | Reduce burden | 
| PRE0804 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Specify the source(s) for the prior cellular therapy | Autologous | Change/Clarification of Information Requested | Specify the donor source(s) for the prior cellular therapy | No Change | No | Capture data accurately | 
| PRE0805 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Specify the source(s) for the prior cellular therapy | Allogeneic, unrelated | Change/Clarification of Information Requested | Specify the donor source(s) for the prior cellular therapy | No Change | No | Capture data accurately | 
| PRE0806 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | Yes | Specify the source(s) for the prior cellular therapy | Allogeneic, related | Change/Clarification of Information Requested | Specify the donor source(s) for the prior cellular therapy | No Change | No | Capture data accurately | 
| PRE0807 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Yes | Change/Clarification of Information Requested | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0808 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | No | Change/Clarification of Information Requested | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0809 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Not approached | Change/Clarification of Information Requested | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0810 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to the NMDP / CIBMTR? | Not applicable | Change/Clarification of Information Requested | Has the recipient signed an IRB / ethics committee (or similar body) approved consent form to donate research blood samples to NMDP / CIBMTR? | No Change | No | Capture data accurately | 
| PRE0811 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Date form signed | Open text | No Change | No Change | No Change | No | |
| PRE0812 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Did the recipient submit a research sample to the NMDP/CIBMTR repository? | Yes | No Change | No Change | No Change | No | |
| PRE0813 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Did the recipient submit a research sample to the NMDP/CIBMTR repository? | No | No Change | No Change | No Change | No | |
| PRE0814 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Hematopoietic Cellular Transplant (HCT) and Cellular Therapy | No | Research sample recipient ID | Open text | No Change | No Change | No Change | No | |
| PRE0815 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | What scale was used to determine the recipient’s functional status? | Karnofsky | No Change | No Change | No Change | No | |
| PRE0816 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | What scale was used to determine the recipient’s functional status? | Lansky | No Change | No Change | No Change | No | |
| PRE0817 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 100 Normal; no complaints; no evidence of disease | No Change | No Change | No Change | No | |
| PRE0818 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 90 Able to carry on normal activity | No Change | No Change | No Change | No | |
| PRE0819 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 80 Normal activity with effort | No Change | No Change | No Change | No | |
| PRE0820 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 70 Cares for self; unable to carry on normal activity or to do active work | No Change | No Change | No Change | No | |
| PRE0821 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 60 Requires occasional assistance but is able to care for most needs | No Change | No Change | No Change | No | |
| PRE0822 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 50 Requires considerable assistance and frequent medical care | No Change | No Change | No Change | No | |
| PRE0823 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 40 Disabled; requires special care and assistance | No Change | No Change | No Change | No | |
| PRE0824 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 30 Severely disabled; hospitalization indicated, although death not imminent | No Change | No Change | No Change | No | |
| PRE0825 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 20 Very sick; hospitalization necessary | No Change | No Change | No Change | No | |
| PRE0826 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Karnofsky Scale | 10 Moribund; fatal process progressing rapidly | No Change | No Change | No Change | No | |
| PRE0827 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 100 Fully active | No Change | No Change | No Change | No | |
| PRE0828 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 90 Minor restriction in physically strenuous play | No Change | No Change | No Change | No | |
| PRE0829 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 80 Restricted in strenuous play, tires more easily, otherwise active | No Change | No Change | No Change | No | |
| PRE0830 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 70 Both greater restrictions of, and less time spent in, active play | No Change | No Change | No Change | No | |
| PRE0831 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 60 Ambulatory up to 50% of time, limited active play with assistance / supervision | No Change | No Change | No Change | No | |
| PRE0832 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 50 Considerable assistance required for any active play; fully able to engage in quiet play | No Change | No Change | No Change | No | |
| PRE0833 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 40 Able to initiate quiet activities | No Change | No Change | No Change | No | |
| PRE0834 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 30 Needs considerable assistance for quiet activity | No Change | No Change | No Change | No | |
| PRE0835 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 20 Limited to very passive activity initiated by others (e.g., TV) | No Change | No Change | No Change | No | |
| PRE0836 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Lansky Scale | 10 Completely disabled, not even passive play | No Change | No Change | No Change | No | |
| PRE0837 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify blood type | A | No Change | No Change | No Change | No | |
| PRE0838 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify blood type | B | No Change | No Change | No Change | No | |
| PRE0839 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify blood type | AB | No Change | No Change | No Change | No | |
| PRE0840 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify blood type | O | No Change | No Change | No Change | No | |
| PRE0841 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify blood type | Addition of Information Requested | No Change | Mixed | No | Capture data accurately | |
| PRE0842 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify Rh factor | Positive | No Change | No Change | No Change | No | |
| PRE0843 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Specify Rh factor | Negative | No Change | No Change | No Change | No | |
| PRE0844 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Recipient CMV-antibodies (IgG or Total) | Reactive | No Change | No Change | No Change | No | |
| PRE0845 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Recipient CMV-antibodies (IgG or Total) | Non-reactive | No Change | No Change | No Change | No | |
| PRE0846 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Recipient CMV-antibodies (IgG or Total) | Indeterminate | No Change | No Change | No Change | No | |
| PRE0847 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Recipient CMV-antibodies (IgG or Total) | Not done | No Change | No Change | No Change | No | |
| PRE0848 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Height at initiation of pre-HCT preparative regimen: | Open text | Change/Clarification of Information Requested | Height at start of preparative regimen: | No Change | No | Capture data accurately | 
| PRE0849 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | inches | checked | No Change | No Change | No Change | No | |
| PRE0850 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | centimeters | checked | No Change | No Change | No Change | No | |
| PRE0851 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | Actual weight at initiation of pre-HCT preparative regimen: | Open text | Change/Clarification of Information Requested | Actual weight at start of the preparative regimen: | Open text | No | Capture data accurately | 
| PRE0852 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | pounds | checked | No Change | No Change | No Change | No | |
| PRE0853 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Clinical Status of Recipient Prior to the Preparative Regimen (Conditioning) | No | kilograms | checked | No Change | No Change | No Change | No | |
| PRE0854 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Has the patient been infected with COVID-19 (SARS-CoV-2) based on a positive test result at any time prior to the start of the preparative regimen / infusion? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0855 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Has the patient been infected with COVID-19 (SARS-CoV-2) based on a positive test result at any time prior to the start of the preparative regimen / infusion? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0856 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Did the patient require hospitalization for management of COVID-19 (SARS-CoV-2) infection? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0857 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Did the patient require hospitalization for management of COVID-19 (SARS-CoV-2) infection? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0858 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was mechanical ventilation used for COVID-19 (SARS-CoV-2) infection? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0859 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was mechanical ventilation used for COVID-19 (SARS-CoV-2) infection? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0860 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was a vaccine for COVID-19 (SARS-CoV-2) received? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0861 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was a vaccine for COVID-19 (SARS-CoV-2) received? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0862 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was a vaccine for COVID-19 (SARS-CoV-2) received? | Unknown | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0863 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | AstraZeneca | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0864 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | Johnson & Johnson / Janssen | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0865 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | Moderna | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0866 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | Novavax | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0867 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | Pfizer-BioNTECH | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0868 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify vaccine brand | Other (specify) | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0869 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify other type: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0870 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Select dose(s) received | One dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0871 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Select dose(s) received | First dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0872 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Select dose(s) received | Second dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0873 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Select dose(s) received | Third dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0874 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Select dose(s) received | Booster dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0875 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Date received: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0876 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Date estimated | checked | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE0877 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Is there a history of mechanical ventilation? | yes | No Change | No Change | No Change | No | |
| PRE0878 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Is there a history of mechanical ventilation? | no | No Change | No Change | No Change | No | |
| PRE0879 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Is there a history of invasive fungal infection? | Yes | No Change | No Change | No Change | No | |
| PRE0880 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Is there a history of invasive fungal infection? | No | No Change | No Change | No Change | No | |
| PRE0881 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Does the recipient have known complex congenital heart disease? | Yes | No Change | No Change | No Change | No | |
| PRE0882 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Does the recipient have known complex congenital heart disease? | No | No Change | No Change | No Change | No | |
| PRE0883 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Did the recipient have a prior malignancy? | Yes | No | Capture data accurately | ||
| PRE0884 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Did the recipient have a prior malignancy? | No | No | Capture data accurately | ||
| PRE0885 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Acute lymphoblastic leukemia (ALL) | No Change | No Change | No Change | No | |
| PRE0886 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Acute myeloid leukemia (AML / ANLL) | No Change | No Change | No Change | No | |
| PRE0887 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Breast cancer | No Change | No Change | No Change | No | |
| PRE0888 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Central nervous system (CNS) malignancy (e.g. glioblastoma, astrocytoma) | No Change | No Change | No Change | No | |
| PRE0889 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Chronic lymphocytic leukemia | No Change | No Change | No Change | No | |
| PRE0890 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Chronic myeloid leukemia | No Change | No Change | No Change | No | |
| PRE0891 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Gastrointestinal malignancy (e.g. colon, rectum, stomach, pancreas, intestine) | No Change | No Change | No Change | No | |
| PRE0892 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Genitourinary malignancy (e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix) | No Change | No Change | No Change | No | |
| PRE0893 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Lung cancer | No Change | No Change | No Change | No | |
| PRE0894 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Lymphoma | No Change | No Change | No Change | No | |
| PRE0895 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Myelodysplasia / myeloproliferative neoplasm (MDS / MPN) | No Change | No Change | No Change | No | |
| PRE0896 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Melanoma | No Change | No Change | No Change | No | |
| PRE0897 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Multiple myeloma / plasma cell disorder (PCD) | No Change | No Change | No Change | No | |
| PRE0898 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Oropharyngeal cancer (e.g. tongue, buccal mucosa) | No Change | No Change | No Change | No | |
| PRE0899 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Sarcoma | No Change | No Change | No Change | No | |
| PRE0900 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Thyroid cancer | No Change | No Change | No Change | No | |
| PRE0901 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Other skin malignancy (basal cell, squamous) | No Change | No Change | No Change | No | |
| PRE0902 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Other hematologic malignancy | No Change | No Change | No Change | No | |
| PRE0903 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify prior malignancy | Other solid tumor | No Change | No Change | No Change | No | |
| PRE0904 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify other hematologic malignancy: | Open text | No Change | No Change | No Change | No | |
| PRE0905 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify other solid tumor: | Open text | No Change | No Change | No Change | No | |
| PRE0906 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Was the prior malignancy treated? | Yes | No | Capture data accurately | ||
| PRE0907 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Was the prior malignancy treated? | No | No | Capture data accurately | ||
| PRE0908 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Were there any co-existing diseases or organ impairment present according to the HCT comorbidity index (HCT-CI)? | Yes | No Change | No Change | No Change | No | |
| PRE0909 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Were there any co-existing diseases or organ impairment present according to the HCT comorbidity index (HCT-CI)? | No | No Change | No Change | No Change | No | |
| PRE0910 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Arrhythmia | No Change | No Change | No Change | No | |
| PRE0911 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Cardiac | No Change | No Change | No Change | No | |
| PRE0912 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Cerebrovascular disease | No Change | No Change | No Change | No | |
| PRE0913 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Diabetes | No Change | No Change | No Change | No | |
| PRE0914 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Heart valve disease | No Change | No Change | No Change | No | |
| PRE0915 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Hepatic, mild | No Change | No Change | No Change | No | |
| PRE0916 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Hepatic, moderate / severe | No Change | No Change | No Change | No | |
| PRE0917 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Infection | No Change | No Change | No Change | No | |
| PRE0918 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Inflammatory bowel disease | No Change | No Change | No Change | No | |
| PRE0919 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Obesity | No Change | No Change | No Change | No | |
| PRE0920 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Peptic ulcer | No Change | No Change | No Change | No | |
| PRE0921 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Psychiatric disturbance | No Change | No Change | No Change | No | |
| PRE0922 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Pulmonary, moderate | No Change | No Change | No Change | No | |
| PRE0923 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Pulmonary, severe | No Change | No Change | No Change | No | |
| PRE0924 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Renal, moderate / severe | No Change | No Change | No Change | No | |
| PRE0925 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Rheumatologic | No Change | No Change | No Change | No | |
| PRE0926 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Specify co-existing diseases or organ impairment | Prior malignancy | Deletion of Information Requested | No Change | No | Reduce burden - prevent / reduce data redundancy | |
| PRE0927 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was the recipient on dialysis immediately prior to start of preparative regimen? | Yes | No Change | No Change | No Change | No | |
| PRE0928 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was the recipient on dialysis immediately prior to start of preparative regimen? | No | No Change | No Change | No Change | No | |
| PRE0929 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Was the recipient on dialysis immediately prior to start of preparative regimen? | Unknown | No Change | No Change | No Change | No | |
| PRE0930 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Serum ferritin | Known | No Change | No Change | No Change | No | |
| PRE0931 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Serum ferritin | Unknown | No Change | No Change | No Change | No | |
| PRE0932 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | [Serum ferritin value in ng/mL (μg/L)] | Open text | Change/Clarification of Information Requested | Serum ferritin [value in ng/mL (μg/L)] | No Change | No | Capture data accurately | 
| PRE0933 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Date sample collected: | Open text | No Change | No Change | No Change | No | |
| PRE0934 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Upper limit of normal for your institution: | Open text | No Change | No Change | No Change | No | |
| PRE0935 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | C-reactive protein (CRP) | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0936 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | C-reactive protein (CRP) | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0937 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | C-reactive protein (CRP) [value]: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0938 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | mg/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0939 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | mg/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0940 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Date sample collected: | Open Test | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0941 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Upper limit of normal for your institution: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0942 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Cystatin-C | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0943 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Cystatin-C | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0944 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Cystatin-C [value in mg/L]: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0945 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Date sample collected: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0946 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Glomerular filtration rate (GFR) before start of preparative regimen (pediatric only) | Known | Change/Clarification of Information Requested | Glomerular filtration rate (GFR) | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0947 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Glomerular filtration rate (GFR) before start of preparative regimen (pediatric only) | Unknown | Change/Clarification of Information Requested | Glomerular filtration rate (GFR) | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE0948 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Glomerular filtration rate (GFR) [value in mL/min/1.73m2] | Open text | No Change | No Change | No Change | No | |
| PRE0949 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | GFR estimated | checked | No | Capture data accurately | ||
| PRE0950 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Date sample collected: | Open text | No | Capture data accurately | ||
| PRE0951 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Serum albumin | Known | No Change | No Change | No Change | No | |
| PRE0952 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Serum albumin | Unknown | No Change | No Change | No Change | No | |
| PRE0953 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | [Serum albumin value]: | Open text | Change/Clarification of Information Requested | Serum albumin [value]: | No Change | No | Capture data accurately | 
| PRE0954 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE0955 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE0956 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Date sample collected: | Open text | No Change | No Change | No Change | No | |
| PRE0957 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Platelets | Known | No Change | No Change | No Change | No | |
| PRE0958 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Platelets | Unknown | No Change | No Change | No Change | No | |
| PRE0959 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | [Platelets value] | Open text | Change/Clarification of Information Requested | Platelets [value]: | No Change | No | Capture data accurately | 
| PRE0960 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | x 10⁹/L (x 10³/mm³) | checked | No Change | No Change | No Change | No | |
| PRE0961 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | x 10⁶/L | checked | Change/Clarification of Information Requested | x 10⁶/L (x 1/mm³) (x1/µL) (cells/µL) | No Change | No | Capture data accurately | 
| PRE0962 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Date sample collected: | Open text | No | Capture data accurately | ||
| PRE0963 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Were platelets transfused ≤ 7 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE0964 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Were platelets transfused ≤ 7 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE0965 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Were platelets transfused ≤ 7 days before date of test? | Unknown | No Change | No Change | No Change | No | |
| PRE0966 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Weight loss over the preceding 12 months %: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0967 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Addition of Information Requested | Montreal Cognitive Assessment (MoCA) Score: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0968 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Did the recipient have a prior solid organ transplant? | Yes | No Change | No Change | No Change | No | |
| PRE0969 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | No | Did the recipient have a prior solid organ transplant? | No | No Change | No Change | No Change | No | |
| PRE0970 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Bowel | No Change | No Change | No Change | No | |
| PRE0971 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Heart | No Change | No Change | No Change | No | |
| PRE0972 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Kidney(s) | No Change | No Change | No Change | No | |
| PRE0973 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Liver | No Change | No Change | No Change | No | |
| PRE0974 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Lung(s) | No Change | No Change | No Change | No | |
| PRE0975 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Pancreas | No Change | No Change | No Change | No | |
| PRE0976 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify organ | Other organ | No Change | No Change | No Change | No | |
| PRE0977 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Specify other organ: | Open text | No Change | No Change | No Change | No | |
| PRE0978 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Comorbid Conditions | Yes | Year of prior solid organ transplant: | Open text | No Change | No Change | No Change | No | |
| PRE0979 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Addition of Information Requested | Dosing weight used for preparative regimen orders: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0980 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Addition of Information Requested | pounds | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0981 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Addition of Information Requested | kilograms | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE0982 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was a pre-HCT preparative regimen prescribed? | yes | No Change | No Change | No Change | No | |
| PRE0983 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was a pre-HCT preparative regimen prescribed? | no | No Change | No Change | No Change | No | |
| PRE0984 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Classify the recipient’s prescribed preparative regimen | Myeloablative | No Change | No Change | No Change | No | |
| PRE0985 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Classify the recipient’s prescribed preparative regimen | Non-myeloablative (NST) | No Change | No Change | No Change | No | |
| PRE0986 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Classify the recipient’s prescribed preparative regimen | Reduced intensity (RIC) | No Change | No Change | No Change | No | |
| PRE0987 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was irradiation planned as part of the pre-HCT preparative regimen? | yes | No Change | No Change | No Change | No | |
| PRE0988 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was irradiation planned as part of the pre-HCT preparative regimen? | no | No Change | No Change | No Change | No | |
| PRE0989 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | What was the prescribed radiation field? | Total body | No Change | No Change | No Change | No | |
| PRE0990 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | What was the prescribed radiation field? | Total body by intensity-modulated radiation therapy (IMRT) | No Change | No Change | No Change | No | |
| PRE0991 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | What was the prescribed radiation field? | Total lymphoid or nodal regions | No Change | No Change | No Change | No | |
| PRE0992 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | What was the prescribed radiation field? | Thoracoabdominal region | No Change | No Change | No Change | No | |
| PRE0993 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Total prescribed dose: | Open text | No Change | No Change | No Change | No | |
| PRE0994 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Gy | checked | No Change | No Change | No Change | No | |
| PRE0995 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | cGy | checked | No Change | No Change | No Change | No | |
| PRE0996 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Date started: | Open text | No Change | No Change | No Change | No | |
| PRE0997 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was the radiation fractionated? | yes | No Change | No Change | No Change | No | |
| PRE0998 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Was the radiation fractionated? | no | No Change | No Change | No Change | No | |
| PRE0999 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | No | Total number of fractions: | Open text | No Change | No Change | No Change | No | |
| PRE1000 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Azathioprine | No Change | No Change | No Change | No | |
| PRE1001 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Bendamustine | No Change | No Change | No Change | No | |
| PRE1002 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Bortezomib | No Change | No Change | No Change | No | |
| PRE1003 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Busulfan | No Change | No Change | No Change | No | |
| PRE1004 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Carboplatin | No Change | No Change | No Change | No | |
| PRE1005 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Carmustine (BCNU) | No Change | No Change | No Change | No | |
| PRE1006 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | CCNU (Lomustine) | No Change | No Change | No Change | No | |
| PRE1007 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Cisplatin | No Change | No Change | No Change | No | |
| PRE1008 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Addition of Information Requested | No Change | Cladribine | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1009 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Clofarabine (Clolar) | No Change | No Change | No Change | No | |
| PRE1010 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Cyclophosphamide (Cytoxan) | No Change | No Change | No Change | No | |
| PRE1011 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Cytarabine (Ara-C) | No Change | No Change | No Change | No | |
| PRE1012 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Addition of Information Requested | No Change | Intrathecal cytarabine (Ara-C) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1013 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Etoposide (VP-16, VePesid) | No Change | No Change | No Change | No | |
| PRE1014 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Fludarabine | No Change | No Change | No Change | No | |
| PRE1015 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Gemcitabine | No Change | No Change | No Change | No | |
| PRE1016 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Hydroxyurea (Hydrea) | No Change | No Change | No Change | No | |
| PRE1017 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Ibritumomab tiuxetan (Zevalin) | No Change | No Change | No Change | No | |
| PRE1018 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Ifosfamide | No Change | No Change | No Change | No | |
| PRE1019 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Melphalan (L-Pam) | No Change | No Change | No Change | No | |
| PRE1020 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Methylprednisolone | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1021 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Addition of Information Requested | No Change | Intrathecal methotrexate | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1022 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Pentostatin | No Change | No Change | No Change | No | |
| PRE1023 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Propylene glycol-free melphalan | No Change | No Change | No Change | No | |
| PRE1024 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Rituximab (Rituxan) | No Change | No Change | No Change | No | |
| PRE1025 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Thiotepa | No Change | No Change | No Change | No | |
| PRE1026 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Addition of Information Requested | No Change | Intrathecal thiotepa | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1027 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Tositumomab (Bexxar) | No Change | No Change | No Change | No | |
| PRE1028 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Treosulfan | No Change | No Change | No Change | No | |
| PRE1029 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Vincristine | No Change | No Change | No Change | No | |
| PRE1030 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Drug | Other drug | No Change | No Change | No Change | No | |
| PRE1031 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Specify other drug: | Open text | No Change | No Change | No Change | No | |
| PRE1032 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Total prescribed dose value: | Open text | No Change | No Change | No Change | No | |
| PRE1033 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | mg/m2 | checked | No Change | No Change | No Change | No | |
| PRE1034 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | mg/kg | checked | No Change | No Change | No Change | No | |
| PRE1035 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Addition of Information Requested | mg | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1036 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | AUC (mg x h/L) | checked | No Change | No Change | No Change | No | |
| PRE1037 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | AUC (µmol x min/L) | checked | No Change | No Change | No Change | No | |
| PRE1038 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | CSS (ng/mL) | checked | No Change | No Change | No Change | No | |
| PRE1039 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Date started: | Open text | No Change | No Change | No Change | No | |
| PRE1040 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Specify administration | Oral | No Change | No Change | No Change | No | |
| PRE1041 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Specify administration | IV | No Change | No Change | No Change | No | |
| PRE1042 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Pre-HCT Preparative Regimen (Conditioning) | Yes | Specify administration | Both | No Change | No Change | No Change | No | |
| PRE1043 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | ALG, ALS, ATG, ATS | No Change | No Change | No Change | No | |
| PRE1044 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | Alemtuzumab (Campath) | No Change | No Change | No Change | No | |
| PRE1045 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | Defibrotide | No Change | No Change | No Change | No | |
| PRE1046 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | KGF | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1047 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | Ursodiol | No Change | No Change | No Change | No | |
| PRE1048 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify drugs given | None | No Change | No Change | No Change | No | |
| PRE1049 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Total prescribed dose [in mg/kg] | Open text | Change/Clarification of Information Requested | Total prescribed dose of ATG [in mg/kg]: | No Change | No | Capture data accurately | 
| PRE1050 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify source | ATGAM (horse) | No Change | No Change | No Change | No | |
| PRE1051 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify source | ATG - Fresnius (rabbit) | Change/Clarification of Information Requested | No Change | ATG - Fresenius (rabbit) | No | Typographical/grammatical errors corrected for clarification | 
| PRE1052 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify source | Thymoglobulin (rabbit) | No Change | No Change | No Change | No | |
| PRE1053 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify source | Other | No Change | No Change | No Change | No | |
| PRE1054 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Specify other source: | Open text | No Change | No Change | No Change | No | |
| PRE1055 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | Total prescribed dose: | Open text | Change/Clarification of Information Requested | Total prescribed dose of Campath: | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1056 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | mg | checked | No Change | No Change | No Change | No | |
| PRE1057 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | mg/kg | checked | No Change | No Change | No Change | No | |
| PRE1058 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Additional Drugs Given In the Peri-Transplant Period | No | mg/m² | checked | No Change | No Change | No Change | No | |
| PRE1059 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Was GVHD prophylaxis planned? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1060 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Was GVHD prophylaxis planned? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1061 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Abatacept | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1062 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Anti CD 25 (Zenapax, Daclizumab, AntiTAC) | Deletion of Information Requested | No | Capture data accurately | ||
| PRE1063 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Blinded randomized trial | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1064 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Bortezomib | Deletion of Information Requested | No | Catpure data accurately | ||
| PRE1065 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | CD34 enriched (CD34+ selection) | Change/Clarification of Information Requested | Specify intervention | No Change | No | Capture data accurately | 
| PRE1066 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Corticosteriods (systemic) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1067 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Cyclophosphamide (Cytoxan) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1068 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Cyclosporine (CSA, Neoral, Sandimmune) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1069 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Addition of Information Requested | Specify drugs | Emapalumab-Izsg (Gamifant) | No | Capture data accurately | |
| PRE1070 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Extra-corporeal photopheresis (ECP) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1071 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Ex-vivo T-cell depletion | Change/Clarification of Information Requested | Specify intervention | No Change | No | Capture data accurately | 
| PRE1072 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Filgotinib | Deletion of Information Requested | No | Capture data accurately | ||
| PRE1073 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Maraviroc | Deletion of Information Requested | No | Capture data accurately | ||
| PRE1074 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Methotrexate (MTX) (Amethopterin) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1075 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Mycophenolate mofetil (MMF) (Cellcept) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1076 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Addition of Information Requested | Specify drugs | Obinutuzumab (Gazyva) | No | Capture data accurately | |
| PRE1077 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Ruxolitinib | Change/Clarification of Information Requested | Specify drugs | Ruxolitinib (Jakifi) | No | Capture data accurately | 
| PRE1078 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Sirolimus (Rapamycin, Rapamune) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1079 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Tacrolimus (FK506) | Change/Clarification of Information Requested | Specify drugs | No Change | No | Capture data accurately | 
| PRE1080 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Tocilizumab | Change/Clarification of Information Requested | Specify drugs | Tocilizumab (Actemra) | No | Capture data accurately | 
| PRE1081 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Addition of Information Requested | Specify drugs | None | No | Capture data accurately | |
| PRE1082 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Other agent | Change/Clarification of Information Requested | Specify drugs | Other drug | No | Capture data accurately | 
| PRE1083 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Change/Clarification of Information Requested and Addition of Response Option | Specify intervention | None | No | Capture data accurately | |
| PRE1084 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify drugs / intervention | Change/Clarification of Information Requested and Addition of Response Option | Specify intervention | Other intervention | No | Capture data accurately | |
| PRE1085 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Specify other agent: | Open text | Change/Clarification of Information Requested | Specify other drug: | No Change | No | Capture data accurately | 
| PRE1086 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Planned start date of abatacept: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1087 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Total planned number of doses of abatacept: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1088 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/kg | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1089 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/m² | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1090 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Planned start date of cyclophosphamide: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1091 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Total planned number of doses of cyclophosphamide: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1092 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/kg | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1093 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/m² | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1094 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Planned start date of methotrexate: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1095 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Total planned number of doses of methotrexate: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1096 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/kg | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1097 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | mg/m² | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1098 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | GVHD Prophylaxis | No | Addition of Information Requested | Specify other intervention: | Open Text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1099 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Is additional post-HCT therapy planned? | yes | No Change | No Change | No Change | No | |
| PRE1100 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Is additional post-HCT therapy planned? | no | No Change | No Change | No Change | No | |
| PRE1101 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Azacitidine (Vidaza) | No Change | No Change | No Change | No | |
| PRE1102 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Blinatumomab | No Change | No Change | No Change | No | |
| PRE1103 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Bortezomib (Velcade) | No Change | No Change | No Change | No | |
| PRE1104 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Bosutinib | No Change | No Change | No Change | No | |
| PRE1105 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Brentuximab | No Change | No Change | No Change | No | |
| PRE1106 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Carfilzomib | No Change | No Change | No Change | No | |
| PRE1107 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 1 | No | Specify post-HCT therapy planned | Addition of Information Requested | No Change | CAR-T | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1108 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Cellular therapy | No Change | No Change | No Change | No | |
| PRE1109 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Crenolanib | No Change | No Change | No Change | No | |
| PRE1110 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Daratumumab | No Change | No Change | No Change | No | |
| PRE1111 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Dasatinib | No Change | No Change | No Change | No | |
| PRE1112 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Decitabine | No Change | No Change | No Change | No | |
| PRE1113 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Elotuzumab | No Change | No Change | No Change | No | |
| PRE1114 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Enasidenib | No Change | No Change | No Change | No | |
| PRE1115 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Gilteritinib | No Change | No Change | No Change | No | |
| PRE1116 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Ibrutinib | No Change | No Change | No Change | No | |
| PRE1117 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Imanitib mesylate (Gleevec, Glivec) | No Change | No Change | No Change | No | |
| PRE1118 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Intrathecal therapy | No Change | No Change | No Change | No | |
| PRE1119 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Ivosidenib | No Change | No Change | No Change | No | |
| PRE1120 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Ixazomib | No Change | No Change | No Change | No | |
| PRE1121 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Lenalidomide (Revlimid) | No Change | No Change | No Change | No | |
| PRE1122 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Lestaurtinib | No Change | No Change | No Change | No | |
| PRE1123 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Local radiotherapy | No Change | No Change | No Change | No | |
| PRE1124 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Midostaurin | No Change | No Change | No Change | No | |
| PRE1125 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Nilotinib | No Change | No Change | No Change | No | |
| PRE1126 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Obinutuzumab | No Change | No Change | No Change | No | |
| PRE1127 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Pacritinib | No Change | No Change | No Change | No | |
| PRE1128 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Ponatinib | No Change | No Change | No Change | No | |
| PRE1129 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Quizartinib | No Change | No Change | No Change | No | |
| PRE1130 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Rituximab (Rituxan, MabThera) | No Change | No Change | No Change | No | |
| PRE1131 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Sorafenib | No Change | No Change | No Change | No | |
| PRE1132 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Sunitinib | No Change | No Change | No Change | No | |
| PRE1133 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Thalidomide (Thalomid) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1134 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Addition of Information Requested | No Change | Venetoclax (Venclexta) | No | Capture data accurately | |
| PRE1135 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Other therapy | No Change | No Change | No Change | No | |
| PRE1136 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify post-HCT therapy planned | Unknown | No Change | No Change | No Change | No | |
| PRE1137 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Post-HCT Disease Therapy Planned as of Day 0 | No | Specify other therapy: | Open text | No Change | No Change | No Change | No | |
| PRE1138 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | Blinatumomab (Blincyto) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1139 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | Gemtuzumab ozogamicin (Mylotarg) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1140 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | Inotuzumab ozogamicin (Besponsa) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1141 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | Adienne Tepadina® | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1142 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | Mogamulizumab (Poteligeo) | No Change | No Change | No Change | No | |
| PRE1143 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | Prior Exposure: Potential Study Eligibility | No | Specify if the recipient received any of the following (at any time prior to HCT / infusion) | None | No Change | No Change | No Change | No | |
| PRE1144 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Was the HCT impacted for a reason related to the COVID-19 (SARS-CoV-2) pandemic? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1145 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Was the HCT impacted for a reason related to the COVID-19 (SARS-CoV-2) pandemic? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1146 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the HCT date different than the originally intended HCT date? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1147 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the HCT date different than the originally intended HCT date? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1148 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Original date of HCT: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1149 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Date estimated | checked | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1150 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the donor different than the originally intended donor? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1151 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the donor different than the originally intended donor? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1152 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended donor | Unrelated donor | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1153 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended donor | Syngeneic | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1154 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended donor | HLA-identical sibling | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1155 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended donor | HLA-matched other relative | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1156 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended donor | HLA-mismatched relative | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1157 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the product type (bone marrow, PBSC, cord blood unit) different than the originally intended product type? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1158 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Is the product type (bone marrow, PBSC, cord blood unit) different than the originally intended product type? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1159 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended product type | Bone marrow | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1160 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended product type | PBSC | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1161 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended product type | Single cord blood unit | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1162 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify the originally intended product type | Other product | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1163 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Specify other product type: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1164 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Was the current product thawed from a cryopreserved state prior to infusion? | yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1165 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Was the current product thawed from a cryopreserved state prior to infusion? | no | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1166 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Did the preparative regimen change from the original plan? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1167 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Did the preparative regimen change from the original plan? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1168 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Did the GVHD prophylaxis change from the original plan? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1169 | Pre-Transplant Information Collection | Pre-Transplant Essential Data | COVID-19 (SARS-CoV-2) Impact on Hematopoietic Cell Transplantation (HCT) | No | Did the GVHD prophylaxis change from the original plan? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1170 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | Date of diagnosis of primary disease for HCT / Cellular therapy | Open text | Change/Clarification of Information Requested | Date of diagnosis of primary disease for infusion | No Change | No | Capture data accurately | 
| PRE1171 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Acute myelogenous leukemia (AML) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1172 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Acute lymphoblastic leukemia (ALL) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1173 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Acute leukemia of ambiguous lineage and other myeloid neoplasms | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | Acute leukemia of mixed or ambiguous lineage | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1174 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Chronic myeloid leukemia (CML) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1175 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Myelodysplastic syndrome (MDS) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1176 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Myeloproliferative neoplasms (MPN) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1177 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Other leukemia | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1178 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Hodgkin lymphoma | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1179 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Non-Hodgkin lymphoma | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1180 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Multiple myeloma / plasma cell disorder (PCD) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1181 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Solid tumors | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1182 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Aplastic Anemia | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1183 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Inherited bone marrow failure syndromes | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1184 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Hemoglobinopathies | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1185 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Paroxysmal nocturnal hemoglobinuria (PNH) | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1186 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Disorders of the immune system | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | Inborn Errors of Immunity (IEI) | No | Capture data accurately | 
| PRE1187 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Inherited abnormalities of platelets | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1188 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Inherited disorders of metabolism | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1189 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Histiocytic disorders | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1190 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Autoimmune diseases | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1191 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Tolerance induction associated with solid organ transplant | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1192 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Recessive dystrophic epidermolysis bullosa | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1193 | Pre-Transplant Information Collection | Disease Classification | Primary Disease for Infusion | No | What was the primary disease for which the HCT / cellular therapy was performed? | Other disease | Change/Clarification of Information Requested | What was the primary disease for which the infusion was performed? | No Change | No | Capture data accurately | 
| PRE1194 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with MLLT3::KMT2A fusion | No Change | No Change | No Change | No | |
| PRE1195 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with other KMT2A rearrangements | No Change | No Change | No Change | No | |
| PRE1196 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with DEK::NUP214 fusion | No Change | No Change | No Change | No | |
| PRE1197 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with MECOM (EVI1), GATA2 rearrangement | No Change | No Change | No Change | No | |
| PRE1198 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with Other MECOM rearrangements | No Change | No Change | No Change | No | |
| PRE1199 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with RBM15::MRTFA fusion | No Change | No Change | No Change | No | |
| PRE1200 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with RUNX1::RUNX1T1 fusion | No Change | No Change | No Change | No | |
| PRE1201 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with CBFB::MYH11 fusion | No Change | No Change | No Change | No | |
| PRE1202 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute promyelocytic leukemia with PML::RARA fusion | No Change | No Change | No Change | No | |
| PRE1203 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute promyelocytic leukemia with other RARA fusions | No Change | No Change | No Change | No | |
| PRE1204 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with BCR::ABL1 fusion | No Change | No Change | No Change | No | |
| PRE1205 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with NPM1 mutation | No Change | No Change | No Change | No | |
| PRE1206 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with CEBPA mutation | No Change | No Change | No Change | No | |
| PRE1207 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with myelodysplasia - related | No Change | No Change | No Change | No | |
| PRE1208 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with NUP98 rearrangement | No Change | No Change | No Change | No | |
| PRE1209 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with mutated TP53 | No Change | No Change | No Change | No | |
| PRE1210 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with other defined genetic alterations | No Change | No Change | No Change | No | |
| PRE1211 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with minimal differentiation | No Change | No Change | No Change | No | |
| PRE1212 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia without maturation | No Change | No Change | No Change | No | |
| PRE1213 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia with maturation | No Change | No Change | No Change | No | |
| PRE1214 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myelomonocytic leukemia | No Change | No Change | No Change | No | |
| PRE1215 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute monocytic leukemia | No Change | No Change | No Change | No | |
| PRE1216 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute erythroid leukemia | No Change | No Change | No Change | No | |
| PRE1217 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute megakaryoblastic leukemia | No Change | No Change | No Change | No | |
| PRE1218 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute basophilic leukemia | No Change | No Change | No Change | No | |
| PRE1219 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Myeloid sarcoma | No Change | No Change | No Change | No | |
| PRE1220 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the AML classification | Acute myeloid leukemia, not otherwise specified | No Change | No Change | No Change | No | |
| PRE1221 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did AML transform from MDS or MPN? | Yes, MDS | No Change | No Change | No Change | No | |
| PRE1222 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did AML transform from MDS or MPN? | Yes, MPN | No Change | No Change | No Change | No | |
| PRE1223 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did AML transform from MDS or MPN? | No | No Change | No Change | No Change | No | |
| PRE1224 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Is the disease (AML) therapy related? | yes | No Change | No Change | No Change | No | |
| PRE1225 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Is the disease (AML) therapy related? | no | No Change | No Change | No Change | No | |
| PRE1226 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Is the disease (AML) therapy related? | Unknown | No Change | No Change | No Change | No | |
| PRE1227 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have a predisposing condition? | Yes | Change/Clarification of Information Requested | Did the recipient have a predisposing condition or antecedent hematologic disorder? | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1228 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have a predisposing condition? | No | Change/Clarification of Information Requested | Did the recipient have a predisposing condition or antecedent hematologic disorder? | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1229 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have a predisposing condition? | Unknown | Change/Clarification of Information Requested | Did the recipient have a predisposing condition or antecedent hematologic disorder? | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1230 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Aplastic anemia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1231 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Biallelic germline BLM variant (Bloom syndrome) | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1232 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Childhood MDS with low blasts, hypocellular | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1233 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Childhood MDS with low blasts, not otherwise specified | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1234 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Childhood MDS with increased blasts | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1235 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Chronic eosinophilic leukemia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1236 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Chronic myelomonocytic leukemia (CMML), Myelodysplastic | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1237 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Chronic myelomonocytic leukemia (CMML), Myeloproliferative | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1238 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Chronic neutrophilic leukemia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1239 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Diamond-Blackfan Anemia (pure red cell aplasia) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1240 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Down syndrome | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1241 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Essential thrombocythemia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1242 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Fanconi anemia | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1243 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline CEBPA variant (CEBPA-associated familial AML) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1244 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline DDX41 variant | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1245 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline TP53 variant (Li-Fraumeni Syndrome) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1246 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline RUNX1 variant | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1247 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline ANKRD26 variant (Thrombocytopenia 2) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1248 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline ETV6 variant (Thrombocytopenia 5) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1249 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline GATA2 variant (GATA2 deficiency) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1250 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline SAMD9 variant (MIRAGE Syndrome) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1251 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Germline SAMD9L variant (SAMD9L-related Ataxia Pancytopenia Syndrome) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1252 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Juvenile myelomonocytic leukemia (JMML) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1253 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS, with low blasts (MDS-LB; <5% BM, <2% PB) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1254 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS, hypoplastic (MDS-h) <=25% cellularity by age | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1255 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS with increased blasts (MDS-IB1) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1256 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS with increased blasts (MDS-IB2) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1257 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS with fibrosis (MDS-f) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1258 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | MDS / MPN with ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) and thrombocytosis | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1259 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic / myeloproliferative neoplasm with neutrophilia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1260 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic / myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1261 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic / myeloproliferative neoplasm, NOS | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1262 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic syndrome with low blasts and isolated 5q deletion (MDS-5q) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1263 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic syndrome with low blasts and SF3B1 mutation (MDS-SF3B1) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1264 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic syndrome with low blasts and ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1265 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myelodysplastic syndrome with biallelic TP53 inactivation (MDS-biTP53) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1266 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Myeloproliferative neoplasm (MPN), NOS | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1267 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Polycythemia vera (PCV) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1268 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify AML predisposing condition or antecedent hematologic disorder | Primary myelofibrosis (PMF) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1269 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | RASopathies (Neurofibromatosis type 1, CBL syndrome, Noonan syndrome, Noonan syndrome-like disorders | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1270 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Severe congenital neutropenia (SCN) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1271 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Shwachman-Diamond syndrome (SDS) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1272 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Telomere biology disorders (Dyskeratosis congenita and others) | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1273 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify condition | Other condition | Change/Clarification of Information Requested | Specify AML predisposing condition or antecedent hematologic disorder | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1274 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other condition: | Open text | Change/Clarification of Information Requested | Specify other AML predisposing condition antecedent hematologic disorder: | No Change | No | Capture data accurately | 
| PRE1275 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE1276 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE1277 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No Change | No Change | No Change | No | |
| PRE1278 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE1279 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE1280 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE1281 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1282 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1283 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1284 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1285 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1286 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1287 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1288 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1289 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1290 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1291 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1292 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1293 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1294 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1295 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1296 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1297 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1298 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1299 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1300 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1301 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | Change/Clarification of Information Requested | No Change | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1302 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1303 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1304 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | Change/Clarification of Information Requested | No Change | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1305 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | Change/Clarification of Information Requested | No Change | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1306 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1307 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | Change/Clarification of Information Requested | No Change | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1308 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | Change/Clarification of Information Requested | No Change | t(16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1309 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1310 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1311 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1312 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1313 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1314 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1315 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1316 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1317 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1318 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | Change/Clarification of Information Requested | No Change | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1319 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | Change/Clarification of Information Requested | No Change | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1320 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(3q26.2;v), MECOM (EVI1) - rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1321 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1322 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1323 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1324 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1325 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE1326 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE1327 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE1328 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE1329 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1330 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE1331 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1332 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1333 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1334 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1335 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1336 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1337 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1338 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1339 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1340 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1341 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1342 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1343 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1344 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1345 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1346 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1347 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1348 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1349 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1350 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | No Change | No Change | No Change | No | |
| PRE1351 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE1352 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | No Change | No Change | No Change | No | |
| PRE1353 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | No Change | No Change | No Change | No | |
| PRE1354 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE1355 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | No Change | No Change | No Change | No | |
| PRE1356 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | No Change | No Change | No Change | No | |
| PRE1357 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1358 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1359 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1360 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1361 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1362 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1363 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1364 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1365 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1366 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE1367 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | No Change | No Change | No Change | No | |
| PRE1368 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE1369 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1370 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1371 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1372 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1373 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1374 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE1375 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE1376 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE1377 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1378 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1379 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1380 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1381 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1382 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1383 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1384 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1385 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1386 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Positive | No Change | No Change | No Change | No | |
| PRE1387 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Negative | No Change | No Change | No Change | No | |
| PRE1388 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Not Done | No Change | No Change | No Change | No | |
| PRE1389 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1390 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1391 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1392 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Biallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1393 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Monoallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1394 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Unknown | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1395 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1396 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1397 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1398 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1399 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1400 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1401 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1402 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1403 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1404 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Positive | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1405 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Negative | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1406 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Not Done | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1407 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Known | No Change | No Change | No Change | No | |
| PRE1408 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Unknown | No Change | No Change | No Change | No | |
| PRE1409 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify FLT3 - ITD allelic ratio: | Open text | No Change | No Change | No Change | No | |
| PRE1410 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1411 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1412 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1413 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1414 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1415 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1416 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1417 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1418 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1419 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1420 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1421 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Not done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1422 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Positive | No Change | No Change | No Change | No | |
| PRE1423 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Negative | No Change | No Change | No Change | No | |
| PRE1424 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Not Done | No Change | No Change | No Change | No | |
| PRE1425 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1426 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1427 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1428 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1429 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1430 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1431 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1432 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1433 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1434 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1435 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1436 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1437 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1438 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1439 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1440 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1441 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1442 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1443 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1444 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1445 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1446 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | Specify any other positive molecular marker(s) identified | No | Reduce burden | |
| PRE1447 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | Specify any other positive molecular marker(s) identified | No | Reduce burden | |
| PRE1448 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | Specify any other positive molecular marker(s) identified | No | Reduce burden | |
| PRE1449 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1450 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1451 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1452 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1453 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1454 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1455 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE1456 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE1457 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE1458 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE1459 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1460 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE1461 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE1462 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1463 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1464 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | Yes | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1465 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1466 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1467 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1468 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1469 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1470 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1471 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1472 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1473 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1474 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1475 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1476 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1477 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1478 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1479 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1480 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1481 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1482 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | Change/Clarification of Information Requested | No Change | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1483 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1484 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1485 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | Change/Clarification of Information Requested | No Change | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1486 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | Change/Clarification of Information Requested | No Change | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1487 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1488 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | Change/Clarification of Information Requested | No Change | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1489 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | Change/Clarification of Information Requested | No Change | t(16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1490 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1491 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1492 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1493 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1494 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1495 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1496 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1497 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1498 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1499 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | Change/Clarification of Information Requested | No Change | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1500 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | Change/Clarification of Information Requested | No Change | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1501 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(3q26.2;v), MECOM (EVI1) - rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1502 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1503 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1504 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1505 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1506 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE1507 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE1508 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE1509 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1510 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE1511 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1512 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | Yes | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1513 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1514 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1515 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1516 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1517 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1518 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1519 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1520 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1521 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1522 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1523 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1524 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1525 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1526 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1527 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1528 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1529 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1530 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | No Change | No Change | No Change | No | |
| PRE1531 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE1532 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | No Change | No Change | No Change | No | |
| PRE1533 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | No Change | No Change | No Change | No | |
| PRE1534 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE1535 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | No Change | No Change | No Change | No | |
| PRE1536 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | No Change | No Change | No Change | No | |
| PRE1537 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1538 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1539 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1540 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1541 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1542 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1543 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1544 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1545 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1546 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE1547 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | No Change | No Change | No Change | No | |
| PRE1548 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE1549 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1550 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1551 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1552 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1553 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1554 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE1555 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE1556 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE1557 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1558 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1559 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1560 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1561 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1562 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1563 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1564 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1565 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1566 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Positive | No Change | No Change | No Change | No | |
| PRE1567 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Negative | No Change | No Change | No Change | No | |
| PRE1568 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Not Done | No Change | No Change | No Change | No | |
| PRE1569 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1570 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1571 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1572 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Biallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1573 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Monoallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1574 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Unknown | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1575 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1576 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1577 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1578 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1579 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1580 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1581 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1582 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1583 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1584 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Positive | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1585 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Negative | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1586 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Not Done | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1587 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Known | No Change | No Change | No Change | No | |
| PRE1588 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Unknown | No Change | No Change | No Change | No | |
| PRE1589 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify FLT3 - ITD allelic ratio: | Open text | No Change | No Change | No Change | No | |
| PRE1590 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1591 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1592 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1593 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1594 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1595 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1596 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1597 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1598 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1599 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1600 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1601 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Not done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1602 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Positive | No Change | No Change | No Change | No | |
| PRE1603 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Negative | No Change | No Change | No Change | No | |
| PRE1604 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Not Done | No Change | No Change | No Change | No | |
| PRE1605 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1606 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1607 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1608 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1609 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1610 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1611 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1612 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1613 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1614 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1615 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1616 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1617 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1618 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1619 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1620 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1621 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1622 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1623 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1624 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1625 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1626 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1627 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1628 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1629 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1630 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1631 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1632 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1633 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1634 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1635 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE1636 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE1637 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE1638 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE1639 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1640 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE1641 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE1642 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1643 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1644 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1645 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1646 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1647 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1648 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1649 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1650 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1651 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1652 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1653 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1654 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1655 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1656 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1657 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1658 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1659 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1660 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1661 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1662 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | Change/Clarification of Information Requested | No Change | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1663 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1664 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1665 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | Change/Clarification of Information Requested | No Change | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1666 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | Change/Clarification of Information Requested | No Change | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1667 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1668 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | Change/Clarification of Information Requested | No Change | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1669 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | Change/Clarification of Information Requested | No Change | t(16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1670 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1671 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1672 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1673 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1674 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1675 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1676 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1677 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1678 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1679 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | Change/Clarification of Information Requested | No Change | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1680 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | Change/Clarification of Information Requested | No Change | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1681 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Addition of Information Requested | No Change | t(3q26.2;v), MECOM (EVI1) - rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1682 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1683 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1684 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1685 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1686 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE1687 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE1688 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE1689 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1690 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE1691 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1692 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1693 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1694 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1695 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1696 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1697 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE1698 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1699 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE1700 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -18 | No Change | No Change | No Change | No | |
| PRE1701 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -X | No Change | No Change | No Change | No | |
| PRE1702 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE1703 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1704 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1705 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE1706 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +13 | No Change | No Change | No Change | No | |
| PRE1707 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +14 | No Change | No Change | No Change | No | |
| PRE1708 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1709 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | +22 | No Change | No Change | No Change | No | |
| PRE1710 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(3;3) | No Change | No Change | No Change | No | |
| PRE1711 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE1712 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(8;21) | No Change | No Change | No Change | No | |
| PRE1713 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;11) | No Change | No Change | No Change | No | |
| PRE1714 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE1715 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(15;17) and variants | No Change | No Change | No Change | No | |
| PRE1716 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | t(16;16) | No Change | No Change | No Change | No | |
| PRE1717 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE1718 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE1719 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE1720 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE1721 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE1722 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(16q) / 16q- | No Change | No Change | No Change | No | |
| PRE1723 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(17q) / 17q- | No Change | No Change | No Change | No | |
| PRE1724 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE1725 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | del(21q) / 21q- | No Change | No Change | No Change | No | |
| PRE1726 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE1727 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | inv(16) | No Change | No Change | No Change | No | |
| PRE1728 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE1729 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | 12p any abnormality | No Change | No Change | No Change | No | |
| PRE1730 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1731 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE1732 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1733 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1734 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE1735 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE1736 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE1737 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1738 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1739 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1740 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1741 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1742 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1743 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1744 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1745 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1746 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Positive | No Change | No Change | No Change | No | |
| PRE1747 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Negative | No Change | No Change | No Change | No | |
| PRE1748 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | CEBPA | Not Done | No Change | No Change | No Change | No | |
| PRE1749 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1750 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1751 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1752 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Biallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1753 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Monoallelic | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1754 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify the CEBPA mutation | Unknown | Change/Clarification of Information Requested | Specify CEBPA allelic expression | No Change | No | Capture data accurately | 
| PRE1755 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1756 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1757 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1758 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1759 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1760 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1761 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1762 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1763 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – TKD | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1764 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Positive | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1765 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Negative | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1766 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 – ITD mutation | Not Done | Change/Clarification of Information Requested | FLT3 – ITD | No Change | No | Capture data accurately | 
| PRE1767 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Known | No Change | No Change | No Change | No | |
| PRE1768 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | FLT3 - ITD allelic ratio | Unknown | No Change | No Change | No Change | No | |
| PRE1769 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify FLT3 - ITD allelic ratio: | Open text | No Change | No Change | No Change | No | |
| PRE1770 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1771 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1772 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1773 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1774 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1775 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1776 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1777 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1778 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | IDH2 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1779 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1780 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1781 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | KIT | Not done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1782 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Positive | No Change | No Change | No Change | No | |
| PRE1783 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Negative | No Change | No Change | No Change | No | |
| PRE1784 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | NPM1 | Not Done | No Change | No Change | No Change | No | |
| PRE1785 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1786 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1787 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1788 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1789 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1790 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1791 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1792 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1793 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1794 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1795 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1796 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1797 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1798 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1799 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1800 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1801 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1802 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1803 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1804 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1805 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1806 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1807 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1808 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1809 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1810 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1811 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1812 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1813 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1814 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1815 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE1816 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE1817 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | yes | No Change | No Change | No Change | No | |
| PRE1818 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | no | No Change | No Change | No Change | No | |
| PRE1819 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | Unknown | No Change | No Change | No Change | No | |
| PRE1820 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | Primary induction failure | No Change | No Change | No Change | No | |
| PRE1821 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | 1st complete remission | No Change | No Change | No Change | No | |
| PRE1822 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | 2nd complete remission | No Change | No Change | No Change | No | |
| PRE1823 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | >3rd complete remission | No Change | No Change | No Change | No | |
| PRE1824 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | 1st relapse | No Change | No Change | No Change | No | |
| PRE1825 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | 2nd relapse | No Change | No Change | No Change | No | |
| PRE1826 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | >3rd relapse | No Change | No Change | No Change | No | |
| PRE1827 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | What was the disease status? | No treatment | No Change | No Change | No Change | No | |
| PRE1828 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | 1 | No Change | No Change | No Change | No | |
| PRE1829 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | 2 | No Change | No Change | No Change | No | |
| PRE1830 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | >3 | No Change | No Change | No Change | No | |
| PRE1831 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | Addition of Information Requested | No Change | Treatment not given in cycles | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1832 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Date CR first achieved: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1833 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Addition of Information Requested | Date of most recent relapse: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1834 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | FISH | No Change | No Change | No Change | No | |
| PRE1835 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | Karyotyping | No Change | No Change | No Change | No | |
| PRE1836 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | Flow Cytometry | No Change | No Change | No Change | No | |
| PRE1837 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | PCR | No Change | No Change | No Change | No | |
| PRE1838 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | NGS | No Change | No Change | No Change | No | |
| PRE1839 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Specify method(s) that was used to assess measurable residual disease status | Not assessed | No Change | No Change | No Change | No | |
| PRE1840 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by FISH? | Yes | No Change | No Change | No Change | No | |
| PRE1841 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by FISH? | No | No Change | No Change | No Change | No | |
| PRE1842 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by karyotyping assay? | Yes | No Change | No Change | No Change | No | |
| PRE1843 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by karyotyping assay? | No | No Change | No Change | No Change | No | |
| PRE1844 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by flow cytometry? | Yes | No Change | No Change | No Change | No | |
| PRE1845 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by flow cytometry? | No | No Change | No Change | No Change | No | |
| PRE1846 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Which leukemia immunophenotype was used for measurable residual disease detection? | Original leukemia immunophenotype | No Change | No Change | No Change | No | |
| PRE1847 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Which leukemia immunophenotype was used for measurable residual disease detection? | Aberrant phenotype | No Change | No Change | No Change | No | |
| PRE1848 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Lower limit of detection [original]: | Open text | No Change | No Change | No Change | No | |
| PRE1849 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Lower limit of detection [aberrant]: | Open text | No Change | No Change | No Change | No | |
| PRE1850 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by PCR? | Yes | No Change | No Change | No Change | No | |
| PRE1851 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by PCR? | No | No Change | No Change | No Change | No | |
| PRE1852 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by NGS? | Yes | No Change | No Change | No Change | No | |
| PRE1853 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Was measurable residual disease detected by NGS? | No | No Change | No Change | No Change | No | |
| PRE1854 | Pre-Transplant Information Collection | Disease Classification | Acute Myeloid Leukemia (AML) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE1855 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE1856 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with high hyperdiploidy | No Change | No Change | No Change | No | |
| PRE1857 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with hypodiploidy | No Change | No Change | No Change | No | |
| PRE1858 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma, with iAMP21 | No Change | No Change | No Change | No | |
| PRE1859 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with BCR::ABL1 fusion | No Change | No Change | No Change | No | |
| PRE1860 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma, BCR::ABL1-like features | No Change | No Change | No Change | No | |
| PRE1861 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with KMT2A rearrangement | No Change | No Change | No Change | No | |
| PRE1862 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with ETV6::RUNX1 fusion | No Change | No Change | No Change | No | |
| PRE1863 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with ETV6::RUNX1-like features | No Change | No Change | No Change | No | |
| PRE1864 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with TCF3::PBX1 fusion | No Change | No Change | No Change | No | |
| PRE1865 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with IGH::IL3 fusion | No Change | No Change | No Change | No | |
| PRE1866 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with TCF3::HLF fusion | No Change | No Change | No Change | No | |
| PRE1867 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with DUX4 rearrangement | No Change | No Change | No Change | No | |
| PRE1868 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with IG::MYC fusion | No Change | No Change | No Change | No | |
| PRE1869 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with MEF2D rearrangement | No Change | No Change | No Change | No | |
| PRE1870 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with ZNF384 rearrangement | No Change | No Change | No Change | No | |
| PRE1871 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with NUTM1 rearrangement | No Change | No Change | No Change | No | |
| PRE1872 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with PAX5alt abnormalities | No Change | No Change | No Change | No | |
| PRE1873 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | B-lymphoblastic leukemia / lymphoma with PAX5 p.P80R abnormalities | No Change | No Change | No Change | No | |
| PRE1874 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | T-lymphoblastic leukemia / lymphoma | No Change | No Change | No Change | No | |
| PRE1875 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | Early T-precursor lymphoblastic leukemia / lymphoma | No Change | No Change | No Change | No | |
| PRE1876 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | Early T-precursor lymphoblastic leukemia / lymphoma, with BCL11B rearrangement | No Change | No Change | No Change | No | |
| PRE1877 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify ALL classification | Natural killer (NK)- cell lymphoblastic leukemia / lymphoma | No Change | No Change | No Change | No | |
| PRE1878 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have a predisposing condition? | yes | No Change | No Change | No Change | No | |
| PRE1879 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have a predisposing condition? | no | No Change | No Change | No Change | No | |
| PRE1880 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have a predisposing condition? | Unknown | No Change | No Change | No Change | No | |
| PRE1881 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Aplastic anemia | No Change | No Change | No Change | No | |
| PRE1882 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Biallelic germline BLM variant (Bloom syndrome) | No Change | No Change | No Change | No | |
| PRE1883 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Down Syndrome | No Change | No Change | No Change | No | |
| PRE1884 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Fanconi anemia | No Change | No Change | No Change | No | |
| PRE1885 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline DDX41 variant | No Change | No Change | No Change | No | |
| PRE1886 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline TP53 variant (Li-Fraumeni Syndrome) | No Change | No Change | No Change | No | |
| PRE1887 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline RUNX1 variant (familial platelet disorder with associated myeloid malignancy, FPD-MM) | No Change | No Change | No Change | No | |
| PRE1888 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline ANKRD26 variant (Thrombocytopenia 2) | No Change | No Change | No Change | No | |
| PRE1889 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline ETV6 variant (Thrombocytopenia 5) | No Change | No Change | No Change | No | |
| PRE1890 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline PAX5 mutation | No Change | No Change | No Change | No | |
| PRE1891 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Germline IKZF1 mutation | No Change | No Change | No Change | No | |
| PRE1892 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify condition | Other condition | No Change | No Change | No Change | No | |
| PRE1893 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other condition: | Open text | No Change | No Change | No Change | No | |
| PRE1894 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tyrosine kinase inhibitors given for therapy at any time prior to the start of the preparative regimen / infusion? | yes | No Change | No Change | No Change | No | |
| PRE1895 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tyrosine kinase inhibitors given for therapy at any time prior to the start of the preparative regimen / infusion? | no | No Change | No Change | No Change | No | |
| PRE1896 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify tyrosine kinase inhibitors | Dasatinib (Spycel) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1897 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify tyrosine kinase inhibitors | Imatinib (Gleevec) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1898 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify tyrosine kinase inhibitors | Nilotinib (AMN107, Tasigna) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1899 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify tyrosine kinase inhibitors | Ponatinib (Iclusig) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1900 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify tyrosine kinase inhibitors | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1901 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Specify other tyrosine kinase inhibitor: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE1902 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE1903 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE1904 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No Change | No Change | No Change | No | |
| PRE1905 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE1906 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE1907 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE1908 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1909 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1910 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1911 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1912 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1913 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1914 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1915 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1916 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1917 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1918 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1919 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE1920 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1921 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | Change/Clarification of Information Requested | No Change | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1922 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | Change/Clarification of Information Requested | No Change | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1923 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | Change/Clarification of Information Requested | No Change | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1924 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | Change/Clarification of Information Requested | No Change | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1925 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | Change/Clarification of Information Requested | No Change | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1926 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | Change/Clarification of Information Requested | No Change | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1927 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1928 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | Change/Clarification of Information Requested | No Change | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1929 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | Change/Clarification of Information Requested | No Change | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1930 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | Change/Clarification of Information Requested | No Change | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1931 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE1932 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2), IZKF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1933 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE1934 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE1935 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE1936 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE1937 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE1938 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE1939 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1940 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE1941 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE1942 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | No Change | No Change | No Change | No | |
| PRE1943 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1944 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE1945 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE1946 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE1947 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE1948 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE1949 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE1950 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE1951 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE1952 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE1953 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1954 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE1955 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE1956 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE1957 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE1958 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE1959 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE1960 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1961 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE1962 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE1963 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | No Change | No Change | No Change | No | |
| PRE1964 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | No Change | No Change | No Change | No | |
| PRE1965 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | No Change | No Change | No Change | No | |
| PRE1966 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | No Change | No Change | No Change | No | |
| PRE1967 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | No Change | No Change | No Change | No | |
| PRE1968 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | No Change | No Change | No Change | No | |
| PRE1969 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE1970 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | No Change | No Change | No Change | No | |
| PRE1971 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | No Change | No Change | No Change | No | |
| PRE1972 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | No Change | No Change | No Change | No | |
| PRE1973 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE1974 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1975 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE1976 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE1977 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE1978 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE1979 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE1980 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE1981 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE1982 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE1983 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE1984 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE1985 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE1986 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE1987 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1988 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE1989 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE1990 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE1991 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE1992 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1993 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1994 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1995 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1996 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1997 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1998 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE1999 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2000 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2001 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2002 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2003 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2004 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2005 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2006 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2007 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2008 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2009 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2010 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DYRK1a | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2011 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2012 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2013 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2014 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2015 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2016 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2017 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2018 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-ITD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2019 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2020 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2021 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2022 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2023 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2024 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2025 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2026 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2027 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2028 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2029 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2030 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2031 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2032 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2033 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2034 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2035 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2036 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2037 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2038 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NTRK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2039 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2040 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2041 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2042 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2043 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2044 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2045 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2046 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2047 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2048 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2049 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TP53 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2050 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2051 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2052 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2053 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2054 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE2055 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE2056 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE2057 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE2058 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2059 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE2060 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE2061 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE2062 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE2063 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | Yes | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE2064 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2065 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE2066 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE2067 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE2068 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE2069 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE2070 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE2071 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2072 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE2073 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE2074 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | Change/Clarification of Information Requested | No Change | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2075 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | Change/Clarification of Information Requested | No Change | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2076 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | Change/Clarification of Information Requested | No Change | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2077 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | Change/Clarification of Information Requested | No Change | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2078 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | Change/Clarification of Information Requested | No Change | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2079 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | Change/Clarification of Information Requested | No Change | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2080 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2081 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | Change/Clarification of Information Requested | No Change | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2082 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | Change/Clarification of Information Requested | No Change | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2083 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | Change/Clarification of Information Requested | No Change | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2084 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE2085 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2), IZKF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2086 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE2087 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE2088 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE2089 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2090 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE2091 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE2092 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2093 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE2094 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE2095 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | No Change | No Change | No Change | No | |
| PRE2096 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE2097 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE2098 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE2099 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE2100 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE2101 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | Yes | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE2102 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE2103 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE2104 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE2105 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2106 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE2107 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE2108 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE2109 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE2110 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE2111 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE2112 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2113 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE2114 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE2115 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | No Change | No Change | No Change | No | |
| PRE2116 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | No Change | No Change | No Change | No | |
| PRE2117 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | No Change | No Change | No Change | No | |
| PRE2118 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | No Change | No Change | No Change | No | |
| PRE2119 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | No Change | No Change | No Change | No | |
| PRE2120 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | No Change | No Change | No Change | No | |
| PRE2121 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE2122 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | No Change | No Change | No Change | No | |
| PRE2123 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | No Change | No Change | No Change | No | |
| PRE2124 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | No Change | No Change | No Change | No | |
| PRE2125 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE2126 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2127 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE2128 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE2129 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE2130 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE2131 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE2132 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE2133 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2134 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE2135 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE2136 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2137 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE2138 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE2139 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE2140 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE2141 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE2142 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE2143 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE2144 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2145 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2146 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2147 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2148 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2149 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2150 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2151 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2152 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2153 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2154 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2155 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2156 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2157 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2158 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2159 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2160 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2161 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2162 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DYRK1a | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2163 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2164 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2165 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2166 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2167 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2168 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2169 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2170 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-ITD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2171 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2172 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2173 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2174 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2175 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2176 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2177 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2178 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2179 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2180 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2181 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2182 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2183 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2184 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2185 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2186 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2187 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2188 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2189 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2190 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NTRK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2191 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2192 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2193 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2194 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2195 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2196 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2197 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2198 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2199 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2200 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2201 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TP53 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2202 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2203 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2204 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2205 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2206 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE2207 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE2208 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE2209 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE2210 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2211 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE2212 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE2213 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE2214 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE2215 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE2216 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2217 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE2218 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE2219 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE2220 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE2221 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE2222 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE2223 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2224 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE2225 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE2226 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | Change/Clarification of Information Requested | No Change | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2227 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | Change/Clarification of Information Requested | No Change | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2228 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | Change/Clarification of Information Requested | No Change | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2229 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | Change/Clarification of Information Requested | No Change | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2230 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | Change/Clarification of Information Requested | No Change | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2231 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | Change/Clarification of Information Requested | No Change | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2232 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | Change/Clarification of Information Requested | No Change | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2233 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | Change/Clarification of Information Requested | No Change | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2234 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | Change/Clarification of Information Requested | No Change | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2235 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | Change/Clarification of Information Requested | No Change | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2236 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE2237 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2), IZKF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2238 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE2239 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE2240 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE2241 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | Change/Clarification of Information Requested | No Change | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE2242 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE2243 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE2244 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2245 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE2246 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE2247 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | No Change | No Change | No Change | No | |
| PRE2248 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE2249 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE2250 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||||
| PRE2251 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE2252 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE2253 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE2254 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE2255 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE2256 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE2257 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2258 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE2259 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE2260 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE2261 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE2262 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +4 | No Change | No Change | No Change | No | |
| PRE2263 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE2264 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2265 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +17 | No Change | No Change | No Change | No | |
| PRE2266 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | +21 | No Change | No Change | No Change | No | |
| PRE2267 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(1;19) | No Change | No Change | No Change | No | |
| PRE2268 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(2;8) | No Change | No Change | No Change | No | |
| PRE2269 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(4;11) | No Change | No Change | No Change | No | |
| PRE2270 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(5;14) | No Change | No Change | No Change | No | |
| PRE2271 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;14) | No Change | No Change | No Change | No | |
| PRE2272 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(8;22) | No Change | No Change | No Change | No | |
| PRE2273 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(9;22) | No Change | No Change | No Change | No | |
| PRE2274 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(10;14) | No Change | No Change | No Change | No | |
| PRE2275 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(11;14) | No Change | No Change | No Change | No | |
| PRE2276 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | t(12;21) | No Change | No Change | No Change | No | |
| PRE2277 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(6q) / 6q- | No Change | No Change | No Change | No | |
| PRE2278 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2279 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(9p) / 9p- | No Change | No Change | No Change | No | |
| PRE2280 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE2281 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | add(14q) | No Change | No Change | No Change | No | |
| PRE2282 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | (11q23) any abnormality | No Change | No Change | No Change | No | |
| PRE2283 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 9p any abnormality | Change/Clarification of Information Requested | No Change | 9p any abnormality (except for del(9p) / 9p–) | No | Capture data accurately | 
| PRE2284 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | 12p any abnormality | Change/Clarification of Information Requested | No Change | 12p any abnormality (except for del(12p) / 12p–) | No | Capture data accurately | 
| PRE2285 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Addition of Information Requested | No Change | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2286 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hyperdiploid (> 50) | No Change | No Change | No Change | No | |
| PRE2287 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Hypodiploid (< 46) | No Change | No Change | No Change | No | |
| PRE2288 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | iAMP21 | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE2289 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE2290 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other abnormality | Open text | No Change | No Change | No Change | No | |
| PRE2291 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE2292 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE2293 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | yes | Deletion of Information Requested | No | Reduce burden | ||
| PRE2294 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | no | Deletion of Information Requested | No | Reduce burden | ||
| PRE2295 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Were tests for molecular markers performed? | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE2296 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2297 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2298 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | BCR / ABL | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2299 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2300 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2301 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | TEL-AML / AML1 | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2302 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Positive | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2303 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Negative | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2304 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Other molecular marker | Not Done | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE2305 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2306 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2307 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2308 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2309 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2310 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2311 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2312 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2313 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2314 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | DYRK1a | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2315 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2316 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2317 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2318 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2319 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2320 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2321 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2322 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-ITD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2323 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2324 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2325 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2326 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2327 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2328 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2329 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2330 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2331 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2332 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2333 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2334 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2335 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2336 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2337 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2338 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2339 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2340 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2341 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2342 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | NTRK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2343 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2344 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2345 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2346 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2347 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2348 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2349 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2350 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2351 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2352 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2353 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TP53 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2354 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2355 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2356 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2357 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Merged to Check all that Apply (Addition of Information Requested) | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2358 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify other molecular marker | Open text | Change/Clarification of Information Requested | Specify other positive molecular marker(s): | No Change | No | Capture data accurately | 
| PRE2359 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||||
| PRE2360 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | yes | No Change | No Change | No Change | No | |
| PRE2361 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | no | No Change | No Change | No Change | No | |
| PRE2362 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Did the recipient have central nervous system leukemia at any time prior to the start of the preparative regimen / infusion? | Unknown | No Change | No Change | No Change | No | |
| PRE2363 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | Primary induction failure | No Change | No Change | No Change | No | |
| PRE2364 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | 1st complete remission | No Change | No Change | No Change | No | |
| PRE2365 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | 2nd complete remission | No Change | No Change | No Change | No | |
| PRE2366 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | >3rd complete remission | No Change | No Change | No Change | No | |
| PRE2367 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | 1st relapse | No Change | No Change | No Change | No | |
| PRE2368 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | 2nd relapse | No Change | No Change | No Change | No | |
| PRE2369 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | >3rd relapse | No Change | No Change | No Change | No | |
| PRE2370 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | What was the disease status? | No treatment | No Change | No Change | No Change | No | |
| PRE2371 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | 1 | No Change | No Change | No Change | No | |
| PRE2372 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | 2 | No Change | No Change | No Change | No | |
| PRE2373 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | >3 | No Change | No Change | No Change | No | |
| PRE2374 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | How many cycles of induction therapy were required to achieve 1st complete remission? | Addition of Information Requested | No Change | Treatment not given in cycles | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2375 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Date CR first achieved: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2376 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Date of most recent relapse | Open text | No Change | No Change | No Change | No | |
| PRE2377 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | FISH | No Change | No Change | No Change | No | |
| PRE2378 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | Karyotyping | No Change | No Change | No Change | No | |
| PRE2379 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | Flow Cytometry | No Change | No Change | No Change | No | |
| PRE2380 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | PCR | No Change | No Change | No Change | No | |
| PRE2381 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | NGS | No Change | No Change | No Change | No | |
| PRE2382 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | Addition of Information Requested | No Change | ClonoSEQ | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE2383 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Specify method(s) that was used to assess measurable residual disease status | Not assessed | No Change | No Change | No Change | No | |
| PRE2384 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by FISH? | Yes | No Change | No Change | No Change | No | |
| PRE2385 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by FISH? | No | No Change | No Change | No Change | No | |
| PRE2386 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by karyotyping assay? | Yes | No Change | No Change | No Change | No | |
| PRE2387 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by karyotyping assay? | No | No Change | No Change | No Change | No | |
| PRE2388 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by flow cytometry? | Yes | No Change | No Change | No Change | No | |
| PRE2389 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by flow cytometry? | No | No Change | No Change | No Change | No | |
| PRE2390 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Which leukemia immunophenotype was used for measurable residual disease detection? | Original leukemia immunophenotype | No Change | No Change | No Change | No | |
| PRE2391 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Which leukemia immunophenotype was used for measurable residual disease detection? | Aberrant phenotype | No Change | No Change | No Change | No | |
| PRE2392 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Lower limit of detection [original]: | Open text | No Change | No Change | No Change | No | |
| PRE2393 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Lower limit of detection [aberrant]: | Open text | No Change | No Change | No Change | No | |
| PRE2394 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by PCR? | Yes | No Change | No Change | No Change | No | |
| PRE2395 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by PCR? | No | No Change | No Change | No Change | No | |
| PRE2396 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by NGS? | Yes | No Change | No Change | No Change | No | |
| PRE2397 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Was measurable residual disease detected by NGS? | No | No Change | No Change | No Change | No | |
| PRE2398 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Was measurable residual disease detected by ClonoSEQ? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2399 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Addition of Information Requested | Was measurable residual disease detected by ClonoSEQ? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2400 | Pre-Transplant Information Collection | Disease Classification | Acute Lymphoblastic Leukemia (ALL) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE2401 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Blastic plasmacytoid dendritic cell neoplasm | No Change | No Change | No Change | No | |
| PRE2402 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Acute undifferentiated leukemia | No Change | No Change | No Change | No | |
| PRE2403 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed phenotype acute leukemia (MPAL) with BCR::ABL1 fusion | No Change | No Change | No Change | No | |
| PRE2404 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed phenotype acute leukemia with KMT2A rearrangement | No Change | No Change | No Change | No | |
| PRE2405 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed-phenotype acute leukemia with ZNF384 rearrangement | No Change | No Change | No Change | No | |
| PRE2406 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Acute leukemia of ambiguous lineage with BCL11B rearrangement | No Change | No Change | No Change | No | |
| PRE2407 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed-phenotype acute leukemia, B / myeloid | No Change | No Change | No Change | No | |
| PRE2408 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed-phenotype acute leukemia, T / myeloid | No Change | No Change | No Change | No | |
| PRE2409 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Mixed-phenotype acute leukemia, rare types | No Change | No Change | No Change | No | |
| PRE2410 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify acute leukemias of mixed or ambiguous | Acute leukemia of ambiguous lineage, NOS | No Change | No Change | No Change | No | |
| PRE2411 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Specify other acute leukemia of ambiguous lineage or myeloid neoplasm | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE2412 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2413 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | no | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2414 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2415 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2416 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2417 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2418 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2419 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2420 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2421 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2422 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2423 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2424 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2425 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2426 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2427 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2428 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2429 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2430 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2431 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2432 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2433 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2434 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2435 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2436 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2437 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2438 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2439 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2440 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2441 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2442 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2443 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2444 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2445 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2446 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2447 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2448 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2449 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2450 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2451 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2452 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2453 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2454 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2455 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2456 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2457 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2458 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2459 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2), (IZKF1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2460 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2461 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2462 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2463 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2464 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2465 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2466 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2467 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2468 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2469 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2470 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2471 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2472 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3q26.2;v) / MECOM(EVI1)-rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2473 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2474 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2475 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2476 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2477 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2478 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2479 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | iAMP21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2480 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2481 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2482 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2483 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2484 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2485 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2486 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2487 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No evaluable metaphases | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2488 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2489 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2490 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2491 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2492 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2493 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2494 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2495 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2496 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2497 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2498 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2499 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2500 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2501 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2502 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2503 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2504 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2505 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2506 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2507 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2508 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2509 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2510 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2511 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2512 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2513 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2514 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2515 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2516 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2517 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2518 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2519 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2520 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2521 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2522 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2523 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(16;16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2524 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2525 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2526 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2527 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2528 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2529 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2530 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2531 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2532 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2533 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2534 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2535 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2536 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2537 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2538 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2539 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2540 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2541 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2542 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2543 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2544 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2545 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2546 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2547 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2548 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2549 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2550 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2551 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2552 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2553 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2554 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2555 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2556 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2557 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2558 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2559 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2560 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2561 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2562 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2563 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2564 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Biallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2565 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Monoallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2566 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2567 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2568 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2569 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2570 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2571 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2572 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2573 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2574 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2575 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2576 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2577 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2578 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify FLT3 - ITD allelic ratio: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2579 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2580 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2581 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2582 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2583 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2584 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2585 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2586 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2587 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2588 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2589 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2590 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2591 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2592 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2593 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2594 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2595 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2596 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2597 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2598 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2599 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2600 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2601 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2602 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2603 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2604 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2605 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2606 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2607 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2608 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2609 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2610 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2611 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2612 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2613 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2614 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DYRK1A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2615 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2616 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2617 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2618 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2619 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2620 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2621 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2622 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2623 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2624 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2625 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2626 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2627 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2628 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2629 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2630 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2631 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2632 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2633 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2634 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2635 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2636 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2637 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2638 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2639 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2640 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2641 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2642 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2643 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2644 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2645 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2646 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2647 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2648 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2649 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2650 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2651 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2652 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2653 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2654 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | no | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2655 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2656 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2657 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2658 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2659 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | Yes | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2660 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2661 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2662 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2663 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2664 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2665 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2666 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2667 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2668 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2669 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2670 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2671 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2672 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2673 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2674 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2675 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2676 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2677 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2678 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2679 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2680 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2681 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2682 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2683 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2684 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2685 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2686 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2687 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2688 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2689 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2690 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2691 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2692 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2693 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2694 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2695 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2696 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2697 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2698 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2), (IZKF1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2699 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2700 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2701 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2702 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2703 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2704 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2705 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2706 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2707 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2708 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2709 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2710 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2711 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3q26.2;v) / MECOM(EVI1)-rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2712 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2713 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2714 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2715 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2716 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2717 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2718 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | iAMP21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2719 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2720 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2721 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2722 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2723 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2724 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2725 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No evaluable metaphases | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2726 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2727 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | Yes | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2728 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2729 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2730 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2731 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2732 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2733 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2734 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2735 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2736 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2737 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2738 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2739 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2740 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2741 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2742 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2743 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2744 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2745 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2746 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2747 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2748 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2749 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2750 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2751 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2752 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2753 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2754 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2755 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2756 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2757 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2758 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2759 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2760 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2761 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(16;16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2762 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2763 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2764 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2765 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2766 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2767 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2768 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2769 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2770 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2771 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2772 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2773 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2774 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2775 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2776 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2777 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2778 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2779 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2780 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2781 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2782 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2783 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2784 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2785 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2786 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2787 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2788 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2789 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2790 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2791 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2792 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2793 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2794 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2795 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2796 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2797 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2798 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2799 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2800 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2801 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2802 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Biallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2803 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Monoallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2804 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2805 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2806 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2807 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2808 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2809 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2810 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2811 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2812 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2813 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2814 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2815 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2816 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify FLT3 - ITD allelic ratio: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2817 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2818 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2819 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2820 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2821 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2822 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2823 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2824 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2825 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2826 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2827 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2828 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2829 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2830 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2831 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2832 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2833 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2834 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2835 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2836 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2837 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2838 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2839 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2840 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2841 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2842 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2843 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2844 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2845 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2846 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2847 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2848 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2849 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2850 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2851 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2852 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DYRK1A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2853 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2854 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2855 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2856 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2857 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2858 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2859 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2860 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2861 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2862 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2863 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2864 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2865 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2866 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2867 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2868 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2869 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2870 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2871 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2872 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2873 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2874 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2875 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2876 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2877 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2878 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2879 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2880 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2881 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2882 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2883 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2884 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2885 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2886 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2887 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2888 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2889 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2890 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2891 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2892 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | no | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2893 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2894 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via FISH? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2895 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2896 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2897 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2898 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2899 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2900 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2901 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2902 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2903 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2904 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2905 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2906 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2907 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2908 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2909 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2910 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2911 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2912 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2913 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2914 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2915 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2916 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19), PBX1 / TCF3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2917 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8), IGK / MYC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2918 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2919 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11), AFF1 (AF4) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2920 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14), IL3 / IGH or TLX3 / BCL11B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2921 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9), DEK / NUP214 (CAN) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2922 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14), MYC / IGH (TRAD) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2923 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;16), KATA6A::CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2924 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22), MYC / IGL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2925 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21), RUNX1T1 / RUNX1 or ETO / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2926 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11), MLLT3 (AF9) / MLL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2927 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22), BCR::ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2928 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14), TLX1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2929 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14), CCND1 / IGH or LMO1 / TRAD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2930 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21), TEL / AML1 or ETV6 / RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2931 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants, PML / RARA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2932 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (16;16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2933 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2934 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2935 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2936 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2), (IZKF1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2937 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2938 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2939 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2940 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2941 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2942 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2943 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2944 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2945 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2946 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2947 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16), MYH11 / CBFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2948 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2949 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3q26.2;v) / MECOM(EVI1)-rearranged | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2950 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality, MLL (KMT2A) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2951 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2952 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2953 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 NUTM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2954 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2955 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2956 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | iAMP21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2957 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2958 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2959 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE2960 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2961 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2962 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2963 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No evaluable metaphases | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2964 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2965 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2966 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | >3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2967 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | 3 - 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2968 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify number of distinct cytogenetic abnormalities | > 5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2969 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2970 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2971 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2972 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -18 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2973 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -X | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2974 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | -Y | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2975 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +4 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2976 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +8 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2977 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +10 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2978 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2979 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2980 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2981 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2982 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +21 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2983 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | +22 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2984 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(1;19) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2985 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(2;8) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2986 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(3;3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2987 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(4;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2988 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(5;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2989 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(6;9) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2990 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2991 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2992 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(8;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2993 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;11) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2994 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(9;22) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2995 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(10;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2996 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(11;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2997 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(12;21) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2998 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(15;17) and variants | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE2999 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | t(16;16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3000 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(3q) / 3q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3001 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(5q) / 5q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3002 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(6q) / 6q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3003 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7p12.2) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3004 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(7q) / 7q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3005 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9p) / 9p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3006 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(9q) / 9q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3007 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(11q) / 11q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3008 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(12p) / 12p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3009 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(16q) / 16q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3010 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(17q) / 17q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3011 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(20q) / 20q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3012 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | del(21q) / 21q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3013 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(3) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3014 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | inv(16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3015 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | add(14q) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3016 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | (11q23) any abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3017 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 9p any abnormality (except for del(9p) / 9p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3018 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 12p any abnormality (except for del(12p) / 12p–) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3019 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | 15q14 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3020 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hyperdiploid (> 50) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3021 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Hypodiploid (< 46) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3022 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3023 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3024 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE3025 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3026 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3027 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ASXL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3028 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3029 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3030 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCOR | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3031 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3032 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3033 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | BCR::ABL1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3034 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3035 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3036 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | CEBPA | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3037 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | bZip in-frame mutation | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3038 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Other | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3039 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify the CEBPA variant mutation | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3040 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Biallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3041 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Monoallelic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3042 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify CEBPA allelic expression | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3043 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3044 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3045 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | DDX41 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3046 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3047 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3048 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | EZH2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3049 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3050 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3051 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 – ITD | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3052 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3053 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | FLT3 - ITD allelic ratio | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3054 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify FLT3 - ITD allelic ratio: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3055 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3056 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3057 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | GATA2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3058 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3059 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3060 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | NPM1 | Not Done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3061 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3062 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3063 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | RUNX1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3064 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3065 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3066 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SF3B1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3067 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3068 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3069 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | SRSF2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3070 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3071 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3072 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | STAG2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3073 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3074 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3075 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | TP53 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3076 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3077 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3078 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | U2AF1 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3079 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Positive | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3080 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Negative | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3081 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | ZRSR2 | Not done | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3082 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3083 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ABL2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3084 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | BRAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3085 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3086 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | CSF1R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3087 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DGKH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3088 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNM2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3089 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3090 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | DYRK1A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3091 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EBF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3092 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | ECT2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3093 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EED | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3094 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EP300 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3095 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | EPOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3096 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | FLT3-TKD | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3097 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | GATA3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3098 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3099 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3100 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGFR1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3101 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IGH-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3102 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IKZF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3103 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL2RB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3104 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | IL7R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3105 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3106 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3107 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | JAK3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3108 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KIT | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3109 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3110 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LMO2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3111 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3112 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | LYN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3113 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | NOTCH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3114 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | P2RY8-CRLF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3115 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PAX5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3116 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRA | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3117 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PDGFRB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3118 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | PTK2B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3119 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | RELN | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3120 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SH2B3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3121 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | SUZ12 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3122 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TEL-AML / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3123 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TSLP | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3124 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | TYK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3125 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3126 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify any other positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3127 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3128 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE3129 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | Primary induction failure | No Change | No Change | No Change | No | |
| PRE3130 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | 1st complete remission | No Change | No Change | No Change | No | |
| PRE3131 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | 2nd complete remission | No Change | No Change | No Change | No | |
| PRE3132 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | >3rd complete remission | No Change | No Change | No Change | No | |
| PRE3133 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | 1st relapse | No Change | No Change | No Change | No | |
| PRE3134 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | 2nd relapse | No Change | No Change | No Change | No | |
| PRE3135 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | >3rd relapse | No Change | No Change | No Change | No | |
| PRE3136 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | What was the disease status? | No treatment | No Change | No Change | No Change | No | |
| PRE3137 | Pre-Transplant Information Collection | Disease Classification | Acute Leukemias of Mixed or Ambiguous Lineage | No | Date assessed: | Open text | Deletion of Information Requested | No | Reduce burden | ||
| PRE3138 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Was therapy given prior to this HCT? | yes | Change/Clarification of Information Requested | Was therapy given prior to this infusion? | No Change | No | Capture data accurately | 
| PRE3139 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Was therapy given prior to this HCT? | no | Change/Clarification of Information Requested | Was therapy given prior to this infusion? | No Change | No | Capture data accurately | 
| PRE3140 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Combination chemotherapy | yes | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3141 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Combination chemotherapy | no | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3142 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Hydroxyurea (Droxia, Hydrea) | yes | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3143 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Hydroxyurea (Droxia, Hydrea) | no | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3144 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Tyrosine kinase inhibitor | yes | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3145 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Tyrosine kinase inhibitor | no | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3146 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Interferon-alpha (Intron, Roferon) (includes PEG) | yes | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3147 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Interferon-alpha (Intron, Roferon) (includes PEG) | no | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3148 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Other therapy | yes | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3149 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Other therapy | no | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3150 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Merged to Check all that Apply (Addition of information requested) | Specify the therapy for CML | Combination chemotherapy | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3151 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Merged to Check all that Apply (Addition of information requested) | Specify the therapy for CML | Hydroxyurea (Droxia, Hydrea) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3152 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Merged to Check all that Apply (Addition of information requested) | Specify the therapy for CML | Interferon-a (Intron, Roferon) (includes PEG) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3153 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Merged to Check all that Apply (Addition of information requested) | Specify the therapy for CML | Tyrosine kinase inhibitor | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3154 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Merged to Check all that Apply (Addition of information requested) | Specify the therapy for CML | Other therapy | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3155 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify other therapy: | Open Text | Change/Clarification of Information Requested | Specify other therapy for CML | No Change | No | Capture data accurately | 
| PRE3156 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | What was the disease status? | Complete hematologic response (CHR) preceded only by chronic phase | No Change | No Change | No Change | No | |
| PRE3157 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | What was the disease status? | Complete hematologic response (CHR) preceded by accelerated phase and/or blast phase | No Change | No Change | No Change | No | |
| PRE3158 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | What was the disease status? | Chronic phase | No Change | No Change | No Change | No | |
| PRE3159 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | What was the disease status? | Accelerated phase | No Change | No Change | No Change | No | |
| PRE3160 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | What was the disease status? | Blast phase | No Change | No Change | No Change | No | |
| PRE3161 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | No cytogenetic response (No CyR) | No Change | No Change | No Change | No | |
| PRE3162 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Minimal cytogenetic response | No Change | No Change | No Change | No | |
| PRE3163 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Minor cytogenetic response | No Change | No Change | No Change | No | |
| PRE3164 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Partial cytogenetic response (PCyR) | No Change | No Change | No Change | No | |
| PRE3165 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Complete cytogenetic response (CCyR) | No Change | No Change | No Change | No | |
| PRE3166 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Major molecular remission (MMR) | No Change | No Change | No Change | No | |
| PRE3167 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Specify level of response | Complete molecular remission (CMR) | No Change | No Change | No Change | No | |
| PRE3168 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Addition of Information Requested | Specify blast phase phenotype | Lymphoid | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3169 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Addition of Information Requested | Specify blast phase phenotype | Myeloid | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3170 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Addition of Information Requested | Specify blast phase phenotype | Mixed phenotype | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3171 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Addition of Information Requested | Specify blast phase phenotype | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3172 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Number | 1st | No Change | No Change | No Change | No | |
| PRE3173 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Number | 2nd | No Change | No Change | No Change | No | |
| PRE3174 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Number | 3rd or higher | No Change | No Change | No Change | No | |
| PRE3175 | Pre-Transplant Information Collection | Disease Classification | Chronic Myeloid Leukemia (CML) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE3176 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with low blasts and isolated 5q deletion (MDS-5q) | No Change | No Change | No Change | No | |
| PRE3177 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with low blasts and SF3B1 mutation (MDS-SF3B1) | No Change | No Change | No Change | No | |
| PRE3178 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with low blasts and ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) | No Change | No Change | No Change | No | |
| PRE3179 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with biallelic TP53 inactivation (MDS-biTP53) | No Change | No Change | No Change | No | |
| PRE3180 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with low blasts (MDS-LB; <5% BM, <2%PB) | No Change | No Change | No Change | No | |
| PRE3181 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome, hypoplastic (MDS-h) <=25% cellularity by age | No Change | No Change | No Change | No | |
| PRE3182 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with increased blasts (MDS-IB1) | No Change | No Change | No Change | No | |
| PRE3183 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with increased blasts (MDS-IB2) | No Change | No Change | No Change | No | |
| PRE3184 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome with fibrosis (MDS-f) | No Change | No Change | No Change | No | |
| PRE3185 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Childhood MDS with low blasts, hypocellular | No Change | No Change | No Change | No | |
| PRE3186 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Childhood MDS with low blasts, not otherwise specified | No Change | No Change | No Change | No | |
| PRE3187 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Childhood MDS with increased blasts | No Change | No Change | No Change | No | |
| PRE3188 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Chronic myelomonocytic leukemia (CMML), Myelodysplastic | No Change | No Change | No Change | No | |
| PRE3189 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Chronic myelomonocytic leukemia (CMML), Myeloproliferative | No Change | No Change | No Change | No | |
| PRE3190 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | No Change | No Change | No Change | No | |
| PRE3191 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | MDS/MPN with ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) and thrombocytosis | No Change | No Change | No Change | No | |
| PRE3192 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Juvenile myelomonocytic leukemia (JMML) | No Change | No Change | No Change | No | |
| PRE3193 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic/myeloproliferative neoplasm with neutrophilia | No Change | No Change | No Change | No | |
| PRE3194 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the MDS subtype at diagnosis? | Myelodysplastic syndrome / myeloproliferative neoplasm, NOS | No Change | No Change | No Change | No | |
| PRE3195 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report used for diagnosis | Reduce burden - information no longer needed | ||
| PRE3196 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report used for diagnosis | Reduce burden - information no longer needed | ||
| PRE3197 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was the disease MDS therapy related? | yes | No Change | No Change | No Change | No | |
| PRE3198 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was the disease MDS therapy related? | no | No Change | No Change | No Change | No | |
| PRE3199 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was the disease MDS therapy related? | Unknown | No Change | No Change | No Change | No | |
| PRE3200 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Did the recipient have a predisposing condition? | yes | No Change | No Change | No Change | No | |
| PRE3201 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Did the recipient have a predisposing condition? | no | No Change | No Change | No Change | No | |
| PRE3202 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Did the recipient have a predisposing condition? | Unknown | No Change | No Change | No Change | No | |
| PRE3203 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Aplastic anemia | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3204 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline CEBPA variant (CEBPA-associated familial AML) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3205 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline DDX41 variant | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3206 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline ANKRD26 variant (Thrombocytopenia 2) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3207 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline ETV6 variant (Thrombocytopenia 5) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3208 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Diamond-Blackfan Anemia | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3209 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify MDS predisposing condition | Essential thrombocythemia | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE3210 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Fanconi anemia | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3211 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline GATA2 variant (GATA2 deficiency) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3212 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline TP53 variant (Li-Fraumeni Syndrome) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3213 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Paroxysmal nocturnal hemoglobinuria | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3214 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Change/Clarification of Information Requested and Addition of Response Option | Specify MDS predisposing condition | Polycythemia vera | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE3215 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline RUNX1 variant | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3216 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Germline SAMD9 variant (MIRAGE Syndrome) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3217 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | SAMD9L variant (SAMD9L-related Ataxia Pancytopenia Syndrome) | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3218 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Severe congenital neutropenia | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3219 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Shwachman-Diamond Syndrome | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3220 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Telomere biology disorder | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3221 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify condition | Other condition | Change/Clarification of Information Requested | Specify MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3222 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify other condition: | Other condition | Change/Clarification of Information Requested | Specify other MDS predisposing condition | No Change | No | Capture data accurately | 
| PRE3223 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow | Known | No Change | No Change | No Change | No | |
| PRE3224 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow | Unknown | No Change | No Change | No Change | No | |
| PRE3225 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow percentage | Open text | No Change | No Change | No Change | No | |
| PRE3226 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3227 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3228 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3229 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3230 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3231 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3232 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3233 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3234 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3235 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3236 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | WBC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3237 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Neutrophils | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3238 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Blasts in blood | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3239 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3240 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Platelets | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3241 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3242 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Date CBC drawn: | Open text | Change/Clarification of Information Requested | Date complete blood count (CBC) drawn: | No Change | No | Capture data accurately | 
| PRE3243 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC value | Open text | No Change | No Change | No Change | No | |
| PRE3244 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3245 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3246 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils percentage | Open text | No Change | No Change | No Change | No | |
| PRE3247 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood percentage | Open text | No Change | No Change | No Change | No | |
| PRE3248 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin value | Open text | No Change | No Change | No Change | No | |
| PRE3249 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE3250 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE3251 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | mmol/L | checked | No Change | No Change | No Change | No | |
| PRE3252 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were RBC transfused < 30 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3253 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were RBC transfused < 30 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3254 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets value | Open text | No Change | No Change | No Change | No | |
| PRE3255 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3256 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3257 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were platelets transfused < 7 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3258 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were platelets transfused < 7 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3259 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE3260 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE3261 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No Change | No Change | No Change | No | |
| PRE3262 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE3263 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE3264 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via FISH? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE3265 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3266 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3267 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3268 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3269 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3270 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3271 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3272 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3273 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3274 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3275 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3276 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE3277 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -20 | No Change | No Change | No Change | No | |
| PRE3278 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3279 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3280 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE3281 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(1;3) | Change/Clarification of Information Requested | No Change | t(1;3), PRDM16 / RPN1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3282 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(2;11) | No Change | No Change | No Change | No | |
| PRE3283 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;3) | Change/Clarification of Information Requested | No Change | t(3;3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3284 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;21) | Change/Clarification of Information Requested | No Change | t(3;21), MECOM / RUNX1or EVI1 / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3285 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK / NUP214 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3286 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(11;16) | Change/Clarification of Information Requested | No Change | t(11;16), KMT2A (MLL) CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3287 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE3288 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3289 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3290 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE3291 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3292 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3293 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3294 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3295 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | inv(3) | Change/Clarification of Information Requested | No Change | inv(3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3296 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3297 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3298 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3299 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3300 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3301 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE3302 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE3303 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via karyotyping? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE3304 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3305 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3306 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3307 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE3308 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3309 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3310 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3311 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3312 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3313 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3314 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3315 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3316 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE3317 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -20 | No Change | No Change | No Change | No | |
| PRE3318 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3319 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3320 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE3321 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(1;3) | No Change | No Change | No Change | No | |
| PRE3322 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(2;11) | No Change | No Change | No Change | No | |
| PRE3323 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;3) | No Change | No Change | No Change | No | |
| PRE3324 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;21) | No Change | No Change | No Change | No | |
| PRE3325 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE3326 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(11;16) | No Change | No Change | No Change | No | |
| PRE3327 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE3328 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3329 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3330 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE3331 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3332 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3333 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3334 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3335 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3336 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3337 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3338 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3339 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3340 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3341 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ASXL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3342 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3343 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCORL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3344 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CBL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3345 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CSF3R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3346 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CUX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3347 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3348 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ETV6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3349 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3350 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | FLT3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3351 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | GATA2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3352 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3353 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3354 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3355 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3356 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3357 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NPM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3358 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3359 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | P53 (TP53) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3360 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PHF6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3361 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PPM1D | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3362 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PTPN11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3363 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3364 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SETBP1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3365 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SF3B1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3366 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SRSF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3367 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | STAG2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3368 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | TET2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3369 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | U2AF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3370 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | WT1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3371 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ZRSR2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3372 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3373 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3374 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3375 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Amino acid change | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3376 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Amino acid change | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3377 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | p.: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3378 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE3379 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Did the recipient progress or transform to a different MDS subtype or AML between diagnosis and the start of the preparative regimen/ infusion? | Yes | No Change | No Change | No Change | No | |
| PRE3380 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Did the recipient progress or transform to a different MDS subtype or AML between diagnosis and the start of the preparative regimen/ infusion? | No | No Change | No Change | No Change | No | |
| PRE3381 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with low blasts and isolated 5q deletion (MDS-5q) | No Change | No Change | No Change | No | |
| PRE3382 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with low blasts and SF3B1 mutation (MDS-SF3B1) | No Change | No Change | No Change | No | |
| PRE3383 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with low blasts and ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) | No Change | No Change | No Change | No | |
| PRE3384 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with biallelic TP53 inactivation (MDS-biTP53) | No Change | No Change | No Change | No | |
| PRE3385 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with low blasts (MDS-LB; <5% BM, <2%PB) | No Change | No Change | No Change | No | |
| PRE3386 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome, hypoplastic (MDS-h) <=25% cellularity by age | No Change | No Change | No Change | No | |
| PRE3387 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with increased blasts (MDS-IB1) | No Change | No Change | No Change | No | |
| PRE3388 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with increased blasts (MDS-IB2) | No Change | No Change | No Change | No | |
| PRE3389 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome with fibrosis (MDS-f) | No Change | No Change | No Change | No | |
| PRE3390 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Childhood MDS with low blasts, hypocellular | No Change | No Change | No Change | No | |
| PRE3391 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Childhood MDS with low blasts, not otherwise specified | No Change | No Change | No Change | No | |
| PRE3392 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Childhood MDS with increased blasts | No Change | No Change | No Change | No | |
| PRE3393 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Chronic myelomonocytic leukemia (CMML), Myelodysplastic | No Change | No Change | No Change | No | |
| PRE3394 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Chronic myelomonocytic leukemia (CMML), Myeloproliferative | No Change | No Change | No Change | No | |
| PRE3395 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic/myeloproliferative neoplasm with neutrophilia | No Change | No Change | No Change | No | |
| PRE3396 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | No Change | No Change | No Change | No | |
| PRE3397 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | MDS/MPN with ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) and thrombocytosis | No Change | No Change | No Change | No | |
| PRE3398 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Myelodysplastic syndrome / myeloproliferative neoplasm, NOS | No Change | No Change | No Change | No | |
| PRE3399 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the MDS subtype or AML after transformation | Transformed to AML | No Change | No Change | No Change | No | |
| PRE3400 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the date of the most recent transformation: | Open text | No Change | No Change | No Change | No | |
| PRE3401 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Date of MDS diagnosis: | Open text | No Change | No Change | No Change | No | |
| PRE3402 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow | Known | No Change | No Change | No Change | No | |
| PRE3403 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow | Unknown | No Change | No Change | No Change | No | |
| PRE3404 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in bone marrow percentage | Open text | No Change | No Change | No Change | No | |
| PRE3405 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3406 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3407 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3408 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3409 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3410 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3411 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3412 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3413 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | WBC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3414 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Neutrophils | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3415 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Blasts in blood | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3416 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3417 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3418 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Date CBC drawn: | Open text | Change/Clarification of Information Requested | Date complete blood count (CBC) drawn: | No Change | No | Capture data accurately | 
| PRE3419 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | WBC value | Open text | No Change | No Change | No Change | No | |
| PRE3420 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3421 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3422 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Neutrophils percentage | Open text | No Change | No Change | No Change | No | |
| PRE3423 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Blasts in blood percentage | Open text | No Change | No Change | No Change | No | |
| PRE3424 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Hemoglobin value | Open text | No Change | No Change | No Change | No | |
| PRE3425 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE3426 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE3427 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | mmol/L | checked | No Change | No Change | No Change | No | |
| PRE3428 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were RBC transfused < 30 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3429 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were RBC transfused < 30 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3430 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets | Known | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3431 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets | Unknown | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3432 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Platelets value | Open text | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3433 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 109/L (x 103/mm3) | checked | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3434 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | x 106/L | checked | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3435 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were platelets transfused < 7 days before date of test? | Yes | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3436 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were platelets transfused < 7 days before date of test? | No | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3437 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE3438 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE3439 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3440 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE3441 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE3442 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3443 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3444 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3445 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3446 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3447 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3448 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3449 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3450 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3451 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3452 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3453 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE3454 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -20 | No Change | No Change | No Change | No | |
| PRE3455 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3456 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3457 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE3458 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(1;3) | Change/Clarification of Information Requested | No Change | t(1;3), PRDM16 / RPN1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3459 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(2;11) | No Change | No Change | No Change | No | |
| PRE3460 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;3) | Change/Clarification of Information Requested | No Change | t(3;3), RPN1 / MECOM (EVI1) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3461 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;21) | Change/Clarification of Information Requested | No Change | t(3;21), MECOM / RUNX1or EVI1 / AML1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3462 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK / NUP214 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3463 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(11;16) | Change/Clarification of Information Requested | No Change | t(11;16), KMT2A (MLL) CREBBP | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3464 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE3465 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3466 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3467 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE3468 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3469 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3470 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3471 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3472 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | inv(3) | Change/Clarification of Information Requested | No Change | inv(3), RPN1 / MECOM or RPN1 / EVI1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3473 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3474 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3475 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3476 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3477 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3478 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE3479 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE3480 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3481 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3482 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3483 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE3484 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3485 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3486 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3487 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3488 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3489 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3490 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3491 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3492 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE3493 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -20 | No Change | No Change | No Change | No | |
| PRE3494 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3495 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3496 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE3497 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(1;3) | No Change | No Change | No Change | No | |
| PRE3498 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(2;11) | No Change | No Change | No Change | No | |
| PRE3499 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;3) | No Change | No Change | No Change | No | |
| PRE3500 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(3;21) | No Change | No Change | No Change | No | |
| PRE3501 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE3502 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | t(11;16) | No Change | No Change | No Change | No | |
| PRE3503 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(3q) / 3q- | No Change | No Change | No Change | No | |
| PRE3504 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3505 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3506 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(9q) / 9q- | No Change | No Change | No Change | No | |
| PRE3507 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3508 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3509 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3510 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3511 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3512 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3513 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3514 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3515 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3516 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3517 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ASXL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3518 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3519 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCORL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3520 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CBL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3521 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CSF3R | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3522 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CUX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3523 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3524 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ETV6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3525 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3526 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | FLT3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3527 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | GATA2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3528 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3529 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3530 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | JAK2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3531 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3532 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3533 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NPM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3534 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3535 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | P53 (TP53) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3536 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PHF6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3537 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PPM1D | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3538 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PTPN11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3539 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3540 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SETBP1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3541 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SF3B1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3542 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SRSF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3543 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | STAG2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3544 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | TET2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3545 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | U2AF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3546 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | WT1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3547 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ZRSR2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3548 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3549 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3550 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3551 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Amino acid change | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3552 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | Amino acid change | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3553 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | Yes | Addition of Information Requested | p.: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3554 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE3555 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | Complete remission (CR) | No Change | No Change | No Change | No | |
| PRE3556 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | Hematologic improvement (HI) | No Change | No Change | No Change | No | |
| PRE3557 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | No response (NR) / stable disease (SD) | No Change | No Change | No Change | No | |
| PRE3558 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | Progression from hematologic improvement (Prog from HI) | No Change | No Change | No Change | No | |
| PRE3559 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | Relapse from complete remission (Rel from CR) | No Change | No Change | No Change | No | |
| PRE3560 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | What was the disease status? | Not assessed | Change/Clarification of Information Requested | No Change | No treatment | No | Capture data accurately | 
| PRE3561 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the cell lines examined to determine HI status | HI-E | No Change | No Change | No Change | No | |
| PRE3562 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the cell lines examined to determine HI status | HI-P | No Change | No Change | No Change | No | |
| PRE3563 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify the cell lines examined to determine HI status | HI-N | No Change | No Change | No Change | No | |
| PRE3564 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify transfusion dependence | Non-transfused (NTD) | No Change | No Change | No Change | No | |
| PRE3565 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Specify transfusion dependence | Low-transfusion burden (LTB) | No Change | No Change | No Change | No | |
| PRE3566 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE3567 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Chronic neutrophilic leukemia | No Change | No Change | No Change | No | |
| PRE3568 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Chronic eosinophilic leukemia | No Change | No Change | No Change | No | |
| PRE3569 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Essential thrombocythemia | No Change | No Change | No Change | No | |
| PRE3570 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Myeloproliferative neoplasm, NOS | No Change | No Change | No Change | No | |
| PRE3571 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Polycythemia vera (PCV) | No Change | No Change | No Change | No | |
| PRE3572 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Primary myelofibrosis (PMF) | No Change | No Change | No Change | No | |
| PRE3573 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Cutaneous mastocytosis (CM) | No Change | No Change | No Change | No | |
| PRE3574 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Mast cell sarcoma (MCS) | No Change | No Change | No Change | No | |
| PRE3575 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the MPN subtype at diagnosis? | Systemic mastocytosis | No Change | No Change | No Change | No | |
| PRE3576 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Indolent systemic mastocytosis (ISM) | No Change | No Change | No Change | No | |
| PRE3577 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Smoldering systemic mastocytosis (SSM) | No Change | No Change | No Change | No | |
| PRE3578 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Systemic mastocytosis with an associated hematological neoplasm (SM-AHN) | No Change | No Change | No Change | No | |
| PRE3579 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Aggressive systemic mastocytosis (ASM) | No Change | No Change | No Change | No | |
| PRE3580 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Mast cell leukemia (MCL) | No Change | No Change | No Change | No | |
| PRE3581 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify systemic mastocytosis | Bone marrow mastocytosis | No Change | No Change | No Change | No | |
| PRE3582 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report used for diagnosis | Reduce burden - information no longer needed | ||
| PRE3583 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report used for diagnosis | Reduce burden - information no longer needed | ||
| PRE3584 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms? | Yes | No Change | No Change | No Change | No | |
| PRE3585 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms? | No | No Change | No Change | No Change | No | |
| PRE3586 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms? | Unknown | No Change | No Change | No Change | No | |
| PRE3587 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow | Known | No Change | No Change | No Change | No | |
| PRE3588 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow | Unknown | No Change | No Change | No Change | No | |
| PRE3589 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow percentage | Open text | No Change | No Change | No Change | No | |
| PRE3590 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3591 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3592 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3593 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3594 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3595 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3596 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3597 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3598 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3599 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3600 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | WBC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3601 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Neutrophils | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3602 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Blasts in blood | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3603 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3604 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Platelets | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3605 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3606 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date CBC drawn: | Open text | Change/Clarification of Information Requested | Date complete blood count (CBC) drawn: | No Change | No | Capture data accurately | 
| PRE3607 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC value | Open text | No Change | No Change | No Change | No | |
| PRE3608 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3609 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3610 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils percentage | Open text | No Change | No Change | No Change | No | |
| PRE3611 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood percentage | Open text | No Change | No Change | No Change | No | |
| PRE3612 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin value | Open text | No Change | No Change | No Change | No | |
| PRE3613 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE3614 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE3615 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | mmol/L | checked | No Change | No Change | No Change | No | |
| PRE3616 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were RBC transfused < 30 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3617 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were RBC transfused < 30 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3618 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets value | Open text | No Change | No Change | No Change | No | |
| PRE3619 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3620 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3621 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were platelets transfused < 7 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3622 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were platelets transfused < 7 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3623 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE3624 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE3625 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No Change | No Change | No Change | No | |
| PRE3626 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE3627 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE3628 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via FISH? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE3629 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3630 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3631 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3632 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3633 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3634 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3635 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3636 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3637 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3638 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3639 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3640 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3641 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3642 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE3643 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(1;any) | No Change | No Change | No Change | No | |
| PRE3644 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(3q21;any) | Change/Clarification of Information Requested | No Change | t(3q21;any), MECOM, RPN1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3645 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(11q23;any) | Change/Clarification of Information Requested | No Change | t(11q23;any), KMT2A (MLL) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3646 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(12p11.2;any) | No Change | No Change | No Change | No | |
| PRE3647 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK/NUP214 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3648 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3649 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3650 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3651 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3652 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3653 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3654 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | dup(1) | No Change | No Change | No Change | No | |
| PRE3655 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3656 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3657 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3658 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3659 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3660 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3661 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE3662 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE3663 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via karyotyping? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE3664 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3665 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3666 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3667 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE3668 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3669 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3670 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3671 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3672 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3673 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3674 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3675 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3676 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3677 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3678 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE3679 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(1;any) | No Change | No Change | No Change | No | |
| PRE3680 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(3q21;any) | No Change | No Change | No Change | No | |
| PRE3681 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(11q23;any) | No Change | No Change | No Change | No | |
| PRE3682 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(12p11.2;any) | No Change | No Change | No Change | No | |
| PRE3683 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE3684 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3685 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3686 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3687 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3688 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3689 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3690 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | dup(1) | No Change | No Change | No Change | No | |
| PRE3691 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3692 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3693 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3694 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3695 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3696 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3697 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | Yes | No Change | No Change | No Change | No | |
| PRE3698 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | No | No Change | No Change | No Change | No | |
| PRE3699 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | Unknown | No Change | No Change | No Change | No | |
| PRE3700 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Positive | No Change | No Change | No Change | No | |
| PRE3701 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Negative | No Change | No Change | No Change | No | |
| PRE3702 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Not done | No Change | No Change | No Change | No | |
| PRE3703 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Positive | No Change | No Change | No Change | No | |
| PRE3704 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Negative | No Change | No Change | No Change | No | |
| PRE3705 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Not done | No Change | No Change | No Change | No | |
| PRE3706 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Positive | No Change | No Change | No Change | No | |
| PRE3707 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Negative | No Change | No Change | No Change | No | |
| PRE3708 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Not done | No Change | No Change | No Change | No | |
| PRE3709 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Positive | No Change | No Change | No Change | No | |
| PRE3710 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Negative | No Change | No Change | No Change | No | |
| PRE3711 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Not done | No Change | No Change | No Change | No | |
| PRE3712 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Positive | No Change | No Change | No Change | No | |
| PRE3713 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Negative | No Change | No Change | No Change | No | |
| PRE3714 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Not done | No Change | No Change | No Change | No | |
| PRE3715 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Positive | No Change | No Change | No Change | No | |
| PRE3716 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Negative | No Change | No Change | No Change | No | |
| PRE3717 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Not done | No Change | No Change | No Change | No | |
| PRE3718 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Positive | No Change | No Change | No Change | No | |
| PRE3719 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Negative | No Change | No Change | No Change | No | |
| PRE3720 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Not done | No Change | No Change | No Change | No | |
| PRE3721 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Positive | No Change | No Change | No Change | No | |
| PRE3722 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Negative | No Change | No Change | No Change | No | |
| PRE3723 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Not done | No Change | No Change | No Change | No | |
| PRE3724 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Positive | No Change | No Change | No Change | No | |
| PRE3725 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Negative | No Change | No Change | No Change | No | |
| PRE3726 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Not done | No Change | No Change | No Change | No | |
| PRE3727 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ASXL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3728 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3729 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCORL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3730 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CBL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3731 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CUX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3732 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3733 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ETV6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3734 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3735 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | FLT3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3736 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | GATA2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3737 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3738 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3739 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3740 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | LNK | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3741 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3742 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NPM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3743 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3744 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | P53 (TP53) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3745 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PHF6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3746 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PPM1D | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3747 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PTPN11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3748 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3749 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SETBP1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3750 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SF3B1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3751 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SRSF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3752 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | STAG2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3753 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | TET2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3754 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | U2AF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3755 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | WT1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3756 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ZRSR2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3757 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3758 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3759 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3760 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Amino acid change | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3761 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Amino acid change | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3762 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | p.: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3763 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||
| PRE3764 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||
| PRE3765 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient progress or transform to a different MPN subtype or AML between diagnosis and the start of the preparative regimen / infusion? | Yes | No Change | No Change | No Change | No | |
| PRE3766 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient progress or transform to a different MPN subtype or AML between diagnosis and the start of the preparative regimen / infusion? | No | No Change | No Change | No Change | No | |
| PRE3767 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the MPN subtype or AML after transformation | Post-essential thrombocythemic myelofibrosis | No Change | No Change | No Change | No | |
| PRE3768 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the MPN subtype or AML after transformation | Post-polycythemic myelofibrosis | No Change | No Change | No Change | No | |
| PRE3769 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the MPN subtype or AML after transformation | Transformed to AML | No Change | No Change | No Change | No | |
| PRE3770 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the date of the most recent transformation: | Open text | No Change | No Change | No Change | No | |
| PRE3771 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date of MPN diagnosis: | Open text | No Change | No Change | No Change | No | |
| PRE3772 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify transfusion dependence at last evaluation prior to the start of the preparative regimen / infusion | Non-transfused (NTD) | No Change | No Change | No Change | No | |
| PRE3773 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify transfusion dependence at last evaluation prior to the start of the preparative regimen / infusion | Low-transfusion burden (LTB) | No Change | No Change | No Change | No | |
| PRE3774 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify transfusion dependence at last evaluation prior to the start of the preparative regimen / infusion | High-transfusion burden (HTB) | No Change | No Change | No Change | No | |
| PRE3775 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms in six months before last evaluation prior to the start of the preparative regimen / infusion? | Yes | No Change | No Change | No Change | No | |
| PRE3776 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms in six months before last evaluation prior to the start of the preparative regimen / infusion? | No | No Change | No Change | No Change | No | |
| PRE3777 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have constitutional symptoms in six months before last evaluation prior to the start of the preparative regimen / infusion? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3778 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have splenomegaly at last evaluation prior to the start of the preparative regimen / infusion? | Yes | No Change | No Change | No Change | No | |
| PRE3779 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have splenomegaly at last evaluation prior to the start of the preparative regimen / infusion? | No | No Change | No Change | No Change | No | |
| PRE3780 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have splenomegaly at last evaluation prior to the start of the preparative regimen / infusion? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3781 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have splenomegaly at last evaluation prior to the start of the preparative regimen / infusion? | Not applicable | No Change | No Change | No Change | No | |
| PRE3782 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure spleen size | Physical assessment | No Change | No Change | No Change | No | |
| PRE3783 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure spleen size | Ultrasound | No Change | No Change | No Change | No | |
| PRE3784 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure spleen size | CT/MRI | No Change | No Change | No Change | No | |
| PRE3785 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the spleen size centimeters below left costal margin : | Open text | No Change | No Change | No Change | No | |
| PRE3786 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the spleen size centimeters: | Open text | No Change | No Change | No Change | No | |
| PRE3787 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have hepatomegaly at last evaluation prior to the start of the preparative regimen / infusion? | Yes | No Change | No Change | No Change | No | |
| PRE3788 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have hepatomegaly at last evaluation prior to the start of the preparative regimen / infusion? | No | No Change | No Change | No Change | No | |
| PRE3789 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Did the recipient have hepatomegaly at last evaluation prior to the start of the preparative regimen / infusion? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3790 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure liver size | Physical exam | No Change | No Change | No Change | No | |
| PRE3791 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure liver size | Ultrasound | No Change | No Change | No Change | No | |
| PRE3792 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the method used to measure liver size | CT/MRI | No Change | No Change | No Change | No | |
| PRE3793 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the liver size centimeters below left costal margin : | Open text | No Change | No Change | No Change | No | |
| PRE3794 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the liver size centimeters: | Open text | No Change | No Change | No Change | No | |
| PRE3795 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow | Known | No Change | No Change | No Change | No | |
| PRE3796 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow | Unknown | No Change | No Change | No Change | No | |
| PRE3797 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in bone marrow percentage | Open text | No Change | No Change | No Change | No | |
| PRE3798 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3799 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3800 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3801 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3802 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3803 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3804 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3805 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE3806 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | WBC | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3807 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Neutrophils | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3808 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Blasts in blood | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3809 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3810 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Merged to Check all that Apply (Addition of information requested) | Complete blood count (CBC) results available | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3811 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date CBC drawn: | Open text | Change/Clarification of Information Requested | Date complete blood count (CBC) drawn: | No Change | No | Capture data accurately | 
| PRE3812 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | WBC value | Open text | No Change | No Change | No Change | No | |
| PRE3813 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 109/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE3814 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE3815 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Neutrophils percentage | Open text | No Change | No Change | No Change | No | |
| PRE3816 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Blasts in blood percentage | Open text | No Change | No Change | No Change | No | |
| PRE3817 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Hemoglobin value | Open text | No Change | No Change | No Change | No | |
| PRE3818 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE3819 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE3820 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | mmol/L | checked | No Change | No Change | No Change | No | |
| PRE3821 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were RBC transfused < 30 days before date of test? | Yes | No Change | No Change | No Change | No | |
| PRE3822 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were RBC transfused < 30 days before date of test? | No | No Change | No Change | No Change | No | |
| PRE3823 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets | Known | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3824 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets | Unknown | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3825 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Platelets value | Open text | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3826 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 109/L (x 103/mm3) | checked | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3827 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | x 106/L | checked | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3828 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were platelets transfused < 7 days before date of test? | Yes | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3829 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were platelets transfused < 7 days before date of test? | No | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE3830 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE3831 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE3832 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3833 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE3834 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE3835 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3836 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3837 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3838 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3839 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3840 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3841 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3842 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3843 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3844 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3845 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3846 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3847 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3848 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE3849 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(1;any) | No Change | No Change | No Change | No | |
| PRE3850 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(3q21;any) | Change/Clarification of Information Requested | No Change | t(3q21;any), MECOM, RPN1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3851 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(11q23;any) | Change/Clarification of Information Requested | No Change | t(11q23;any), KMT2A (MLL) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3852 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(12p11.2;any) | No Change | No Change | No Change | No | |
| PRE3853 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(6;9) | Change/Clarification of Information Requested | No Change | t(6;9), DEK/NUP214 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE3854 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3855 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3856 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3857 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3858 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3859 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3860 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | dup(1) | No Change | No Change | No Change | No | |
| PRE3861 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3862 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3863 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3864 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3865 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3866 | Pre-Transplant Information Collection | Disease Classification | Myelodysplastic Syndrome (MDS) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE3867 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE3868 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE3869 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Blood | No Change | No Change | No Change | No | |
| PRE3870 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Sample source | Bone marrow | No Change | No Change | No Change | No | |
| PRE3871 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE3872 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE3873 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE3874 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE3875 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | One (1) | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3876 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Two (2) | Change/Clarification of Information Requested | No Change | <3 | No | Capture data accurately | 
| PRE3877 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Three (3) | Change/Clarification of Information Requested | No Change | 3-5 | No | Capture data accurately | 
| PRE3878 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify number of distinct cytogenetic abnormalities | Four or more (4 or more) | Change/Clarification of Information Requested | No Change | >5 | No | Capture data accurately | 
| PRE3879 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -5 | No Change | No Change | No Change | No | |
| PRE3880 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -7 | No Change | No Change | No Change | No | |
| PRE3881 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | -Y | No Change | No Change | No Change | No | |
| PRE3882 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +8 | No Change | No Change | No Change | No | |
| PRE3883 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE3884 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(1;any) | No Change | No Change | No Change | No | |
| PRE3885 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(3q21;any) | No Change | No Change | No Change | No | |
| PRE3886 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(11q23;any) | No Change | No Change | No Change | No | |
| PRE3887 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(12p11.2;any) | No Change | No Change | No Change | No | |
| PRE3888 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | t(6;9) | No Change | No Change | No Change | No | |
| PRE3889 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(5q) / 5q- | No Change | No Change | No Change | No | |
| PRE3890 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(7q) / 7q- | No Change | No Change | No Change | No | |
| PRE3891 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(11q) / 11q- | No Change | No Change | No Change | No | |
| PRE3892 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(12p) / 12p- | No Change | No Change | No Change | No | |
| PRE3893 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE3894 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | del(20q) / 20q- | No Change | No Change | No Change | No | |
| PRE3895 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | dup(1) | No Change | No Change | No Change | No | |
| PRE3896 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | inv(3) | No Change | No Change | No Change | No | |
| PRE3897 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | i17q | No Change | No Change | No Change | No | |
| PRE3898 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE3899 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE3900 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3901 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE3902 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | Yes | No Change | No Change | No Change | No | |
| PRE3903 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | No | No Change | No Change | No Change | No | |
| PRE3904 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Were tests for driver mutations performed? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE3905 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Positive | No Change | No Change | No Change | No | |
| PRE3906 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Negative | No Change | No Change | No Change | No | |
| PRE3907 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 | Not done | No Change | No Change | No Change | No | |
| PRE3908 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Positive | No Change | No Change | No Change | No | |
| PRE3909 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Negative | No Change | No Change | No Change | No | |
| PRE3910 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 V617F | Not done | No Change | No Change | No Change | No | |
| PRE3911 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Positive | No Change | No Change | No Change | No | |
| PRE3912 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Negative | No Change | No Change | No Change | No | |
| PRE3913 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | JAK2 Exon 12 | Not done | No Change | No Change | No Change | No | |
| PRE3914 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Positive | No Change | No Change | No Change | No | |
| PRE3915 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Negative | No Change | No Change | No Change | No | |
| PRE3916 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR | Not done | No Change | No Change | No Change | No | |
| PRE3917 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Positive | No Change | No Change | No Change | No | |
| PRE3918 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Negative | No Change | No Change | No Change | No | |
| PRE3919 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 1 | Not done | No Change | No Change | No Change | No | |
| PRE3920 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Positive | No Change | No Change | No Change | No | |
| PRE3921 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Negative | No Change | No Change | No Change | No | |
| PRE3922 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CALR type 2 | Not done | No Change | No Change | No Change | No | |
| PRE3923 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Positive | No Change | No Change | No Change | No | |
| PRE3924 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Negative | No Change | No Change | No Change | No | |
| PRE3925 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Not defined | Not done | No Change | No Change | No Change | No | |
| PRE3926 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Positive | No Change | No Change | No Change | No | |
| PRE3927 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Negative | No Change | No Change | No Change | No | |
| PRE3928 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | MPL | Not done | No Change | No Change | No Change | No | |
| PRE3929 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Positive | No Change | No Change | No Change | No | |
| PRE3930 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Negative | No Change | No Change | No Change | No | |
| PRE3931 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | CSF3R | Not done | No Change | No Change | No Change | No | |
| PRE3932 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ASXL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3933 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCOR | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3934 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | BCORL1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3935 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CBL | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3936 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | CUX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3937 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | DNMT3A | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3938 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ETV6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3939 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | EZH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3940 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | FLT3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3941 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | GATA2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3942 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3943 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | IDH2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3944 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | KRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3945 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | LNK | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3946 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3947 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NPM1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3948 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | NRAS | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3949 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | P53 (TP53) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3950 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PHF6 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3951 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PPM1D | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3952 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | PTPN11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3953 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | RUNX1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3954 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SETBP1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3955 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SF3B1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3956 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | SRSF2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3957 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | STAG2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3958 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | TET2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3959 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | U2AF1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3960 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | WT1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3961 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | ZRSR2 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3962 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | Other molecular marker | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3963 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify any positive molecular marker(s) identified | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3964 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Specify other positive molecular marker(s): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3965 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Amino acid change | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3966 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | Amino acid change | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3967 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | Yes | Addition of Information Requested | p.: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE3968 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||
| PRE3969 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the molecular marker report. | Reduce burden | ||
| PRE3970 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Complete clinical remission (CR) | No Change | No Change | No Change | No | |
| PRE3971 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Partial clinical remission (PR) | No Change | No Change | No Change | No | |
| PRE3972 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Clinical improvement (CI) | No Change | No Change | No Change | No | |
| PRE3973 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Stable disease (SD) | No Change | No Change | No Change | No | |
| PRE3974 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Progressive disease | No Change | No Change | No Change | No | |
| PRE3975 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Relapse | No Change | No Change | No Change | No | |
| PRE3976 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | What was the disease status? | Not assessed | Change/Clarification of Information Requested | No Change | No treatment | No | Capture data accurately | 
| PRE3977 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was an anemia response achieved? | Yes | No Change | No Change | No Change | No | |
| PRE3978 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was an anemia response achieved? | No | No Change | No Change | No Change | No | |
| PRE3979 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was a spleen response achieved? | Yes | No Change | No Change | No Change | No | |
| PRE3980 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was a spleen response achieved? | No | No Change | No Change | No Change | No | |
| PRE3981 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was a symptom response achieved? | Yes | No Change | No Change | No Change | No | |
| PRE3982 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Was a symptom response achieved? | No | No Change | No Change | No Change | No | |
| PRE3983 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE3984 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Complete response (CR) | No Change | No Change | No Change | No | |
| PRE3985 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Partial response (PR) | No Change | No Change | No Change | No | |
| PRE3986 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Addition of Information Requested | No Change | No response | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE3987 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Re-emergence of pre-existing cytogenetic abnormality | No Change | No Change | No Change | No | |
| PRE3988 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Not assessed | No Change | No Change | No Change | No | |
| PRE3989 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | Not applicable | No Change | No Change | No Change | No | |
| PRE3990 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the cytogenetic response | None of the above | No Change | No Change | No Change | No | |
| PRE3991 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE3992 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Complete response (CR) | No Change | No Change | No Change | No | |
| PRE3993 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Partial response (PR) | No Change | No Change | No Change | No | |
| PRE3994 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Addition of Information Requested | No Change | No response | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE3995 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Re-emergence of a pre-existing molecular abnormality | No Change | No Change | No Change | No | |
| PRE3996 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Not assessed | No Change | No Change | No Change | No | |
| PRE3997 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | Not applicable | No Change | No Change | No Change | No | |
| PRE3998 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Specify the molecular response | None of the above | No Change | No Change | No Change | No | |
| PRE3999 | Pre-Transplant Information Collection | Disease Classification | Myeloproliferative Neoplasms (MPN) | No | Date assessed: | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4000 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Chronic lymphocytic leukemia (CLL), NOS | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4001 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Chronic lymphocytic leukemia / small lymphocytic lymphoma | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4002 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Hairy cell leukemia | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4003 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Splenic B-cell lymphoma/leukemia with prominent nucleoli | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4004 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | T-prolymphocytic leukemia | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4005 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Other leukemia, NOS | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4006 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify the other leukemia classification | Other leukemia | Change/Clarification of Information Requested | Specify the other hematologic leukemia disease | No Change | No | Capture data accurately | 
| PRE4007 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Specify other leukemia: | Open text | No Change | No Change | No Change | No | |
| PRE4008 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Was any 17p abnormality detected? | yes | No Change | No Change | No Change | No | |
| PRE4009 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Was any 17p abnormality detected? | No | No Change | No Change | No Change | No | |
| PRE4010 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Did a histologic transformation to diffuse large B-cell lymphoma (Richter syndrome) occur at any time after CLL diagnosis? | yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4011 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Did a histologic transformation to diffuse large B-cell lymphoma (Richter syndrome) occur at any time after CLL diagnosis? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4012 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | Primary induction failure | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4013 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | 1st complete remission (no previous bone marrow or extramedullary relapse) | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4014 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | 2nd complete remission | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4015 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | > 3rd complete remission | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4016 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | 1st relapse | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4017 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | 2nd relapse | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4018 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | > 3rd relapse | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4019 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [atypical CML] | No treatment | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| PRE4020 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Complete remission (CR) | No Change | No Change | No Change | No | |
| PRE4021 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Partial remission (PR) | No Change | No Change | No Change | No | |
| PRE4022 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Stable disease (SD) | No Change | No Change | No Change | No | |
| PRE4023 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Progressive disease (Prog) | No Change | No Change | No Change | No | |
| PRE4024 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Untreated | Change/Clarification of Information Requested | No Change | No treatment | No | Capture data accurately | 
| PRE4025 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | What was the disease status? [CLL, PLL, Hairy cell leukemia, Other leukemia] | Not assessed | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE4026 | Pre-Transplant Information Collection | Disease Classification | Other Leukemia (OL) | No | Date assessed: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4027 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Classic Hodgkin lymphoma | No Change | No Change | No Change | No | |
| PRE4028 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Lymphocyte depleted | No Change | No Change | No Change | No | |
| PRE4029 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Lymphocyte-rich | No Change | No Change | No Change | No | |
| PRE4030 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Mixed cellularity | No Change | No Change | No Change | No | |
| PRE4031 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodular lymphocyte predominant Hodgkin lymphoma | No Change | No Change | No Change | No | |
| PRE4032 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodular sclerosis | No Change | No Change | No Change | No | |
| PRE4033 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Burkitt lymphoma | No Change | No Change | No Change | No | |
| PRE4034 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | ALK-positive large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4035 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma - Activated B-cell type subtype | No Change | No Change | No Change | No | |
| PRE4036 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma associated with chronic inflammation | No Change | No Change | No Change | No | |
| PRE4037 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma - Germinal Center B-cell subtype | No Change | No Change | No Change | No | |
| PRE4038 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma / high-grade B-cell lymphoma with MYC and BCL2 rearrangements | No Change | No Change | No Change | No | |
| PRE4039 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL6 rearrangements | No Change | No Change | No Change | No | |
| PRE4040 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements | No Change | No Change | No Change | No | |
| PRE4041 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Diffuse large B-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4042 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | EBV-positive diffuse large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4043 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Fibrin-associated large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4044 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Fluid overload-associated large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4045 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | High-grade B-cell lymphoma with 11q aberration | No Change | No Change | No Change | No | |
| PRE4046 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Intravascular large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4047 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Large B-cell lymphoma with IRF4 rearrangement | No Change | No Change | No Change | No | |
| PRE4048 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Lymphomatoid granulomatosis | No Change | No Change | No Change | No | |
| PRE4049 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Mediastinal grey zone lymphoma | No Change | No Change | No Change | No | |
| PRE4050 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Plasmablastic lymphoma | No Change | No Change | No Change | No | |
| PRE4051 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous diffuse large B-cell lymphoma, leg type | No Change | No Change | No Change | No | |
| PRE4052 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary mediastinal large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4053 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | T-cell / histiocytic-rich large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4054 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | High-grade B-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4055 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary large B-cell lymphoma of the CNS | No Change | No Change | No Change | No | |
| PRE4056 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary large B-cell lymphoma of the testis | No Change | No Change | No Change | No | |
| PRE4057 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary large B-cell lymphoma of the vitreoretina | No Change | No Change | No Change | No | |
| PRE4058 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | KSHV / HHV8-positive diffuse large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4059 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary effusion lymphoma | No Change | No Change | No Change | No | |
| PRE4060 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Lymphoplasmacytic lymphoma | No Change | No Change | No Change | No | |
| PRE4061 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | IgM-LPL / Waldenstrom macroglobulinemia | No Change | No Change | No Change | No | |
| PRE4062 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Non-IgM-LPL / Waldenstrom macroglobulinemia | No Change | No Change | No Change | No | |
| PRE4063 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | No Change | No Change | No Change | No | |
| PRE4064 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodal marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4065 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Pediatric marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4066 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4067 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Splenic, B-cell lymphoma / leukemia with prominent nucleoli | No Change | No Change | No Change | No | |
| PRE4068 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Splenic diffuse red pulp small B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4069 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Splenic marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4070 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Duodenal-type follicular lymphoma | No Change | No Change | No Change | No | |
| PRE4071 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular, mixed, small cleaved and large cell (Grade II follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4072 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular, predominantly large cell (Grade IIIA follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4073 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular, predominantly large cell (Grade IIIB follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4074 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular, predominantly large cell (Grade IIIA vs IIIB not specified) | No Change | No Change | No Change | No | |
| PRE4075 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular, predominantly small cleaved cell (Grade I follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4076 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Pediatric-type follicular lymphoma | No Change | No Change | No Change | No | |
| PRE4077 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Follicular (grade unknown) | No Change | No Change | No Change | No | |
| PRE4078 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous follicle center lymphoma | No Change | No Change | No Change | No | |
| PRE4079 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Mantle cell lymphoma | No Change | No Change | No Change | No | |
| PRE4080 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Leukemic non-nodal mantle cell lymphoma | No Change | No Change | No Change | No | |
| PRE4081 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Transformations of indolent B-cell lymphomas | No Change | No Change | No Change | No | |
| PRE4082 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Classical Hodgkin lymphoma PTLD | No Change | No Change | No Change | No | |
| PRE4083 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | EBV-positive mucocutaneous ulcer | No Change | No Change | No Change | No | |
| PRE4084 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Hyperplasia arising in immune deficiencies (e.g. PTLD) | No Change | No Change | No Change | No | |
| PRE4085 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Infectious mononucleosis PTLD | No Change | No Change | No Change | No | |
| PRE4086 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Monomorphic PTLD (B- and T-/NK-cell types) | No Change | No Change | No Change | No | |
| PRE4087 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | No Change | No Change | No Change | No | |
| PRE4088 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Adult T-cell lymphoma / leukemia | No Change | No Change | No Change | No | |
| PRE4089 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Aggressive NK-cell leukemia | No Change | No Change | No Change | No | |
| PRE4090 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | NK-large granular lymphocytic leukemia | No Change | No Change | No Change | No | |
| PRE4091 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Sézary syndrome | No Change | No Change | No Change | No | |
| PRE4092 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | T-large granular lymphocytic leukemia | No Change | No Change | No Change | No | |
| PRE4093 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Mycosis fungoides | No Change | No Change | No Change | No | |
| PRE4094 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous acral CD8-positive lymphoproliferative disorder | No Change | No Change | No Change | No | |
| PRE4095 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | No Change | No Change | No Change | No | |
| PRE4096 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4097 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: lymphomatoid papulosis | No Change | No Change | No Change | No | |
| PRE4098 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4099 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous gamma / delta T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4100 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Subcutaneous panniculitis-like T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4101 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Primary cutaneous peripheral T-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4102 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Enteropathy-associated T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4103 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Indolent T-cell lymphoma of the gastrointestinal tract | No Change | No Change | No Change | No | |
| PRE4104 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | No Change | No Change | No Change | No | |
| PRE4105 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Monomorphic epitheliotropic intestinal T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4106 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Intestinal T-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4107 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Hepatosplenic T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4108 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | ALK-positive anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4109 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | ALK-negative anaplastic large-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4110 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Breast implant-associated anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4111 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodal TFH cell lymphoma, angioimmunoblastic-type | No Change | No Change | No Change | No | |
| PRE4112 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodal TFH cell lymphoma, follicular-type | No Change | No Change | No Change | No | |
| PRE4113 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Nodal TFH cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4114 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Peripheral T-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4115 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | EBV-positive nodal T- and NK-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4116 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Extranodal NK / T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4117 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Systemic EBV+ T-cell lymphoma of childhood | No Change | No Change | No Change | No | |
| PRE4118 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Other B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4119 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the lymphoma histology | Other T-cell / NK-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4120 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify other lymphoma histology: | Open text | No Change | No Change | No Change | No | |
| PRE4121 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Assignment of DLBCL (germinal center B-cell type vs. activated B-cell type) subtype was based on | Immunohistochemistry | No Change | No Change | No Change | No | |
| PRE4122 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Assignment of DLBCL (germinal center B-cell type vs. activated B-cell type) subtype was based on | Gene expression profile | No Change | No Change | No Change | No | |
| PRE4123 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Assignment of DLBCL (germinal center B-cell type vs. activated B-cell type) subtype was based on | Unknown | No Change | No Change | No Change | No | |
| PRE4124 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Is the lymphoma histology reported at transplant a transformation from CLL? | yes | No Change | No Change | No Change | No | |
| PRE4125 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Is the lymphoma histology reported at transplant a transformation from CLL? | no | No Change | No Change | No Change | No | |
| PRE4126 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was any 17p abnormality detected? | yes | No Change | No Change | No Change | No | |
| PRE4127 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was any 17p abnormality detected? | no | No Change | No Change | No Change | No | |
| PRE4128 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Is the lymphoma histology reported at transplant a transformation from a different lymphoma histology? | Yes | No Change | No Change | No Change | No | |
| PRE4129 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Is the lymphoma histology reported at transplant a transformation from a different lymphoma histology? | No | No Change | No Change | No Change | No | |
| PRE4130 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Classic Hodgkin lymphoma | No Change | No Change | No Change | No | |
| PRE4131 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Lymphocyte depleted | No Change | No Change | No Change | No | |
| PRE4132 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Lymphocyte-rich | No Change | No Change | No Change | No | |
| PRE4133 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Mixed cellularity | No Change | No Change | No Change | No | |
| PRE4134 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodular lymphocyte predominant Hodgkin lymphoma | No Change | No Change | No Change | No | |
| PRE4135 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodular sclerosis | No Change | No Change | No Change | No | |
| PRE4136 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Burkitt lymphoma | No Change | No Change | No Change | No | |
| PRE4137 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | ALK-positive large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4138 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma - Activated B-cell type subtype | No Change | No Change | No Change | No | |
| PRE4139 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma associated with chronic inflammation | No Change | No Change | No Change | No | |
| PRE4140 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma - Germinal Center B-cell subtype | No Change | No Change | No Change | No | |
| PRE4141 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma / high-grade B-cell lymphoma with MYC and BCL2 rearrangements | No Change | No Change | No Change | No | |
| PRE4142 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL6 rearrangements | No Change | No Change | No Change | No | |
| PRE4143 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements | No Change | No Change | No Change | No | |
| PRE4144 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Diffuse large B-cell lymphoma, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4145 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | EBV-positive diffuse large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4146 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Fibrin-associated large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4147 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Fluid overload-associated large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4148 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | High-grade B-cell lymphoma with 11q aberration | No Change | No Change | No Change | No | |
| PRE4149 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Intravascular large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4150 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Large B-cell lymphoma with IRF4 rearrangement | No Change | No Change | No Change | No | |
| PRE4151 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Lymphomatoid granulomatosis | No Change | No Change | No Change | No | |
| PRE4152 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Mediastinal grey zone lymphoma | No Change | No Change | No Change | No | |
| PRE4153 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Plasmablastic lymphoma | No Change | No Change | No Change | No | |
| PRE4154 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous diffuse large B-cell lymphoma, leg type | No Change | No Change | No Change | No | |
| PRE4155 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary mediastinal large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4156 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | T-cell / histiocytic-rich large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4157 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | High-grade B-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4158 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary large B-cell lymphoma of the CNS | No Change | No Change | No Change | No | |
| PRE4159 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary large B-cell lymphoma of the testis | No Change | No Change | No Change | No | |
| PRE4160 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary large B-cell lymphoma of the vitreoretina | No Change | No Change | No Change | No | |
| PRE4161 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | KSHV / HHV8-positive diffuse large B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4162 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary effusion lymphoma | No Change | No Change | No Change | No | |
| PRE4163 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Lymphoplasmacytic lymphoma | No Change | No Change | No Change | No | |
| PRE4164 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | IgM-LPL / Waldenstrom macroglobulinemia | No Change | No Change | No Change | No | |
| PRE4165 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Non-IgM-LPL / Waldenstrom macroglobulinemia | No Change | No Change | No Change | No | |
| PRE4166 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | No Change | No Change | No Change | No | |
| PRE4167 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodal marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4168 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Pediatric marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4169 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4170 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Splenic, B-cell lymphoma / leukemia with prominent nucleoli | No Change | No Change | No Change | No | |
| PRE4171 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Splenic diffuse red pulp small B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4172 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Splenic marginal zone lymphoma | No Change | No Change | No Change | No | |
| PRE4173 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Duodenal-type follicular lymphoma | No Change | No Change | No Change | No | |
| PRE4174 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular, mixed, small cleaved and large cell (Grade II follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4175 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular, predominantly large cell (Grade IIIA follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4176 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular, predominantly large cell (Grade IIIB follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4177 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular, predominantly large cell (Grade IIIA vs IIIB not specified) | No Change | No Change | No Change | No | |
| PRE4178 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular, predominantly small cleaved cell (Grade I follicle center lymphoma) | No Change | No Change | No Change | No | |
| PRE4179 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Pediatric-type follicular lymphoma | No Change | No Change | No Change | No | |
| PRE4180 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Follicular (grade unknown) | No Change | No Change | No Change | No | |
| PRE4181 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous follicle center lymphoma | No Change | No Change | No Change | No | |
| PRE4182 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Mantle cell lymphoma | No Change | No Change | No Change | No | |
| PRE4183 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Leukemic non-nodal mantle cell lymphoma | No Change | No Change | No Change | No | |
| PRE4184 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Transformations of indolent B-cell lymphomas | No Change | No Change | No Change | No | |
| PRE4185 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Classical Hodgkin lymphoma PTLD | No Change | No Change | No Change | No | |
| PRE4186 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | EBV-positive mucocutaneous ulcer | No Change | No Change | No Change | No | |
| PRE4187 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Hyperplasia arising in immune deficiencies (e.g. PTLD) | No Change | No Change | No Change | No | |
| PRE4188 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Infectious mononucleosis PTLD | No Change | No Change | No Change | No | |
| PRE4189 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Monomorphic PTLD (B- and T-/NK-cell types) | No Change | No Change | No Change | No | |
| PRE4190 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | No Change | No Change | No Change | No | |
| PRE4191 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Adult T-cell lymphoma / leukemia | No Change | No Change | No Change | No | |
| PRE4192 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Aggressive NK-cell leukemia | No Change | No Change | No Change | No | |
| PRE4193 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | NK-large granular lymphocytic leukemia | No Change | No Change | No Change | No | |
| PRE4194 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Sézary syndrome | No Change | No Change | No Change | No | |
| PRE4195 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | T-large granular lymphocytic leukemia | No Change | No Change | No Change | No | |
| PRE4196 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Mycosis fungoides | No Change | No Change | No Change | No | |
| PRE4197 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous acral CD8-positive lymphoproliferative disorder | No Change | No Change | No Change | No | |
| PRE4198 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | No Change | No Change | No Change | No | |
| PRE4199 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4200 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | No Change | No Change | No Change | No | |
| PRE4201 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4202 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous gamma / delta T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4203 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Subcutaneous panniculitis-like T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4204 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Primary cutaneous peripheral T-cell lymphoma, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4205 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Enteropathy-associated T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4206 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Indolent T-cell lymphoma of the gastrointestinal tract | No Change | No Change | No Change | No | |
| PRE4207 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | No Change | No Change | No Change | No | |
| PRE4208 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Monomorphic epitheliotropic intestinal T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4209 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Intestinal T-cell lymphoma, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4210 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Hepatosplenic T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4211 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | ALK-positive anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4212 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | ALK-negative anaplastic large-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4213 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Breast implant-associated anaplastic large cell lymphoma | No Change | No Change | No Change | No | |
| PRE4214 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodal TFH cell lymphoma, angioimmunoblastic-type | No Change | No Change | No Change | No | |
| PRE4215 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodal TFH cell lymphoma, follicular-type | No Change | No Change | No Change | No | |
| PRE4216 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Nodal TFH cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4217 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Peripheral T-cell lymphoma, NOS | No Change | No Change | No Change | No | |
| PRE4218 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | EBV-positive nodal T- and NK-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4219 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Extranodal NK / T-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4220 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Systemic EBV+ T-cell lymphoma of childhood | No Change | No Change | No Change | No | |
| PRE4221 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Other B-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4222 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify the original lymphoma histology | Other T-cell / NK-cell lymphoma | No Change | No Change | No Change | No | |
| PRE4223 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Specify other lymphoma histology: | Open text | No Change | No Change | No Change | No | |
| PRE4224 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Date of original lymphoma diagnosis: | Open text | No Change | No Change | No Change | No | |
| PRE4225 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was a PET (or PET/CT) scan performed? | yes | No Change | No Change | No Change | No | |
| PRE4226 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was a PET (or PET/CT) scan performed? | no | No Change | No Change | No Change | No | |
| PRE4227 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was the PET (or PET/CT) scan positive for lymphoma involvement at any disease site? | yes | No Change | No Change | No Change | No | |
| PRE4228 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Was the PET (or PET/CT) scan positive for lymphoma involvement at any disease site? | no | No Change | No Change | No Change | No | |
| PRE4229 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Date of PET (or PET/CT) scan | Known | No Change | No Change | No Change | No | |
| PRE4230 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Date of PET (or PET/CT) scan | Unknown | No Change | No Change | No Change | No | |
| PRE4231 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Date of PET (or PET/CT) scan: | Open text | No Change | No Change | No Change | No | |
| PRE4232 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Deauville (five-point) score of the PET (or PET/CT) scan | Known | No Change | No Change | No Change | No | |
| PRE4233 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Deauville (five-point) score of the PET (or PET/CT) scan | Unknown | No Change | No Change | No Change | No | |
| PRE4234 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Scale | 1 - no uptake or no residual uptake | No Change | No Change | No Change | No | |
| PRE4235 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Scale | 2 - slight uptake, but below blood pool | No Change | No Change | No Change | No | |
| PRE4236 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Scale | 3 - uptake above mediastinal, but below or equal to uptake in the liver | No Change | No Change | No Change | No | |
| PRE4237 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Scale | 4 - uptake slightly to moderately higher than liver | No Change | No Change | No Change | No | |
| PRE4238 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Scale | 5 - markedly increased uptake or any new lesion | No Change | No Change | No Change | No | |
| PRE4239 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | Disease untreated | No Change | No Change | No Change | No | |
| PRE4240 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | PIF res - Primary induction failure – resistant: NEVER in COMPLETE remission but with stable or progressive disease on treatment. | No Change | No Change | No Change | No | |
| PRE4241 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | PIF sen / PR1 - Primary induction failure – sensitive: NEVER in COMPLETE remission but with partial remission on treatment. | No Change | No Change | No Change | No | |
| PRE4242 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | PIF unk - Primary induction failure – sensitivity unknown | No Change | No Change | No Change | No | |
| PRE4243 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | CR1 - 1st complete remission: no bone marrow or extramedullary relapse prior to transplant | No Change | No Change | No Change | No | |
| PRE4244 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | CR2 - 2nd complete remission | No Change | No Change | No Change | No | |
| PRE4245 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | CR3+ - 3rd or subsequent complete remission | No Change | No Change | No Change | No | |
| PRE4246 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL1 unt - 1st relapse – untreated; includes either bone marrow or extramedullary relapse | No Change | No Change | No Change | No | |
| PRE4247 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL1 res - 1st relapse – resistant: stable or progressive disease with treatment | No Change | No Change | No Change | No | |
| PRE4248 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL1 sen - 1st relapse – sensitive: partial remission (if complete remission was achieved, classify as CR2) | No Change | No Change | No Change | No | |
| PRE4249 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL1 unk - 1st relapse – sensitivity unknown | No Change | No Change | No Change | No | |
| PRE4250 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL2 unt - 2nd relapse – untreated: includes either bone marrow or extramedullary relapse | No Change | No Change | No Change | No | |
| PRE4251 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL2 res - 2nd relapse – resistant: stable or progressive disease with treatment | No Change | No Change | No Change | No | |
| PRE4252 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL2 sen - 2nd relapse – sensitive: partial remission (if complete remission achieved, classify as CR3+) | No Change | No Change | No Change | No | |
| PRE4253 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL2 unk - 2nd relapse – sensitivity unknown | No Change | No Change | No Change | No | |
| PRE4254 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL3+ unt - 3rd or subsequent relapse – untreated; includes either bone marrow or extramedullary relapse | No Change | No Change | No Change | No | |
| PRE4255 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL3+ res - 3rd or subsequent relapse – resistant: stable or progressive disease with treatment | No Change | No Change | No Change | No | |
| PRE4256 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL3+ sen - 3rd or subsequent relapse – sensitive: partial remission (if complete remission achieved, classify as CR3+) | No Change | No Change | No Change | No | |
| PRE4257 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | What was the disease status? | REL3+ unk - 3rd relapse or greater – sensitivity unknown | No Change | No Change | No Change | No | |
| PRE4258 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Total number of lines of therapy received | 1 line | No Change | No Change | No Change | No | |
| PRE4259 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Total number of lines of therapy received | 2 lines | No Change | No Change | No Change | No | |
| PRE4260 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Total number of lines of therapy received | 3+ lines | No Change | No Change | No Change | No | |
| PRE4261 | Pre-Transplant Information Collection | Disease Classification | Hodgkin and Non-Hodgkin Lymphoma | No | Date assessed: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4262 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Multiple myeloma | No Change | No Change | No Change | No | |
| PRE4263 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Multiple myeloma-light chain only | Deletion of Information Requested | No Change | No | Reduce burden - prevent / reduce data redundancy | |
| PRE4264 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Multiple myeloma-non-secretory | No Change | No Change | No Change | No | |
| PRE4265 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Plasma cell leukemia | No Change | No Change | No Change | No | |
| PRE4266 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Plasmacytoma | No Change | No Change | No Change | No | |
| PRE4267 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Smoldering myeloma | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE4268 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Immuno-globulin-related (AL) amyloidosis | No Change | No Change | No Change | No | |
| PRE4269 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | POEMS syndrome | No Change | No Change | No Change | No | |
| PRE4270 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Monoclonal gammopathy of renal significance (MGRS) | No Change | No Change | No Change | No | |
| PRE4271 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify the multiple myeloma/plasma cell disorder (PCD) classification | Other plasma cell disorder | No Change | No Change | No Change | No | |
| PRE4272 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify other plasma cell disorder: | Open text | No Change | No Change | No Change | No | |
| PRE4273 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgG kappa | No Change | No Change | No Change | No | |
| PRE4274 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgA kappa | No Change | No Change | No Change | No | |
| PRE4275 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgM kappa | No Change | No Change | No Change | No | |
| PRE4276 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgD kappa | No Change | No Change | No Change | No | |
| PRE4277 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgE kappa | No Change | No Change | No Change | No | |
| PRE4278 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgG lambda | No Change | No Change | No Change | No | |
| PRE4279 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgA lambda | No Change | No Change | No Change | No | |
| PRE4280 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgM lambda | No Change | No Change | No Change | No | |
| PRE4281 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgD lambda | No Change | No Change | No Change | No | |
| PRE4282 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgE lambda | No Change | No Change | No Change | No | |
| PRE4283 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgG (heavy chain only) | No Change | No Change | No Change | No | |
| PRE4284 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgA (heavy chain only) | No Change | No Change | No Change | No | |
| PRE4285 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgM (heavy chain only) | No Change | No Change | No Change | No | |
| PRE4286 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgD (heavy chain only) | No Change | No Change | No Change | No | |
| PRE4287 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | IgE (heavy chain only) | No Change | No Change | No Change | No | |
| PRE4288 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | Kappa (light chain only) | No Change | No Change | No Change | No | |
| PRE4289 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify heavy and/or light chain type | Lambda (light chain only) | No Change | No Change | No Change | No | |
| PRE4290 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify Amyloidosis classification | AL amyloidosis | No Change | No Change | No Change | No | |
| PRE4291 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify Amyloidosis classification | AH amyloidosis | No Change | No Change | No Change | No | |
| PRE4292 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify Amyloidosis classification | AHL amyloidosis | No Change | No Change | No Change | No | |
| PRE4293 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Light chain fanconi syndrome | No Change | No Change | No Change | No | |
| PRE4294 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Proximal tubulopathy without crystals | No Change | No Change | No Change | No | |
| PRE4295 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Crystal-storing histiocytosis | No Change | No Change | No Change | No | |
| PRE4296 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Non-amyloid fibrillary glomerulonephritis | No Change | No Change | No Change | No | |
| PRE4297 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Immunotactoid glomerulopathy (ITGN)/ Glomerulonephritis with organized monoclonal microtubular immunoglobulin deposits (GOMMID) | No Change | No Change | No Change | No | |
| PRE4298 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Type 1 cryoglobulinemic glomerulonephritis | No Change | No Change | No Change | No | |
| PRE4299 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Monoclonal immunoglobulin deposition disease (MIDD) | No Change | No Change | No Change | No | |
| PRE4300 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits (PGNMID) | No Change | No Change | No Change | No | |
| PRE4301 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | C3 glomerulopathy with monoclonal gammopathy | No Change | No Change | No Change | No | |
| PRE4302 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal gammopathy of renal significance (MGRS) classification | Unknown | No Change | No Change | No Change | No | |
| PRE4303 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal immunoglobulin deposition disease (MIDD) subtype | Light chain deposition disease (LCDD) | No Change | No Change | No Change | No | |
| PRE4304 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal immunoglobulin deposition disease (MIDD) subtype | Monoclonal immunoglobulin deposition disease | No Change | No Change | No Change | No | |
| PRE4305 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Select monoclonal immunoglobulin deposition disease (MIDD) subtype | Heavy chain deposition disease (HCDD) | No Change | No Change | No Change | No | |
| PRE4306 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report for MGRS diagnoses | Reduce burden | ||
| PRE4307 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the pathology report for MGRS diagnoses | Reduce burden | ||
| PRE4308 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Solitary plasmacytoma was | Extraosseous plasmacytoma | No Change | No Change | No Change | No | |
| PRE4309 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Solitary plasmacytoma was | Solitary plasmacytoma of bone | No Change | No Change | No Change | No | |
| PRE4310 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Did the recipient have a preceding or concurrent plasma cell disorder? | Yes | No Change | No Change | No Change | No | |
| PRE4311 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Did the recipient have a preceding or concurrent plasma cell disorder? | No | No Change | No Change | No Change | No | |
| PRE4312 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Multiple myeloma | No Change | No Change | No Change | No | |
| PRE4313 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Multiple myeloma-light chain only | Deletion of Information Requested | No Change | No | Reduce burden - prevent / reduce data redundancy | |
| PRE4314 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Multiple myeloma-non-secretory | No Change | No Change | No Change | No | |
| PRE4315 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Plasma cell leukemia | No Change | No Change | No Change | No | |
| PRE4316 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Plasmacytoma | No Change | No Change | No Change | No | |
| PRE4317 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Smoldering myeloma | No Change | No Change | No Change | No | |
| PRE4318 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Immuno-globulin-related (AL) amyloidosis | No Change | No Change | No Change | No | |
| PRE4319 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | POEMS syndrome | No Change | No Change | No Change | No | |
| PRE4320 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Monoclonal gammopathy of unknown significance (MGUS) | No Change | No Change | No Change | No | |
| PRE4321 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Monoclonal gammopathy of renal significance (MGRS) | No Change | No Change | No Change | No | |
| PRE4322 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify preceding / concurrent disorder | Other plasma cell disorder (PCD) | No Change | No Change | No Change | No | |
| PRE4323 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Specify other preceding/concurrent disorder | Open text | No Change | No Change | No Change | No | |
| PRE4324 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | Yes | Date of diagnosis of preceding / concurrent disorder: | Open text | No Change | No Change | No Change | No | |
| PRE4325 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of Information Requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Serum calcium | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4326 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of Information Requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Serum creatinine | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4327 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of Information Requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4328 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | LDH | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4329 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Serum albumin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4330 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Serum B2 microglobulin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4331 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | Plasma cells in peripheral blood by morphologic assessment | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4332 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at diagnosis for the disease for which the infusion is being done | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4333 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Serum calcium: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4334 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mg/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4335 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4336 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mEq/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4337 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Serum creatinine: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4338 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mg/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4339 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4340 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | µmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4341 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Hemoglobin: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4342 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | g/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4343 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | g/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4344 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4345 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | LDH | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4346 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | LDH | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4347 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | LDH: | Open text | No Change | No Change | No Change | No | |
| PRE4348 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | U/L | checked | No Change | No Change | No Change | No | |
| PRE4349 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | µkat/L | checked | No Change | No Change | No Change | No | |
| PRE4350 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Upper limit of normal for LDH: | Open text | No Change | No Change | No Change | No | |
| PRE4351 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum albumin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4352 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum albumin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4353 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum albumin: | Open text | No Change | No Change | No Change | No | |
| PRE4354 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | g/dL | checked | No Change | No Change | No Change | No | |
| PRE4355 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | g/L | checked | No Change | No Change | No Change | No | |
| PRE4356 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum β2 - microglobulin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4357 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum β2 - microglobulin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4358 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Serum β2 - microglobulin | Open text | No Change | No Change | No Change | No | |
| PRE4359 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | µg/dL | checked | No Change | No Change | No Change | No | |
| PRE4360 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | mg/L | checked | No Change | No Change | No Change | No | |
| PRE4361 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | nmol/L | checked | No Change | No Change | No Change | No | |
| PRE4362 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by morphologic assessment | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4363 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by morphologic assessment | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4364 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by morphologic assessment [percentage] | Open text | No Change | No Change | No Change | No | |
| PRE4365 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by morphologic assessment [value] | Open text | No Change | No Change | No Change | No | |
| PRE4366 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | x 109 Cells/L (x 103/mm3) | checked | No Change | No Change | No Change | No | |
| PRE4367 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | x 106/L | checked | Change/Clarification of Information Requested | No Change | x 106/L (x1/mm3) (x1/µL) (cells µL) | No | Capture data accurately | 
| PRE4368 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by flow cytometry | Known | No Change | No Change | No Change | No | |
| PRE4369 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by flow cytometry | Unknown | No Change | No Change | No Change | No | |
| PRE4370 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Plasma cells in peripheral blood by flow cytometry | Open text | No Change | No Change | No Change | No | |
| PRE4371 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage [ISS] | Known | Deletion of Information Requested | No | Reduce burden | ||
| PRE4372 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage [ISS] | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE4373 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 1 | Change/Clarification of Information Requested | I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4374 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 2 | Change/Clarification of Information Requested | I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4375 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 3 | Change/Clarification of Information Requested | I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4376 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | Change/Clarification of Information Requested and Addition of Response Option | I.S.S. stage | Unknown | No | Capture data accurately | |
| PRE4377 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage [R-ISS] | Known | Deletion of Information Requested | No | Reduce burden | ||
| PRE4378 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage [R-ISS ] | Unknown | Deletion of Information Requested | No | Reduce burden | ||
| PRE4379 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 1 | Change/Clarification of Information Requested | R-I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4380 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 2 | Change/Clarification of Information Requested | R-I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4381 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | 3 | Change/Clarification of Information Requested | R-I.S.S. stage | No Change | No | Capture data accurately | 
| PRE4382 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Stage | Change/Clarification of Information Requested and Addition of Response Option | R-I.S.S. stage | Unknown | No | Capture data accurately | |
| PRE4383 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon staging? | Stage I | Change/Clarification of Information Requested | Durie-Salmon stage | No Change | No | Capture data accurately | 
| PRE4384 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon staging? | Stage II | Change/Clarification of Information Requested | Durie-Salmon stage | No Change | No | Capture data accurately | 
| PRE4385 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon staging? | Stage III | Change/Clarification of Information Requested | Durie-Salmon stage | No Change | No | Capture data accurately | 
| PRE4386 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon staging? | Unknown | Change/Clarification of Information Requested | Durie-Salmon stage | No Change | No | Capture data accurately | 
| PRE4387 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon sub classification? | A - relatively normal renal function | Change/Clarification of Information Requested | Durie-Salmon sub classification | No Change | No | Capture data accurately | 
| PRE4388 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What was the Durie-Salmon sub classification? | B - abnormal renal function | Change/Clarification of Information Requested | Durie-Salmon sub classification | No Change | No | Capture data accurately | 
| PRE4389 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested (karyotyping or FISH)? | yes | No Change | No Change | No Change | No | |
| PRE4390 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested (karyotyping or FISH)? | no | No Change | No Change | No Change | No | |
| PRE4391 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested (karyotyping or FISH)? | Unknown | No Change | No Change | No Change | No | |
| PRE4392 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via FISH? | Yes | No Change | No Change | No Change | No | |
| PRE4393 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via FISH? | No | No Change | No Change | No Change | No | |
| PRE4394 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via FISH? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE4395 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE4396 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE4397 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE4398 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +3 | No Change | No Change | No Change | No | |
| PRE4399 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +5 | No Change | No Change | No Change | No | |
| PRE4400 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +7 | No Change | No Change | No Change | No | |
| PRE4401 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE4402 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE4403 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +15 | No Change | No Change | No Change | No | |
| PRE4404 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE4405 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(4;14) | Change/Clarification of Information Requested | No Change | t(4;14), IGH / FGFR3 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4406 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(6;14) | Change/Clarification of Information Requested | No Change | t(6;14), IGH / CCND3 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4407 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(11;14) | Change/Clarification of Information Requested | No Change | t(11;14), IGH / CCND1 | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4408 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(14;16) | Change/Clarification of Information Requested | No Change | t(14;16), IGH / MAF | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4409 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(14;20) | Change/Clarification of Information Requested | No Change | t(14;20), IGH / MAFB | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4410 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Addition of Information Requested | No Change | Other IGH rearrangement | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4411 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE4412 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | del(17p) / 17p- | Change/Clarification of Information Requested | del (17p) / 17p-, TP53 | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4413 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE4414 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE4415 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Hyperdiploid (> 50) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4416 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Hypodiploid (< 46) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4417 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | MYC rearrangement | No Change | No Change | No Change | No | |
| PRE4418 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Any abnormality at 1q | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4419 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Addition of Information Requested | No Change | Amplification of 1q, CKS1B | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4420 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Addition of Information Requested | No Change | Duplication of 1q, CKS1B | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4421 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Any abnormality at 1p | Change/Clarification of Information Requested | No Change | Any abnormality at 1p, CDKN2C | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4422 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE4423 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE4424 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE4425 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Reduce burden | ||
| PRE4426 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via karyotyping? | Yes | No Change | No Change | No Change | No | |
| PRE4427 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via karyotyping? | No | No Change | No Change | No Change | No | |
| PRE4428 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Were cytogenetics tested via karyotyping? | Addition of Information Requested | No Change | Unknown | No | Capture data accurately | |
| PRE4429 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Results of tests | Abnormalities identified | No Change | No Change | No Change | No | |
| PRE4430 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Results of tests | No evaluable metaphases | No Change | No Change | No Change | No | |
| PRE4431 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Results of tests | No abnormalities | No Change | No Change | No Change | No | |
| PRE4432 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No Change | No Change | No Change | No | |
| PRE4433 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +3 | No Change | No Change | No Change | No | |
| PRE4434 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +5 | No Change | No Change | No Change | No | |
| PRE4435 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +7 | No Change | No Change | No Change | No | |
| PRE4436 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +9 | No Change | No Change | No Change | No | |
| PRE4437 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +11 | No Change | No Change | No Change | No | |
| PRE4438 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +15 | No Change | No Change | No Change | No | |
| PRE4439 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | +19 | No Change | No Change | No Change | No | |
| PRE4440 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(4;14) | No Change | No Change | No Change | No | |
| PRE4441 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(6;14) | No Change | No Change | No Change | No | |
| PRE4442 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(11;14) | No Change | No Change | No Change | No | |
| PRE4443 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(14;16) | No Change | No Change | No Change | No | |
| PRE4444 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | t(14;20) | No Change | No Change | No Change | No | |
| PRE4445 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | del(13q) / 13q- | No Change | No Change | No Change | No | |
| PRE4446 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | del(17p) / 17p- | No Change | No Change | No Change | No | |
| PRE4447 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | -13 | No Change | No Change | No Change | No | |
| PRE4448 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | -17 | No Change | No Change | No Change | No | |
| PRE4449 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Hyperdiploid (> 50) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4450 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Hypodiploid (< 46) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4451 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | MYC rearrangement | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4452 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Addition of Information Requested | No Change | Duplication of 1q | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4453 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Any abnormality at 1q | Change/Clarification of Information Requested | No Change | Any other abnormality at 1q | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4454 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Any abnormality at 1p | No Change | No Change | No Change | No | |
| PRE4455 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify abnormalities | Other abnormality | No Change | No Change | No Change | No | |
| PRE4456 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify other abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE4457 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE4458 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Reduce burden | ||
| PRE4459 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Laboratory studies at last evaluation prior to start of preparative regimen | Serum creatinine | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4460 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Laboratory studies at last evaluation prior to start of preparative regimen | Hemoglobin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4461 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Laboratory studies at last evaluation prior to start of preparative regimen | Plasma cells in peripheral blood by morphologic assessment | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4462 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Laboratory studies at last evaluation prior to start of preparative regimen | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4463 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Serum creatinine: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4464 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mg/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4465 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4466 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | µmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4467 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Hemoglobin: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4468 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | g/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4469 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | g/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4470 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | mmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4471 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Plasma cells in peripheral blood by morphologic assessment [percentage] | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4472 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Plasma cells in peripheral blood by morphologic assessment [value] | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4473 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | x 109 Cells/L (x 103/mm3) | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4474 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | x 106/L (x1/mm3) (x1/µL) (cells µL) | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4475 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Plasma cells in peripheral blood by flow cytometry | Known | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4476 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Plasma cells in peripheral blood by flow cytometry | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4477 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Plasma cells in peripheral blood by flow cytometry | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4478 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4479 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested (karyotyping or FISH)? | no | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4480 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested via FISH? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4481 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested via FISH? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4482 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4483 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4484 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4485 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4486 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4487 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4488 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +9 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4489 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4490 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +15 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4491 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +19 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4492 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(4;14), IGH / FGFR3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4493 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(6;14), IGH / CCND3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4494 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(11;14), IGH / CCND1 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4495 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(14;16), IGH / MAF | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4496 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(14;20), IGH / MAFB | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4497 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Other IGH rearrangement | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4498 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | del(13q) / 13q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4499 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | del(17p) / 17p-, TP53 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4500 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | -13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4501 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4502 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | MYC rearrangement | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4503 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Amplification of 1q, CKS1B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4504 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Duplication of 1q, CKS1B | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4505 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Any abnormality at 1p, CDKN2C | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4506 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4507 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4508 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the FISH report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE4509 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4510 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Were cytogenetics tested via karyotyping? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4511 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Results of tests | Abnormalities identified | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4512 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Results of tests | No evaluable metaphases | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4513 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Results of tests | No abnormalities | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4514 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | International System for Human Cytogenetic Nomenclature (ISCN) compatible string: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4515 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +3 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4516 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +5 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4517 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +7 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4518 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +9 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4519 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +11 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4520 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +15 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4521 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | +19 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4522 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(4;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4523 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(6;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4524 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(11;14) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4525 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(14;16) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4526 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | t(14;20) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4527 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | del(13q) / 13q- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4528 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | del(17p) / 17p- | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4529 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | -13 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4530 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | -17 | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4531 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Duplication of 1q | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4532 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Any other abnormality at 1q | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4533 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Any abnormality at 1p | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4534 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify abnormalities | Other abnormality | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4535 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Information Requested | Specify other abnormality: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4536 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Addition of Instructional text | Yes: CIBMTR strongly encourages attaching the karyotyping report when abnormalities were identified. | Be consistent with current clinical landscape, improve transplant outcome data | ||||
| PRE4537 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Stringent complete response (sCR) | No Change | No Change | No Change | No | |
| PRE4538 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Complete response (CR) | No Change | No Change | No Change | No | |
| PRE4539 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Very good partial response (VGPR) | No Change | No Change | No Change | No | |
| PRE4540 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Partial response (PR) | No Change | No Change | No Change | No | |
| PRE4541 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | No response (NR) / stable disease (SD | No Change | No Change | No Change | No | |
| PRE4542 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Progressive disease (PD) | No Change | No Change | No Change | No | |
| PRE4543 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Relapse from CR (Rel) (untreated) | No Change | No Change | No Change | No | |
| PRE4544 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | What is the hematologic disease status? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE4545 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Date assessed: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4546 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Complete response (CR) | No Change | No Change | No Change | No | |
| PRE4547 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Very good partial response (VGPR) | No Change | No Change | No Change | No | |
| PRE4548 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Partial response (PR) | No Change | No Change | No Change | No | |
| PRE4549 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | No response (NR) / stable disease (SD) | No Change | No Change | No Change | No | |
| PRE4550 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Progressive disease (PD) | No Change | No Change | No Change | No | |
| PRE4551 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Relapse from CR (Rel) (untreated) | No Change | No Change | No Change | No | |
| PRE4552 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Specify amyloidosis hematologic response | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE4553 | Pre-Transplant Information Collection | Disease Classification | Multiple Myeloma / Plasma Cell Disorder (PCD) | No | Date assessed: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRE4554 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Breast cancer | No Change | No Change | No Change | No | |
| PRE4555 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Tumors of the head / neck | No Change | No Change | No Change | No | |
| PRE4556 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Colorectal | No Change | No Change | No Change | No | |
| PRE4557 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Pancreatic | No Change | No Change | No Change | No | |
| PRE4558 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Tumor of the esophagus and gastro-esophageal (GE) junction | No Change | No Change | No Change | No | |
| PRE4559 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Tumors of the stomach | No Change | No Change | No Change | No | |
| PRE4560 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Tumors of liver and intrahepatic bile ducts | No Change | No Change | No Change | No | |
| PRE4561 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Atypical teratoid rhabdoid tumor (ATRT) | No Change | No Change | No Change | No | |
| PRE4562 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Central nervous system tumor, including CNS PNET | No Change | No Change | No Change | No | |
| PRE4563 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Diffuse intrinsic pontine glioma (DIPG) | No Change | No Change | No Change | No | |
| PRE4564 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Ependymoma | No Change | No Change | No Change | No | |
| PRE4565 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Glioblastoma multiforme (GBM) | No Change | No Change | No Change | No | |
| PRE4566 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Medulloblastoma | No Change | No Change | No Change | No | |
| PRE4567 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Bone sarcoma (excluding Ewing family tumors) | No Change | No Change | No Change | No | |
| PRE4568 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Desmoplastic small round cell tumors | No Change | No Change | No Change | No | |
| PRE4569 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Ewing family tumors of bone (including PNET) | No Change | No Change | No Change | No | |
| PRE4570 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Ewing family tumors, extraosseous (including PNET) | No Change | No Change | No Change | No | |
| PRE4571 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Malignant Peripheral Nerve Sheath Tumor | No Change | No Change | No Change | No | |
| PRE4572 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Myxoid round cell sarcoma | No Change | No Change | No Change | No | |
| PRE4573 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Rhabdomyosarcoma | No Change | No Change | No Change | No | |
| PRE4574 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Synovial sarcoma | No Change | No Change | No Change | No | |
| PRE4575 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Other soft tissue sarcoma (excluding Ewing family tumors) | No Change | No Change | No Change | No | |
| PRE4576 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Germ cell tumors, gonadal | No Change | No Change | No Change | No | |
| PRE4577 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Germ cell tumor, extragonadal | No Change | No Change | No Change | No | |
| PRE4578 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Neuroblastoma | No Change | No Change | No Change | No | |
| PRE4579 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Adenocarcinoma | No Change | No Change | No Change | No | |
| PRE4580 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Lung, non-small cell | No Change | No Change | No Change | No | |
| PRE4581 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Lung, small cell | No Change | No Change | No Change | No | |
| PRE4582 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Lung, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4583 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Squamous carcinoma | No Change | No Change | No Change | No | |
| PRE4584 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Tumor of the pleura (Mesothelioma) | No Change | No Change | No Change | No | |
| PRE4585 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Melanoma | No Change | No Change | No Change | No | |
| PRE4586 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Ovarian (epithelial) | No Change | No Change | No Change | No | |
| PRE4587 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Prostate | No Change | No Change | No Change | No | |
| PRE4588 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Renal cell | No Change | No Change | No Change | No | |
| PRE4589 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Testicular | No Change | No Change | No Change | No | |
| PRE4590 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Vaginal | No Change | No Change | No Change | No | |
| PRE4591 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Malignant Rhabdoid Tumor of the Kidney | No Change | No Change | No Change | No | |
| PRE4592 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Retinoblastoma | No Change | No Change | No Change | No | |
| PRE4593 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Wilms tumor | No Change | No Change | No Change | No | |
| PRE4594 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Solid tumor, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4595 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify the solid tumor classification | Other solid tumor | No Change | No Change | No Change | No | |
| PRE4596 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Specify other solid tumor: | Open text | No Change | No Change | No Change | No | |
| PRE4597 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Addition of Information Requested | What was the disease status? | Complete Response (CR) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4598 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Addition of Information Requested | What was the disease status? | Partial Response | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4599 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Addition of Information Requested | What was the disease status? | Stable disease | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4600 | Pre-Transplant Information Collection | Disease Classification | Solid Tumors | No | Addition of Information Requested | What was the disease status? | Progressive disease | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4601 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired AA, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4602 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquried AA secondary to chemotherapy | No Change | No Change | No Change | No | |
| PRE4603 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired AA, secondary to hepatitis | No Change | No Change | No Change | No | |
| PRE4604 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired AA secondary to immunotherapy or immune effector cell therapy | No Change | No Change | No Change | No | |
| PRE4605 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired AA, secondary to toxin / other drug | No Change | No Change | No Change | No | |
| PRE4606 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired amegakaryocytosis (not congenital) | No Change | No Change | No Change | No | |
| PRE4607 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Acquired pure red cell aplasia (not congenital) | No Change | No Change | No Change | No | |
| PRE4608 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify the aplastic anemia classification | Other acquired cytopenic syndrome | No Change | No Change | No Change | No | |
| PRE4609 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify severity | Severe / very severe | No Change | No Change | No Change | No | |
| PRE4610 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify severity | Not severe | No Change | No Change | No Change | No | |
| PRE4611 | Pre-Transplant Information Collection | Disease Classification | Aplastic Anemia | No | Specify other acquired cytopenic syndrome: | Open text | No Change | No Change | No Change | No | |
| PRE4612 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Diamond-Blackfan anemia (pure red cell aplasia) | No Change | No Change | No Change | No | |
| PRE4613 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Telomere Biology Disorders including Dyskeratosis congenita (DKC1, TERT, TERC, and other mutations) | No Change | No Change | No Change | No | |
| PRE4614 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Fanconi anemia | No Change | No Change | No Change | No | |
| PRE4615 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Severe congenital neutropenia (Elastase deficiency / ELANE or Kostmann disease / HAX1 mutations) | No Change | No Change | No Change | No | |
| PRE4616 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Shwachman-Diamond (DNAJC21, EFL1, or SBDS mutations) | No Change | No Change | No Change | No | |
| PRE4617 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Germline SAMD9 variant (MIRAGE Syndrome) | No Change | No Change | No Change | No | |
| PRE4618 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Germline SAMD9L variant (SAMD9L-related Ataxia Pancytopenia Syndrome) | No Change | No Change | No Change | No | |
| PRE4619 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Addition of Information Requested | No Change | Bone Marrow Failure due to Germline GATA2 variant (GATA2 deficiency ) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4620 | Pre-Transplant Information Collection | Disease Classification | Inherited Bone Marrow Failure Syndromes | No | Specify the inherited bone marrow failure syndrome classification | Other inherited bone marrow failure syndrome | No Change | No Change | No Change | No | |
| PRE4621 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify the hemoglobinopathy classification | Sickle cell disease | No Change | No Change | No Change | No | |
| PRE4622 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify the hemoglobinopathy classification | Transfusion dependent thalassemia | No Change | No Change | No Change | No | |
| PRE4623 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify the hemoglobinopathy classification | Other hemoglobinopathy | No Change | No Change | No Change | No | |
| PRE4624 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify transfusion dependent thalassemia | Transfusion dependent beta thalassemia | No Change | No Change | No Change | No | |
| PRE4625 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify transfusion dependent thalassemia | Other transfusion dependent thalassemia | No Change | No Change | No Change | No | |
| PRE4626 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify other hemoglobinopathy: | Open text | No Change | No Change | No Change | No | |
| PRE4627 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was tricuspid regurgitant jet velocity (TRJV) measured by echocardiography? | Yes | No Change | No Change | No Change | No | |
| PRE4628 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was tricuspid regurgitant jet velocity (TRJV) measured by echocardiography? | No | No Change | No Change | No Change | No | |
| PRE4629 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was tricuspid regurgitant jet velocity (TRJV) measured by echocardiography? | Unknown | No Change | No Change | No Change | No | |
| PRE4630 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | TRJV measurement | Known | No Change | No Change | No Change | No | |
| PRE4631 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | TRJV measurement | Unknown | No Change | No Change | No Change | No | |
| PRE4632 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | TRJV m/sec: | Open text | No Change | No Change | No Change | No | |
| PRE4633 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was liver iron content (LIC) tested within 6 months prior to infusion? | Yes | No Change | No Change | No Change | No | |
| PRE4634 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was liver iron content (LIC) tested within 6 months prior to infusion? | No | No Change | No Change | No Change | No | |
| PRE4635 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | LIC: | Open text | No Change | No Change | No Change | No | |
| PRE4636 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | mg Fe/g liver dry weight | checked | No Change | No Change | No Change | No | |
| PRE4637 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | g Fe/kg liver dry weight | checked | No Change | No Change | No Change | No | |
| PRE4638 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | mmol Fe/g liver dry weight | checked | No Change | No Change | No Change | No | |
| PRE4639 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Method used to estimate LIC? | T2*MRI | No Change | No Change | No Change | No | |
| PRE4640 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Method used to estimate LIC? | SQUID MRI | No Change | No Change | No Change | No | |
| PRE4641 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Method used to estimate LIC? | FerriScan | No Change | No Change | No Change | No | |
| PRE4642 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Method used to estimate LIC? | Liver Biopsy | No Change | No Change | No Change | No | |
| PRE4643 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Method used to estimate LIC? | Other | No Change | No Change | No Change | No | |
| PRE4644 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Is the recipient red blood cell transfusion dependent? | Yes | No Change | No Change | No Change | No | |
| PRE4645 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Is the recipient red blood cell transfusion dependent? | No | No Change | No Change | No Change | No | |
| PRE4646 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Year of first transfusion: | Open text | No Change | No Change | No Change | No | |
| PRE4647 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was iron chelation therapy given at any time since diagnosis? | Yes | No Change | No Change | No Change | No | |
| PRE4648 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was iron chelation therapy given at any time since diagnosis? | No | No Change | No Change | No Change | No | |
| PRE4649 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was iron chelation therapy given at any time since diagnosis? | Unknown | No Change | No Change | No Change | No | |
| PRE4650 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did iron chelation therapy meet the following criteria: initiated within 18 months of the first transfusion and administered for at least 5 days / week (either oral or parenteral iron chelation medication)? | Yes, iron chelation therapy given as specified | No Change | No Change | No Change | No | |
| PRE4651 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did iron chelation therapy meet the criteria: initiated within 18 months of the first transfusion and administered for at least 5 days / week (either oral or parenteral iron chelation medication)? | No, iron chelation therapy given, but not meeting criteria listed | No Change | No Change | No Change | No | |
| PRE4652 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did iron chelation therapy meet the criteria: initiated within 18 months of the first transfusion and administered for at least 5 days / week (either oral or parenteral iron chelation medication)? | Iron chelation therapy given, but details of administration unknown | No Change | No Change | No Change | No | |
| PRE4653 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify reason criteria not met | Non-adherence | No Change | No Change | No Change | No | |
| PRE4654 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify reason criteria not met | Toxicity due to iron chelation therapy | No Change | No Change | No Change | No | |
| PRE4655 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify reason criteria not met | Addition of Information Requested | No Change | Treatment started more than 18 months from first transfusion | No | Capture data accurately | |
| PRE4656 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify reason criteria not met | Other | No Change | No Change | No Change | No | |
| PRE4657 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Specify other reason criteria not met: | Open text | No Change | No Change | No Change | No | |
| PRE4658 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Year iron chelation therapy started | Known | No Change | No Change | No Change | No | |
| PRE4659 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Year iron chelation therapy started | Unknown | No Change | No Change | No Change | No | |
| PRE4660 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Year started: | Open text | No Change | No Change | No Change | No | |
| PRE4661 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have hepatomegaly? | Yes | No Change | No Change | No Change | No | |
| PRE4662 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have hepatomegaly? | No | No Change | No Change | No Change | No | |
| PRE4663 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have hepatomegaly? | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRE4664 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Liver size as measured below the costal margin at most recent evaluation: | Open text | Change/Clarification of Information Requested | Liver size at most recent evaluation: | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRE4665 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was a liver biopsy performed at any time since diagnosis? | yes | No Change | No Change | No Change | No | |
| PRE4666 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was a liver biopsy performed at any time since diagnosis? | no | No Change | No Change | No Change | No | |
| PRE4667 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Date assessed | Known | Change/Clarification of Information Requested | Date liver biopsy performed | No Change | No | Capture data accurately | 
| PRE4668 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Date assessed | Unknown | Change/Clarification of Information Requested | Date liver biopsy performed | No Change | No | Capture data accurately | 
| PRE4669 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Date assessed | Open text | Change/Clarification of Information Requested | Date liver biopsy performed | No Change | No | Capture data accurately | 
| PRE4670 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Date estimated | checked | No Change | No Change | No Change | No | |
| PRE4671 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver cirrhosis? | Yes | No Change | No Change | No Change | No | |
| PRE4672 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver cirrhosis? | No | No Change | No Change | No Change | No | |
| PRE4673 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver cirrhosis? | Unknown | No Change | No Change | No Change | No | |
| PRE4674 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver fibrosis? | Yes | No Change | No Change | No Change | No | |
| PRE4675 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver fibrosis? | No | No Change | No Change | No Change | No | |
| PRE4676 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of liver fibrosis? | Unknown | No Change | No Change | No Change | No | |
| PRE4677 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Type of fibrosis | Bridging | No Change | No Change | No Change | No | |
| PRE4678 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Type of fibrosis | Periportal | No Change | No Change | No Change | No | |
| PRE4679 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Type of fibrosis | Other | No Change | No Change | No Change | No | |
| PRE4680 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Type of fibrosis | Unknown | No Change | No Change | No Change | No | |
| PRE4681 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of chronic hepatitis? | Yes | No Change | No Change | No Change | No | |
| PRE4682 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of chronic hepatitis? | No | No Change | No Change | No Change | No | |
| PRE4683 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was there evidence of chronic hepatitis? | Unknown | No Change | No Change | No Change | No | |
| PRE4684 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the liver biopsy report. | Reduce burden | ||
| PRE4685 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the liver biopsy report. | Reduce burden | ||
| PRE4686 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Is there evidence of abnormal cardiac iron deposition based on MRI of the heart at time of infusion? | Yes | No Change | No Change | No Change | No | |
| PRE4687 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Is there evidence of abnormal cardiac iron deposition based on MRI of the heart at time of infusion? | No | No Change | No Change | No Change | No | |
| PRE4688 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have a splenectomy? | yes | No Change | No Change | No Change | No | |
| PRE4689 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have a splenectomy? | no | No Change | No Change | No Change | No | |
| PRE4690 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Did the recipient have a splenectomy? | Unknown | No Change | No Change | No Change | No | |
| PRE4691 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at last evaluation prior to start of preparative regimen | Serum iron | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4692 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at last evaluation prior to start of preparative regimen | Total iron binding capacity (TIBC) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4693 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at last evaluation prior to start of preparative regimen | Direct bilirubin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4694 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at last evaluation prior to start of preparative regimen | Total serum bilirubin | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4695 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Merged to Check all that Apply (Addition of information requested) | Laboratory studies at last evaluation prior to start of preparative regimen | None | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4696 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Serum iron | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4697 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Serum iron | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4698 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Serum iron: | Open text | No Change | No Change | No Change | No | |
| PRE4699 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | µg/dL | checked | No Change | No Change | No Change | No | |
| PRE4700 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | µmol/L | checked | No Change | No Change | No Change | No | |
| PRE4701 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Total Iron binding capacity (TIBC) | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4702 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Total Iron binding capacity (TIBC) | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4703 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | TIBC: | Open text | No Change | No Change | No Change | No | |
| PRE4704 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | µg/dL | checked | No Change | No Change | No Change | No | |
| PRE4705 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | µmol/L | checked | No Change | No Change | No Change | No | |
| PRE4706 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Addition of Information Requested | Direct bilirubin | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4707 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Addition of Information Requested | mg/dL | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4708 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Addition of Information Requested | µmol/L | checked | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4709 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Total serum bilirubin | Known | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4710 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Total serum bilirubin | Unknown | Merged to Check all that Apply (Deletion of Information Requested) | No | Reduce burden | ||
| PRE4711 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Total serum bilirubin | Open text | No Change | No Change | No Change | No | |
| PRE4712 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | mg/dL | checked | No Change | No Change | No Change | No | |
| PRE4713 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | µmol/L | checked | No Change | No Change | No Change | No | |
| PRE4714 | Pre-Transplant Information Collection | Disease Classification | Hemoglobinopathies | No | Upper limit of normal for total serum bilirubin: | Open text | No Change | No Change | No Change | No | |
| PRE4715 | Pre-Transplant Information Collection | Disease Classification | Paroxysmal nocturnal hemoglobinuria (PNH) | No | Addition of Information Requested | Did PNH co-occur with aplastic anemia? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4716 | Pre-Transplant Information Collection | Disease Classification | Paroxysmal nocturnal hemoglobinuria (PNH) | No | Addition of Information Requested | Did PNH co-occur with aplastic anemia? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4717 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B+ NK-, JAK3 mutation | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4718 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B+ NK-, IL2RG mutations, X-linked SCID | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4719 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B- NK-, Adenosine deaminase (ADA) deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4720 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B- NK-, reticular dysgenesis | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4721 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B- NK+, RAG 1/2 deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4722 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Change/Clarification of Information Requested and Addition of Response Option | Specify inborn error of immunity classification | SCID, T-B-NK+ (RAG mutation) with Omenn Syndrome | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4723 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Change/Clarification of Information Requested and Addition of Response Option | Specify inborn error of immunity classification | SCID, T-B-NK+ (RAG mutation) without Omenn Syndrome | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4724 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B- NK+, DCLRE1C (Artemis) deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4725 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID,T- B+ NK+, ILR alpha deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | SCID,T- B+ NK+, IL7R alpha deficiency | No | Capture data accurately | 
| PRE4726 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, T- B- NK-, NOS | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4727 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | SCID, not otherwise specified | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4728 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Other SCID (with known genetic mutation) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4729 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | CD40 ligand deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4730 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | DOCK8 Deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4731 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | MHC Class II Deficiency (Bare lymphocyte syndrome) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4732 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Omenn syndrome | Change/Clarification of Information Requested | Specify inborn error of immunity classification | Omenn syndrome, NOS | No | Capture data accurately | 
| PRE4733 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | ZAP-70 deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4734 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Ataxia telangiectasia | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4735 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Cartilage-hair hypoplasia | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4736 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | DiGeorge anomaly | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4737 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | NEMO Deficiency Syndrome | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4738 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Wiskott-Aldrich syndrome | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4739 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Common variable immunodeficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4740 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Activated PI3 Kinase Delta Deficiency Syndrome (APDS1 or PIK3CD) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4741 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Autoimmune Lymphoproliferative Syndrome (ALPS) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4742 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | CTLA4 deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4743 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | IPEX, Immune Dysregulation Polyendocrinopathy, enteropathy X-linked (FOXP3 deficiency) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4744 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | LRBA Deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4745 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | STAT3 Gain of Function | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4746 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Change/Clarification of Information Requested and Addition of Response Option | Specify inborn error of immunity classification | VEXAS Syndrome (associated with UBA1 mutations or other) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4747 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Chronic granulomatous disease | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4748 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | GATA2 deficiency | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4749 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Leukocyte adhesion deficiencies | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4750 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Neutropenia with combined immune deficiency (MKL1 deficiency, Actin deficiency) | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4751 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | HIV infection | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4752 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | STAT1 Gain of Function | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4753 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Change/Clarification of Information Requested and Addition of Response Option | Specify inborn error of immunity classification | Hyper IGE | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4754 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Other immunodeficiencies | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4755 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify disorder of immune system classification | Immune deficiency, not otherwise specified | Change/Clarification of Information Requested | Specify inborn error of immunity classification | No Change | No | Capture data accurately | 
| PRE4756 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify other SCID: | Open text | No Change | No Change | No Change | No | |
| PRE4757 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify other immunodeficiency: | Open text | No Change | No Change | No Change | No | |
| PRE4758 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Did the recipient have an active or recent infection with a viral pathogen within 60 days of HCT? | Yes | Change/Clarification of Information Requested | Did the recipient have an active or recent infection with a viral pathogen within 60 days of infusion? | No Change | No | Capture data accurately | 
| PRE4759 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Did the recipient have an active or recent infection with a viral pathogen within 60 days of HCT? | No | Change/Clarification of Information Requested | Did the recipient have an active or recent infection with a viral pathogen within 60 days of infusion? | No Change | No | Capture data accurately | 
| PRE4760 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Adenovirus | No Change | No Change | No Change | No | |
| PRE4761 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | BK Virus | No Change | No Change | No Change | No | |
| PRE4762 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Coronavirus | No Change | No Change | No Change | No | |
| PRE4763 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Cytomegalovirus (CMV) | No Change | No Change | No Change | No | |
| PRE4764 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Chikungunya Virus | No Change | No Change | No Change | No | |
| PRE4765 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Dengue Virus | No Change | No Change | No Change | No | |
| PRE4766 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Enterovirus (ECHO, Coxsackie) | No Change | No Change | No Change | No | |
| PRE4767 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Enterovirus D68 (EV-D68) | No Change | No Change | No Change | No | |
| PRE4768 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Enterovirus (polio) | No Change | No Change | No Change | No | |
| PRE4769 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Enterovirus, NOS | No Change | No Change | No Change | No | |
| PRE4770 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Epstein-Barr Virus (EBV) | No Change | No Change | No Change | No | |
| PRE4771 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Hepatitis A Virus | No Change | No Change | No Change | No | |
| PRE4772 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Hepatitis B Virus | No Change | No Change | No Change | No | |
| PRE4773 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Hepatitis C Virus | No Change | No Change | No Change | No | |
| PRE4774 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Hepatitis E | No Change | No Change | No Change | No | |
| PRE4775 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Herpes Simplex Virus (HSV) | No Change | No Change | No Change | No | |
| PRE4776 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human herpesvirus 6 (HHV-6) | No Change | No Change | No Change | No | |
| PRE4777 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human Immunodeficiency Virus 1 or 2 | No Change | No Change | No Change | No | |
| PRE4778 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human metapneumovirus | No Change | No Change | No Change | No | |
| PRE4779 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human Papillomavirus (HPV) | No Change | No Change | No Change | No | |
| PRE4780 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human T-lymphotropic Virus 1 or 2 | No Change | No Change | No Change | No | |
| PRE4781 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Influenza, NOS | No Change | No Change | No Change | No | |
| PRE4782 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Influenza A Virus | No Change | No Change | No Change | No | |
| PRE4783 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Influenza B Virus | No Change | No Change | No Change | No | |
| PRE4784 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | JC Virus (Progressive Multifocal Leukoencephalopathy (PML)) | No Change | No Change | No Change | No | |
| PRE4785 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Measles Virus (Rubeola) | No Change | No Change | No Change | No | |
| PRE4786 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Mumps Virus | No Change | No Change | No Change | No | |
| PRE4787 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Norovirus | No Change | No Change | No Change | No | |
| PRE4788 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Human Parainfluenza Virus (all species) | No Change | No Change | No Change | No | |
| PRE4789 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Respiratory Syncytial Virus (RSV) | No Change | No Change | No Change | No | |
| PRE4790 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Rhinovirus (all species) | No Change | No Change | No Change | No | |
| PRE4791 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Rotavirus (all species) | No Change | No Change | No Change | No | |
| PRE4792 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Rubella Virus | No Change | No Change | No Change | No | |
| PRE4793 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | Varicella Virus | No Change | No Change | No Change | No | |
| PRE4794 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Specify viral pathogen | West Nile Virus (WNV) | No Change | No Change | No Change | No | |
| PRE4795 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Has the recipient ever been infected with PCP / PJP? | Yes | No Change | No Change | No Change | No | |
| PRE4796 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Has the recipient ever been infected with PCP / PJP? | No | No Change | No Change | No Change | No | |
| PRE4797 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Does the recipient have GVHD due to maternal cell engraftment pre-HCT? | Yes | Change/Clarification of Information Requested | Does the recipient have GVHD due to maternal cell engraftment pre-infusion? | No Change | No | Capture data accurately | 
| PRE4798 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Does the recipient have GVHD due to maternal cell engraftment pre-HCT? | No | Change/Clarification of Information Requested | Does the recipient have GVHD due to maternal cell engraftment pre-infusion? | No Change | No | Capture data accurately | 
| PRE4799 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Addition of Information Requested | Was the recipient identified based on an abnormal newborn screen? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4800 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Addition of Information Requested | Was the recipient identified based on an abnormal newborn screen? | No | No | be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4801 | Pre-Transplant Information Collection | Disease Classification | Inborn Errors of Immunity (IEI) | No | Addition of Information Requested | Was the recipient identified based on an abnormal newborn screen? | Unknown | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRE4802 | Pre-Transplant Information Collection | Disease Classification | Inherited Abnormalities of Platelets | No | Specify inherited abnormalities of platelets classification | Congenital amegakaryocytosis / congenital thrombocytopenia | No Change | No Change | No Change | No | |
| PRE4803 | Pre-Transplant Information Collection | Disease Classification | Inherited Abnormalities of Platelets | No | Specify inherited abnormalities of platelets classification | Glanzmann thrombasthenia | No Change | No Change | No Change | No | |
| PRE4804 | Pre-Transplant Information Collection | Disease Classification | Inherited Abnormalities of Platelets | No | Specify inherited abnormalities of platelets classification | Other inherited platelet abnormality | No Change | No Change | No Change | No | |
| PRE4805 | Pre-Transplant Information Collection | Disease Classification | Inherited Abnormalities of Platelets | No | Specify other inherited platelet abnormality: | Open text | No Change | No Change | No Change | No | |
| PRE4806 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Osteopetrosis (malignant infantile osteopetrosis) | No Change | No Change | No Change | No | |
| PRE4807 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Metachromatic leukodystrophy (MLD) | No Change | No Change | No Change | No | |
| PRE4808 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Adrenoleukodystrophy (ALD) | No Change | No Change | No Change | No | |
| PRE4809 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Addition of Information Requested | No Change | Adrenomyeloneuropathy (AMN) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRE4810 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Krabbe disease (globoid leukodystrophy) | No Change | No Change | No Change | No | |
| PRE4811 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Lesch-Nyhan (HGPRT deficiency) | No Change | No Change | No Change | No | |
| PRE4812 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Neuronal ceroid lipofuscinosis (Batten disease) | No Change | No Change | No Change | No | |
| PRE4813 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Hereditary diffuse leukoencephalopathy with spheroids (HDLS) | No Change | No Change | No Change | No | |
| PRE4814 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Hurler syndrome (IH) | No Change | No Change | No Change | No | |
| PRE4815 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Scheie syndrome (IS) | No Change | No Change | No Change | No | |
| PRE4816 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Hunter syndrome (II) | No Change | No Change | No Change | No | |
| PRE4817 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Sanfilippo (III) | No Change | No Change | No Change | No | |
| PRE4818 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Morquio (IV) | No Change | No Change | No Change | No | |
| PRE4819 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Maroteaux-Lamy (VI) | No Change | No Change | No Change | No | |
| PRE4820 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Beta-glucuronidase deficiency (VII) | No Change | No Change | No Change | No | |
| PRE4821 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Mucopolysaccharidosis (V) | No Change | No Change | No Change | No | |
| PRE4822 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Mucopolysaccharidosis, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4823 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Gaucher disease | No Change | No Change | No Change | No | |
| PRE4824 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Niemann-Pick disease | No Change | No Change | No Change | No | |
| PRE4825 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | I-cell disease | No Change | No Change | No Change | No | |
| PRE4826 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Wolman disease | No Change | No Change | No Change | No | |
| PRE4827 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Glucose storage disease | No Change | No Change | No Change | No | |
| PRE4828 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Mucolipidoses, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4829 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Aspartyl glucosaminidase | No Change | No Change | No Change | No | |
| PRE4830 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Fucosidosis | No Change | No Change | No Change | No | |
| PRE4831 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Mannosidosis | No Change | No Change | No Change | No | |
| PRE4832 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Polysaccharide hydrolase abnormality, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4833 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Other inherited metabolic disorder | No Change | No Change | No Change | No | |
| PRE4834 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify inherited disorders of metabolism classification | Inherited metabolic disorder, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4835 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Specify other inherited metabolic disorder: | Open text | No Change | No Change | No Change | No | |
| PRE4836 | Pre-Transplant Information Collection | Disease Classification | Inherited Disorders of Metabolism | No | Loes composite score | Open text | No Change | No Change | No Change | No | |
| PRE4837 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, Perforin deficiency (FHL2) | No Change | No Change | No Change | No | |
| PRE4838 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, UNC13D (FHL3) | No Change | No Change | No Change | No | |
| PRE4839 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, STX11 (FHL4) | No Change | No Change | No Change | No | |
| PRE4840 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, STXBP2 (FHL5) | No Change | No Change | No Change | No | |
| PRE4841 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, no mutation identified | No Change | No Change | No Change | No | |
| PRE4842 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Familial Hemophagocytic Lymphohistiocytosis, other mutations | No Change | No Change | No Change | No | |
| PRE4843 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Langerhans cell histiocytosis (histiocytosis-X) | No Change | No Change | No Change | No | |
| PRE4844 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Hemophagocytosis (reactive or viral associated) | No Change | No Change | No Change | No | |
| PRE4845 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Malignant histiocytosis | No Change | No Change | No Change | No | |
| PRE4846 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Other histiocytic disorder | No Change | No Change | No Change | No | |
| PRE4847 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Histiocytic disorder, not otherwise specified | No Change | No Change | No Change | No | |
| PRE4848 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Chediak-Higashi syndrome | No Change | No Change | No Change | No | |
| PRE4849 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Griscelli syndrome type 2 | No Change | No Change | No Change | No | |
| PRE4850 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Hermansky-Pudlak syndrome type 2 | No Change | No Change | No Change | No | |
| PRE4851 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Other pigmentary dilution disorder | No Change | No Change | No Change | No | |
| PRE4852 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | SAP deficiency (XIAP-1) | No Change | No Change | No Change | No | |
| PRE4853 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | XIAP-2 deficiency | No Change | No Change | No Change | No | |
| PRE4854 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | ITK deficiency | No Change | No Change | No Change | No | |
| PRE4855 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Specify other histiocytic disorder | No Change | No Change | No Change | No | |
| PRE4856 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify histiocytic disorder classification | Specify other pigmentary dilution disorder | No Change | No Change | No Change | No | |
| PRE4857 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Did the recipient have an active or recent infection with a viral pathogen within 60 days of HCT? | Yes | Change/clarification of information requested | Did the recipient have an active or recent infection with a viral pathogen within 60 days of infusion? | No Change | No | Capture data accurately | 
| PRE4858 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Did the recipient have an active or recent infection with a viral pathogen within 60 days of HCT? | No | Change/clarification of information requested | Did the recipient have an active or recent infection with a viral pathogenwithin 60 days of infusion? | No Change | No | Capture data accurately | 
| PRE4859 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Adenovirus | No Change | No Change | No Change | No | |
| PRE4860 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | BK Virus | No Change | No Change | No Change | No | |
| PRE4861 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Coronavirus | No Change | No Change | No Change | No | |
| PRE4862 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Cytomegalovirus (CMV) | No Change | No Change | No Change | No | |
| PRE4863 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Chikungunya Virus | No Change | No Change | No Change | No | |
| PRE4864 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Dengue Virus | No Change | No Change | No Change | No | |
| PRE4865 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Enterovirus (ECHO, Coxsackie) | No Change | No Change | No Change | No | |
| PRE4866 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Enterovirus D68 (EV-D68) | No Change | No Change | No Change | No | |
| PRE4867 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Enterovirus (polio) | No Change | No Change | No Change | No | |
| PRE4868 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Enterovirus, NOS | No Change | No Change | No Change | No | |
| PRE4869 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Epstein-Barr Virus (EBV) | No Change | No Change | No Change | No | |
| PRE4870 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Hepatitis A Virus | No Change | No Change | No Change | No | |
| PRE4871 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Hepatitis B Virus | No Change | No Change | No Change | No | |
| PRE4872 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Hepatitis C Virus | No Change | No Change | No Change | No | |
| PRE4873 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Hepatitis E | No Change | No Change | No Change | No | |
| PRE4874 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Herpes Simplex Virus (HSV) | No Change | No Change | No Change | No | |
| PRE4875 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human herpesvirus 6 (HHV-6) | No Change | No Change | No Change | No | |
| PRE4876 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human Immunodeficiency Virus 1 or 2 | No Change | No Change | No Change | No | |
| PRE4877 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human metapneumovirus | No Change | No Change | No Change | No | |
| PRE4878 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human Papillomavirus (HPV) | No Change | No Change | No Change | No | |
| PRE4879 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human T-lymphotropic Virus 1 or 2 | No Change | No Change | No Change | No | |
| PRE4880 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Influenza, NOS | No Change | No Change | No Change | No | |
| PRE4881 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Influenza A Virus | No Change | No Change | No Change | No | |
| PRE4882 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Influenza B Virus | No Change | No Change | No Change | No | |
| PRE4883 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | JC Virus (Progressive Multifocal Leukoencephalopathy (PML)) | No Change | No Change | No Change | No | |
| PRE4884 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Measles Virus (Rubeola) | No Change | No Change | No Change | No | |
| PRE4885 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Mumps Virus | No Change | No Change | No Change | No | |
| PRE4886 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Norovirus | No Change | No Change | No Change | No | |
| PRE4887 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Human Parainfluenza Virus (all species) | No Change | No Change | No Change | No | |
| PRE4888 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Respiratory Syncytial Virus (RSV) | No Change | No Change | No Change | No | |
| PRE4889 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Rhinovirus (all species) | No Change | No Change | No Change | No | |
| PRE4890 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Rotavirus (all species) | No Change | No Change | No Change | No | |
| PRE4891 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Rubella Virus | No Change | No Change | No Change | No | |
| PRE4892 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | Varicella Virus | No Change | No Change | No Change | No | |
| PRE4893 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Specify viral pathogen | West Nile Virus (WNV) | No Change | No Change | No Change | No | |
| PRE4894 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Has the recipient ever been infected with PCP / PJP? | Yes | No Change | No Change | No Change | No | |
| PRE4895 | Pre-Transplant Information Collection | Disease Classification | Histiocytic Disorders | No | Has the recipient ever been infected with PCP / PJP? | No | No Change | No Change | No Change | No | |
| PRE4896 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Rheumatoid arthritis | No Change | No Change | No Change | No | |
| PRE4897 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Psoriatic arthritis / psoriasis | No Change | No Change | No Change | No | |
| PRE4898 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Juvenile idiopathic arthritis (JIA): systemic (Still's disease) | No Change | No Change | No Change | No | |
| PRE4899 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Juvenile idiopathic arthritis (JIA): oligoarticular | No Change | No Change | No Change | No | |
| PRE4900 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Juvenile idiopathic arthritis (JIA): polyarticular | No Change | No Change | No Change | No | |
| PRE4901 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Juvenile idiopathic arthritis (JIA): other | No Change | No Change | No Change | No | |
| PRE4902 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other arthritis | No Change | No Change | No Change | No | |
| PRE4903 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Multiple sclerosis | No Change | No Change | No Change | No | |
| PRE4904 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Systemic sclerosis (scleroderma) | No Change | No Change | No Change | No | |
| PRE4905 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Systemic lupus erythematosis (SLE) | No Change | No Change | No Change | No | |
| PRE4906 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Sjögren syndrome | No Change | No Change | No Change | No | |
| PRE4907 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Polymyositis / dermatomyositis | No Change | No Change | No Change | No | |
| PRE4908 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Antiphospholipid syndrome | No Change | No Change | No Change | No | |
| PRE4909 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other connective tissue disease | No Change | No Change | No Change | No | |
| PRE4910 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Wegener granulomatosis | No Change | No Change | No Change | No | |
| PRE4911 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Classical polyarteritis nodosa | No Change | No Change | No Change | No | |
| PRE4912 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Microscopic polyarteritis nodosa | No Change | No Change | No Change | No | |
| PRE4913 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Churg-Strauss | No Change | No Change | No Change | No | |
| PRE4914 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Giant cell arteritis | No Change | No Change | No Change | No | |
| PRE4915 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Takayasu | No Change | No Change | No Change | No | |
| PRE4916 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Behcet syndrome | No Change | No Change | No Change | No | |
| PRE4917 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Overlap necrotizing arteritis | No Change | No Change | No Change | No | |
| PRE4918 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other vasculitis | No Change | No Change | No Change | No | |
| PRE4919 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Myasthenia gravis | No Change | No Change | No Change | No | |
| PRE4920 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other autoimmune neurological disorder | No Change | No Change | No Change | No | |
| PRE4921 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Idiopathic thrombocytopenic purpura (ITP) | No Change | No Change | No Change | No | |
| PRE4922 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Hemolytic anemia | No Change | No Change | No Change | No | |
| PRE4923 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Evans syndrome | No Change | No Change | No Change | No | |
| PRE4924 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other autoimmune cytopenia | No Change | No Change | No Change | No | |
| PRE4925 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Crohn's disease | No Change | No Change | No Change | No | |
| PRE4926 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Ulcerative colitis | No Change | No Change | No Change | No | |
| PRE4927 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other autoimmune bowel disorder | No Change | No Change | No Change | No | |
| PRE4928 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Diabetes mellitus type 1 | No Change | No Change | No Change | No | |
| PRE4929 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify autoimmune disease classification | Other autoimmune disease | No Change | No Change | No Change | No | |
| PRE4930 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify other autoimmune cytopenia: | Open text | No Change | No Change | No Change | No | |
| PRE4931 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify other autoimmune bowel disorder: | Open text | No Change | No Change | No Change | No | |
| PRE4932 | Pre-Transplant Information Collection | Disease Classification | Autoimmune Diseases | No | Specify other autoimmune disease: | Open text | No Change | No Change | No Change | No | |
| PRE4933 | Pre-Transplant Information Collection | Disease Classification | Tolerance Induction Associated with Solid Organ Transplant | No | Specify solid organ transplanted | Kidney | No Change | No Change | No Change | No | |
| PRE4934 | Pre-Transplant Information Collection | Disease Classification | Tolerance Induction Associated with Solid Organ Transplant | No | Specify solid organ transplanted | Liver | No Change | No Change | No Change | No | |
| PRE4935 | Pre-Transplant Information Collection | Disease Classification | Tolerance Induction Associated with Solid Organ Transplant | No | Specify solid organ transplanted | Pancreas | No Change | No Change | No Change | No | |
| PRE4936 | Pre-Transplant Information Collection | Disease Classification | Tolerance Induction Associated with Solid Organ Transplant | No | Specify solid organ transplanted | Other organ | No Change | No Change | No Change | No | |
| PRE4937 | Pre-Transplant Information Collection | Disease Classification | Tolerance Induction Associated with Solid Organ Transplant | No | Specify other organ: | Open text | No Change | No Change | No Change | No | |
| PRE4938 | Pre-Transplant Information Collection | Disease Classification | Other Disease | No | Specify other disease: | Open text | No Change | No Change | No Change | No | 
| Item ID | Time Point | Information Collection Domain Sub-Type | Information Collection Domain Additional Sub Domain | Information Collection may be requested multiple times | Current Information Collection Data Element (if applicable) | Current Information Collection Data Element Response Option (if applicable) | Information Collection update | Proposed Information Collection Data Element Update (if applicable) | Proposed Information Collection Data Element Response Option Update (if applicable) | Instructional Text Indicating an Action | Rationale for Information Collection Update | 
| PRO001 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | HCT type | Auto-filled field | No Change | No Change | No Change | No | |
| PRO002 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Product type | Auto-filled field | No Change | No Change | No Change | No | |
| PRO003 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Specify: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO004 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Registry donor ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO005 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Non-NMDP cord blood unit ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO006 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Global Registration Identifier for Donors (GRID) | Auto-filled field | No Change | No Change | No Change | No | |
| PRO007 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | ISBT DIN: | Auto-filled field | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO008 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Registry or UCB Bank ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO009 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Donor DOB: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO010 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Donor age: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO011 | Transplant Procedure and Product | Infectious Disease Markers | Key Fields | No | Donor sex: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO012 | Transplant Procedure and Product | Infectious Disease Markers | Donor / Cord Blood Unit Information | No | Who is being tested for IDMs? | Donor IDM (marrow or PBSC) | No Change | No Change | No Change | No | |
| PRO013 | Transplant Procedure and Product | Infectious Disease Markers | Donor / Cord Blood Unit Information | No | Who is being tested for IDMs? | Maternal IDM (cord blood) | No Change | No Change | No Change | No | |
| PRO014 | Transplant Procedure and Product | Infectious Disease Markers | Donor / Cord Blood Unit Information | No | Who is being tested for IDMs? | Cord blood unit IDM | No Change | No Change | No Change | No | |
| PRO015 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HBsAg: (hepatitis B surface antigen) | Reactive | No Change | No Change | No Change | No | |
| PRO016 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HBsAg: (hepatitis B surface antigen) | Non-reactive | No Change | No Change | No Change | No | |
| PRO017 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HBsAg: (hepatitis B surface antigen) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO018 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HBsAg: (hepatitis B surface antigen) | Not done | No Change | No Change | No Change | No | |
| PRO019 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for HBsAg collected: | No Change | No | Capture data accurately | 
| PRO020 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti HBc: (hepatitis B core antibody) | Reactive | No Change | No Change | No Change | No | |
| PRO021 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti HBc: (hepatitis B core antibody) | Non-reactive | No Change | No Change | No Change | No | |
| PRO022 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti HBc: (hepatitis B core antibody) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO023 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti HBc: (hepatitis B core antibody) | Not done | No Change | No Change | No Change | No | |
| PRO024 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti HBc collected: | No Change | No | Capture data accurately | 
| PRO025 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HBV | Positive | No Change | No Change | No Change | No | |
| PRO026 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HBV | Negative | No Change | No Change | No Change | No | |
| PRO027 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HBV | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO028 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HBV | Not done | No Change | No Change | No Change | No | |
| PRO029 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for NAAT testing for HBV collected: | No Change | No | Capture data accurately | 
| PRO030 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HCV: (hepatitis C antibody) | Reactive | No Change | No Change | No Change | No | |
| PRO031 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HCV: (hepatitis C antibody) | Non-reactive | No Change | No Change | No Change | No | |
| PRO032 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HCV: (hepatitis C antibody) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO033 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HCV: (hepatitis C antibody) | Not done | No Change | No Change | No Change | No | |
| PRO034 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti-HCV collected: | No Change | No | Capture data accurately | 
| PRO035 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HCV | Positive | No Change | No Change | No Change | No | |
| PRO036 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HCV | Negative | No Change | No Change | No Change | No | |
| PRO037 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HCV | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO038 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HCV | Not done | No Change | No Change | No Change | No | |
| PRO039 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample NAAT testing for HCV collected: | No Change | No | Capture data accurately | 
| PRO040 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HIV-1 p24 antigen | Reactive | No Change | No Change | No Change | No | |
| PRO041 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HIV-1 p24 antigen | Non-reactive | No Change | No Change | No Change | No | |
| PRO042 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HIV-1 p24 antigen | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO043 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HIV-1 p24 antigen | Not done | No Change | No Change | No Change | No | |
| PRO044 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | HIV-1 p24 antigen | Not reported | No Change | No Change | No Change | No | |
| PRO045 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for HIV-1 p24 antigen collected: | No Change | No | Capture data accurately | 
| PRO046 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HIV-1 | Positive | No Change | No Change | No Change | No | |
| PRO047 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HIV-1 | Negative | No Change | No Change | No Change | No | |
| PRO048 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HIV-1 | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO049 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HIV-1 | Not done | No Change | No Change | No Change | No | |
| PRO050 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | FDA licensed NAAT testing for HIV-1 | Addition of Information Requested | No Change | Not reported | No | Capture data accurately | |
| PRO051 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for NAAT testing for HIV-1 collected: | No Change | No | Capture data accurately | 
| PRO052 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses) | Reactive | No Change | No Change | No Change | No | |
| PRO053 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses) | Non-reactive | No Change | No Change | No Change | No | |
| PRO054 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO055 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses) | Not done | No Change | No Change | No Change | No | |
| PRO056 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HIV 1 and anti-HIV 2*: (antibodies to Human Immunodeficiency Viruses) | Not reported | No Change | No Change | No Change | No | |
| PRO057 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti-HIV 1 and anti-HIV 2 collected: | No Change | No | Capture data accurately | 
| PRO058 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Chagas testing | Positive | No Change | No Change | No Change | No | |
| PRO059 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Chagas testing | Negative | No Change | No Change | No Change | No | |
| PRO060 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Chagas testing | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO061 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Chagas testing | Not Done | No Change | No Change | No Change | No | |
| PRO062 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Chagas collected: | No Change | No | Capture data accurately | 
| PRO063 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HSV (Herpes simplex virus antibody) | Positive | No Change | No Change | No Change | No | |
| PRO064 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HSV (Herpes simplex virus antibody) | Negative | No Change | No Change | No Change | No | |
| PRO065 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HSV (Herpes simplex virus antibody) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO066 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-HSV (Herpes simplex virus antibody) | Not Done | No Change | No Change | No Change | No | |
| PRO067 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti-HSV collected: | No Change | No | Capture data accurately | 
| PRO068 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-EBV (Epstein-Barr virus antibody) | Positive | No Change | No Change | No Change | No | |
| PRO069 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-EBV (Epstein-Barr virus antibody) | Negative | No Change | No Change | No Change | No | |
| PRO070 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-EBV (Epstein-Barr virus antibody) | Inconclusive | No Change | No Change | No Change | No | |
| PRO071 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-EBV (Epstein-Barr virus antibody) | Not done | No Change | No Change | No Change | No | |
| PRO072 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti-EBV collected: | No Change | No | Capture data accurately | 
| PRO073 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-VZV (Varicella zoster virus antibody) | Positive | No Change | No Change | No Change | No | |
| PRO074 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-VZV (Varicella zoster virus antibody) | Negative | No Change | No Change | No Change | No | |
| PRO075 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-VZV (Varicella zoster virus antibody) | Addition of Information Requested | No Change | Inconclusive | No | Capture data accurately | |
| PRO076 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Anti-VZV (Varicella zoster virus antibody) | Not Done | No Change | No Change | No Change | No | |
| PRO077 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for Anti-VZV collected: | No Change | No | Capture data accurately | 
| PRO078 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Other infectious disease marker, specify | yes | Change/Clarification of Information Requested | Other positive infectious disease marker, specify | No Change | No | Reduce burden - information no longer needed | 
| PRO079 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Other infectious disease marker, specify | no | Change/Clarification of Information Requested | Other positive infectious disease marker, specify | No Change | No | Reduce burden - information no longer needed | 
| PRO080 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | Yes | Date sample collected: | Open text | Change/Clarification of Information Requested | Date sample for other infectious disease marker collected: | No Change | No | Capture data accurately | 
| PRO081 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | Yes | Specify test and method: | Open text | No Change | No Change | No Change | No | |
| PRO082 | Transplant Procedure and Product | Infectious Disease Markers | Infectious Disease Marker | No | Specify test results: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO083 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Registry donor ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO084 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Non-NMDP cord blood unit ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO085 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Global Registration Identifier for Donors (GRID) | Auto-filled field | No Change | No Change | No Change | No | |
| PRO086 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | ISBT DIN: | Auto-filled field | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO087 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Registry or UCB Bank ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO088 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Donor DOB: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO089 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Donor age: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO090 | Transplant Procedure and Product | Confirmation of HLA Typing | Key Fields | No | Donor sex: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO091 | Transplant Procedure and Product | Confirmation of HLA Typing | Donor / Cord Blood Unit Identification | No | Specify the person for whom this typing is being done | Recipient-final typing | No Change | No Change | No Change | No | |
| PRO092 | Transplant Procedure and Product | Confirmation of HLA Typing | Donor / Cord Blood Unit Identification | No | Specify the person for whom this typing is being done | Donor | No Change | No Change | No Change | No | |
| PRO093 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the HLA laboratory report. | Reduce burden | ||
| PRO094 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the HLA laboratory report. | Reduce burden | ||
| PRO095 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus A | Known | No Change | No Change | No Change | No | |
| PRO096 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus A | Unknown | No Change | No Change | No Change | No | |
| PRO097 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First A* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO098 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second A* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO099 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus B | Known | No Change | No Change | No Change | No | |
| PRO100 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus B | Unknown | No Change | No Change | No Change | No | |
| PRO101 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First B* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO102 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second B* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO103 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus C | Known | No Change | No Change | No Change | No | |
| PRO104 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus C | Unknown | No Change | No Change | No Change | No | |
| PRO105 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First C* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO106 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second C* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO107 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB1 | Known | No Change | No Change | No Change | No | |
| PRO108 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB1 | Unknown | No Change | No Change | No Change | No | |
| PRO109 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DRB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO110 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DRB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO111 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB3 | Known | No Change | No Change | No Change | No | |
| PRO112 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB3 | Unknown | No Change | No Change | No Change | No | |
| PRO113 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DRB3* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO114 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DRB3* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO115 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB4 | Known | No Change | No Change | No Change | No | |
| PRO116 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB4 | Unknown | No Change | No Change | No Change | No | |
| PRO117 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DRB4* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO118 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DRB4* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO119 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB5 | Known | No Change | No Change | No Change | No | |
| PRO120 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DRB5 | Unknown | No Change | No Change | No Change | No | |
| PRO121 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DRB5* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO122 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DRB5* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO123 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DQB1 | Known | No Change | No Change | No Change | No | |
| PRO124 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DQB1 | Unknown | No Change | No Change | No Change | No | |
| PRO125 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DQB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO126 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DQB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO127 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DPB1 | Known | No Change | No Change | No Change | No | |
| PRO128 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DPB1 | Unknown | No Change | No Change | No Change | No | |
| PRO129 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DPB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO130 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DPB1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO131 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DQA1 | Known | No Change | No Change | No Change | No | |
| PRO132 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DQA1 | Unknown | No Change | No Change | No Change | No | |
| PRO133 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DQA1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO134 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DQA1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO135 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DPA1 | Known | No Change | No Change | No Change | No | |
| PRO136 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Locus DPA1 | Unknown | No Change | No Change | No Change | No | |
| PRO137 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | First DPA1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO138 | Transplant Procedure and Product | Confirmation of HLA Typing | HLA Typing by DNA Technology | No | Second DPA1* allele designations: | Open text | No Change | No Change | No Change | No | |
| PRO139 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO140 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO141 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A1 | No Change | No Change | No Change | No | |
| PRO142 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A2 | No Change | No Change | No Change | No | |
| PRO143 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A203 | No Change | No Change | No Change | No | |
| PRO144 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A210 | No Change | No Change | No Change | No | |
| PRO145 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A3 | No Change | No Change | No Change | No | |
| PRO146 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A9 | No Change | No Change | No Change | No | |
| PRO147 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A10 | No Change | No Change | No Change | No | |
| PRO148 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A11 | No Change | No Change | No Change | No | |
| PRO149 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A19 | No Change | No Change | No Change | No | |
| PRO150 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A23(9) | No Change | No Change | No Change | No | |
| PRO151 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A24(9) | No Change | No Change | No Change | No | |
| PRO152 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A2403 | No Change | No Change | No Change | No | |
| PRO153 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A25(10) | No Change | No Change | No Change | No | |
| PRO154 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A26(10) | No Change | No Change | No Change | No | |
| PRO155 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A28 | No Change | No Change | No Change | No | |
| PRO156 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A29(19) | No Change | No Change | No Change | No | |
| PRO157 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A30(19) | No Change | No Change | No Change | No | |
| PRO158 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A31(19) | No Change | No Change | No Change | No | |
| PRO159 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A32(19) | No Change | No Change | No Change | No | |
| PRO160 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A33(19) | No Change | No Change | No Change | No | |
| PRO161 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A34(10) | No Change | No Change | No Change | No | |
| PRO162 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A36 | No Change | No Change | No Change | No | |
| PRO163 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A43 | No Change | No Change | No Change | No | |
| PRO164 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A66(10) | No Change | No Change | No Change | No | |
| PRO165 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A68(28) | No Change | No Change | No Change | No | |
| PRO166 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A69(28) | No Change | No Change | No Change | No | |
| PRO167 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A74(19) | No Change | No Change | No Change | No | |
| PRO168 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | A80 | No Change | No Change | No Change | No | |
| PRO169 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | AX | No Change | No Change | No Change | No | |
| PRO170 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A1 | No Change | No Change | No Change | No | |
| PRO171 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A2 | No Change | No Change | No Change | No | |
| PRO172 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A203 | No Change | No Change | No Change | No | |
| PRO173 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A210 | No Change | No Change | No Change | No | |
| PRO174 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A3 | No Change | No Change | No Change | No | |
| PRO175 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A9 | No Change | No Change | No Change | No | |
| PRO176 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A10 | No Change | No Change | No Change | No | |
| PRO177 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A11 | No Change | No Change | No Change | No | |
| PRO178 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A19 | No Change | No Change | No Change | No | |
| PRO179 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A23(9) | No Change | No Change | No Change | No | |
| PRO180 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A24(9) | No Change | No Change | No Change | No | |
| PRO181 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A2403 | No Change | No Change | No Change | No | |
| PRO182 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A25(10) | No Change | No Change | No Change | No | |
| PRO183 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A26(10) | No Change | No Change | No Change | No | |
| PRO184 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A28 | No Change | No Change | No Change | No | |
| PRO185 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A29(19) | No Change | No Change | No Change | No | |
| PRO186 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A30(19) | No Change | No Change | No Change | No | |
| PRO187 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A31(19) | No Change | No Change | No Change | No | |
| PRO188 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A32(19) | No Change | No Change | No Change | No | |
| PRO189 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A33(19) | No Change | No Change | No Change | No | |
| PRO190 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A34(10) | No Change | No Change | No Change | No | |
| PRO191 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A36 | No Change | No Change | No Change | No | |
| PRO192 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A43 | No Change | No Change | No Change | No | |
| PRO193 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A66(10) | No Change | No Change | No Change | No | |
| PRO194 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A68(28) | No Change | No Change | No Change | No | |
| PRO195 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A69(28) | No Change | No Change | No Change | No | |
| PRO196 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A74(19) | No Change | No Change | No Change | No | |
| PRO197 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | A80 | No Change | No Change | No Change | No | |
| PRO198 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | AX | No Change | No Change | No Change | No | |
| PRO199 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO200 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO201 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B5 | No Change | No Change | No Change | No | |
| PRO202 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B7 | No Change | No Change | No Change | No | |
| PRO203 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B703 | No Change | No Change | No Change | No | |
| PRO204 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B8 | No Change | No Change | No Change | No | |
| PRO205 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B12 | No Change | No Change | No Change | No | |
| PRO206 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B13 | No Change | No Change | No Change | No | |
| PRO207 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B14 | No Change | No Change | No Change | No | |
| PRO208 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B15 | No Change | No Change | No Change | No | |
| PRO209 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B16 | No Change | No Change | No Change | No | |
| PRO210 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B17 | No Change | No Change | No Change | No | |
| PRO211 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B18 | No Change | No Change | No Change | No | |
| PRO212 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B21 | No Change | No Change | No Change | No | |
| PRO213 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B22 | No Change | No Change | No Change | No | |
| PRO214 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B27 | No Change | No Change | No Change | No | |
| PRO215 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B2708 | No Change | No Change | No Change | No | |
| PRO216 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B35 | No Change | No Change | No Change | No | |
| PRO217 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B37 | No Change | No Change | No Change | No | |
| PRO218 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B38(16) | No Change | No Change | No Change | No | |
| PRO219 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B39(16) | No Change | No Change | No Change | No | |
| PRO220 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B3901 | No Change | No Change | No Change | No | |
| PRO221 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B3902 | No Change | No Change | No Change | No | |
| PRO222 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B40 | No Change | No Change | No Change | No | |
| PRO223 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B4005 | No Change | No Change | No Change | No | |
| PRO224 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B41 | No Change | No Change | No Change | No | |
| PRO225 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B42 | No Change | No Change | No Change | No | |
| PRO226 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B44(12) | No Change | No Change | No Change | No | |
| PRO227 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B45(12) | No Change | No Change | No Change | No | |
| PRO228 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B46 | No Change | No Change | No Change | No | |
| PRO229 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B47 | No Change | No Change | No Change | No | |
| PRO230 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B48 | No Change | No Change | No Change | No | |
| PRO231 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B49(21) | No Change | No Change | No Change | No | |
| PRO232 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B50(21) | No Change | No Change | No Change | No | |
| PRO233 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B51(5) | No Change | No Change | No Change | No | |
| PRO234 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B5102 | No Change | No Change | No Change | No | |
| PRO235 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B5103 | No Change | No Change | No Change | No | |
| PRO236 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B52(5) | No Change | No Change | No Change | No | |
| PRO237 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B53 | No Change | No Change | No Change | No | |
| PRO238 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B54(22) | No Change | No Change | No Change | No | |
| PRO239 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B55(22) | No Change | No Change | No Change | No | |
| PRO240 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B56(22) | No Change | No Change | No Change | No | |
| PRO241 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B57(17) | No Change | No Change | No Change | No | |
| PRO242 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B58(17) | No Change | No Change | No Change | No | |
| PRO243 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B59 | No Change | No Change | No Change | No | |
| PRO244 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B60(40) | No Change | No Change | No Change | No | |
| PRO245 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B61(40) | No Change | No Change | No Change | No | |
| PRO246 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B62(15) | No Change | No Change | No Change | No | |
| PRO247 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B63(15) | No Change | No Change | No Change | No | |
| PRO248 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B64(14) | No Change | No Change | No Change | No | |
| PRO249 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B65(14) | No Change | No Change | No Change | No | |
| PRO250 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B67 | No Change | No Change | No Change | No | |
| PRO251 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B70 | No Change | No Change | No Change | No | |
| PRO252 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B71(70) | No Change | No Change | No Change | No | |
| PRO253 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B72(70) | No Change | No Change | No Change | No | |
| PRO254 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B73 | No Change | No Change | No Change | No | |
| PRO255 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B75(15) | No Change | No Change | No Change | No | |
| PRO256 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B76(15) | No Change | No Change | No Change | No | |
| PRO257 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B77(15) | No Change | No Change | No Change | No | |
| PRO258 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B78 | No Change | No Change | No Change | No | |
| PRO259 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B81 | No Change | No Change | No Change | No | |
| PRO260 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | B82 | No Change | No Change | No Change | No | |
| PRO261 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 1st antigen | BX | No Change | No Change | No Change | No | |
| PRO262 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B5 | No Change | No Change | No Change | No | |
| PRO263 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B7 | No Change | No Change | No Change | No | |
| PRO264 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B703 | No Change | No Change | No Change | No | |
| PRO265 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B8 | No Change | No Change | No Change | No | |
| PRO266 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B12 | No Change | No Change | No Change | No | |
| PRO267 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B13 | No Change | No Change | No Change | No | |
| PRO268 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B14 | No Change | No Change | No Change | No | |
| PRO269 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B15 | No Change | No Change | No Change | No | |
| PRO270 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B16 | No Change | No Change | No Change | No | |
| PRO271 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B17 | No Change | No Change | No Change | No | |
| PRO272 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B18 | No Change | No Change | No Change | No | |
| PRO273 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B21 | No Change | No Change | No Change | No | |
| PRO274 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B22 | No Change | No Change | No Change | No | |
| PRO275 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B27 | No Change | No Change | No Change | No | |
| PRO276 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B2708 | No Change | No Change | No Change | No | |
| PRO277 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B35 | No Change | No Change | No Change | No | |
| PRO278 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B37 | No Change | No Change | No Change | No | |
| PRO279 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B38(16) | No Change | No Change | No Change | No | |
| PRO280 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B39(16) | No Change | No Change | No Change | No | |
| PRO281 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B3901 | No Change | No Change | No Change | No | |
| PRO282 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B3902 | No Change | No Change | No Change | No | |
| PRO283 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B40 | No Change | No Change | No Change | No | |
| PRO284 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B4005 | No Change | No Change | No Change | No | |
| PRO285 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B41 | No Change | No Change | No Change | No | |
| PRO286 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B42 | No Change | No Change | No Change | No | |
| PRO287 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B44(12) | No Change | No Change | No Change | No | |
| PRO288 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B45(12) | No Change | No Change | No Change | No | |
| PRO289 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B46 | No Change | No Change | No Change | No | |
| PRO290 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B47 | No Change | No Change | No Change | No | |
| PRO291 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B48 | No Change | No Change | No Change | No | |
| PRO292 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B49(21) | No Change | No Change | No Change | No | |
| PRO293 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B50(21) | No Change | No Change | No Change | No | |
| PRO294 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B51(5) | No Change | No Change | No Change | No | |
| PRO295 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B5102 | No Change | No Change | No Change | No | |
| PRO296 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B5103 | No Change | No Change | No Change | No | |
| PRO297 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B52(5) | No Change | No Change | No Change | No | |
| PRO298 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B53 | No Change | No Change | No Change | No | |
| PRO299 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B54(22) | No Change | No Change | No Change | No | |
| PRO300 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B55(22) | No Change | No Change | No Change | No | |
| PRO301 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B56(22) | No Change | No Change | No Change | No | |
| PRO302 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B57(17) | No Change | No Change | No Change | No | |
| PRO303 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B58(17) | No Change | No Change | No Change | No | |
| PRO304 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B59 | No Change | No Change | No Change | No | |
| PRO305 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B60(40) | No Change | No Change | No Change | No | |
| PRO306 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B61(40) | No Change | No Change | No Change | No | |
| PRO307 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B62(15) | No Change | No Change | No Change | No | |
| PRO308 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B63(15) | No Change | No Change | No Change | No | |
| PRO309 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B64(14) | No Change | No Change | No Change | No | |
| PRO310 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B65(14) | No Change | No Change | No Change | No | |
| PRO311 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B67 | No Change | No Change | No Change | No | |
| PRO312 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B70 | No Change | No Change | No Change | No | |
| PRO313 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B71(70) | No Change | No Change | No Change | No | |
| PRO314 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B72(70) | No Change | No Change | No Change | No | |
| PRO315 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B73 | No Change | No Change | No Change | No | |
| PRO316 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B75(15) | No Change | No Change | No Change | No | |
| PRO317 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B76(15) | No Change | No Change | No Change | No | |
| PRO318 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B77(15) | No Change | No Change | No Change | No | |
| PRO319 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B78 | No Change | No Change | No Change | No | |
| PRO320 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B81 | No Change | No Change | No Change | No | |
| PRO321 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | B82 | No Change | No Change | No Change | No | |
| PRO322 | Transplant Procedure and Product | Confirmation of HLA Typing | Antigens Defined by Serologic Testing | No | Specificity – 2nd antigen | BX | No Change | No Change | No Change | No | |
| PRO323 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO324 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO325 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw1 | No Change | No Change | No Change | No | |
| PRO326 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw2 | No Change | No Change | No Change | No | |
| PRO327 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw3 | No Change | No Change | No Change | No | |
| PRO328 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw4 | No Change | No Change | No Change | No | |
| PRO329 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw5 | No Change | No Change | No Change | No | |
| PRO330 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw6 | No Change | No Change | No Change | No | |
| PRO331 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw7 | No Change | No Change | No Change | No | |
| PRO332 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw8 | No Change | No Change | No Change | No | |
| PRO333 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw9(w3) | No Change | No Change | No Change | No | |
| PRO334 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | Cw10(w3) | No Change | No Change | No Change | No | |
| PRO335 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | CX | No Change | No Change | No Change | No | |
| PRO336 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw1 | No Change | No Change | No Change | No | |
| PRO337 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw2 | No Change | No Change | No Change | No | |
| PRO338 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw3 | No Change | No Change | No Change | No | |
| PRO339 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw4 | No Change | No Change | No Change | No | |
| PRO340 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw5 | No Change | No Change | No Change | No | |
| PRO341 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw6 | No Change | No Change | No Change | No | |
| PRO342 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw7 | No Change | No Change | No Change | No | |
| PRO343 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw8 | No Change | No Change | No Change | No | |
| PRO344 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw9(w3) | No Change | No Change | No Change | No | |
| PRO345 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | Cw10(w3) | No Change | No Change | No Change | No | |
| PRO346 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | CX | No Change | No Change | No Change | No | |
| PRO347 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity Bw4 present? | yes | No Change | No Change | No Change | No | |
| PRO348 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity Bw4 present? | no | No Change | No Change | No Change | No | |
| PRO349 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity Bw6 present? | yes | No Change | No Change | No Change | No | |
| PRO350 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity Bw6 present? | no | No Change | No Change | No Change | No | |
| PRO351 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO352 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO353 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR1 | No Change | No Change | No Change | No | |
| PRO354 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR103 | No Change | No Change | No Change | No | |
| PRO355 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR2 | No Change | No Change | No Change | No | |
| PRO356 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR3 | No Change | No Change | No Change | No | |
| PRO357 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR4 | No Change | No Change | No Change | No | |
| PRO358 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR5 | No Change | No Change | No Change | No | |
| PRO359 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR6 | No Change | No Change | No Change | No | |
| PRO360 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR7 | No Change | No Change | No Change | No | |
| PRO361 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR8 | No Change | No Change | No Change | No | |
| PRO362 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR9 | No Change | No Change | No Change | No | |
| PRO363 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR10 | No Change | No Change | No Change | No | |
| PRO364 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR11(5) | No Change | No Change | No Change | No | |
| PRO365 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR12(5) | No Change | No Change | No Change | No | |
| PRO366 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR13(6) | No Change | No Change | No Change | No | |
| PRO367 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR14(6) | No Change | No Change | No Change | No | |
| PRO368 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR1403 | No Change | No Change | No Change | No | |
| PRO369 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR1404 | No Change | No Change | No Change | No | |
| PRO370 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR15(2) | No Change | No Change | No Change | No | |
| PRO371 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR16(2) | No Change | No Change | No Change | No | |
| PRO372 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR17(3) | No Change | No Change | No Change | No | |
| PRO373 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DR18(3) | No Change | No Change | No Change | No | |
| PRO374 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DRX | No Change | No Change | No Change | No | |
| PRO375 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR1 | No Change | No Change | No Change | No | |
| PRO376 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR103 | No Change | No Change | No Change | No | |
| PRO377 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR2 | No Change | No Change | No Change | No | |
| PRO378 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR3 | No Change | No Change | No Change | No | |
| PRO379 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR4 | No Change | No Change | No Change | No | |
| PRO380 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR5 | No Change | No Change | No Change | No | |
| PRO381 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR6 | No Change | No Change | No Change | No | |
| PRO382 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR7 | No Change | No Change | No Change | No | |
| PRO383 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR8 | No Change | No Change | No Change | No | |
| PRO384 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR9 | No Change | No Change | No Change | No | |
| PRO385 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR10 | No Change | No Change | No Change | No | |
| PRO386 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR11(5) | No Change | No Change | No Change | No | |
| PRO387 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR12(5) | No Change | No Change | No Change | No | |
| PRO388 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR13(6) | No Change | No Change | No Change | No | |
| PRO389 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR14(6) | No Change | No Change | No Change | No | |
| PRO390 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR1403 | No Change | No Change | No Change | No | |
| PRO391 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR1404 | No Change | No Change | No Change | No | |
| PRO392 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR15(2) | No Change | No Change | No Change | No | |
| PRO393 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR16(2) | No Change | No Change | No Change | No | |
| PRO394 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR17(3) | No Change | No Change | No Change | No | |
| PRO395 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DR18(3) | No Change | No Change | No Change | No | |
| PRO396 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DRX | No Change | No Change | No Change | No | |
| PRO397 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR51 present? | yes | No Change | No Change | No Change | No | |
| PRO398 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR51 present? | no | No Change | No Change | No Change | No | |
| PRO399 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR52 present? | yes | No Change | No Change | No Change | No | |
| PRO400 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR52 present? | no | No Change | No Change | No Change | No | |
| PRO401 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR53 present? | yes | No Change | No Change | No Change | No | |
| PRO402 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity DR53 present? | no | No Change | No Change | No Change | No | |
| PRO403 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO404 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO405 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ1 | No Change | No Change | No Change | No | |
| PRO406 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ2 | No Change | No Change | No Change | No | |
| PRO407 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ3 | No Change | No Change | No Change | No | |
| PRO408 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ4 | No Change | No Change | No Change | No | |
| PRO409 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ5(1) | No Change | No Change | No Change | No | |
| PRO410 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ6(1) | No Change | No Change | No Change | No | |
| PRO411 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ7(3) | No Change | No Change | No Change | No | |
| PRO412 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ8(3) | No Change | No Change | No Change | No | |
| PRO413 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQ9(3) | No Change | No Change | No Change | No | |
| PRO414 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DQX | No Change | No Change | No Change | No | |
| PRO415 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ1 | No Change | No Change | No Change | No | |
| PRO416 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ2 | No Change | No Change | No Change | No | |
| PRO417 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ3 | No Change | No Change | No Change | No | |
| PRO418 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ4 | No Change | No Change | No Change | No | |
| PRO419 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ5(1) | No Change | No Change | No Change | No | |
| PRO420 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ6(1) | No Change | No Change | No Change | No | |
| PRO421 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ7(3) | No Change | No Change | No Change | No | |
| PRO422 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ8(3) | No Change | No Change | No Change | No | |
| PRO423 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQ9(3) | No Change | No Change | No Change | No | |
| PRO424 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DQX | No Change | No Change | No Change | No | |
| PRO425 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | one | No Change | No Change | No Change | No | |
| PRO426 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Number of antigens provided | two | No Change | No Change | No Change | No | |
| PRO427 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw1 | No Change | No Change | No Change | No | |
| PRO428 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw2 | No Change | No Change | No Change | No | |
| PRO429 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw3 | No Change | No Change | No Change | No | |
| PRO430 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw4 | No Change | No Change | No Change | No | |
| PRO431 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw5 | No Change | No Change | No Change | No | |
| PRO432 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPw6 | No Change | No Change | No Change | No | |
| PRO433 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 1st antigen | DPX | No Change | No Change | No Change | No | |
| PRO434 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw1 | No Change | No Change | No Change | No | |
| PRO435 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw2 | No Change | No Change | No Change | No | |
| PRO436 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw3 | No Change | No Change | No Change | No | |
| PRO437 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw4 | No Change | No Change | No Change | No | |
| PRO438 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw5 | No Change | No Change | No Change | No | |
| PRO439 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPw6 | No Change | No Change | No Change | No | |
| PRO440 | Transplant Procedure and Product | Confirmation of HLA Typing | Optional Antigen Reporting | No | Specificity – 2nd antigen | DPX | No Change | No Change | No Change | No | |
| PRO441 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | HCT type | Auto-filled field | No Change | No Change | No Change | No | |
| PRO442 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Product type | Auto-filled field | No Change | No Change | No Change | No | |
| PRO443 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Specify: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO444 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | NMDP Product | Auto-filled field | No Change | No Change | No Change | No | |
| PRO445 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | NMDP cord blood unit ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO446 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | NMDP donor ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO447 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Registry donor ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO448 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Non-NMDP cord blood unit ID: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO449 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Global Registration Identifier for Donors (GRID) | Auto-filled field | No Change | No Change | No Change | No | |
| PRO450 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | ISBT DIN: | Auto-filled field | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO451 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Registry or UCB Bank ID | Auto-filled field | No Change | No Change | No Change | No | |
| PRO452 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Donor DOB: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO453 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Donor age: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO454 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Key Fields | No | Donor sex: | Auto-filled field | No Change | No Change | No Change | No | |
| PRO455 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Did the donor receive growth and mobilizing factors, prior to any stem cell harvest, to enhance the product collection? | Yes | No Change | No Change | No Change | No | |
| PRO456 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Did the donor receive growth and mobilizing factors, prior to any stem cell harvest, to enhance the product collection? | No | No Change | No Change | No Change | No | |
| PRO457 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify growth and mobilizing factors | G-CSF (filgrastim, Neupogen) | Change/Clarification of Information Requested | No Change | G-CSF (TBO-filgrastim, filgrastim, Granix, Neupogen and biosimilars) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO458 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify growth and mobilizing factors | Pegylated G-CSF (pegfilgrastim, Neulasta) | No Change | No Change | No Change | No | |
| PRO459 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify growth and mobilizing factors | Motixafortide (Aphexda) | No Change | No Change | No Change | No | |
| PRO460 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify growth and mobilizing factors | Plerixafor (Mozobil) | Change/Clarification of Information Requested | No Change | Plerixafor (Mozobil, and biosimilars) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO461 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify growth and mobilizing factors | Other growth or mobilization factor | No Change | No Change | No Change | No | |
| PRO462 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Pre-Collection Therapy | No | Specify other growth or mobilizing factor: | Open text | No Change | No Change | No Change | No | |
| PRO463 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Date of first collection for this mobilization: | Open text | No Change | No Change | No Change | No | |
| PRO464 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Were anticoagulants or other agents added to the product between collection and infusion? | Yes | No Change | No Change | No Change | No | |
| PRO465 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Were anticoagulants or other agents added to the product between collection and infusion? | No | No Change | No Change | No Change | No | |
| PRO466 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Acid citrate dextrose (ACD, ACD-A) | No Change | No Change | No Change | No | |
| PRO467 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Citrate phosphate dextrose (CPD, CDPD-A) | No Change | No Change | No Change | No | |
| PRO468 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Addition of Information Requested | No Change | Dimethylsulfoxide (DMSO) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO469 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Ethylenediaminetetraacetic acid (EDTA) | No Change | No Change | No Change | No | |
| PRO470 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Heparin | No Change | No Change | No Change | No | |
| PRO471 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Addition of Information Requested | No Change | Plasmalyte | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO472 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify anticoagulant(s) or other agents | Other agent | No Change | No Change | No Change | No | |
| PRO473 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Collection | No | Specify other agent: | Open text | No Change | No Change | No Change | No | |
| PRO474 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was this product collected off-site and shipped to your facility? | yes | No Change | No Change | No Change | No | |
| PRO475 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was this product collected off-site and shipped to your facility? | no | No Change | No Change | No Change | No | |
| PRO476 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Date of receipt of product at your facility: | Open text | No Change | No Change | No Change | No | |
| PRO477 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Time of receipt of product (24-hour clock): | Open text | No Change | No Change | No Change | No | |
| PRO478 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | standard time | checked | New Functionality | No Change | Auto-filled field (standard time) | No | Reduce burden | 
| PRO479 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | daylight savings time | checked | New Functionality | No Change | Auto-filled field (daylight savings time) | No | Reduce burden | 
| PRO480 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the shipping environment of the product(s) | Room temperature | No Change | No Change | No Change | No | |
| PRO481 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the shipping environment of the product(s) | Cooled | No Change | No Change | No Change | No | |
| PRO482 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the shipping environment of the product(s) | Frozen | No Change | No Change | No Change | No | |
| PRO483 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the shipping environment of the product(s) | Other shipping environment | No Change | No Change | No Change | No | |
| PRO484 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify other shipping environment: | Open text | No Change | No Change | No Change | No | |
| PRO485 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was there any indication that the environment within the shipper was outside the expected temperature range for this product at any time during shipment? | yes | No Change | No Change | No Change | No | |
| PRO486 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was there any indication that the environment within the shipper was outside the expected temperature range for this product at any time during shipment? | no | No Change | No Change | No Change | No | |
| PRO487 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Were the secondary containers (e.g., insulated shipping containers and unit cassette) intact when they arrived at your center? | yes | No Change | No Change | No Change | No | |
| PRO488 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Were the secondary containers (e.g., insulated shipping containers and unit cassette) intact when they arrived at your center? | no | No Change | No Change | No Change | No | |
| PRO489 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was the cord blood unit stored at your center prior to thawing? | yes | No Change | No Change | No Change | No | |
| PRO490 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Was the cord blood unit stored at your center prior to thawing? | no | No Change | No Change | No Change | No | |
| PRO491 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the storage method used for the cord blood unit | Electric freezer | No Change | No Change | No Change | No | |
| PRO492 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the storage method used for the cord blood unit | Liquid nitrogen | No Change | No Change | No Change | No | |
| PRO493 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Specify the storage method used for the cord blood unit | Vapor phase | No Change | No Change | No Change | No | |
| PRO494 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Temperature during storage | < -150° C | Change/Clarification of Information Requested | No Change | ≤ 150° C | No | Capture data accurately | 
| PRO495 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Temperature during storage | ≥-150°C to < -135°C | Change/Clarification of Information Requested | No Change | -149°C to ≥-80° C | No | Reduce burden - information no longer needed | 
| PRO496 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Temperature during storage | ≥ -135° C to < -80°C | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| PRO497 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Temperature during storage | ≥-80°C | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| PRO498 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Date storage started: | Open text | No Change | No Change | No Change | No | |
| PRO499 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Total nucleated cells: | Open text | No Change | No Change | No Change | No | |
| PRO500 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Total nucleated cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO501 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | CD34+ cells | Done | No Change | No Change | No Change | No | |
| PRO502 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | CD34+ cells | Not done | No Change | No Change | No Change | No | |
| PRO503 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Total number of CD34+ cells: | Open text | No Change | No Change | No Change | No | |
| PRO504 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Transport and Receipt | No | Total number of CD34+ cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO505 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product thawed from a cryopreserved state prior to infusion? | yes | No Change | No Change | No Change | No | |
| PRO506 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product thawed from a cryopreserved state prior to infusion? | no | No Change | No Change | No Change | No | |
| PRO507 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the entire product thawed? | yes | Change/Clarification of Information Requested | Was the entire product received by the center thawed? | No Change | No | Capture data accurately | 
| PRO508 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the entire product thawed? | no | Change/Clarification of Information Requested | Was the entire product received by the center thawed? | No Change | No | Capture data accurately | 
| PRO509 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify the percent of the product that was thawed? | 80% | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO510 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify the percent of the product that was thawed? | 20% | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO511 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify the percent of the product that was thawed? | Other percent | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO512 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify other percent: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO513 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Date thawing process initiated: | Open text | No Change | No Change | No Change | No | |
| PRO514 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Time at initiation of thaw (24-hour clock): | Open text | No Change | No Change | No Change | No | |
| PRO515 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | standard time | checked | New Functionality | No Change | Auto-filled field (standard time) | No | Reduce burden | 
| PRO516 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | daylight savings time | checked | New Functionality | No Change | Auto-filled field (daylight savings time) | No | Reduce burden | 
| PRO517 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Time of thaw completion (24-hour clock): | Open text | No Change | No Change | No Change | No | |
| PRO518 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | standard time | checked | New Functionality | No Change | Auto-filled field (standard time) | No | Reduce burden | 
| PRO519 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | daylight savings time | checked | New Functionality | No Change | Auto-filled field (daylight savings time) | No | Reduce burden | 
| PRO520 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | What method was used to thaw the product? | Waterbath | No Change | No Change | No Change | No | |
| PRO521 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | What method was used to thaw the product? | Electric warmer | No Change | No Change | No Change | No | |
| PRO522 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | What method was used to thaw the product? | Other method | No Change | No Change | No Change | No | |
| PRO523 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify other method: | Open text | Change/Clarification of Information Requested | Specify other method used to thaw the product: | No Change | No | Capture data accurately | 
| PRO524 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Did any incidents or product complaints occur while preparing or thawing the product? | Yes | No Change | No Change | No Change | No | |
| PRO525 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Did any incidents or product complaints occur while preparing or thawing the product? | No | No Change | No Change | No Change | No | |
| PRO526 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product processed prior to infusion? | Yes | No Change | No Change | No Change | No | |
| PRO527 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product processed prior to infusion? | No | No Change | No Change | No Change | No | |
| PRO528 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify processing | Buffy coat enriched | No Change | No Change | No Change | No | |
| PRO529 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify processing | Diluted | No Change | No Change | No Change | No | |
| PRO530 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify processing | Plasma reduced | No Change | No Change | No Change | No | |
| PRO531 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify processing | RBC reduced | No Change | No Change | No Change | No | |
| PRO532 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify processing | Washed | No Change | No Change | No Change | No | |
| PRO533 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product manipulated prior to infusion? | yes | No Change | No Change | No Change | No | |
| PRO534 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Was the product manipulated prior to infusion? | no | No Change | No Change | No Change | No | |
| PRO535 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | Ex-vivo expansion | No Change | No change | No change | No | |
| PRO536 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | Genetic manipulation (gene transfer / transduction) | No Change | No Change | No Change | No | |
| PRO537 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | CD34 enriched (CD34+ selection) | No Change | No Change | No Change | No | |
| PRO538 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | Ex-vivo T-cell depetion | No Change | No Change | No Change | No | |
| PRO539 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | Addition of Information Requested | No Change | Negative fraction | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO540 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify manipulations performed | Other cell manipulation | No Change | No Change | No Change | No | |
| PRO541 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Addition of Information Requested | Specify ex-vivo expansion | Omidubicel (OMISIRGE) | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRO542 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Addition of Information Requested | Specify ex-vivo expansion | Other method | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRO543 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Addition of Information Requested | Specify other ex-vivo expansion: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRO544 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Addition of Information Requested | Specify genetic manipulation (gene transfer / gene transduction): | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| PRO545 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify antibodies used | Anti CD3 | No Change | No Change | No Change | No | |
| PRO546 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify antibodies used | Anti CD4 | No Change | No Change | No Change | No | |
| PRO547 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify antibodies used | Anti CD8 | No Change | No Change | No Change | No | |
| PRO548 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify antibodies used | Anti CD19 | No Change | No Change | No Change | No | |
| PRO549 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Processing / Manipulation | No | Specify antibodies used | Anti CD45RA | No Change | No Change | No Change | No | |
| PRO550 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify antibodies used | Alpha/beta antibody | No Change | No Change | No Change | No | |
| PRO551 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify antibodies used | Anti CD52 | No Change | No Change | No Change | No | |
| PRO552 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify antibodies used | Other antibody | No Change | No Change | No Change | No | |
| PRO553 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify other antibody: | Open text | Change/Clarification of Information Requested | Specify other antibody used: | No Change | No | Capture data accurately | 
| PRO554 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify T-cell depletion method | Antibody affinity column | No Change | No Change | No Change | No | |
| PRO555 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify T-cell depletion method | Immunomagnetic beads | No Change | No Change | No Change | No | |
| PRO556 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify T-cell depletion method | Other Method | No Change | No Change | No Change | No | |
| PRO557 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify other method: | Open text | Change/Clarification of Information Requested | Specify other T-cell depletion method: | No Change | No | Capture data accurately | 
| PRO558 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis | No | Specify other cell manipulation: | Open text | No Change | No Change | No Change | No | |
| PRO559 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify the timepoint in the product preparation phase that the product was analyzed | Product arrival | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO560 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify the timepoint in the product preparation phase that the product was analyzed | At infusion | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO561 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Date of product analysis: | Open text | No Change | No Change | No Change | No | |
| PRO562 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total volume of product plus additives: | Open text | Change/Clarification of Information Requested | Total volume of product received by center plus additives: | No Change | No | Capture data accurately | 
| PRO563 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total nucleated cells (TNC) | Done | No Change | No Change | No Change | No | |
| PRO564 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total nucleated cells (TNC) | Not done | No Change | No Change | No Change | No | |
| PRO565 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total nucleated cells: | Open text | No Change | No Change | No Change | No | |
| PRO566 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total nucleated cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO567 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of TNC | Done | No Change | No Change | No Change | No | |
| PRO568 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of TNC | Not done | No Change | No Change | No Change | No | |
| PRO569 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of TNC: | Open text | No Change | No Change | No Change | No | |
| PRO570 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing TNC viability | Flow cytometry based | No Change | No Change | No Change | No | |
| PRO571 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing TNC viability | Trypan blue | No Change | No Change | No Change | No | |
| PRO572 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing TNC viability | Other method | No Change | No Change | No Change | No | |
| PRO573 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other method: | Open text | Change/Clarification of Information Requested | Specify other of testing TNC viability: | No Change | No | Capture data accurately | 
| PRO574 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Nucleated white blood cells | Done | No Change | No Change | No Change | No | |
| PRO575 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Nucleated white blood cells | Not done | No Change | No Change | No Change | No | |
| PRO576 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of nucleated white blood cells: | Open text | No Change | No Change | No Change | No | |
| PRO577 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of nucleated white blood cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO578 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Mononuclear cells | Done | No Change | No Change | No Change | No | |
| PRO579 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Mononuclear cells | Not done | No Change | No Change | No Change | No | |
| PRO580 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of mononuclear cells: | Open text | No Change | No Change | No Change | No | |
| PRO581 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of mononuclear cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO582 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Nucleated red blood cells | Done | No Change | No Change | No Change | No | |
| PRO583 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Nucleated red blood cells | Not done | No Change | No Change | No Change | No | |
| PRO584 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of nucleated red blood cells: | Open text | No Change | No Change | No Change | No | |
| PRO585 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of nucleated red blood cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO586 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD34+ cells | Done | No Change | No Change | No Change | No | |
| PRO587 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD34+ cells | Not done | No Change | No Change | No Change | No | |
| PRO588 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD34+ cells: | Open text | No Change | No Change | No Change | No | |
| PRO589 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD34+ cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO590 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD34+ cells | Done | No Change | No Change | No Change | No | |
| PRO591 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD34+ cells | Not done | No Change | No Change | No Change | No | |
| PRO592 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD34+ cells | Unknown | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| PRO593 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD34+ cells percentage | Open text | No Change | No Change | No Change | No | |
| PRO594 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD34+ cell viability | Flow cytometry based | No Change | No Change | No Change | No | |
| PRO595 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD34+ cell viability | Trypan blue | No Change | No Change | No Change | No | |
| PRO596 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD34+ cell viability | Other method | No Change | No Change | No Change | No | |
| PRO597 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other method: | Open text | Change/Clarification of Information Requested | Specify other method of testing CD34+ cell viability: | No Change | No | Capture data accurately | 
| PRO598 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+ cells | Done | No Change | No Change | No Change | No | |
| PRO599 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+ cells | Not done | No Change | No Change | No Change | No | |
| PRO600 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+ cells: | Open text | No Change | No Change | No Change | No | |
| PRO601 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+ cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO602 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+ cells | Done | No Change | No Change | No Change | No | |
| PRO603 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+ cells | Not done | No Change | No Change | No Change | No | |
| PRO604 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+ cells | Unknown | Deletion of Information Requested | No Change | No | Capture data accurately | |
| PRO605 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+ cells percentage | Open text | No Change | No Change | No Change | No | |
| PRO606 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+ cell viability | Flow cytometry based | No Change | No Change | No Change | No | |
| PRO607 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+ cell viability | Trypan blue | No Change | No Change | No Change | No | |
| PRO608 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+ cell viability | Other method | No Change | No Change | No Change | No | |
| PRO609 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other method: | Open text | Change/Clarification of Information Requested | Specify other method of testing CD3+ cell viability: | No Change | No | Capture data accurately | 
| PRO610 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+CD4+ cells | Done | No Change | No Change | No Change | No | |
| PRO611 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+CD4+ cells | Not done | No Change | No Change | No Change | No | |
| PRO612 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+CD4+ cells: | Open text | No Change | No Change | No Change | No | |
| PRO613 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+CD4+ cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO614 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD4+ cells | Done | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO615 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD4+ cells | Not done | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO616 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD4+ cells | Unknown | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO617 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD4+ cells percentage | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO618 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD4+ cell viability | Flow cytometry based | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO619 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD4+ cell viability | Trypan blue | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO620 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD4+ cell viability | Other method | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO621 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other method: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO622 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+CD8+ cells | Done | No Change | No Change | No Change | No | |
| PRO623 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | CD3+CD8+ cells | Not done | No Change | No Change | No Change | No | |
| PRO624 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+CD8+ cells: | Open text | No Change | No Change | No Change | No | |
| PRO625 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total number of CD3+CD8+ cells exponent: | Open text | No Change | No Change | No Change | No | |
| PRO626 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD8+ cells | Done | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO627 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD8+ cells | Not done | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO628 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Viability of CD3+CD8+ cells | Unknown | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO629 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | No | Viability of CD3+CD8+ cells percentage | Open Text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO630 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD8+ cell viability | Flow cytometry based | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO631 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD8+ cell viability | Trypan blue | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO632 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Method of testing CD3+CD8+ cell viability | Other method | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO633 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other method: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| PRO634 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were the colony-forming units (CFU) assessed after thawing? | yes | No Change | No Change | No Change | No | |
| PRO635 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were the colony-forming units (CFU) assessed after thawing? | no | No Change | No Change | No Change | No | |
| PRO636 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Was there growth? | yes | No Change | No Change | No Change | No | |
| PRO637 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Was there growth? | no | No Change | No Change | No Change | No | |
| PRO638 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Indicate which assessments were carried out | Total CFU-GM | No Change | No Change | No Change | No | |
| PRO639 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Indicate which assessments were carried out | Total CFU-GEMM | No Change | No Change | No Change | No | |
| PRO640 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Indicate which assessments were carried out | Total BFU-E | No Change | No Change | No Change | No | |
| PRO641 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total CFU-GM: | Open text | No Change | No Change | No Change | No | |
| PRO642 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total CFU-GM exponent: | Open text | No Change | No Change | No Change | No | |
| PRO643 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total CFU-GEMM: | Open text | No Change | No Change | No Change | No | |
| PRO644 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total CFU-GEMM exponent: | Open text | No Change | No Change | No Change | No | |
| PRO645 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total BFU-E: | Open text | No Change | No Change | No Change | No | |
| PRO646 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Total BFU-E exponent: | Open text | No Change | No Change | No Change | No | |
| PRO647 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were any positive cultures (for bacterial or fungal infections) obtained from the product at the transplant center? | Yes | No Change | No Change | No Change | No | |
| PRO648 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were any positive cultures (for bacterial or fungal infections) obtained from the product at the transplant center? | No | No Change | No Change | No Change | No | |
| PRO649 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were any positive cultures (for bacterial or fungal infections) obtained from the product at the transplant center? | Pending | No Change | No Change | No Change | No | |
| PRO650 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Were any positive cultures (for bacterial or fungal infections) obtained from the product at the transplant center? | Unknown | No Change | No Change | No Change | No | |
| PRO651 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Acinetobacter (all species) | No Change | No Change | No Change | No | |
| PRO652 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Bordetella pertussis (whooping cough) | No Change | No Change | No Change | No | |
| PRO653 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Campylobacter (all species) | No Change | No Change | No Change | No | |
| PRO654 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Capnocytophaga (all species) | No Change | No Change | No Change | No | |
| PRO655 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Chlamydia (pneumoniae) | No Change | No Change | No Change | No | |
| PRO656 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Citrobacter (freundii, other species) | No Change | No Change | No Change | No | |
| PRO657 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Clostridium (all species except difficile) | No Change | No Change | No Change | No | |
| PRO658 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Clostridium difficile | No Change | No Change | No Change | No | |
| PRO659 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Corynebacterium jeikeium | No Change | No Change | No Change | No | |
| PRO660 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Addition of Information Requested | No Change | Cutibacterium acnes (Propionibacterium) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO661 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Enterobacter (all species) | No Change | No Change | No Change | No | |
| PRO662 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Enterococcus (all species) | No Change | No Change | No Change | No | |
| PRO663 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Enterococcus, vancomycin resistant (VRE) | No Change | No Change | No Change | No | |
| PRO664 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Escherichia (also E. coli) | No Change | No Change | No Change | No | |
| PRO665 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Fusobacterium (all species) | No Change | No Change | No Change | No | |
| PRO666 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Haemophilus influenzae | No Change | No Change | No Change | No | |
| PRO667 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Haemophilus non-influenzae | No Change | No Change | No Change | No | |
| PRO668 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Klebsiella (all species) | No Change | No Change | No Change | No | |
| PRO669 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Lactobacillus (bulgaricus, acidophilus, other species) | No Change | No Change | No Change | No | |
| PRO670 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Legionella pneumophila | No Change | No Change | No Change | No | |
| PRO671 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Legionella non-pneumophila | No Change | No Change | No Change | No | |
| PRO672 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Leptospira (all species) | No Change | No Change | No Change | No | |
| PRO673 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Leptotrichia buccalis | No Change | No Change | No Change | No | |
| PRO674 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Leuconostoc (all species) | No Change | No Change | No Change | No | |
| PRO675 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Listeria monocytogenes | No Change | No Change | No Change | No | |
| PRO676 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Micrococcus, NOS | No Change | No Change | No Change | No | |
| PRO677 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium abscessus | No Change | No Change | No Change | No | |
| PRO678 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium avium - intracellulare (MAC, MAI) | No Change | No Change | No Change | No | |
| PRO679 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium cheloneae | No Change | No Change | No Change | No | |
| PRO680 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium fortuitum | No Change | No Change | No Change | No | |
| PRO681 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium haemophilum | No Change | No Change | No Change | No | |
| PRO682 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium kansasii | No Change | No Change | No Change | No | |
| PRO683 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium marinum | No Change | No Change | No Change | No | |
| PRO684 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium mucogenicum | No Change | No Change | No Change | No | |
| PRO685 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycobacterium tuberculosis (tuberculosis, Koch bacillus) | No Change | No Change | No Change | No | |
| PRO686 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mycoplasma (all species) | No Change | No Change | No Change | No | |
| PRO687 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Neisseria gonorrhoeae | No Change | No Change | No Change | No | |
| PRO688 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Neisseria meningitidis | No Change | No Change | No Change | No | |
| PRO689 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Nocardia (all species) | No Change | No Change | No Change | No | |
| PRO690 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Pasteurella multocida | No Change | No Change | No Change | No | |
| PRO691 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Proteus (all species) | No Change | No Change | No Change | No | |
| PRO692 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Pseudomonas or Burkholderia cepacia | No Change | No Change | No Change | No | |
| PRO693 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Pseudomonas aeruginosa | No Change | No Change | No Change | No | |
| PRO694 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Pseudomonas non-aeruginosa | No Change | No Change | No Change | No | |
| PRO695 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Rhodococcus (all species) | No Change | No Change | No Change | No | |
| PRO696 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Rickettsia (all species) | No Change | No Change | No Change | No | |
| PRO697 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Salmonella (all species) | No Change | No Change | No Change | No | |
| PRO698 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Serratia marcescens | No Change | No Change | No Change | No | |
| PRO699 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Shigella (all species) | No Change | No Change | No Change | No | |
| PRO700 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Staphylococcus aureus (Methicillin Resistant) | No Change | No Change | No Change | No | |
| PRO701 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Staphylococcus aureus (Methicillin Sensitive) | No Change | No Change | No Change | No | |
| PRO702 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Stenotrophomonas maltophilia | No Change | No Change | No Change | No | |
| PRO703 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Stomatococcus mucilaginosis | No Change | No Change | No Change | No | |
| PRO704 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Streptococcus, alpha-hemolytic | No Change | No Change | No Change | No | |
| PRO705 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Streptococcus, Group B | No Change | No Change | No Change | No | |
| PRO706 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Streptococcus pneumoniae | No Change | No Change | No Change | No | |
| PRO707 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Treponema (syphilis) | No Change | No Change | No Change | No | |
| PRO708 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Vibrio (all species) | No Change | No Change | No Change | No | |
| PRO709 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus, NOS | No Change | No Change | No Change | No | |
| PRO710 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus flavus | No Change | No Change | No Change | No | |
| PRO711 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus fumigatus | No Change | No Change | No Change | No | |
| PRO712 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus niger | No Change | No Change | No Change | No | |
| PRO713 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus terreus | No Change | No Change | No Change | No | |
| PRO714 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Aspergillus ustus | No Change | No Change | No Change | No | |
| PRO715 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Blastomyces (dermatitidis) | No Change | No Change | No Change | No | |
| PRO716 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Candida albicans | No Change | No Change | No Change | No | |
| PRO717 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Candida non-albicans | No Change | No Change | No Change | No | |
| PRO718 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Coccidioides (all species) | No Change | No Change | No Change | No | |
| PRO719 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Cryptococcus gattii | No Change | No Change | No Change | No | |
| PRO720 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Cryptococcus neoformans | No Change | No Change | No Change | No | |
| PRO721 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Fusarium (all species) | No Change | No Change | No Change | No | |
| PRO722 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Histoplasma (capsulatum) | No Change | No Change | No Change | No | |
| PRO723 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Mucorales (all species) | No Change | No Change | No Change | No | |
| PRO724 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Pneumocystis (PCP / PJP) | No Change | No Change | No Change | No | |
| PRO725 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Rhizopus (all species) | No Change | No Change | No Change | No | |
| PRO726 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Scedosporium (all species) | No Change | No Change | No Change | No | |
| PRO727 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Zygomycetes, NOS | No Change | No Change | No Change | No | |
| PRO728 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Suspected fungal infection | No Change | No Change | No Change | No | |
| PRO729 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | Other organism | No Change | No Change | No Change | No | |
| PRO730 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | 2nd optional response for additional organisms - see organism list above | No Change | No Change | No Change | No | |
| PRO731 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | 3rd optional response for additional organisms - see organism list above | No Change | No Change | No Change | No | |
| PRO732 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | [Specify organism] | 4th optional response for additional organisms - see organism list above | No Change | No Change | No Change | No | |
| PRO733 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Analysis at Infusion | Yes | Specify other organism: | Open text | No Change | No Change | No Change | No | |
| PRO734 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Date of this product infusion: | Open text | No Change | No Change | No Change | No | |
| PRO735 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Was the entire volume of received product infused? | yes | Change/Clarification of Information Requested | Was the entire volume of the product received by the center infused? | Yes | No | Capture data accurately | 
| PRO736 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Was the entire volume of received product infused? | no | Change/Clarification of Information Requested | Was the entire volume of the product received by the center infused? | No | No | Capture data accurately | 
| PRO737 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify what happened to the reserved portion | discarded | No Change | No Change | No Change | No | |
| PRO738 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify what happened to the reserved portion | cryopreserved for future use | No Change | No Change | No Change | No | |
| PRO739 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify what happened to the reserved portion | Addition of Information Requested | No Change | Research | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO740 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify what happened to the reserved portion | Addition of Information Requested | No Change | Training or Quality Control | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO741 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify what happened to the reserved portion | other fate | No Change | No Change | No Change | No | |
| PRO742 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify other fate: | Open text | No Change | No Change | No Change | No | |
| PRO743 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Time product infusion initiated (24-hour clock): | Open text | No Change | No Change | No Change | No | |
| PRO744 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | standard time | checked | New Functionality | No Change | Auto-filled field (standard time) | No | Reduce burden | 
| PRO745 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | daylight savings time | checked | New Functionality | No Change | Auto-filled field (daylight savings time) | No | Reduce burden | 
| PRO746 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Date infusion stopped: | Open text | No Change | No Change | No Change | No | |
| PRO747 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Time product infusion completed (24-hour clock): | Open text | No Change | No Change | No Change | No | |
| PRO748 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | standard time | checked | New Functionality | No Change | Auto-filled field (standard time) | No | Reduce burden | 
| PRO749 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | daylight savings time | checked | New Functionality | No Change | Auto-filled field (daylight savings time) | No | Reduce burden | 
| PRO750 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify the route of product infusion | Intravenous | No Change | No Change | No Change | No | |
| PRO751 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify the route of product infusion | Intramedullary | No Change | No Change | No Change | No | |
| PRO752 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify the route of product infusion | Other route of infusion | No Change | No Change | No Change | No | |
| PRO753 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify other route of infusion: | Open text | No Change | No Change | No Change | No | |
| PRO754 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Were there any adverse events or incidents associated with the stem cell infusion? | yes | No Change | No Change | No Change | No | |
| PRO755 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Were there any adverse events or incidents associated with the stem cell infusion? | no | No Change | No Change | No Change | No | |
| PRO756 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Brachycardia | yes | No Change | No Change | No Change | No | |
| PRO757 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Brachycardia | no | No Change | No Change | No Change | No | |
| PRO758 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO759 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO760 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Chest tightness / pain | yes | No Change | No Change | No Change | No | |
| PRO761 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Chest tightness / pain | no | No Change | No Change | No Change | No | |
| PRO762 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO763 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO764 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Chills at time of infusion | yes | No Change | No Change | No Change | No | |
| PRO765 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Chills at time of infusion | no | No Change | No Change | No Change | No | |
| PRO766 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO767 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO768 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Fever ≤ 103° F within 24 hours of infusion | yes | No Change | No Change | No Change | No | |
| PRO769 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Fever ≤ 103° F within 24 hours of infusion | no | No Change | No Change | No Change | No | |
| PRO770 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO771 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO772 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Fever > 103° F within 24 hours of infusion | yes | No Change | No Change | No Change | No | |
| PRO773 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Fever > 103° F within 24 hours of infusion | no | No Change | No Change | No Change | No | |
| PRO774 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO775 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO776 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Gross hemoglobinuria | yes | No Change | No Change | No Change | No | |
| PRO777 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Gross hemoglobinuria | no | No Change | No Change | No Change | No | |
| PRO778 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO779 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO780 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Headache | yes | No Change | No Change | No Change | No | |
| PRO781 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Headache | no | No Change | No Change | No Change | No | |
| PRO782 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO783 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO784 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hives | yes | No Change | No Change | No Change | No | |
| PRO785 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hives | no | No Change | No Change | No Change | No | |
| PRO786 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO787 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO788 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypertension | yes | No Change | No Change | No Change | No | |
| PRO789 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypertension | no | No Change | No Change | No Change | No | |
| PRO790 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO791 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO792 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypotension | yes | No Change | No Change | No Change | No | |
| PRO793 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypotension | no | No Change | No Change | No Change | No | |
| PRO794 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO795 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO796 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypoxia requiring oxygen (O2) support | yes | No Change | No Change | No Change | No | |
| PRO797 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Hypoxia requiring oxygen (O2) support | no | No Change | No Change | No Change | No | |
| PRO798 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO799 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO800 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Nausea | yes | No Change | No Change | No Change | No | |
| PRO801 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Nausea | no | No Change | No Change | No Change | No | |
| PRO802 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO803 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO804 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Rigors, mild | yes | No Change | No Change | No Change | No | |
| PRO805 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Rigors, mild | no | No Change | No Change | No Change | No | |
| PRO806 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO807 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO808 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Rigors, severe | yes | No Change | No Change | No Change | No | |
| PRO809 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Rigors, severe | no | No Change | No Change | No Change | No | |
| PRO810 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO811 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO812 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Shortness of breath (SOB) | yes | No Change | No Change | No Change | No | |
| PRO813 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Shortness of breath (SOB) | no | No Change | No Change | No Change | No | |
| PRO814 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO815 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO816 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Tachycardia | yes | No Change | No Change | No Change | No | |
| PRO817 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Tachycardia | no | No Change | No Change | No Change | No | |
| PRO818 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO819 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO820 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Vomiting | yes | No Change | No Change | No Change | No | |
| PRO821 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Vomiting | no | No Change | No Change | No Change | No | |
| PRO822 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO823 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO824 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Other expected AE | yes | No Change | No Change | No Change | No | |
| PRO825 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Other expected AE | no | No Change | No Change | No Change | No | |
| PRO826 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify other expected AE: | Open text | No Change | No Change | No Change | No | |
| PRO827 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO828 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO829 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Other unexpected AE | yes | No Change | No Change | No Change | No | |
| PRO830 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Other unexpected AE | no | No Change | No Change | No Change | No | |
| PRO831 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | Specify other unexpected AE: | Open text | No Change | No Change | No Change | No | |
| PRO832 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | yes | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | Yes | No | Capture data accurately | 
| PRO833 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Product Infusion | No | In the Medical Director's judgment, was the adverse event a direct result of the infusion? | no | Change/Clarification of Information Requested | In the clinician's judgment, was the adverse event a direct result of the infusion? | No | No | Capture data accurately | 
| PRO834 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor ever pregnant? | Yes | No Change | No Change | No Change | No | |
| PRO835 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor ever pregnant? | No | No Change | No Change | No Change | No | |
| PRO836 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor ever pregnant? | Unknown | No Change | No Change | No Change | No | |
| PRO837 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor ever pregnant? | Not Applicable | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| PRO838 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Number of pregnancies | Known | No Change | No Change | No Change | No | |
| PRO839 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Number of pregnancies | Unknown | No Change | No Change | No Change | No | |
| PRO840 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify number of pregnancies: | Open text | No Change | No Change | No Change | No | |
| PRO841 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Ethnicity | Hispanic or Latino | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO842 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Ethnicity | Not Hispanic or Latino | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO843 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Ethnicity | Not applicable (not a resident of the USA) | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO844 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Ethnicity | Unknown | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO845 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | White | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO846 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Black or African American | Change/Clarification of Information Requested | Geographic ancestry | Black or African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO847 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Asian | Change/Clarification of Information Requested | Geographic ancestry | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO848 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | American Indian or Alaska Native | Change/Clarification of Information Requested | Geographic ancestry | Indigenous American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO849 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Native Hawaiian or Other Pacific Islander | Change/Clarification of Information Requested | Geographic ancestry | Pacific Islander | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO850 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Not reported | Change/Clarification of Information Requested | Geographic ancestry | Prefer not to answer | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO851 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Unknown | Change/Clarification of Information Requested | Geographic ancestry | Not otherwise specified | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO852 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry | Jewish | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO853 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry | Middle Eastern or North African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO854 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Eastern European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO855 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Mediterranean | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO856 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Middle Eastern | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO857 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | North Coast of Africa | Change/Clarification of Information Requested | Geographic ancestry detail | North African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO858 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | North American | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO859 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Northern European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO860 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Western European | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO861 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | White Caribbean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO862 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | White South or Central American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO863 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Other White | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified White | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO864 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | African | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO865 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | African American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO866 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Black Caribbean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO867 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Black South or Central American | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO868 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Other Black | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified Black/African | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO869 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Alaskan Native or Aleut | Change/Clarification of Information Requested | Geographic ancestry detail | Alaska Native | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO870 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | North American Indian | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous North American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO871 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | American Indian, South or Central America | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous South/Central American | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO872 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Caribbean Indian | Change/Clarification of Information Requested | Geographic ancestry detail | Indigenous Caribbean | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO873 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | South Asian | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO874 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Filipino (Pilipino) | Change/Clarification of Information Requested | Geographic ancestry detail | Filipino | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO875 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Japanese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO876 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Korean | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO877 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Chinese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO878 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Vietnamese | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO879 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Other Southeast Asian | Change/Clarification of Information Requested | Geographic ancestry detail | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO880 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Guamanian | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO881 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Hawaiian | Change/Clarification of Information Requested | Geographic ancestry detail | Native Hawaiian | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO882 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Samoan | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO883 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Other Pacific Islander | Change/Clarification of Information Requested | Geographic ancestry detail | Not otherwise specified Pacific Islander | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| PRO884 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Unknown | Change/Clarification of Information Requested and Deletion of Response Option | Geographic ancestry detail | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO885 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Caribbean Indian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO886 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Indian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO887 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Malaysian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO888 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mongolian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO889 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Pakistani | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO890 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Taiwanese | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO891 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Thai | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO892 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Other Indian Subcontinent | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO893 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Asian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO894 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | East African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO895 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | South African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO896 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | West African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO897 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Brazilian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO898 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Caribbean Hispanic | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO899 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Cuban | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO900 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mexican | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO901 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Puerto Rican | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO902 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | South / Central American Hispanic | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO903 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Hispanic / Latino | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO904 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Indigenous Caribbean | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO905 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Indigenous American | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO906 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Ashkenazi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO907 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Mizrahi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO908 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Sephardi | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO909 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Jewish | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO910 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Arab Peninsula | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO911 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Central Asian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO912 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | East Mediterranean | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO913 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Not otherwise specified Middle Eastern / North African | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO914 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Melanesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO915 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Micronesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO916 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Polynesian | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO917 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Russian or Former Soviet Union | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO918 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Race detail | Change/Clarification of Information Requested and Addition of Response Option | Geographic ancestry detail | Southern European | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| PRO919 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor a carrier for potentially transferable genetic diseases? | Yes | No Change | No Change | No Change | No | |
| PRO920 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor a carrier for potentially transferable genetic diseases? | No | No Change | No Change | No Change | No | |
| PRO921 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify potentially transferable genetic disease | Sickle cell anemia | No Change | No Change | No Change | No | |
| PRO922 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify potentially transferable genetic disease | Thalassemia | No Change | No Change | No Change | No | |
| PRO923 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify potentially transferable genetic disease | Other hemoglobinopathy | No Change | No Change | No Change | No | |
| PRO924 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify potentially transferable genetic disease | Other disease | No Change | No Change | No Change | No | |
| PRO925 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify other disease: | Open text | Change/Clarification of Information Requested | Specify other transferable genetic disease: | No Change | No | Capture data accurately | 
| PRO926 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor / product tested for other transferable genetic or clonal abnormalities? | Yes | No Change | No Change | No Change | No | |
| PRO927 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor / product tested for other transferable genetic or clonal abnormalities? | No | No Change | No Change | No Change | No | |
| PRO928 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor / product tested for other transferable genetic or clonal abnormalities? | Unknown | No Change | No Change | No Change | No | |
| PRO929 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Clonal hematopoiesis of indeterminate potential (CHIP) | Yes | No Change | No Change | No Change | No | |
| PRO930 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Clonal hematopoiesis of indeterminate potential (CHIP) | No | No Change | No Change | No Change | No | |
| PRO931 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | What was the method of testing used: | Open text | No Change | No Change | No Change | No | |
| PRO932 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Monoclonal B-cell lymphocytosis | Yes | No Change | No Change | No Change | No | |
| PRO933 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Monoclonal B-cell lymphocytosis | No | No Change | No Change | No Change | No | |
| PRO934 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Other transferable genetic or clonal abnormality | Yes | No Change | No Change | No Change | No | |
| PRO935 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Other transferable genetic or clonal abnormality | No | No Change | No Change | No Change | No | |
| PRO936 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify other transferable genetic or clonal abnormality: | Open text | No Change | No Change | No Change | No | |
| PRO937 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor have a central line placed? | yes | No Change | No Change | No Change | No | |
| PRO938 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor have a central line placed? | no | No Change | No Change | No Change | No | |
| PRO939 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor hospitalized (inpatient) during or after the collection? | yes | No Change | No Change | No Change | No | |
| PRO940 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Was the donor hospitalized (inpatient) during or after the collection? | no | No Change | No Change | No Change | No | |
| PRO941 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor experience any life-threatening complications during or after the collection? | yes | No Change | No Change | No Change | No | |
| PRO942 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor experience any life-threatening complications during or after the collection? | no | No Change | No Change | No Change | No | |
| PRO943 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify: | Open text | Change/Clarification of Information Requested | Specify the life-threatening complication experienced: | No Change | No | Capture data accurately | 
| PRO944 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the allogeneic donor give one or more autologous transfusion units? | Yes | No Change | No Change | No Change | No | |
| PRO945 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the allogeneic donor give one or more autologous transfusion units? | No | No Change | No Change | No Change | No | |
| PRO946 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Date of collection: | Open text | No Change | No Change | No Change | No | |
| PRO947 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Number of units: | Open text | No Change | No Change | No Change | No | |
| PRO948 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor receive blood transfusions as a result of the collection? | Autologous transfusions | No Change | No Change | No Change | No | |
| PRO949 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor receive blood transfusions as a result of the collection? | Allogeneic transfusions | No Change | No Change | No Change | No | |
| PRO950 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor receive blood transfusions as a result of the collection? | No | No Change | No Change | No Change | No | |
| PRO951 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify number of autologous units: | Open text | No Change | No Change | No Change | No | |
| PRO952 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify number of allogeneic units: | Open text | No Change | No Change | No Change | No | |
| PRO953 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor die as a result of the collection? | yes | No Change | No Change | No Change | No | |
| PRO954 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Did the donor die as a result of the collection? | no | No Change | No Change | No Change | No | |
| PRO955 | Transplant Procedure and Product | Hematopoietic Cellular Transplant (HCT) Infusion | Donor / Infant Demographic Information | No | Specify cause of death: | Open text | No Change | No Change | No Change | No | 
| Item ID | Time Point | Information Collection Domain Sub-Type | Information Collection Domain Additional Sub Domain | Information Collection may be requested multiple times | Current Information Collection Data Element (if applicable) | Current Information Collection Data Element Response Option (if applicable) | Information Collection update | Proposed Information Collection Data Element Update (if applicable) | Proposed Information Collection Data Element Response Option Update (if applicable) | Instructional Text Indicating an Action | Rationale for Information Collection Update | 
| POST001 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Key Fields | No | Visit | Auto-filled field | No Change | No Change | No Change | No | |
| POST002 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Key Fields | No | Specify: | Auto-filled field | No Change | No Change | No Change | No | |
| POST003 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Survival | No | Date of actual contact with the recipient to determine medical status for this follow-up report: | Open text | No Change | No Change | No Change | No | |
| POST004 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Survival | No | Specify the patient's survival status at the date of last contact | Alive | No Change | No Change | No Change | No | |
| POST005 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Survival | No | Specify the patient's survival status at the date of last contact | Dead | No Change | No Change | No Change | No | |
| POST006 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Subsequent Infusion | No | Did the recipient receive a subsequent infusion? | Yes | No Change | No Change | No Change | No | |
| POST007 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Subsequent Infusion | No | Did the recipient receive a subsequent infusion? | No | No Change | No Change | No Change | No | |
| POST008 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Was there evidence of initial hematopoietic recovery? | Yes | No Change | No Change | No Change | No | |
| POST009 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Was there evidence of initial hematopoietic recovery? | No | No Change | No Change | No Change | No | |
| POST010 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Was there evidence of initial hematopoietic recovery? | Not applicable | No Change | No Change | No Change | No | |
| POST011 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Was there evidence of initial hematopoietic recovery? | Previously reported | No Change | No Change | No Change | No | |
| POST012 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Date ANC ≥ 500/mm3 | Open text | No Change | No Change | No Change | No | |
| POST013 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Did late graft failure occur? | Yes | Change/Clarification of Information Requested | Did secondary graft failure occur? | No Change | No | Capture data accurately | 
| POST014 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial ANC Recovery | No | Did late graft failure occur? | No | Change/Clarification of Information Requested | Did secondary graft failure occur? | No Change | No | Capture data accurately | 
| POST015 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial Platelet Recovery | No | Was an initial platelet count > 20 x 109L achieved? | Yes | No Change | No Change | No Change | No | |
| POST016 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial Platelet Recovery | No | Was an initial platelet count > 20 x 109L achieved? | No | No Change | No Change | No Change | No | |
| POST017 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial Platelet Recovery | No | Was an initial platelet count > 20 x 109L achieved? | Not applicable | No Change | No Change | No Change | No | |
| POST018 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial Platelet Recovery | No | Was an initial platelet count > 20 x 109L achieved? | Previously reported | No Change | No Change | No Change | No | |
| POST019 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Initial Platelet Recovery | No | Date platelets > 20 x 109/L: | Open text | No Change | No Change | No Change | No | |
| POST020 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GVHD develop? | Yes | No Change | No Change | No Change | No | |
| POST021 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GVHD develop? | No | No Change | No Change | No Change | No | |
| POST022 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GVHD develop? | Unknown | No Change | No Change | No Change | No | |
| POST023 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Date of acute GVHD diagnosis: | Open text | No Change | No Change | No Change | No | |
| POST024 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GHVD persist? | Yes | No Change | No Change | No Change | No | |
| POST025 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GHVD persist? | No | No Change | No Change | No Change | No | |
| POST026 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did acute GHVD persist? | Unknown | No Change | No Change | No Change | No | |
| POST027 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Overall grade of acute GVHD at diagnosis | I | No Change | No Change | No Change | No | |
| POST028 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Overall grade of acute GVHD at diagnosis | II | No Change | No Change | No Change | No | |
| POST029 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Overall grade of acute GVHD at diagnosis | III | No Change | No Change | No Change | No | |
| POST030 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Overall grade of acute GVHD at diagnosis | IV | No Change | No Change | No Change | No | |
| POST031 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Overall grade of acute GVHD at diagnosis | Not applicable | No Change | No Change | No Change | No | |
| POST032 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 0 | No Change | No Change | No Change | No | |
| POST033 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 1 | No Change | No Change | No Change | No | |
| POST034 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 2 | No Change | No Change | No Change | No | |
| POST035 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 3 | No Change | No Change | No Change | No | |
| POST036 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 4 | No Change | No Change | No Change | No | |
| POST037 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 0 | No Change | No Change | No Change | No | |
| POST038 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 1 | No Change | No Change | No Change | No | |
| POST039 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 2 | No Change | No Change | No Change | No | |
| POST040 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 3 | No Change | No Change | No Change | No | |
| POST041 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 4 | No Change | No Change | No Change | No | |
| POST042 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Upper intestinal tract | Stage 0 | No Change | No Change | No Change | No | |
| POST043 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Upper intestinal tract | Stage 1 | No Change | No Change | No Change | No | |
| POST044 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 0 | No Change | No Change | No Change | No | |
| POST045 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 1 | No Change | No Change | No Change | No | |
| POST046 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 2 | No Change | No Change | No Change | No | |
| POST047 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 3 | No Change | No Change | No Change | No | |
| POST048 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 4 | No Change | No Change | No Change | No | |
| POST049 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Other site(s) involved with acute GVHD | Yes | No Change | No Change | No Change | No | |
| POST050 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Other site(s) involved with acute GVHD | No | No Change | No Change | No Change | No | |
| POST051 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Specify other site(s): | Open text | No Change | No Change | No Change | No | |
| POST052 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum overall grade of acute GVHD | I | No Change | No Change | No Change | No | |
| POST053 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum overall grade of acute GVHD | II | No Change | No Change | No Change | No | |
| POST054 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum overall grade of acute GVHD | III | No Change | No Change | No Change | No | |
| POST055 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum overall grade of acute GVHD | IV | No Change | No Change | No Change | No | |
| POST056 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum overall grade of acute GVHD | Not applicable | No Change | No Change | No Change | No | |
| POST057 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | First date of maximum overall grade of acute GVHD: | Open text | No Change | No Change | No Change | No | |
| POST058 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 0 | No Change | No Change | No Change | No | |
| POST059 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 1 | No Change | No Change | No Change | No | |
| POST060 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 2 | No Change | No Change | No Change | No | |
| POST061 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 3 | No Change | No Change | No Change | No | |
| POST062 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Skin | Stage 4 | No Change | No Change | No Change | No | |
| POST063 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 0 | No Change | No Change | No Change | No | |
| POST064 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 1 | No Change | No Change | No Change | No | |
| POST065 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 2 | No Change | No Change | No Change | No | |
| POST066 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 3 | No Change | No Change | No Change | No | |
| POST067 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Lower intestinal tract | Stage 4 | No Change | No Change | No Change | No | |
| POST068 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Upper intestinal tract | Stage 0 | No Change | No Change | No Change | No | |
| POST069 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Upper intestinal tract | Stage 1 | No Change | No Change | No Change | No | |
| POST070 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 0 | No Change | No Change | No Change | No | |
| POST071 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 1 | No Change | No Change | No Change | No | |
| POST072 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 2 | No Change | No Change | No Change | No | |
| POST073 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 3 | No Change | No Change | No Change | No | |
| POST074 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Liver | Stage 4 | No Change | No Change | No Change | No | |
| POST075 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Other site(s) involved with acute GVHD | Yes | No Change | No Change | No Change | No | |
| POST076 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Other site(s) involved with acute GVHD | No | No Change | No Change | No Change | No | |
| POST077 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Specify other site(s): | Open text | No Change | No Change | No Change | No | |
| POST078 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD develop? | Yes | No Change | No Change | No Change | No | |
| POST079 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD develop? | No | No Change | No Change | No Change | No | |
| POST080 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD develop? | Unknown | No Change | No Change | No Change | No | |
| POST081 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Date of chronic GVHD diagnosis: | Open text | No Change | No Change | No Change | No | |
| POST082 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD persist? | Yes | No Change | No Change | No Change | No | |
| POST083 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD persist? | No | No Change | No Change | No Change | No | |
| POST084 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Did chronic GVHD persist? | Unknown | No Change | No Change | No Change | No | |
| POST085 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum grade of chronic GVHD | Mild | Change/Clarification of Information Requested | Maximum overall grade of chronic GVHD | No Change | No | Capture data accurately | 
| POST086 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum grade of chronic GVHD | Moderate | Change/Clarification of Information Requested | Maximum overall grade of chronic GVHD | No Change | No | Capture data accurately | 
| POST087 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum grade of chronic GVHD | Severe | Change/Clarification of Information Requested | Maximum overall grade of chronic GVHD | No Change | No | Capture data accurately | 
| POST088 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Maximum grade of chronic GVHD | Unknown | Change/Clarification of Information Requested and Deletion of Response Option | Maximum overall grade of chronic GVHD | No | Capture data accurately | |
| POST089 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Date of maximum grade of chronic GVHD: | Open text | No Change | No Change | No Change | No | |
| POST090 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Specify if chronic GVHD was limited or extensive | Limited | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST091 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Specify if chronic GVHD was limited or extensive | Extensive | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST092 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking systemic steroids? | Yes | No Change | No Change | No Change | No | |
| POST093 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking systemic steroids? | No | No Change | No Change | No Change | No | |
| POST094 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking systemic steroids? | Not Applicable | No Change | No Change | No Change | No | |
| POST095 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking systemic steroids? | Unknown | No Change | No Change | No Change | No | |
| POST096 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking (non-steroid) immunosuppressive agents (including PUVA) for GVHD? | Yes | No Change | No Change | No Change | No | |
| POST097 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking (non-steroid) immunosuppressive agents (including PUVA) for GVHD? | No | No Change | No Change | No Change | No | |
| POST098 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking (non-steroid) immunosuppressive agents (including PUVA) for GVHD? | Not Applicable | No Change | No Change | No Change | No | |
| POST099 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Graft vs. Host Disease | No | Is the recipient still taking (non-steroid) immunosuppressive agents (including PUVA) for GVHD? | Unknown | No Change | No Change | No Change | No | |
| POST100 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Was specific therapy used to prevent liver toxicity? | Yes | No Change | No Change | No Change | No | |
| POST101 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Was specific therapy used to prevent liver toxicity? | No | No Change | No Change | No Change | No | |
| POST102 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Defibrotide | No Change | No Change | No Change | No | |
| POST103 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Enoxaparin | Change/Clarification of Information Requested | No Change | Low molecular weight heparin (Clexane, Enoxaparin, Lovenox) | No | Capture data accurately | 
| POST104 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Heparin | No Change | No Change | No Change | No | |
| POST105 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | N-acetylcysteine | No Change | No Change | No Change | No | |
| POST106 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Tissue plasminogen activator (TPA) | No Change | No Change | No Change | No | |
| POST107 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Ursodiol | No Change | No Change | No Change | No | |
| POST108 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Addition of Information Requested | No Change | Vitamin E | No | Capture data accurately | |
| POST109 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify therapy | Other | No Change | No Change | No Change | No | |
| POST110 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Liver Toxicity Prophylaxis | No | Specify other therapy: | Open text | No Change | No Change | No Change | No | |
| POST111 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Veno-Occlusive Disease (VOD) / Sinusoidal Obstruction Syndrome (SOS) | No | Did veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) develop? | Yes | No Change | No Change | No Change | No | |
| POST112 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Veno-Occlusive Disease (VOD) / Sinusoidal Obstruction Syndrome (SOS) | No | Did veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) develop? | No | No Change | No Change | No Change | No | |
| POST113 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Veno-Occlusive Disease (VOD) / Sinusoidal Obstruction Syndrome (SOS) | No | Date of diagnosis: | Open text | No Change | No Change | No Change | No | |
| POST114 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Did the recipient develop COVID-19 (SARS-CoV-2)? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST115 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Did the recipient develop COVID-19 (SARS-CoV-2)? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST116 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Date of diagnosis: | Deletion of Information Requested | No | Reduce burden - information no longer needed | |||
| POST117 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Was a vaccine for COVID-19 (SARS-CoV-2) received? | Yes | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST118 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Was a vaccine for COVID-19 (SARS-CoV-2) received? | No | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST119 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Was a vaccine for COVID-19 (SARS-CoV-2) received? | Unknown | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST120 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | AstraZeneca | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST121 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | Johnson & Johnson | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST122 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | Moderna | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST123 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | Novavax | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST124 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | Pfizer-BioNTECH | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST125 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify vaccine brand | Other type | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST126 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Specify other type: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST127 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Select dose(s) received | One dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST128 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Select dose(s) received | First dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST129 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Select dose(s) received | Second dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST130 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Select dose(s) received | Third dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST131 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Select dose(s) received | Booster dose | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST132 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Date received: | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST133 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Infection | Yes | Date estimated | checked | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST134 | Post-Transplant Periodic Information | Post-Transplant Essential Data | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Did a new malignancy, myelodysplastic, myeloproliferative, or lymphoproliferative disease / disorder occur that is different from the disease / disorder for which the infusion was performed? | Yes | No Change | No Change | No Change | No | |
| POST135 | Post-Transplant Periodic Information | Post-Transplant Essential Data | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Did a new malignancy, myelodysplastic, myeloproliferative, or lymphoproliferative disease / disorder occur that is different from the disease / disorder for which the infusion was performed? | No | No Change | No Change | No Change | No | |
| POST136 | Post-Transplant Periodic Information | Post-Transplant Essential Data | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Did a new malignancy, myelodysplastic, myeloproliferative, or lymphoproliferative disease / disorder occur that is different from the disease / disorder for which the infusion was performed? | Previously reported | No Change | No Change | No Change | No | |
| POST137 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Were chimerism studies performed? | yes | No Change | No Change | No Change | No | |
| POST138 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Were chimerism studies performed? | no | No Change | No Change | No Change | No | |
| POST139 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the chimerism laboratory report. | Reduce burden | ||
| POST140 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the chimerism laboratory report. | Reduce burden | ||
| POST141 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Were chimerism studies assessed for more than one donor / multiple donors? | Yes | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST142 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | No | Were chimerism studies assessed for more than one donor / multiple donors? | No | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST143 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Global Registration Identifier for Donors (GRID) | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST144 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | NMDP cord blood unit ID: | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST145 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Registry donor ID: | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST146 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Non-NMDP cord blood unit ID: | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST147 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Donor date of birth: | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST148 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Donor age: | Open text | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST149 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Months | checked | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST150 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | years | checked | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST151 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Donor sex | male | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST152 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Donor sex | female | Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST153 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Date sample collected: | Open text | No Change | No Change | No Change | No | |
| POST154 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | Karyotyping for XX/XY | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST155 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | Fluorescent in situ hybridization (FISH) for XX/XY | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST156 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | Restriction fragment-length polymorphisms (RFLP) | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST157 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | VNTR or STR, micro or mini satellite | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST158 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | Single nucleotide polymorphisms (SNPs) | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST159 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Method | Other | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST160 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Specify: | Deletion of Information Requested | No | Reduce burden - information no longer needed | |||
| POST161 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell source | Bone marrow | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST162 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell source | Peripheral blood | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST163 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Unsorted / whole | Change/Clarification of Information Requested and Deletion of Response Option | Cells tested | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST164 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Red blood cells | Change/Clarification of Information Requested | Cells tested | Red cells | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST165 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Hematopoietic progenitor cells | Change/Clarification of Information Requested and Deletion of Response Option | Cells tested | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST166 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Total mononuclear cells | Change/Clarification of Information Requested and Deletion of Response Option | Cells tested | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST167 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | T-cells | Change/Clarification of Information Requested | Cells tested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST168 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | B-cells | Change/Clarification of Information Requested and Deletion of Response Option | Cells tested | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST169 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Granulocytes | Change/Clarification of Information Requested and Deletion of Response Option | Cells tested | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST170 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | NK cells | Change/Clarification of Information Requested | Cells tested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST171 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Addition of Information Requested | Cells tested | Unsorted bone marrow | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST172 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Addition of Information Requested | Cells tested | Unsorted peripheral blood | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST173 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Cell type | Other | Change/Clarification of Information Requested | Cells tested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST174 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Specify: | Open text | No Change | No Change | No Change | No | |
| POST175 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Total cells examined | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST176 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Number of donor cells | Open text | Deletion of Information Requested | No | Reduce burden - information no longer needed | ||
| POST177 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Percent donor cells | Open text | Merged from Multiple to Grid (Deletion of Information Requested) | No | Reduce burden - prevent / reduce data redundancy | ||
| POST178 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | Donor Identifier | Auto-filled field | No | Capture data accurately | ||
| POST179 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | Unsorted bone marrow percent donor cells | Open text | No | Capture data accurately | ||
| POST180 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | Unsorted peripheral blood percent donor cells | Open text | No | Capture data accurately | ||
| POST181 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | T-cells percent donor cells | Open text | No | Capture data accurately | ||
| POST182 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | NK cells percent donor cells | Open text | No | Capture data accurately | ||
| POST183 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | Red cells percent donor cells | Open text | No | Capture data accurately | ||
| POST184 | Post-Transplant Periodic Information | Chimerism Essential Data | Chimerism Studies (Cord Blood Units and Non-Malignant Diseases) | Yes | Merged from Multiple to Grid (Addition of Information Requested) | Other cells percent donor cells | Open text | No | Capture data accurately | ||
| POST185 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Compared to the disease status prior to the preparative regimen, what was the best response to infusion? | Continued complete remission (CCR) | No Change | No Change | No Change | No | |
| POST186 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Compared to the disease status prior to the preparative regimen, what was the best response to infusion? | Complete remission (CR) | No Change | No Change | No Change | No | |
| POST187 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Compared to the disease status prior to the preparative regimen, what was the best response to infusion? | Not in complete remission | No Change | No Change | No Change | No | |
| POST188 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Compared to the disease status prior to the preparative regimen, what was the best response to infusion? | Not evaluated | No Change | No Change | No Change | No | |
| POST189 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Specify disease status if not in complete remission | Disease detected | No Change | No Change | No Change | No | |
| POST190 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Specify disease status if not in complete remission | No disease detected but incomplete evaluation to establish CR | No Change | No Change | No Change | No | |
| POST191 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the date of best response previously reported? | yes | No Change | No Change | No Change | No | |
| POST192 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the date of best response previously reported? | no | No Change | No Change | No Change | No | |
| POST193 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | Change/Clarification of Information Requested | Date of best response: | No Change | No | Capture data accurately | 
| POST194 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by molecular testing? | Yes | Change/Clarification of Information Requested | Was the disease status assessed via molecular markers? | No Change | No | Capture data accurately | 
| POST195 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by molecular testing? | No | Change/Clarification of Information Requested | Was the disease status assessed via molecular markers? | No Change | No | Capture data accurately | 
| POST196 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by molecular testing? | Not Applicable | Change/Clarification of Information Requested and Deletion of Response Option | Was the disease status assessed via molecular markers? | No | Capture data accurately | |
| POST197 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST198 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST199 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST200 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Addition of Information Requested | Was the disease status assessed via ClonoSEQ? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST201 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Addition of Information Requested | Was the disease status assessed via ClonoSEQ? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST202 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Addition of Information Requested | Date assessed: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST203 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Addition of Information Requested | Was disease detected? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST204 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Addition of Information Requested | Was disease detected? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST205 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via flow cytometry? | Yes | No Change | No Change | No Change | No | |
| POST206 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via flow cytometry? | No | No Change | No Change | No Change | No | |
| POST207 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via flow cytometry? | Not Applicable | Deletion of Information Requested | No Change | No | Capture data accurately | |
| POST208 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST209 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST210 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST211 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by cytogenetic testing? | Yes | Change/Clarification of Information Requested | Was the disease status assessed via cytogenetic testing? | No Change | No | Capture data accurately | 
| POST212 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by cytogenetic testing? | No | Change/Clarification of Information Requested | Was the disease status assessed via cytogenetic testing? | No Change | No | Capture data accurately | 
| POST213 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by cytogenetic testing? | Not Applicable | Change/Clarification of Information Requested and Deletion of Response Option | Was the disease status assessed via cytogenetic testing? | No | Capture data accurately | |
| POST214 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via FISH? | Yes | No Change | No Change | No Change | No | |
| POST215 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via FISH? | No | No Change | No Change | No Change | No | |
| POST216 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via FISH? | Not Applicable | Deletion of Information Requested | No Change | No | Capture data accurately | |
| POST217 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST218 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST219 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST220 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via karyotyping? | Yes | No Change | No Change | No Change | No | |
| POST221 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via karyotyping? | No | No Change | No Change | No Change | No | |
| POST222 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed via karyotyping? | Not Applicable | Deletion of Information Requested | No Change | No | Capture data accurately | |
| POST223 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST224 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST225 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST226 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by radiological assessment? | Yes | Change/Clarification of Information Requested | Was the disease status assessed via radiological assessment? | No Change | No | Capture data accurately | 
| POST227 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by radiological assessment? | No | Change/Clarification of Information Requested | Was the disease status assessed via radiological assessment? | No Change | No | Capture data accurately | 
| POST228 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by radiological assessment? | Not Applicable | Change/Clarification of Information Requested and Deletion of Response Option | Was the disease status assessed via radiological assessment? | No | Capture data accurately | |
| POST229 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST230 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST231 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST232 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by clinical / hematologic assessment? | yes | Change/Clarification of Information Requested | Was the disease status assessed via clinical / hematologic assessment? | No Change | No | Capture data accurately | 
| POST233 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was the disease status assessed by clinical / hematologic assessment? | no | Change/Clarification of Information Requested | Was the disease status assessed via clinical / hematologic assessment? | No Change | No | Capture data accurately | 
| POST234 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Date assessed: | Open text | No Change | No Change | No Change | No | |
| POST235 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | yes | No Change | No Change | No Change | No | |
| POST236 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Disease Assessment at the Time of Best Response to Infusion | No | Was disease detected? | no | No Change | No Change | No Change | No | |
| POST237 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Did the recipient experience a clinical / hematologic relapse or progression post-HCT? | Yes | Change/Clarification of Information Requested | Did the recipient experience a relapse or progression by any method(s) of assessment post-infusion? | No Change | No | Capture data accurately | 
| POST238 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Did the recipient experience a clinical / hematologic relapse or progression post-HCT? | No | Change/Clarification of Information Requested | Did the recipient experience a relapse or progression by any method(s) of assessment post-infusion? | No Change | No | Capture data accurately | 
| POST239 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Did the recipient experience a clinical / hematologic relapse or progression post-HCT? | Change/Clarification of Information Requested and Addition of Response Option | No Change | Previously reported | No | Capture data accurately | |
| POST240 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Was the date of the first clinical / hematologic relapse or progression previously reported? | Yes | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| POST241 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Was the date of the first clinical / hematologic relapse or progression previously reported? | No | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| POST242 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Date first seen: | Open text | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| POST243 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | Specify the method(s) used to detect relapse or progression | Molecular | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST244 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | Specify the method(s) used to detect relapse or progression | Flow cytometry | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST245 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | Specify the method(s) used to detect relapse or progression | Cytogenetic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST246 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | Specify the method(s) used to detect relapse or progression | Radiological | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST247 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | Specify the method(s) used to detect relapse or progression | Clinical / hematologic | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST248 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | First date relapse or progression detected by molecular methods: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST249 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | First date relapse or progression detected by cytogenetic methods: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST250 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | First date relapse or progression detected by flow cytometry: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST251 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | First date relapse or progression detected by radiological methods: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST252 | Post-Transplant Periodic Information | Post-Transplant Essential Data | First Relapse or Progression Post-Infusion | No | Addition of Information Requested | First date relapse or progression detected by clinical / hematological methods: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST253 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Recurrence of Non- Malignant Disease | No | Addition of Information Requested | Was there recurrence of the primary non-malignant disease post-infusion? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST254 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Recurrence of Non- Malignant Disease | No | Addition of Information Requested | Was there recurrence of the primary non-malignant disease post-infusion? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST255 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Recurrence of Non- Malignant Disease | No | Addition of Information Requested | Was the date of recurrence previously reported? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST256 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Recurrence of Non- Malignant Disease | No | Addition of Information Requested | Was the date of recurrence previously reported? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST257 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Recurrence of Non- Malignant Disease | No | Addition of Information Requested | Date of first recurrence: | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST258 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Was intervention given for relapsed, persistent or progressive disease? | Yes | Change/Clarification of Information Requested | Was intervention given for decreased / loss of chimerism, measurable residual disease, persistent disease, or progressive / relapsed disease? | No Change | No | Capture data accurately | 
| POST259 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Was intervention given for relapsed, persistent or progressive disease? | No | Change/Clarification of Information Requested | Was intervention given for decreased / loss of chimerism, measurable residual disease, persistent disease, or progressive / relapsed disease? | No Change | No | Capture data accurately | 
| POST260 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify reason for which intervention was given | Addition of Information Requested | No Change | Decreased / loss of chimerism | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST261 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify reason for which intervention was given | Addition of Information Requested | No Change | Measurable residual disease | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST262 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify reason for which intervention was given | Persistent disease | No Change | No Change | No Change | No | |
| POST263 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify reason for which intervention was given | Relapsed / progressive disease | Change/Clarification of Information Requested | No Change | Progressive disease | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST264 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify reason for which intervention was given | Addition of Information Requested | No Change | Relapsed disease | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST265 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify the method(s) of detection for which intervention was given | Disease specific molecular marker | Change/Clarification of Information Requested | No Change | Molecular | No | Capture data accurately | 
| POST266 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify the method(s) of detection for which intervention was given | Flow Cytometry | No Change | No Change | No Change | No | |
| POST267 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify the method(s) of detection for which intervention was given | Cytogenetic | No Change | No Change | No Change | No | |
| POST268 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify the method(s) of detection for which intervention was given | Radiological | No Change | No Change | No Change | No | |
| POST269 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify the method(s) of detection for which intervention was given | Clinical / hematologic | No Change | No Change | No Change | No | |
| POST270 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Date intervention started: | Open text | No Change | No Change | No Change | No | |
| POST271 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Change/Clarification of Information Requested and Addition of Response Option | Specify intervention | Accelerated withdrawal of immunosuppression in response to disease assessment | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST272 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Blinded randomized trial | Change/Clarification of Information Requested | Specify intervention | No Change | No | Capture data accurately | 
| POST273 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Cellular therapy | Change/Clarification of Information Requested and Deletion of Response Option | Specify intervention | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST274 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Change/Clarification of Information Requested and Addition of Response Option | Specify intervention | Intrathecal therapy | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST275 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Radiation | Change/Clarification of Information Requested | Specify intervention | No Change | No | Capture data accurately | 
| POST276 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Systemic therapy | Change/Clarification of Information Requested | Specify intervention | No Change | No | Capture data accurately | 
| POST277 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify therapy | Other therapy | Change/Clarification of Information Requested | Specify intervention | Other intervention | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST278 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Alemtuzumab (Campath) | No Change | No Change | No Change | No | |
| POST279 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Azacytidine (Vidaza) | No Change | No Change | No Change | No | |
| POST280 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Blinatumomab (Blincyto) | No Change | No Change | No Change | No | |
| POST281 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Bortezomib (Velcade) | No Change | No Change | No Change | No | |
| POST282 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Bosutinib (Bosulif) | No Change | No Change | No Change | No | |
| POST283 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Carfilzomib (Kyprolis) | No Change | No Change | No Change | No | |
| POST284 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Chemotherapy | No Change | No Change | No Change | No | |
| POST285 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Daratumumab (Darzalex) | No Change | No Change | No Change | No | |
| POST286 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Dasatinib (Sprycel) | No Change | No Change | No Change | No | |
| POST287 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Decitabine (Dacogen) | No Change | No Change | No Change | No | |
| POST288 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Gemtuzumab (Mylotarg, anti-CD33) | No Change | No Change | No Change | No | |
| POST289 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Gilteritinib (Xospata) | No Change | No Change | No Change | No | |
| POST290 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Ibrutinib (Imbruvica) | No Change | No Change | No Change | No | |
| POST291 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Imatinib mesylate (Gleevec) | No Change | No Change | No Change | No | |
| POST292 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Ixazomib (Ninlaro) | No Change | No Change | No Change | No | |
| POST293 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Lenalidomide (Revlimid) | No Change | No Change | No Change | No | |
| POST294 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Lestaurtinib | No Change | No Change | No Change | No | |
| POST295 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Midostaurin (Rydapt) | No Change | No Change | No Change | No | |
| POST296 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Nilotinib (AMN107, Tasigna) | No Change | No Change | No Change | No | |
| POST297 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Nivolumab (Opdivo) | No Change | No Change | No Change | No | |
| POST298 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Pembrolizumab (Keytruda) | No Change | No Change | No Change | No | |
| POST299 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Pomalidomide (Pomalyst) | No Change | No Change | No Change | No | |
| POST300 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Quizartinib (Vanflyta) | No Change | No Change | No Change | No | |
| POST301 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Rituximab (Rituxan, MabThera) | No Change | No Change | No Change | No | |
| POST302 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Sorafenib (Nexavar) | No Change | No Change | No Change | No | |
| POST303 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Sunitinib (Sutent) | No Change | No Change | No Change | No | |
| POST304 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Thalidomide (Thalomid) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST305 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Venetoclax (Venclexta, Venclyxto) | No Change | No Change | No Change | No | |
| POST306 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify systemic therapy | Other systemic therapy | No Change | No Change | No Change | No | |
| POST307 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify other systemic therapy: | Open text | No Change | No Change | No Change | No | |
| POST308 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Intervention for Disease | No | Specify other intervention: | Open text | No Change | No Change | No Change | No | |
| POST309 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Was therapy given for reasons other than relapsed, persistent, or progressive disease ? | yes | Change/Clarification of Information Requested | Was therapy given to prevent relapse or progressive disease? | No Change | No | Capture data accurately | 
| POST310 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Was therapy given for reasons other than relapsed, persistent, or progressive disease ? | no | Change/Clarification of Information Requested | Was therapy given to prevent relapse or progressive disease? | No Change | No | Capture data accurately | 
| POST311 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Blinded randomized trial | No Change | No Change | No Change | No | |
| POST312 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Cellular therapy | Deletion of Information Requested | No Change | No | Reduce burden - prevent / reduce data redundancy | |
| POST313 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Addition of Information Requested | No Change | Intrathecal therapy | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST314 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Radiation | No Change | No Change | No Change | No | |
| POST315 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Systemic therapy | No Change | No Change | No Change | No | |
| POST316 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify therapy | Other therapy | No Change | No Change | No Change | No | |
| POST317 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Alemtuzumab (Campath) | No Change | No Change | No Change | No | |
| POST318 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Azacytidine (Vidaza) | No Change | No Change | No Change | No | |
| POST319 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Blinatumomab (Blincyto) | No Change | No Change | No Change | No | |
| POST320 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Bortezomib (Velcade) | No Change | No Change | No Change | No | |
| POST321 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Bosutinib (Bosulif) | No Change | No Change | No Change | No | |
| POST322 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Brentuximab vedotin (Adcetris) | No Change | No Change | No Change | No | |
| POST323 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Carfilzomib (Kyprolis) | No Change | No Change | No Change | No | |
| POST324 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Daratumumab (Darzalex) | No Change | No Change | No Change | No | |
| POST325 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Dasatinib (Sprycel) | No Change | No Change | No Change | No | |
| POST326 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Decitabine (Dacogen) | No Change | No Change | No Change | No | |
| POST327 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Addition of Information Requested | No Change | Dinutuximab | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST328 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Gemtuzumab (Mylotarg, anti-CD33) | No Change | No Change | No Change | No | |
| POST329 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Gilteritinib (Xospata) | No Change | No Change | No Change | No | |
| POST330 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Ibrutinib (Imbruvica) | No Change | No Change | No Change | No | |
| POST331 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Imatinib mesylate (Gleevec) | No Change | No Change | No Change | No | |
| POST332 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Addition of Information Requested | No Change | Isotretinoin | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST333 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Ixazomib (Ninlaro) | No Change | No Change | No Change | No | |
| POST334 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Lenalidomide (Revlimid) | No Change | No Change | No Change | No | |
| POST335 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Lestaurtinib | No Change | No Change | No Change | No | |
| POST336 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Midostaurin (Rydapt) | No Change | No Change | No Change | No | |
| POST337 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Nilotinib (AMN107, Tasigna) | No Change | No Change | No Change | No | |
| POST338 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Nivolumab (Opdivo) | No Change | No Change | No Change | No | |
| POST339 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Pembrolizumab (Keytruda) | No Change | No Change | No Change | No | |
| POST340 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Pomalidomide (Pomalyst) | No Change | No Change | No Change | No | |
| POST341 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Quizartinib (Vanflyta) | No Change | No Change | No Change | No | |
| POST342 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Rituximab (Rituxan, MabThera) | No Change | No Change | No Change | No | |
| POST343 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Sorafenib (Nexavar) | No Change | No Change | No Change | No | |
| POST344 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Sunitinib (Sutent) | No Change | No Change | No Change | No | |
| POST345 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Thalidomide (Thalomid) | Deletion of Information Requested | No Change | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST346 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify systemic therapy given | Other systemic therapy | No Change | No Change | No Change | No | |
| POST347 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify other systemic therapy: | Open text | No Change | No Change | No Change | No | |
| POST348 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Specify other therapy: | Open text | No Change | No Change | No Change | No | |
| POST349 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Addition of Information Requested | Was the initial therapy date previously reported? | Yes | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST350 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Addition of Information Requested | Was the initial therapy date previously reported? | No | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST351 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Post-Infusion Treatment Given to Prevent Relapse or Progression | No | Addition of Information Requested | Start date of therapy | Open text | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST352 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Did a fecal microbiota transplant (FMT) occur? | Yes | No Change | No Change | No Change | No | |
| POST353 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Did a fecal microbiota transplant (FMT) occur? | No | No Change | No Change | No Change | No | |
| POST354 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Date of FMT: | Open text | No Change | No Change | No Change | No | |
| POST355 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Specify the indication for the FMT | Graft versus host disease (GVHD) | No Change | No Change | No Change | No | |
| POST356 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Specify the indication for the FMT | Clostridium difficile | No Change | No Change | No Change | No | |
| POST357 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Specify the indication for the FMT | Other | No Change | No Change | No Change | No | |
| POST358 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Fecal microbiota transplant (FMT) | No | Specify other indication: | Open text | No Change | No Change | No Change | No | |
| POST359 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | What is the current disease status? | Complete remission (CR) | No Change | No Change | No Change | No | |
| POST360 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | What is the current disease status? | Not in complete remission | No Change | No Change | No Change | No | |
| POST361 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | What is the current disease status? | Not evaluated | No Change | No Change | No Change | No | |
| POST362 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | Specify disease status if not in complete remission | Disease detected | No Change | No Change | No Change | No | |
| POST363 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | Specify disease status if not in complete remission | No disease detected but incomplete evaluation to establish CR | No Change | No Change | No Change | No | |
| POST364 | Post-Transplant Periodic Information | Post-Transplant Essential Data | Current Disease Status | No | Date of assessment of current disease status: | Open text | No Change | No Change | No Change | No | |
| POST365 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Date of death: | Open text | No Change | No Change | No Change | No | |
| POST366 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Date estimated | checked | No Change | No Change | No Change | No | |
| POST367 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was cause of death confirmed by autopsy? | Yes | No Change | No Change | No Change | No | |
| POST368 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was cause of death confirmed by autopsy? | Autopsy pending | No Change | No Change | No Change | No | |
| POST369 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was cause of death confirmed by autopsy? | No | No Change | No Change | No Change | No | |
| POST370 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was cause of death confirmed by autopsy? | Unknown | No Change | No Change | No Change | No | |
| POST371 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the autopsy report. | Reduce burden | ||
| POST372 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching the autopsy report. | Reduce burden | ||
| POST373 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Recurrence / persistence / progression of disease for which the infusion was performed | No Change | No Change | No Change | No | |
| POST374 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Acute GVHD | No Change | No Change | No Change | No | |
| POST375 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Chronic GVHD | No Change | No Change | No Change | No | |
| POST376 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Graft rejection or failure | Change/Clarification of Information Requested | No Change | Graft failure or poor graft function | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST377 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Cytokine release syndrome | No Change | No Change | No Change | No | |
| POST378 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Diffuse alveolar hemorrhage (DAH) | No Change | No Change | No Change | No | |
| POST379 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Gastrointestinal hemorrhage | No Change | No Change | No Change | No | |
| POST380 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Hemorrhagic cystitis | No Change | No Change | No Change | No | |
| POST381 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Intracranial hemorrhage | No Change | No Change | No Change | No | |
| POST382 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Pulmonary hemorrhage | No Change | No Change | No Change | No | |
| POST383 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other hemorrhage | No Change | No Change | No Change | No | |
| POST384 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Bacterial infection | No Change | No Change | No Change | No | |
| POST385 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | COVID-19 (SARS-CoV-2) | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| POST386 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Fungal infection | No Change | No Change | No Change | No | |
| POST387 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Infection, organism not identified | No Change | No Change | No Change | No | |
| POST388 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Protozoal infection | No Change | No Change | No Change | No | |
| POST389 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Viral infection | No Change | No Change | No Change | No | |
| POST390 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other infection | No Change | No Change | No Change | No | |
| POST391 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | New malignancy (post-infusion) | No Change | No Change | No Change | No | |
| POST392 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Prior malignancy (malignancy initially diagnosed prior to infusion, other than the malignancy for which the infusion was performed | No Change | No Change | No Change | No | |
| POST393 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Cardiac failure | No Change | No Change | No Change | No | |
| POST394 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Central nervous system (CNS) failure | No Change | No Change | No Change | No | |
| POST395 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Gastrointestinal (GI) failure (not liver) | No Change | No Change | No Change | No | |
| POST396 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Liver failure (not VOD) | No Change | No Change | No Change | No | |
| POST397 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Multiple organ failure | No Change | No Change | No Change | No | |
| POST398 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Pulmonary failure | No Change | No Change | No Change | No | |
| POST399 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Renal failure | No Change | No Change | No Change | No | |
| POST400 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) | No Change | No Change | No Change | No | |
| POST401 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other organ failure | No Change | No Change | No Change | No | |
| POST402 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Adult respiratory distress syndrome (ARDS) (other than IPS) | No Change | No Change | No Change | No | |
| POST403 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Diffuse alveolar damage (without hemorrhage) | No Change | No Change | No Change | No | |
| POST404 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Idiopathic pneumonia syndrome (IPS) | No Change | No Change | No Change | No | |
| POST405 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Pneumonitis due to Cytomegalovirus (CMV) | No Change | No Change | No Change | No | |
| POST406 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Pneumonitis due to other virus | No Change | No Change | No Change | No | |
| POST407 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other pulmonary syndrome | No Change | No Change | No Change | No | |
| POST408 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Addition of Information Requested | No Change | Macrophage activation syndrome (MAS) / hemophagocytic lymphohistiocytosis-like toxicities (HLH) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST409 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Neurotoxicity (ICANS) | No Change | No Change | No Change | No | |
| POST410 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Tumor lysis syndrome | No Change | No Change | No Change | No | |
| POST411 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Disseminated intravascular coagulation (DIC) | No Change | No Change | No Change | No | |
| POST412 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Addition of Information Requested | No Change | Ischemic stroke | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST413 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Thromboembolism | No Change | No Change | No Change | No | |
| POST414 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Thrombotic microangiopathy (TMA) (Thrombotic thrombocytopenic purpura (TTP) / Hemolytic Uremic Syndrome (HUS)) | No Change | No Change | No Change | No | |
| POST415 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other vascular | No Change | No Change | No Change | No | |
| POST416 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Accidental death | No Change | No Change | No Change | No | |
| POST417 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Suicide | No Change | No Change | No Change | No | |
| POST418 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Addition of Information Requested | No Change | Stroke, unspecified | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST419 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Primary cause of death | Other cause | No Change | No Change | No Change | No | |
| POST420 | Post-Transplant Periodic Information | Recipient Death Data | Recipient Death | No | Specify: | Open text | No Change | No Change | No Change | No | |
| POST421 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Recurrence / persistence / progression of disease for which the infusion was performed | No Change | No Change | No Change | No | |
| POST422 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Acute GVHD | No Change | No Change | No Change | No | |
| POST423 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Chronic GVHD | No Change | No Change | No Change | No | |
| POST424 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Graft rejection or failure | Change/Clarification of Information Requested | No Change | Graft failure or poor graft function | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST425 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Cytokine release syndrome | No Change | No Change | No Change | No | |
| POST426 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Addition of Information Requested | No Change | Failure to thrive | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST427 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Diffuse alveolar hemorrhage (DAH) | No Change | No Change | No Change | No | |
| POST428 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Gastrointestinal hemorrhage | No Change | No Change | No Change | No | |
| POST429 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Hemorrhagic cystitis | No Change | No Change | No Change | No | |
| POST430 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Intracranial hemorrhage | No Change | No Change | No Change | No | |
| POST431 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Pulmonary hemorrhage | No Change | No Change | No Change | No | |
| POST432 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other hemorrhage | No Change | No Change | No Change | No | |
| POST433 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Bacterial infection | No Change | No Change | No Change | No | |
| POST434 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | COVID-19 (SARS-CoV-2) | Deletion of Information Requested | No Change | No | Reduce burden - information no longer needed | |
| POST435 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Fungal infection | No Change | No Change | No Change | No | |
| POST436 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Infection, organism not identified | No Change | No Change | No Change | No | |
| POST437 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Protozoal infection | No Change | No Change | No Change | No | |
| POST438 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Viral infection | No Change | No Change | No Change | No | |
| POST439 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other infection | No Change | No Change | No Change | No | |
| POST440 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | New malignancy (post-infusion) | No Change | No Change | No Change | No | |
| POST441 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Prior malignancy (malignancy initially diagnosed prior to infusion, other than the malignancy for which the infusion was performed | No Change | No Change | No Change | No | |
| POST442 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Cardiac failure | No Change | No Change | No Change | No | |
| POST443 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Central nervous system (CNS) failure | No Change | No Change | No Change | No | |
| POST444 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Gastrointestinal (GI) failure (not liver) | No Change | No Change | No Change | No | |
| POST445 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Liver failure (not VOD) | No Change | No Change | No Change | No | |
| POST446 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Multiple organ failure | No Change | No Change | No Change | No | |
| POST447 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Pulmonary failure | No Change | No Change | No Change | No | |
| POST448 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Renal failure | No Change | No Change | No Change | No | |
| POST449 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) | No Change | No Change | No Change | No | |
| POST450 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other organ failure | No Change | No Change | No Change | No | |
| POST451 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Acute respiratory distress syndrome (ARDS) (other than IPS) | No Change | No Change | No Change | No | |
| POST452 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Diffuse alveolar damage (without hemorrhage) | No Change | No Change | No Change | No | |
| POST453 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Idiopathic pneumonia syndrome (IPS) | No Change | No Change | No Change | No | |
| POST454 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Pneumonitis due to Cytomegalovirus (CMV) | No Change | No Change | No Change | No | |
| POST455 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Pneumonitis due to other virus | No Change | No Change | No Change | No | |
| POST456 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other pulmonary syndrome (excluding pulmonary hemorrhage) | No Change | No Change | No Change | No | |
| POST457 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Addition of Information Requested | No Change | Macrophage activation syndrome (MAS) / hemophagocytic lymphohistiocytosis-like toxicities (HLH) | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST458 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Neurotoxicity (ICANS) | No Change | No Change | No Change | No | |
| POST459 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Tumor lysis syndrome | No Change | No Change | No Change | No | |
| POST460 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Disseminated intravascular coagulation (DIC) | No Change | No Change | No Change | No | |
| POST461 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Addition of Information Requested | No Change | Ischemic stroke | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST462 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Thromboembolism | No Change | No Change | No Change | No | |
| POST463 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Thrombotic microangiopathy (TMA) (Thrombotic thrombocytopenic purpura (TTP) / Hemolytic Uremic Syndrome (HUS)) | No Change | No Change | No Change | No | |
| POST464 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other vascular | No Change | No Change | No Change | No | |
| POST465 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Accidental death | No Change | No Change | No Change | No | |
| POST466 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Suicide | No Change | No Change | No Change | No | |
| POST467 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Addition of Information Requested | No Change | Stroke, unspecified | No | Be consistent with current clinical landscape, improve transplant outcome data | |
| POST468 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Contributing cause of death | Other cause | No Change | No Change | No Change | No | |
| POST469 | Post-Transplant Periodic Information | Recipient Death Data | Contributing Cause of Death | No | Specify: | Open text | No Change | No Change | No Change | No | |
| POST470 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Acute myeloid leukemia (AML / ANLL) | Change/Clarification of Information Requested | No Change | Acute myelogenous leukemia (AML) | No | Be consistent with current clinical landscape, improve transplant outcome data | 
| POST471 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Acute lymphoblastic leukemia (ALL) | No Change | No Change | No Change | No | |
| POST472 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Other leukemia | No Change | No Change | No Change | No | |
| POST473 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Myelodysplastic syndrome (MDS) | No Change | No Change | No Change | No | |
| POST474 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Myeloproliferative neoplasm (MPN) | No Change | No Change | No Change | No | |
| POST475 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Overlapping myelodysplasia / myeloproliferative neoplasm (MDS / MPN) | No Change | No Change | No Change | No | |
| POST476 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Hodgkin lymphoma | No Change | No Change | No Change | No | |
| POST477 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Non-Hodgkin lymphoma | No Change | No Change | No Change | No | |
| POST478 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Multiple myeloma / plasma cell neoplasms | No Change | No Change | No Change | No | |
| POST479 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Clonal cytogenetic abnormality without leukemia or MDS | No Change | No Change | No Change | No | |
| POST480 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Uncontrolled proliferation of donor cells without malignant transformation | No Change | No Change | No Change | No | |
| POST481 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Bone sarcoma | No Change | No Change | No Change | No | |
| POST482 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Soft tissue sarcoma | No Change | No Change | No Change | No | |
| POST483 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Oropharyngeal cancer | No Change | No Change | No Change | No | |
| POST484 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Gastrointestinal malignancy | No Change | No Change | No Change | No | |
| POST485 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Lung cancer | No Change | No Change | No Change | No | |
| POST486 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Melanoma | No Change | No Change | No Change | No | |
| POST487 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Squamous cell skin malignancy | No Change | No Change | No Change | No | |
| POST488 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Basal cell skin malignancy | No Change | No Change | No Change | No | |
| POST489 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Breast cancer | No Change | No Change | No Change | No | |
| POST490 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Genitourinary malignancy | No Change | No Change | No Change | No | |
| POST491 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Central nervous system (CNS) malignancy | No Change | No Change | No Change | No | |
| POST492 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Thyroid cancer | No Change | No Change | No Change | No | |
| POST493 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Addition of Information Requested | No Change | Post-transplant lymphoproliferative disorder (PTLD) | No | Capture data accurately | |
| POST494 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify the new malignancy | Other new malignancy | No Change | No Change | No Change | No | |
| POST495 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was post-transplant lymphoproliferative disorder (PTLD) diagnosed? | Yes | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| POST496 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was post-transplant lymphoproliferative disorder (PTLD) diagnosed? | No | Deletion of Information Requested | No | Reduce burden - prevent / reduce data redundancy | ||
| POST497 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify type of PTLD | Monomorphic | No Change | No Change | No Change | No | |
| POST498 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify type of PTLD | Polymorphic | No Change | No Change | No Change | No | |
| POST499 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify type of PTLD | Unknown | No Change | No Change | No Change | No | |
| POST500 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Addition of Information Requested | Specify type of leukemia / lymphoma | B-cell | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST501 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Addition of Information Requested | Specify type of leukemia / lymphoma | T-cell | No | Be consistent with current clinical landscape, improve transplant outcome data | ||
| POST502 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify oropharyngeal cancer | Tongue | No Change | No Change | No Change | No | |
| POST503 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify oropharyngeal cancer | Mouth | No Change | No Change | No Change | No | |
| POST504 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify oropharyngeal cancer | Throat | No Change | No Change | No Change | No | |
| POST505 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify oropharyngeal cancer | Other | No Change | No Change | No Change | No | |
| POST506 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Esophagus | No Change | No Change | No Change | No | |
| POST507 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Stomach | No Change | No Change | No Change | No | |
| POST508 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Small intestine | No Change | No Change | No Change | No | |
| POST509 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Colon | No Change | No Change | No Change | No | |
| POST510 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Rectum | No Change | No Change | No Change | No | |
| POST511 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Anus | No Change | No Change | No Change | No | |
| POST512 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Liver | No Change | No Change | No Change | No | |
| POST513 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Pancreas | No Change | No Change | No Change | No | |
| POST514 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify gastrointestinal malignancy | Other gastrointestinal malignancy | No Change | No Change | No Change | No | |
| POST515 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Addition of Information Requested | Number of non-melanoma skin cancer lesions | Open text | No | Reduce burden - reduce requirement for multiple sets of data | ||
| POST516 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Kidney | No Change | No Change | No Change | No | |
| POST517 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Bladder | No Change | No Change | No Change | No | |
| POST518 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Cervix | No Change | No Change | No Change | No | |
| POST519 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Uterus | No Change | No Change | No Change | No | |
| POST520 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Ovary | No Change | No Change | No Change | No | |
| POST521 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Prostate | No Change | No Change | No Change | No | |
| POST522 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Testis | No Change | No Change | No Change | No | |
| POST523 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify genitourinary malignancy | Other genitourinary malignancy | No Change | No Change | No Change | No | |
| POST524 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify CNS malignancy | Meningioma | No Change | No Change | No Change | No | |
| POST525 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify CNS malignancy | Glioma | No Change | No Change | No Change | No | |
| POST526 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify CNS malignancy | Other CNS malignancy | No Change | No Change | No Change | No | |
| POST527 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Specify other new malignancy: | Open text | No Change | No Change | No Change | No | |
| POST528 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Date of diagnosis: | Open text | No Change | No Change | No Change | No | |
| POST529 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. pathology report, autopsy report) | Reduce burden | ||
| POST530 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. pathology report, autopsy report) | Reduce burden | ||
| POST531 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was the new malignancy donor / cell product derived? | Yes | No Change | No Change | No Change | No | |
| POST532 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was the new malignancy donor / cell product derived? | No | No Change | No Change | No Change | No | |
| POST533 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was the new malignancy donor / cell product derived? | Not Done | No Change | No Change | No Change | No | |
| POST534 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. cell origin evaluation (VNTR, cytogenetics, FISH) | Reduce burden | ||
| POST535 | Post-Transplant Periodic Information | Subsequent Neoplasms | New Malignancy, Lymphoproliferative or Myeloproliferative Disease / Disorder | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. cell origin evaluation (VNTR, cytogenetics, FISH) | Reduce burden | ||
| POST536 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was PTLD confirmed by biopsy? | Yes | No Change | No Change | No Change | No | |
| POST537 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was PTLD confirmed by biopsy? | No | No Change | No Change | No Change | No | |
| POST538 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was the pathology of the tumor EBV positive? | yes | No Change | No Change | No Change | No | |
| POST539 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was the pathology of the tumor EBV positive? | no | No Change | No Change | No Change | No | |
| POST540 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was documentation submitted to the CIBMTR? | Yes | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. pathology report, autopsy report) | Reduce burden | ||
| POST541 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was documentation submitted to the CIBMTR? | No | Deletion of Information Requested | Yes: CIBMTR strongly encourages attaching documentation (e.g. pathology report, autopsy report) | Reduce burden | ||
| POST542 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was there EBV reactivation in the blood? | Yes | No Change | No Change | No Change | No | |
| POST543 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was there EBV reactivation in the blood? | No | No Change | No Change | No Change | No | |
| POST544 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was there EBV reactivation in the blood? | Not Done | No Change | No Change | No Change | No | |
| POST545 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | How was EBV reactivation diagnosed? | Qualitative PCR of blood | No Change | No Change | No Change | No | |
| POST546 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | How was EBV reactivation diagnosed? | Quantitative PCR of blood | No Change | No Change | No Change | No | |
| POST547 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | How was EBV reactivation diagnosed? | Other method | No Change | No Change | No Change | No | |
| POST548 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify other method: | Open text | No Change | No Change | No Change | No | |
| POST549 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Quantitative EBV viral load of blood: | Open text | No Change | No Change | No Change | No | |
| POST550 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was a quantitative PCR of blood performed again after diagnosis? | Yes | No Change | No Change | No Change | No | |
| POST551 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was a quantitative PCR of blood performed again after diagnosis? | No | No Change | No Change | No Change | No | |
| POST552 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Highest EBV viral load of blood: | Open text | No Change | No Change | No Change | No | |
| POST553 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was there lymphomatous involvement? | Yes | No Change | No Change | No Change | No | |
| POST554 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Was there lymphomatous involvement? | No | No Change | No Change | No Change | No | |
| POST555 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Bone marrow | No Change | No Change | No Change | No | |
| POST556 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Central nervous system | No Change | No Change | No Change | No | |
| POST557 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Liver | No Change | No Change | No Change | No | |
| POST558 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Lung | No Change | No Change | No Change | No | |
| POST559 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Lymph nodes | No Change | No Change | No Change | No | |
| POST560 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Spleen | No Change | No Change | No Change | No | |
| POST561 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify sites of PTLD involvement | Other site | No Change | No Change | No Change | No | |
| POST562 | Post-Transplant Periodic Information | Subsequent Neoplasms | Post-Transplant Lymphoproliferative Disorder | No | Specify other site: | Open text | No Change | No Change | No Change | No | |
| POST563 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Donor ID: | Drop down list of individual donors for the recipient | No | Reduce burden - allogeneic boost data capture | ||
| POST564 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Donor date of birth: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST565 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Donor age: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST566 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Months (use if less than 1 year old) | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST567 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Years | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST568 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Donor sex | Male | No | Reduce burden - allogeneic boost data capture | ||
| POST569 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Information | No | New Structure for Allogeneic Boost Data Capture | Donor sex | Female | No | Reduce burden - allogeneic boost data capture | ||
| POST570 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Date of this DCI: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST571 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | GVHD prophylaxis | No | Reduce burden - allogeneic boost data capture | ||
| POST572 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | GVHD treatment | No | Reduce burden - allogeneic boost data capture | ||
| POST573 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Immune reconstitution | No | Reduce burden - allogeneic boost data capture | ||
| POST574 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Infection treatment | No | Reduce burden - allogeneic boost data capture | ||
| POST575 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Insufficient hematopoietic recovery / Graft failure | No | Reduce burden - allogeneic boost data capture | ||
| POST576 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Prevent disease relapse | No | Reduce burden - allogeneic boost data capture | ||
| POST577 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Suboptimal donor chimerism | No | Reduce burden - allogeneic boost data capture | ||
| POST578 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Treatment of disease relapse/progression | No | Reduce burden - allogeneic boost data capture | ||
| POST579 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Treatment of MRD | No | Reduce burden - allogeneic boost data capture | ||
| POST580 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the primary indication? | Other indication | No | Reduce burden - allogeneic boost data capture | ||
| POST581 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify other indication: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST582 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Was therapy to treat disease given prior to the DCI? | Yes | No | Reduce burden - allogeneic boost data capture | ||
| POST583 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Was therapy to treat disease given prior to the DCI? | No | No | Reduce burden - allogeneic boost data capture | ||
| POST584 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Date complete blood count sample drawn: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST585 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | White blood cell (WBC) | No | Reduce burden - allogeneic boost data capture | ||
| POST586 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | Neutrophils | No | Reduce burden - allogeneic boost data capture | ||
| POST587 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | Lymphocytes | No | Reduce burden - allogeneic boost data capture | ||
| POST588 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | Hemoglobin (Hb) | No | Reduce burden - allogeneic boost data capture | ||
| POST589 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | Hematocrit | No | Reduce burden - allogeneic boost data capture | ||
| POST590 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Complete blood count (CBC) results available | Platelets | No | Reduce burden - allogeneic boost data capture | ||
| POST591 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | WBC: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST592 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | x 109/L (x 103/mm3) | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST593 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | x 106/L (x 1/mm3) (x 1/µL) (cells/µL) | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST594 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Neutrophils: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST595 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Lymphocytes: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST596 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Hemoglobin: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST597 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | g/dL | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST598 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | g/L | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST599 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | mmol/L | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST600 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Hematocrit: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST601 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Was RBC transfused < 30 days before the CBC was drawn? | Yes | No | Reduce burden - allogeneic boost data capture | ||
| POST602 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Was RBC transfused < 30 days before the CBC was drawn? | No | No | Reduce burden - allogeneic boost data capture | ||
| POST603 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Platelets: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST604 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | x 109/L (x 103/mm3) | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST605 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | x 106/L (x 1/mm3) (x 1/µL) (cells/µL) | checked | No | Reduce burden - allogeneic boost data capture | ||
| POST606 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Were platelets transfused < 7 days before the date the sample was drawn? | Yes | No | Reduce burden - allogeneic boost data capture | ||
| POST607 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Were platelets transfused < 7 days before the date the sample was drawn? | No | No | Reduce burden - allogeneic boost data capture | ||
| POST608 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What scale was used to determine the recipient’s functional status prior to the donor cellular infusion? | Karnofsky | No | Reduce burden - allogeneic boost data capture | ||
| POST609 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What scale was used to determine the recipient’s functional status prior to the donor cellular infusion? | Lansky | No | Reduce burden - allogeneic boost data capture | ||
| POST610 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 100 Normal; no complaints; no evidence of disease | No | Reduce burden - allogeneic boost data capture | ||
| POST611 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 90 Able to carry on normal activity | No | Reduce burden - allogeneic boost data capture | ||
| POST612 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 80 Normal activity with effort | No | Reduce burden - allogeneic boost data capture | ||
| POST613 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 70 Cares for self; unable to carry on normal activity or to do active work | No | Reduce burden - allogeneic boost data capture | ||
| POST614 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 60 Requires occasional assistance but is able to care for most needs | No | Reduce burden - allogeneic boost data capture | ||
| POST615 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 50 Requires considerable assistance and frequent medical care | No | Reduce burden - allogeneic boost data capture | ||
| POST616 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 40 Disabled; requires special care and assistance | No | Reduce burden - allogeneic boost data capture | ||
| POST617 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 30 Severely disabled; hospitalization indicated, although death not imminent | No | Reduce burden - allogeneic boost data capture | ||
| POST618 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 20 Very sick; hospitalization necessary | No | Reduce burden - allogeneic boost data capture | ||
| POST619 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Karnofsky Scale | 10 Moribund; fatal process progressing rapidly | No | Reduce burden - allogeneic boost data capture | ||
| POST620 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 100 Fully active | No | Reduce burden - allogeneic boost data capture | ||
| POST621 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 90 Minor restriction in physically strenuous play | No | Reduce burden - allogeneic boost data capture | ||
| POST622 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 80 Restricted in strenuous play, tires more easily, otherwise active | No | Reduce burden - allogeneic boost data capture | ||
| POST623 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 70 Both greater restrictions of, and less time spent in, active play | No | Reduce burden - allogeneic boost data capture | ||
| POST624 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 60 Ambulatory up to 50% of time, limited active play with assistance / supervision | No | Reduce burden - allogeneic boost data capture | ||
| POST625 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 50 Considerable assistance required for any active play; fully able to engage in quiet play | No | Reduce burden - allogeneic boost data capture | ||
| POST626 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 40 Able to initiate quiet activities | No | Reduce burden - allogeneic boost data capture | ||
| POST627 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 30 Needs considerable assistance for quiet activity | No | Reduce burden - allogeneic boost data capture | ||
| POST628 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 20 Limited to very passive activity initiated by others (e.g., TV) | No | Reduce burden - allogeneic boost data capture | ||
| POST629 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Lansky Scale | 10 Completely disabled, not even passive play | No | Reduce burden - allogeneic boost data capture | ||
| POST630 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Date of cell product collection | Known | No | Reduce burden - allogeneic boost data capture | ||
| POST631 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Date of cell product collection | Unknown | No | Reduce burden - allogeneic boost data capture | ||
| POST632 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Date of cell product collection: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST633 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Was the product previously cryopreserved? | Yes | No | Reduce burden - allogeneic boost data capture | ||
| POST634 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Was the product previously cryopreserved? | No | No | Reduce burden - allogeneic boost data capture | ||
| POST635 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Tissue source | Bone marrow | No | Reduce burden - allogeneic boost data capture | ||
| POST636 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Tissue source | Peripheral blood | No | Reduce burden - allogeneic boost data capture | ||
| POST637 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Tissue source | Other | No | Reduce burden - allogeneic boost data capture | ||
| POST638 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify other tissue source: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST639 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Were the cells in the infused product selected / modified / engineered / manipulated prior to infusion? | Yes | No | Reduce burden - allogeneic boost data capture | ||
| POST640 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Were the cells in the infused product selected / modified / engineered / manipulated prior to infusion? | No | No | Reduce burden - allogeneic boost data capture | ||
| POST641 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Cultured | No | Reduce burden - allogeneic boost data capture | ||
| POST642 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Induced cell differentiation | No | Reduce burden - allogeneic boost data capture | ||
| POST643 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Cell selection - positive | No | Reduce burden - allogeneic boost data capture | ||
| POST644 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Cell selection - negative | No | Reduce burden - allogeneic boost data capture | ||
| POST645 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Cell selection based on affinity to a specific antigen | No | Reduce burden - allogeneic boost data capture | ||
| POST646 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify the method(s) used to manipulate the product | Other cell manipulation | No | Reduce burden - allogeneic boost data capture | ||
| POST647 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Specify other cell manipulation: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST648 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | CD34+ cells | No | Reduce burden - allogeneic boost data capture | ||
| POST649 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | Lymphocytes (unselected) | No | Reduce burden - allogeneic boost data capture | ||
| POST650 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | CD4+ lymphocytes | No | Reduce burden - allogeneic boost data capture | ||
| POST651 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | CD8+ lymphocytes | No | Reduce burden - allogeneic boost data capture | ||
| POST652 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | Regulatory T-cells (TREG) | No | Reduce burden - allogeneic boost data capture | ||
| POST653 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify the cell type(s) administered | Other cell type | No | Reduce burden - allogeneic boost data capture | ||
| POST654 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Total number of CD34+ cells: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST655 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | Total number of CD34+ cells exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST656 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of lymphocytes (unselected): | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST657 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of lymphocytes (unselected) exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST658 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of CD4+ lymphocytes: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST659 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of CD4+ lymphocytes exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST660 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of CD8+ lymphocytes: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST661 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of CD8+ lymphocytes exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST662 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of TREG cells: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST663 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of TREG cells exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST664 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Specify other cell type: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST665 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of other cells: | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST666 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Total number of other cells exponent | Open text | No | Reduce burden - allogeneic boost data capture | ||
| POST667 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | Complete response | No | Reduce burden - allogeneic boost data capture | ||
| POST668 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | Partial response | No | Reduce burden - allogeneic boost data capture | ||
| POST669 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | No response | No | Reduce burden - allogeneic boost data capture | ||
| POST670 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | Disease progression | No | Reduce burden - allogeneic boost data capture | ||
| POST671 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | Normalization of blood count | No | Reduce burden - allogeneic boost data capture | ||
| POST672 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture | What was the best response to the DCI? | Partial normalization of blood count | No | Reduce burden - allogeneic boost data capture | ||
| POST673 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | What was the best response to the DCI? | Not assessed | No | Reduce burden - allogeneic boost data capture | ||
| POST674 | Post-Transplant Periodic Information | Donor Cellular Infusion | Donor Cellular Infusion (DCI) | No | New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | Date response established: | Open text | No | Reduce burden - allogeneic boost data capture | 
| Below are pull down options for Column H: Do not delete | Below are pull down options for Column L: Do not delete | |
| No Change | Capture data accurately | |
| Deletion of Information Requested | Be consistent with current clinical landscape, improve transplant outcome data | |
| Addition of Information Requested | Typographical/grammatical errors corrected for clarification | |
| Change/Clarification of Information Requested | Reduce burden | |
| Change/Clarification of Information Requested and Deletion of Response Option | Reduce burden - information no longer needed | |
| Change/Clarification of Information Requested and Addition of Response Option | Reduce burden - prevent / reduce data redundancy | |
| Merged to Check all that Apply (Deletion of Information Requested) | Reduce burden - allogeneic boost data capture | |
| Merged to Check all that Apply (Addition of Information Requested) | Reduce burden - reduce data entry | |
| Merged from Multiple to Grid (Deletion of Information Requested) | Reduce burden - reduce requirement for multiple sets of data | |
| Merged from Multiple to Grid (Deletion of Information Requested and Auto-filled, when applicable) | ||
| Merged from Multiple to Grid (Addition of Information Requested) | ||
| New Structure and Addition of Information Requested | ||
| New Structure and Change/Clarification of Information Requested | ||
| New Structure for Allogeneic Boost Data Capture | ||
| New Structure for Allogeneic Boost Data Capture (Addition of Information Requested) | ||
| New Functionality | ||
| Addition of Instructional text | 
| File Type | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet | 
| File Modified | 0000-00-00 | 
| File Created | 0000-00-00 |